2009 SCIENTIFIC PROGRAM COMMITTEE
Seated (left to right): Drs. Jayaram, Crone, Ahmed, Cheong (Chairperson), Pato, Boland, Worley, 2nd Row Standing (left to right): Drs. Matorin, Lapid, Matthews, Silk, Pandya, Nand, Myers, Pi, 3rd Row Standing (left to right): Drs. Lou, Foulks, Scully, Sen, Moreno, Marks, Spurgeon, Not Pictured: Alarcon, Baron, Guynn, Hilty, Licinio, Mancuso, Spitz.
May 16, 2009
Dear Colleagues and Guests:
A warm welcome to San Francisco and the 162nd Annual Meeting of the American Psychiatric Association, the largest psychiatric meeting in the world. Our city and our meeting are full of exciting opportunities for you. Experts in every subspecialty and on every current psychiatric issue will present hundreds of educational sessions. You can catch up with old friends and meet new ones from every corner of the globe. My meeting theme is “Shaping Our Future: Science and Service.” At this moment in history, we enjoy an explosion of useful knowledge about the brain and the psyche, about prevention, diagnosis, and treatment. At the same time, the world is struggling with an economic crisis and escalating health care costs. It is time for us to play an active role in shaping the future of our science and our clinical care. At this meeting, you can acquire the tools you need to shape our future. World famous scientists will present their latest research, with multiple opportunities for small group discussions with senior clinicians and educators. Sessions address subspecialties including geriatric , child and adolescent, addiction, forensic, and consultation liaison psychiatry. There are workshops and symposia on issues such as mental health care for returning military, college mental health, practical psychopharmacology, new directions in psychotherapy, electronic health records, ethics, and nearly any topic you can mention. You can test yourselves at the “Focus: Live” sessions or watch “Mind Games,” a Jeopardy-like contest for residents. Take some time at the outset to go through the program and plan your stay. Make time to enjoy the mild weather, beautiful vistas, colorful buildings, interesting museums, varied shops, and superb restaurants of San Francisco. Please join me at the Opening Session Sunday from 5:00 p.m.–6:30 p.m., when we offi cially welcome world leaders and all attendees, and plan to attend the Convocation of Distinguished Fellows Monday at 5:30 pm, when we will honor colleagues being inducted as Fellows, and the APA award winners. Do not miss Dr. Atul Gawande of Harvard Medical School, MacArthur ‘genius grant’ recipient, author of prize-winning books including “Better,” groundbreaking thinker about the scientifi c and humanistic improvement of care, and outstanding speaker, who will present the William C. Menninger Memorial Lecture at the Convocation. My thanks to Josepha Cheong, MD, Chair, and members of the Scientifi c Program Committee, and to APA staff members Deborah Hales, MD, and Cathy Nash, and their teams, for the rich content and the complex logistics of this enormous meeting. Please contact any member of the staff if you have problems or questions. And, again, and most importantly, welcome. Sincerely,
Nada L. Stotland, MD, MPH. President, American Psychiatric Association
162ND ANNUAL MEETING American Psychiatric Association
1000 Wilson Boulevard Suite 1825 Arlington, VA 22209-3901 Telephone: 703.907.7808 Fax: 703.907.1090 E-mail: [email protected]
May 16, 2009 162st Annual Meeting San Francisco Dear APA Members and Guests: May 16-21, 2009 Welcome to San Francisco, and the 162nd Annual Meeting of the American Psychiatric President Association. This unique city, with its vibrancy, cultural diversity, and excitement, provides a Nada L. Stotland, M.D. perfect setting for the scientifi c presentations we have planned. As you read through the Program Scientifi c Program Committee Book, you will notice a number of sessions related to the theme “Shaping Our Future: Science and 2008-2009 Josepha Cheong, M.D. Service,” chosen by our President, Dr. Nada Stotland. Let me draw your attention to just a few of Chairperson the many exciting sessions presented this week., including several Presidential Symposia which will be presented on Monday-Wednesday from 2:00 p.m.-5:00 p.m. Donald M. Hilty, M.D. Vice-Chairperson The Business Meeting and the Opening Session will be held at the Moscone Center on Sunday, Iqbal Ahmed, M.D. May 17. At the Opening Session, from 5:00 p.m.-6:30 p.m. on Sunday, Dr. Stotland will offi cially Renato Alarcon, M.D. welcome the leaders from psychiatric societies in the U.S. and around the world, and will present Catherine M. Crone, M.D. Eward Foulks, M.D., Ph.D. her Presidential Address. Please also make sure to attend the Convocation of Distinguished Robert Guynn, M.D. Fellows on Monday night at 5:30 p.m., where honor is given to all those being inducted as fellows Julio Licinio, M.D. and distinguished fellows and many receiving awards from the APA. The William C. Menninger Geetha Jayaram, M.D. Memorial lecture will also be presented immediately following the Convocation. Maria Lapid, M.D. Julio Licinio, M.D. Anu Matorin, M.D. A great way to begin this years’ meeting is to attend the “Advances in Series,” which will focus Annette Matthews, M.D. on the latest advances in neuropsychiatry and clinical neurosciences, psychosomatic medicine and Michael F. Myers, M.D. psychotherapeutic psychiatry, forensic psychiatry, substance abuse, and personality disorders. We Surinder Sucha Nand, M.D. also have Small Interactive Sessions, consisting of 12 clinically-based seminars with outstanding Michelle Pato, M.D. Edmond Hsin T. Pi, M.D. clinician educators. These sessions are held Monday-Thursday and have become an excellent way Kenneth Silk, M.D. to start off the Annual Meeting’s research programs, in conjunction with the Young Investigators’ Deborah Spitz, M.D. Poster and Oral/Slide Sessions also on Monday. Throughout the week, you will fi nd an expanded SAMHSA Fellow number of small group sessions, including Debate/Roundtable Discussions; and Medical Updates Srijan Sen, M.D., Ph.D. with selected experts in the fi eld. This year, we are also offering a new Clinical Knowledge and Consultants Skills Series and an ABPN Board Review course. These are special in-depth courses designed to David Baron, M.D. broaden and enhance your professional skills and knowledge in specialized areas. Robert J. Boland, M.D. John Lou, M.D. Donna M. Mancuso, M.D. A special series of sessions will be presented in collaboration with the National Institute on Tracey Marks, M.D. Alcohol Abuse and Alcoholism. Outstanding leaders in psychiatry and neuroscience research will Arnaldo Moreno, M.D. present across formats from lectures to symposia and discussion groups. The APA is extremely Anand Pandya, M.D. appreciative of their support of these sessions. For detailed information on the sessions, please Joyce Spurgeon, M.D. consult the separate program on this series, which is included your registration packet. Linda Worley, M.D. Committee on Commercial Support It is extremely important that you fi ll out and return the evaluation forms for this meeting. The David Baron, M.D. members of the Scientifi c Program Committee are interested in your opinion regarding the quality Chairperson of the content of the Annual Meeting. The information we obtain will be used to plan next year’s Philip Pardee, Associate Director Annual Meeting. Once again, welcome to San Francisco. I look forward to sharing a week of Commercially-Supported exciting and professionally rewarding activities with you. Activities (703) 907-7841 Sincerely, Offi ce of Scientifi c Program Joy Raether, Associate Director (703) 907-8599 Diane Runels Administrator, Courses (703) 907-7379 Josepha Cheong, M.D. Chermuir M. Kennedy Conference CME Coordinator (703) 907-7807
KEY LOCATIONS
MOSCONE CONVENTION CENTER FIRST AID Located across from Room 106, and across from Room 124, American Journal of Psychiatry and Psychiatric Services Exhibit Level, Moscone Convention Center hours of operation: North/South Concourse Exhibit Level Monday, May 11, through Thursday, May 21, opens 30 minutes APA News Room prior to show opening and closes 30 minutes after the last event of Rooms 250 Mezzanine Level West the evening. APA Meetings and Conventions Offi ce COURTESY SHUTTLE BUS SERVICE Room 208A Mezzanine Level East Service will begin on Saturday, May 16, at approximately 7:00 a.m., and will operate daily throughout the meeting commensurate APA Member Center with the scientifi c program schedule and will conclude on Thurs- North/South Concourse Exhibit Level day, May 21, at 6:00 p.m. The Moscone Convention Center will APA Scientifi c Program Offi ce serve as the “hub” for all shuttle bus routes. The Shuttle Bus Desk Room 206, Mezzanine Level East will be located in the South Lobby, Esplanade Level, Moscone Convention Center, a detailed Shuttle Bus Schedule is included Audiotape and CD Sales in your registration packet and will be posted in the lobbies of South Lobby/Esplanade Level participating hotels. Refer to the city and hotel maps page for A/V Preview Room the location of hotels in relation to the Moscone Convention Room 230/Mezzanine Level East Center. Course Enrollment EXHIBITS Hall D, Exhibit Level Commercial and educational exhibits will be located in Halls A-C, Exhibit Level, Moscone Convention Center, along with CME Certifi cate of Attendance the Publishers’ Bookfair. For your convenience, the Publishers’ Hall D, Exhibit Level Bookfair will be open Saturday, May 16, 10:00 a.m.-5:00 p.m.
Educational and commercial exhibit hours are: Sunday, May 17, Daily Bulletin 10:00 a.m.-4:30 p.m.; Monday, May 18, and Tuesday, May 19, Room 264/Mezzanine Level West 10:00 a.m.-5:00 p.m.; and the fi nal day, Wednesday, May 20, Exhibitor Registration 10:00 a.m.-3:00 p.m. South Lobby/Esplanade Level MESSAGE CENTERS Exhibits/Publishers’ Bookfair Located in South Lobby, North Lobby, and Hall D in the Halls A-C, Exhibit Level Moscone Center and open during registration hours (with the ex- ception of Thursday, May 21, when the Centers will be open until Housing Desk 5:00 p.m.). Messages can be left and picked up at the Message South Lobby/Esplanade Level Center Registrants whose names appear on these monitors should Lost & Found pick up their messages at one of the three Message Centers. Room 208A, Mezzanine Level East APA MEMBER CENTER Message Centers Located in North/South Concourse, Exhibit Level, Moscone South and South Lobby, Hall D Convention Center. Hours of operation will be: Saturday, May 16, 10:00 a.m.-5:00 p.m.; Sunday, May 17, 10:00 a.m.-4:30 p.m.; On-Site Job Bank and Placement Center Monday, May 18, 10:00 a.m.-5:00 p.m., Tuesday, May 19, 10:00 North/South Concourse, Exhibit Level a.m.-5:00 p.m.; and Wednesday, May 20, 10:00 a.m.-3:00 p.m. A Registration few of the many APA activities exhibited include: membership, Hall D, Exhibit Level APA’s internet-based programs, continuing medical education, quality improvement, psychiatric services, clinical resources, advocacy tools, career development, practice management, and FUTURE APA MEETINGS APA periodicals. APA ANNUAL MEETINGS APA JOB BANK 2010 May 22-27 New Orleans, LA Visit the APA Job Bank Hall D Foyer Exhibit Level, Moscone 2011 May 14-19 Honolulu, HI Center to search the most comprehensive online listing of psychi- 2012 May 5-10 Philadelphia, PA atric positions! Candidates: Register to post your resume, receive instant job alerts, use the career tools and more. Employers: Post INSTITUTES ON PSYCHIATRIC SERVICES your job opening during the meeting to get results asap. For more 2009 October 8-11 New York, NY information on the Job Bank, visit www.psych.org/jobbank. A 2010 October 14-17 Boston, MA representative will be available on-site to provide assistance. 2011 October 27-30 San Francisco, CA APA NEWS ROOM Located in Rooms 250, Mezzanine Level West, Moscone Preliminary Programs for the 2009 Institute on Psychiatric Ser- Convention Center. Hours of operation: Saturday, May 16, 11:00 vices are included in the registration packet. a.m.-5:00 p.m.; Sunday-Wednesday, May 17-20, 8:00 a.m.-6:00 p.m.; and Thursday, May 21, 8:00 a.m.-2:00 p.m. This room is
II WWW.PSYCH.ORG KEY LOCATIONS
for the use of registered press only and credentialed/non-profi t On-site fees can be paid by U.S. dollar cash, check, money order, public relations representatives only. American Express, VISA, or MasterCard. Registration fees are waived only for Course Faculty, APA Honorary Fellows (does DAILY BULLETIN not include APA Distinguished Fellows/Fellows/Life Fellows/ The Daily Bulletin accepts written requests from APA members Distinguished Life Fellows), medical students (with proper iden- for publicity of component, committee, and allied group events as tifi cation), and District Branch Executive Staff (who are not APA space allows. Four issues are published. The issue for Saturday/ members). Sunday is printed in advance. Copy for the Monday, Tuesday, and Wednesday/Thursday issues can be dropped off in Room 264, Nonmember psychiatric residents and other full-time students, Mezzanine Level West, by Noon prior to the date of publication. non-member Advocacy Group members, or Mental Health Chap- lains must present documentation to register in their respective AIRPORT AND LUGGAGE CHECK-IN category and qualify for the reduced fee. (Examples include: a You can now check-in at the North Lobby, Moscone Conven- valid full-time [12 + hours per semester] student ID; a letter from tion Center and bypass the airport lines! This unique service your advocacy/Chaplain institution, or from your instructor or allows you to check your bags and receive your boarding pass director of training verifying your status as a psychiatric resident; at the Moscone Convention Center, leaving you more time to or similar documentation.) visit the exhibits and attend sessions. It’s safe and secure: The fi rst TSA-approved remote skycap service; Agents are highly Note: There are no exemptions or reduced fees available for trained and credentialed to issue boarding passes and print bag courses. The registration fee covers admission to all sessions tags on demand. Participating Airlines (Domestic Flights Only): (except courses), shuttle buses, and includes a badge and copy of AirTranAlaska, American, Continental, Delta, JetBlue, North- the Program Book, APA Member Center Guide, and New Research west and United. Rates: $10 per passenger. Normal airline Program and Abstracts Books, and for most categories, a copy of baggage constraints apply. Hours of Operation: Wednesday and the Syllabus. Thursday, May 20-21, 8:00 a.m.– 1:00 p.m., in the main lobby of REGISTRATION BADGES the Moscone Convention Center. Flights may be checked in any- Badges are required for all sessions and the exhibit hall. Only an time the day of departure. Luggage must be checked a minimum of APA member badge will admit you to the Business Meeting. three hours before scheduled fl ight departure. Badge Color Codes: Blue-Members, Yellow-Nonmembers, REGISTRATION Silver-Press, Red-Exhibitors, Green-APA Staff, and Clear-Tempo- Admission to all sessions by registration badge rary Personnel. Located in Hall D, Exhibit Level, Moscone Convention Center. Registered exhibitors will receive red badges, which allow ac- Hours of operation: Friday, 12 noon-5:00 p.m., Saturday to cess only to his or her exhibit booth in the exhibit hall and to ride Wednesday, 7:30 a.m.-5:00 p.m.; and Thursday, 7:30 a.m.- the shuttle bus. If an exhibitor wants to attend sessions, he/she 2:00 p.m. must register for the meeting and pay the appropriate fee. ON-SITE REGISTRATION FEE: COURSE ENROLLMENT Ticket purchase required for Courses APA MEMBERS Located in Hall D, Exhibit Level, Moscone Convention Center. Full-Time Registration (North American Members) ...... $350 Hours of operation are the same as registration. Tickets not sold Full-Time Registration (International Members) ...... $355-$580* in advance will be available online at the on-site fee after April 10, Members in Training (Member Class MT) ...... $ 90 and on-site at the Course Enrollment Area beginning at 12 noon Daily Registration (North American Members) ...... $190 on May 15. You must be registered for the meeting before you can Daily Registration (International Members) ...... $350 enroll in courses. Medical Students ...... no charge APA ART ASSOCIATION *Fee determined by country’s gross national income according Located in the North Lobby, Esplanade Level, Moscone Con- to the World Bank. vention Center and open during the commercial exhibit hours, NONMEMBERS the exhibit includes paintings, photography, ceramics, and crafts Full-Time Registration ...... $940 created by APA members and/or their signifi cant others. Stop by Nonmember Residents, Students, Advocacy for information on joining the APA Art Association. Group Members, or Mental Health Chaplains ...... $130 APA ALLIANCE BOOTH Daily Registration (all Nonmember categories) ...... $500 Located in the South Lobby, Esplanade Level, Moscone Con- Medical Students ...... no charge vention Center. Hour of operation: Saturday, May 16, through FAMILY MEMBER REGISTRATION Wednesday, May 20, 9:00 a.m.-5:00 p.m. Stop by the booth to One only per full-time registrant ...... $130 obtain information on the Alliance’s program schedule and infor- Only one family member is allowed to register with each full-time mation on membership. meeting registrant. The family member must reside in the same APA PERIODICALS household and be able to receive mail at the same address. APA Editorial staff of The American Journal of Psychiatry, Psychi- members cannot register as a “family member”; they must register atric Services, Academic Psychiatry, Journal of Neuropsychiatry as an APA member. ID may be required. and Clinical Neurosciences, Psychosomatics, and APA’s CME One-Day Exhibit Hall Only Pass (18 and older) ...... $25 journal, FOCUS will be on hand to demonstrate online access for (Only paid registrant can purchase an exhibit hall pass) subscribers, and answer questions regarding submissions. Visitors 162ND ANNUAL MEETING III KEY LOCATIONS
can also purchase or renew subscriptions to all APA/APPI journals OR attendees may access the web-based evaluation from their at the booth. Complimentary copies of Psychiatric News will be own computer during or after the meeting by visiting www.psych. available at stands located throughout the Moscone Convention org and browse the Lifelong Learning & CME section. PLEASE Center. Persons who wish to contact editors or reporters of NOTE: APA NO LONGER OFFERS A PAPER GENERAL Psychiatric News are asked to leave a message on the message EVALUATION FORM FOR THE ANNUAL MEETING. board in the Annual Meetings Offi ce located in 208A Level 2. SESSION CAPACITY Written announcements, suggestions for articles, letters to the edi- So that all in attendance may benefi t, we ask your assistance tor, or other material for the newspaper’s consideration may be left when overcrowding occurs: with staff at the Periodicals Exhibit. • Please fi nd seating as far forward as possible. CONTINUING MEDICAL EDUCATION • Move to the center of the row and fi ll all seats so that chairs are Educational Objectives: At the conclusion of this meeting, partici- available on aisles for additional attendees. pants will be able to: • Overcrowding of meeting rooms may subject the session to • Review new research fi ndings in the fi elds of psychiatry and shutdown by the Fire Marshal; therefore, we urge all attendees neuroscience and address gaps in knowledge. to locate seating rather than stand in aisles or against walls. • Acquire new knowledge and skills in clinical psychiatry, which • If space does not permit you to attend a session, an audiotape of can be utilized to improve patient care; that session may be available. Please check the order form • Identify and remove barriers to the transfer of new knowledge included in your registration packet. for their practice, including provision of culturally competent care for diverse populations; AUDIO RECORDINGS OF SESSIONS • Assess a variety of treatment choices, including psychotherapeu- Over 100 hours of CME programs will be available, for purchase tic and pharmacological options; and on DVD and the APA Online Library. Sale booth located in Hall D • Recognize mental health service delivery issues, including bar- Moscone Center. riers to care. SMOKING POLICY The APA is accredited by the Accreditation Council for Continu- There will be NO SMOKING in scientifi c sessions or in the ing Medical Education (ACCME) to provide continuing medical exhibit hall. Smoking will only be permitted in designated areas. education for physicians. The APA designates this educational activity for a maximum of 66 TAPE RECORDING AND VISUAL AMA PRA Category 1 Credits.™ Physicians should only claim REPRODUCTION POLICIES credit commensurate with the extent of their participation in the Audiotape recording is only permitted for personal use. Reg- activity. istrants are welcome to use their own small, portable audiotape Please note: Formats of the scientifi c program, as outlined be- recorders to record any session except Case Conferences, unless low, have been approved for CME credit. prohibited by the presenters. Larger, professional tape record- The scientifi c sessions on the offi cial Annual Meeting program, ers are not permitted except for use by registered members of with some exceptions, meet the criteria for AMA PRA Category 1 the working press in accordance with APA Press Policies. APA Credit.™ Sessions in the following program formats are desig- has authorized a professional taping fi rm to audiotape sessions. nated as category 1: Badges of personnel representing this fi rm will clearly identify Advances in… Series, Case Conferences, CME Courses, Clinical them. Registrants are not permitted to photograph (including with Knowledge and Skills Courses, Focus Live, Forums, Industry- cell phone cameras) or videotape any session because the intrusive Supported Symposia, Lectures, Presidential Symposia, Scientifi c nature of the recording may disrupt the session. and Clinical Reports, Small Interactive Sessions, Symposia, and Workshops. Other scientifi c sessions not listed may be reported as category 2 (Debates and New Research Poster Sessions). Scien- tifi c sessions are open to all Annual Meeting registrants, except for the Case Conferences which are open to APA members only. To document CME credit earned at the Annual Meeting, partici- pants should maintain a list of sessions they attended. Credit is earned on an hour-for-hour basis. A page for listing your sessions and credits is provided in the program.
ANNUAL MEETING EVALUATION AND ANNUAL MEETING CERTIFICATE The Annual Meeting Scientifi c Program Committee needs your recommendations and evaluations to plan next year’s Annual Meeting. The General Evaluation is available online at the CME Certifi cate of Attendance Booth located in Hall B, Lower Level, Moscone Center. By completing the General Evaluation, you will receive a person- alized Certifi cate of Attendance. The certifi cate can be obtained either on-site by visiting the CME Certifi cate of Attendance Booth IV WWW.PSYCH.ORG KEY LOCATIONS
PROGRAM BOOK TABLE OF CONTENTS
Floor Plans for Moscone Convention Center and Hilton San Francisco ...... VI-XI Special Acknowledgments ...... XII-XIII Format Descriptions ...... XIV Advertisements ...... XV-XXIV Disclosure Index ...... XXV-XLIII Saturday Sessions...... 1-2 Sunday Sessions ...... 3-6 2009 Presidents of Allied Organizations ...... 6a-6c Monday Sessions ...... 7-24 Tuesday Sessions ...... 25-39 Wednesday Sessions ...... 40-52 Thursday Sessions ...... 53-60 Topic Index ...... 61-67 Participant Index ...... 68-78 New Research Program Book...... A-Q, 1-52 Certifi cate of Attendance Ad and Chart ...... Final Page 2009 Institute on Psychiatric Service ...... Inside Back Cover APA Member Center ...... Back Cover
News reports or summaries of APA presentations contained in these program materials may not be published or broadcast before the local time and date of the presentation.
Refer to the APA Exhibits Guide for information on: Exhibits, Publishers’ Bookfair, and Dining Facilities in the Moscone Convention Center.
If you have any questions about this book or the scientifi c sessions, please feel free to stop by the Scientifi c Programs Offi ce in Room 206, Mezzanine Level East, Moscone Convention Center, and APA Staff will be glad to help you. All APA staff will be wearing green badges. Please feel free to direct your questions to them.
The information provided and views expressed by presenters on this program are not necessarily those of the American Psychiatric Association, nor does the American Psychiatric Association warrant the accuracy of any information reported.
© American Psychiatric Association
162ND ANNUAL MEETING V MOSCONE CONVENTION CENTER EAST MEZZANINE FLOOR PLAN
EAST MEZZANINE
VI MOSCONE CONVENTION CENTER WEST MEZZANINE FLOOR PLAN
WEST MEZZANINE
VII MOSCONE CONVENTION CENTER EXHIBIT LEVEL - NORTH & SOUTH
VIII HILTON SAN FRANCISCO GRAND BALLROOM/BLDG. 2
IX HILTON SAN FRANCISCO BALLROOM LEVEL/BLDG. 1, 2, 3
X HILTON SAN FRANCISCO FOURTH FLOOR/BLDG. 3
XI SPECIAL ACKNOWLEDGEMENTS
The American Psychiatric Association expresses its deep appreciation for the following: American Academy of Psychiatry and Law: co-support of Estate of Judd Marmor, M.D.: support of the Judd Marmor the Manfred S. Guttmacher Award Lecture Sunday, May 17 Award Lecture.
American Psychiatric Foundation: support of the APIRE Estate of Frank Rundle, M.D.: partial support for the John Practice Research Network.; Transformational Leadership Fryer Award Lecture, May 19. Academy and Reception, May 20, and 21. Forest Laboratories, Inc.: support of the Industry-Supported American Association of Psychiatric Administrators: Symposium, “Effective Treatment of Alzheimer’s Disease support of the Administrative Psychiatry Award Lecture to be – Translating Guidelines Into Practice: An Interactive Panel given at the IPS. Discussion”, Sunday, May 17, 12:30 – 2:30 p.m.
Association of Gay and Lesbian Psychiatrists: partial GlaxoSmithKline: support of the American Psychiatric support for the John Fryer Award Lecture, May 19. Leadership Fellowship Program and reception.
Association of Women Psychiatrists: support of the joint Ittleson Foundation: support of the Blanche F. Ittleson AWP/APA Women’s Caucus reception and meeting, Monday, Award for Research in Child Psychiatry. 18, 7:30 p.m. Alexandra Symonds Award Lecture, Monday, May 18, 2009. Janssen Pharmaceutical and Research Foundation: The APIRE/Jansse Resident Psychiatric Research Scholars AstraZeneca Pharmaceuticals: support of the Industry- Program., Committee of Asian American Psychiatrists Supported Symposia, “Delivering Optimal Care for Complex recruitment reception. Bipolar Patients: An Audience Guided Symposium,” Sunday, May 17, 12:30 – 2:30 p.m.; “Augmentation Strategies for Major Lilly USA, LLC: support of the Industry-Supported Symposia, Depressive Disorder: The Evidence for Effective Clinical “Neurobiology, Prediction and Management of Antipsychotic Decision-Making in Improving Patient Care,” Monday, May 18, Non-Response in Patients With Schizophrenia”, Sunday, May 7:00 – 9:00 a.m.; the George Tarjan Award Lecture, Monday, 17, 7:00 – 9:00 p.m.; “Novel Approaches to Assessing and May 18, 11:00 a.m.-12:30 p.m.; the American Psychiatric Treating Depression in the Medically Ill”, Tuesday, May 19, Foundation “Conversations” event, Tuesday, May 19, 5:30 p.m.; 7:00 – 9:00 p.m.; partial support of the American Psychiatric the APA/AstraZeneca Young Minds International Award; Foundation Annual Benefi t, Saturday, May 16, 7:00 p.m.; partial and Mind Games, Tuesday, May 19, 5:00 p.m.; and the APA/ support of the Simon Bolivar Award Lecture, May 20, 1:00 AstraZeneca Minority Fellowship, minority fellows poster p.m.-2:00 p.m., the APA/Lilly Psychiatric Research Fellowship, session and reception, Tuesday, May 19, 7:00 p.m. APA/Lilly Resident Research Award; and the Chief Resident Leadership Program, May 18, 8:00 a.m.-5:30 p.m. Bristol-Myers Squibb Company: partial support of the American Psychiatric Foundation Annual Benefi t, Saturday, National Institute on Alcohol Abuse and Alcoholism May 16, 7:00 p.m.; support of the Industry Supported (NIAAA): sponsorship of the Special Annual Meeting Symposium “Augmentation Strategies for Major Depressive Research Track, “Alcohol and Health: New Discoveries and Disorder: The Evidence for Effective Clinical Decision- Future Directions.” Making in Improving Patient Care”, Sunday May 17, 7:00p.m. National Institute of Mental Health (NMIH): support of -9:00p.m.; APA Fellowship on Public Psychiatry; and the the Research Colloquium for Junior Investigators; support of Solomon Carter Fuller Award Lecture and Reception, May 18. the American Psychiatric Institute for Research in Education Bristol-Myers Squibb Sweden: support of Global Psychiatry: (APIRE) Annual Meeting activities for research trainees; A Session for U.S. and International Residents, Sunday, May 17, the Program for Minority Research Training in Psychiatry 2:00 p.m. (PMRTP).
Dainippon Sumitomo Pharma America, Inc.: support of Pfi zer, Inc.: partial support of the American Psychiatric the Industry-Supported Symposium, “Development of New Foundation Annual Benefi t, Saturday, May 16, 7:00 p.m.; and Agents for the Treatment of Schizophrenia,” Sunday, May 17, partial support the Simon Bolivar Award Lecture, Saturday, May 7:00 – 9:00 p.m. 16, partial support of the American Psychiatric Foundation Annual Benefi t, Saturday, May 16, 7:00 p.m; upport of the Estate of Kun-Po Soo, M.D. Ph.D.: support of the Kun-Po Industry Supported Symposium “Bipolar Disorder Throughout Soo Award Lecture, May 19, 11:00 a.m.-12:30 p.m. the Life Cycle: Treatment and Treament Experience,” Tuesday May 19, 7 a.m.-9 a.m.
XII WWW.PSYCH.ORG SPECIAL ACKNOWLEDGEMENTS
Professional Risk Management Services, Inc.: co-support of the Manfred S. Guttmacher Award Lecture, Sunday, May 21, 2:30 p.m. Shire US, Inc.: support of the Industry-Supported Symposia, “The Pathophysiology of ADHD: Implications for Treatment,” Sunday, May 17, 7:00 p.m. - 9:00 p.m.; “ADHD FAQs: Practical Answers for the Offi ce-Based Practitioner”, Monday, May 18, 7:00 - 9:00 a.m.; partial support of the American Psychiatric Foundation Annual Benefi t, Saturday, May 16, 7:00 p.m.; and the APA/Shire Child and Adolescent Psychiatry Fellowship.
Substance Abuse and Mental Health Services Administration (CMHS, CSAP, CSAT): sponsorship of the APA/SAMHSA Minority Fellowship Program, the APIRE Practice Research Network (PRN); and the APA’s HIV-related education programs and materials.
Takeda Pharmaceuticals North America, Inc.: support of the Industry-Supported Symposium, “Anxious Depression: Diagnostic and Treatment Issues”, Monday, May 18, 7:00 p.m. – 9:00 p.m.
Wyeth Pharmaceuticals: support of the American Psychiatric Foundation’s ‘Benefi t by the Bay’ Gala, Saturday, May 16, 7:00 p.m.; sponsorship of the Jean Spurlock Congressional Fellowship and the APA/Wyeth MD/PhD Psychiatric Research Fellowship.
162ND ANNUAL MEETING XIII FORMAT DESCRIPTIONS
ADVANCES IN…..SERIES LECTURES These three-hour and thirty-minute sessions are intended to Lectures feature a small number of distinguished speakers highlight important new advances occurring in the fi eld of discussing scientifi c and cultural topics, many of which will psychiatry involving selected disorders or treatments. The extend our understanding beyond the usual limits of clinical sessions are chaired by editors of recent textbooks published psychiatry. The Scientifi c Program Committee invites the by the American Psychiatric Publishing, Inc (APPI) and lecturers. feature selected chapter authors from these texts. The books NEW RESEARCH discussed at these sessions may be purchased at the APPI This format allows for presentation of the very recent fi nd- book store or online at www.appi.org. ings. The three types of presentations include: Posters, CASE CONFERENCES which are visual, self-explanatory presentations; Young During these 90-minute or three-hour sessions, clinical Investigators’ Posters, with presentations from young inves- material is presented by videotape or the treating therapist. tigators, residents, medical students, and research or clinical One or more experts then discuss the case. Some cases will fellows; and Young Investigators’ Oral/Slide which are review the progress of psychotherapy in two successive fi fteen-minute presentations with three minutes for discus- sessions. THESE SESSIONS ARE OPEN TO APA MEM- sion. BERS ONLY. BLUE REGISTRATION BADGE OR APA SCIENTIFIC AND CLINICAL REPORT SESSIONS MEMBERSHIP CARD REQUIRED FOR ADMITTANCE. Scientifi c and Clinical Reports are oral presentations of COURSES papers prepared for submission before publication. In this Courses are designed to emphasize learning experiences 90-minute format, reports are grouped by topic, with fl oor that actively involve participants and include the oppor- discussion from the audience following the presentation of tunity for informal exchange with the faculty. Offered in each paper. There is no formal discussant. four-hour (half-day), six-hour (full-day), and eight-hour SMALL INTERACTIVE SESSIONS (full-day) sessions, courses either review basic concepts This 90-minute format allows small groups to meet infor- in a special subject area or present advanced material on a mally with either selected experts in psychiatry to: discuss circumscribed topic. Participants must purchase tickets to topics chosen by the expert; obtain consultations around attend. problems in research from senior researchers; or, hear clinically-based seminars presented by outstanding educa- DEBATES tors. Some of these sessions are reserved for residents only. Experts in the fi eld, including psychiatrists and nonpsychia- These sessions are limited to 25 participants who are admit- trists will debate a controversial topic in psychiatry. The ted on a fi rst-come, fi rst-served basis. debate format allows for members to hear both pro and con views about important, interesting and timely concerns for SYMPOSIA our members. Someone who has expertise in the topic area Symposia are three-hour sessions consisting of four to six moderates the debate. A portion of the time is allocated for presentations that are thematically linked and focus on questions from the audience to the presenters with active a specifi c topic relevant to clinical psychiatry. They are participation by participants. designed to provide comprehensive treatment of a topic or discussion of the topic from several points of view by the participants and stimulate discussion with the audience. FOCUS LIVE Some symposia are supported by industry and are designat- These 90-minute sessions allow participants to test their ed as “Industry-Supported Symposia” in this Program Book. knowledge using an interactive Audience Response System (ARS), offering a new and entertaining way to learn. ARS WORKSHOPS sessions can make a group of 300 feel like they are having a Workshops are 90-minute sessions which typically involve small group consultation with an expert clinician. Experts, brief presentations from individual panel members, fol- who served as guest editors of FOCUS, will lead lively mul- lowed by the opportunity for lively and informative discus- tiple choice question-based discussions, and the audience sion. This format provides for highly interactive audience will enter their answers with hand-held devices. Results are participation. Media Workshops are three-hour sessions in instantly tallied and projected on the screen. which a feature-length fi lm is shown and discussed.
FORUMS These are fl exible presentations that afford an opportunity to highlight and select topics that are of timely interest to psychiatrists. Speakers and panel members are chosen for their expertise and leadership in the fi eld.
XIV WWW.PSYCH.ORG $50 FOCUS Conference The Journal of Lifelong Learning in Psychiatry Discount May 16-20, 2009 Editors: Deborah Hales, M.D., and Mark Hyman Rapaport, M.D.
FOCUS is the best system for FOCUS addresses the core content in psychiatry in recertification, self-assessment, four-year cycles. and lifelong learning. In one easy Each issue briefs you on new developments and reviews the subscription, FOCUS provides a current state of practice in that topic area through: comprehensive review of cur- rent clinical practice based on ■ Clinical synthesis articles and reviews the content outlined by the ■ Interactive Patient Management Exercise and ABPN recertification exam. “Ask-the-Expert” column Each issue offers: Clinical ■ Influential publications: reprints of new and classic Reviews, Patient Manage- articles that influence practice ment Exercise, Seminal Articles, and a CME quiz with 20 hours of CME FOCUS updates you in core content areas: per year for the journal (20 additional hours can be earned ■ Volume V (2007): Bipolar Disorder; Substance Abuse: through completion of the Self-Assessment Exam). All current Diagnosis and Treatment; OCD and Other Anxiety and back issues are accessible online with available CME cred- Disorders; Ethics and Professionalism: Including End its for your subscription year. of Life Care ■ Volume VI (2008): Major Depressive Disorder; The FOCUS Self-Assessment Exam is an annual 100-question, Schizophrenia: Cognition and Outcomes; Child and multiple-choice supplement written by practicing psychiatrists Adolescent Psychiatry; Panic and Social Phobia and academic experts that allows you to earn 20 CME credits ■ Volume VII (2009): Geriatric Psychiatry; HIV AIDS and the opportunity to anonymously compare your knowledge Psychiatry and Psychosomatic Medicine; PTSD and Disaster to that of your peers either online or on paper. Each question Psychiatry; Sleep, Eating, and Sexual Disorders is similar to those used in board-type exams. The FOCUS ■ Self-Assessment Exam is listed by the ABPN as an approved Volume VIII (2010): Psychotherapy; Personality Disorders and Temperament; Psychiatric Genetics and Clinical self-assessment activity that fulfills the requirement of psychi- Neuroscience; Psychopharmacology atrists applying for and taking the recertification examination.
The American Board of Psychiatry and Neurology has reviewed FOCUS: ABPN approval is time limited to 3 years for each FOCUS CME course. The American Psychiatric Association (APA) is accredited by the Accreditation The Journal of Lifelong Learning in Psychiatry and the FOCUS Self- Refer to APA’s CME website for ABPN approval status of each course. Council for Continuing Medical Education to provide continuing medical Assessment Examination and has approved this program as part of a education for physicians. The FOCUS Self-Assessment Program is approved for up to 20 hours of comprehensive lifelong learning and self-assessment program, which is continuing professional development per year under Section 3 of the The American Psychiatric Association designates the FOCUS educational mandated by the ABMS as a necessary component of maintenance of Maintenance of Certification program of the Royal College of Physicians program for a maximum of 40 AMA PRA Category 1 Credits™. Physicians certification. and Surgeons of Canada. should only claim credit commensurate with the extent of their participation in the activity.
Please Visit the APPI Bookstore for More Information
The First and Last Word in Psychiatry One-Year Prices: American Psychiatric Publishing, Inc. ■ U.S. APA Members: $296 $246 ■ International Member: $373 $323 Web: www.appi.org and focus.psychiatryonline.org Email: [email protected] ■ APA MIT (Online Only): $96 $46 Phone: 1-800-368-5777 | 703-907-7322 | Fax: 703-907-1091 ■ U.S. Non-Member price: $476 $426 ■ International Non-Members: $552 $502 When ordering, please reference priority code AH910AA.
THE FIRST AND LAST
Visit the APPI BOOKSTORE at the 2009 APA ANNUAL MEETING in San Francisco, CA!
Psychiatry’s premiere publisher brings the cutting-edge titles you’ve been waiting for directly to you! Come check out APPI’s latest ground- APPI Bookstore Hours breaking selection, from the newest textbooks, review series, and Saturday, May 16 10:00 am – 5:00 pm journals, to electronic products for your handheld or online—including Sunday, May 17 10:00 am – 4:30 pm PsychiatryOnline.com. Monday, May 18 10:00 am – 5:00 pm Tuesday, May 19 10:00 am – 5:00 pm The APPI Bookstore is the one place you can go to gather all the Wednesday, May 20 10:00 am – 3:00 pm resources you’ll need in the next year. Update subscriptions, complete your series collections, browse through hard to find titles, and even develop your course adoptions—all in one stop. Don’t miss Author Book Signings or discounts for APA Members—see you there! Brain Stimulation Therapies for Clinicians Edmund S. Higgins, M.D., and Mark S. George, M.D. With foreword by Michael Trimble, M.D., F.R.C.P., F.R.C.Psych. Textbook of Psychotherapeutic Treatments Edited by Glen O. Gabbard, M.D. 2009 • 203 pages • ISBN 978-1-58562-280-1 • Hardcover $70.00 • Item #62280 2009 • 896 pages • ISBN 978-1-58562-304-4 • Hardcover $95.00 • Item #62304 Casebook of Psychosomatic Medicine Textbook of Hospital Psychiatry James A. Bourgeois, O.D., M.D., Debra Kahn, M.D., Kemuel L. Philbrick, M.D., and John Michael Bostwick, M.D. Edited by Steven S. Sharfstein, M.D., M.P.A. 2009 • 323 pages • ISBN 978-1-58562-299-3 • Paperback Deputy Editors: Faith B. Dickerson, Ph.D., M.P.H., and John M. Oldham, M.D., M.S. $57.00 • Item #62299 2009 • 528 pages • ISBN 978-1-58562-322-8 • Hardcover • $125.00 • Item #62322 Clinical Manual for Diagnosis and Treatment of Psychotic Depression Approach to the Psychiatric Patient Anthony J. Rothschild, M.D. Case-Based Essays 2009 • 207 pages • ISBN 978-1-58562-292-4 • Paperback Edited by John W. Barnhill, M.D. $55.00 • Item #62292 2009 • 565 pages • ISBN 978-1-58562-300-6 • Paperback $62.00 • Item #62300 Clinical Manual of Drug Interaction Principles for Medical Practice Cognitive-Behavior Therapy for Severe Gary H. Wynn, M.D., Jessica R. Oesterheld, M.D., Mental Illness Kelly L. Cozza, M.D., and Scott C. Armstrong, M.D. An Illustrated Guide 2008 • 608 pages • ISBN 978-1-58562-296-2 • Paperback Jesse H. Wright, M.D., Ph.D., Douglas Turkington, M.D., $55.00 • Item #62296 David G. Kingdon, M.D., and Monica Ramirez Basco, Ph.D. 2009 • 374 pages • ISBN 978-1-58562-321-1 • Paperback • $65.00 • Item #62321 ADHD Comorbidities Handbook for ADHD Complications in Children and Adults Clinical Manual for Evaluation and Treatment of Sleep Disorders Edited by Thomas E. Brown, Ph.D. Martin Reite, M.D., Michael Weissberg, M.D., and John Ruddy, M.D. 2009 • 478 pages • ISBN 978-1-58562-158-3 • Hardcover 2009 • 395 pages • ISBN 978-1-58562-271-9 • Paperback • $55.00 • Item #62271 $89.00 • Item #62158
Clinical Study Guide for the Oral Boards in Resident’s Guide to Clinical Psychiatry Psychiatry, Third Edition Lauren B. Marangell, M.D. Nathan R. Strahl, M.D., Ph.D. 2009 • 410 pages • ISBN 978-1-58562-324-2 • Paperback 2009 • 501 pages • ISBN 978-1-58562-293-1 • Paperback $44.95 • Item #62324 $59.00 • Item #62293 WORD IN PSYCHIATRY
JANUARY MARCH DSM-IV-TR® Casebook and Treatment Guide for Child Mental Health Stress-Induced and Fear Circuitry What Your Patients Need to Know Edited by Cathryn A. Galanter, M.D., and Disorders About Psychiatric Medications, Peter S. Jensen, M.D. Refining the Research Agenda for DSM-V Second Edition 2009 • 752 pages • ISBN 978-1-58562-310-5 Edited by Gavin Andrews, M.D., Dennis S. Robert H. Chew, Pharm.D., Robert E. Hales, Paperback • $85.00 • Item #62310 Charney, M.D., Paul J. Sirovatka, M.S., and M.D., M.B.A., and Stuart C. Yudofsky, M.D. Darrel A. Regier, M.D., M.P.H. 2009 • 440 pages • ISBN 978-1-58562-356-3 Study Guide to Psychopharmacology 2009 • 330 pages • ISBN 978-0-89042-344-8 Paperback • $82.00 • Item #62356 A Companion to The American Psychiatric Paperback • $60.00 • Item #2344 Publishing Textbook of Psychopharmacology, Somatic Presentations of Mental Fourth Edition The Psychiatrist as Expert Witness, Disorders Robert E. Hales, M.D., M.B.A., Narriman C. Second Edition Refining the Research Agenda for DSM-V Shahrokh, Alan F. Schatzberg, M.D., and Charles B. Nemeroff, M.D., Ph.D. Thomas G. Gutheil, M.D. Edited by Joel E. Dimsdale, M.D., F.A.P.M., Yu Xin, M.D., Arthur Kleinman, M.D., 2009 • 240 pages • ISBN 978-1-58562-354-9 2009 • 165 pages • ISBN 978-1-58562-342-6 Vikram Patel, Ph.D., William E. Narrow, M.D., Paperback • $49.00 • Item #62354 Paperback • $55.00 • Item #62342 M.P.H., Paul J. Sirovatka, M.S., and Darrel A. Regier, M.D., M.P.H. Medical Illness and Schizophrenia, Clinical Manual for Management of 2009 • 208 pages • ISBN 978-0-89042-342-4 Second Edition Bipolar Disorder in Children and Paperback • $60.00 • Item #2342 Edited by Jonathan M. Meyer, M.D., and Adolescents Henry A. Nasrallah, M.D. Robert A. Kowatch, M.D., Ph.D., Mary A. Essentials of Personality Disorders Fristad, Ph.D., ABPP, Robert L. Findling, M.D., 2009 • 544 pages • ISBN 978-1-58562-346-4 Edited by John M. Oldham, M.D., M.S., Paperback • $57.00 • Item #62346 and Robert M. Post, M.D. Andrew E. Skodol, M.D., and 2009 • 355 pages • ISBN 978-1-58562-291-7 Donna S. Bender, Ph.D. The American Psychiatric Paperback • $59.00 • Item #62291 2009 • 432 pages • ISBN 978-1-58562-358-7 Publishing Textbook of Paperback • $85.00 • Item #62358 Psychopharmacology, FEBRUARY Fourth Edition The American Psychiatric Publishing Textbook of Edited by Alan F. Schatzberg, M.D., and The American Psychiatric Alzheimer Disease and Charles B. Nemeroff, M.D., Ph.D. Publishing Textbook of Other Dementias 2009 • 1632 pages • ISBN 978-1-58562-309-9 Geriatric Psychiatry, Edited by Myron F. Weiner, M.D., Hardcover • Special Prepublication Price of $245.00 Fourth Edition and Anne M. Lipton, M.D., Ph.D. until May 31, 2009 (thereafter $275.00) Edited by Dan G. Blazer, M.D., Ph.D., and David C. Steffens, M.D., M.H.S. 2009 • 560 pages • ISBN 978-1-58562-278-8 Item #62309 Hardcover • $125.00 • Item #62278 2009 • 694 pages • ISBN 978-1-58562-277-1 Hardcover • $149.00 • Item #62277 MAY Study Guide to Geriatric Psychiatry The First and Last Word in Psychiatry A Companion to The American Psychiatric The American Psychiatric Publishing Publishing Textbook of Geriatric Psychiatry, Board Review Guide for Psychiatry American Psychiatric Publishing, Inc. 1000 Wilson Boulevard, Suite 1825 Fourth Edition Edited by James A. Bourgeois, O.D., M.D., Arlington, VA 22209-3901 Robert E. Hales, M.D., M.B.A., Robert E. Hales, M.D., M.B.A., Julie S. Young, Web: www.appi.org Narriman C. Shahrokh, Dan G. Blazer, M.D., M.D., and Stuart C. Yudofsky, M.D. Ph.D., and David C. Steffens, M.D., M.H.S. Phone: 703-907-7322 or 1-800-368-5777 2009 • pages TBA • ISBN 978-1-58562-297-9 Mon.-Fri., 9 am to 5:30 pm, ET 2009 • 240 pages • ISBN 978-1-58562-352-5 Paperback • $125.00 • Item #62297 Fax: 703-907-1091 Email: [email protected] Paperback • $49.00 • Item #62352
Please reference priority code AH920 when ordering.
APA 2009 Annual Meeting • San Francisco, California Monday, May 18, 2009 • Marriott-San Francisco, Salons 7/8
Breakfast Learning Objective 6:30 AM–7:00 AM At the conclusion of this session, the participant should be able to enumerate adult Scientific Session ADHD criteria, and understand the cardiovascular risks of stimulants, the process of 7:00 AM–9:00 AM ADHD/bipolar differential diagnosis, and the outcome findings of ADHD/SUD comorbidity. Welcome and Preactivity Educational Outcomes Measurement Program Chair 7:00 AM–7:05 AM Gabriel Kaplan, MD Gabriel Kaplan, MD Iliyan Ivanov, MD How Do I Identify and Treat Adult ADHD? Clinical Associate Professor Assistant Professor, Psychiatry 7:05 AM–7:25 AM Gabriel Kaplan, MD of Psychiatry Mt Sinai School of Medicine University of Medicine and Dentistry New York, New York Cardiovascular Effects of Stimulants–Is There Cause for Concern? of New Jersey 7:25 AM–7:45 AM Donald E. Greydanus, MD Newark, New Jersey Jeffrey H. Newcorn, MD How Do I Approach the Bipolar vs ADHD Issue? Executive Director, Psychiatry Associate Professor, Psychiatry and 7:45 AM–8:05 AM Jeffrey H. Newcorn, MD Hoboken University Medical Center Pediatrics How Do I Manage the ADHD/SUD Comorbidity? Hoboken, New Jersey Mount Sinai School of Medicine 8:05 AM–8:25 AM Illyan Ivanov, MD Distinguished Faculty New York, New York Postactivity Measurement Donald E. Greydanus, MD Sponsored by 8:25 AM–8:30 AM Gabriel Kaplan, MD Pediatrics Program Director MSU/Kalamazoo Center for Discussion, Q&A Medical Studies 8:30 AM–9:00 AM Gabriel Kaplan, MD and Faculty Kalamazoo, Michigan
The American Psychiatric Association (APA) is accredited by the Accreditation Attendees must be registered for the APA Annual Meeting to attend this Council for Continuing Medical Education to provide continuing medical symposium. Seating is limited and will be based on first-come, first-served. education for physicians. For more information about the meetings, please visit the APA web site at Supported by an www.psych.org or contact the APA toll free at 1-888-357-7924 (within the U.S. The APA designates this educational activity for a maximum of 2 AMA PRA or Canada) or 703-907-7300. educational grant from Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Registered conference participants and registered guests may attend any industry-supported symposium at the APA meeting. DISCLOSURE INDEX
AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE
The American Psychiatric Association requires disclosure, by presenters at CME activities, of any signifi cant fi nancial or other affi liation with commercial organization(s) that may have a direct or indirect interest in the subject matter of the scientifi c program. A “fi nancial interest” may include, but is not limited to: being an employee, being a shareholder in the organization; being on retainer with the organization; or having research or honoraria paid by the organization. An “affi liation” may include holding a position on an advisory committee, speakers bureau or some other role or benefi t to a supporting organization.
In compliance with the ACCME’s Standards for Commercial Support, the APA has a management of confl ict (MCI) process for all CME activities. This process ensures that all potential confl icts of interest are identifi ed, managed and resolved prior to the educational activity. The prospective audience must be informed of the presenter’s affi liation with every commercial supporter by an acknowledgement in the printed program and verbal or visual disclosure to partici- pants at the session (disclosure by slide or overhead is required if audiovisual equipment is used for the presentation). This policy is intended to openly identify any potential confl ict(s) so that members of the audience in an educational activity are able to form their own judgments about the presentation. The APA also requires verbal disclosure of discus- sion of unlabeled uses of a commercial product or investigational use of a product not yet approved for this purpose.
The presenters on the following pages have indicated that either they or an immediate family member has a signifi cant interest or other affi liation with a commercial supporter of this meeting and/or with the manufacturer(s) of a commercial product(s) and/or provider of commercial services(s), and the company name is listed.
The second group of presenters has indicated neither they nor an immediate family member has any signifi cant relation- ship to disclose.
162ND ANNUAL MEETING XXV DISCLOSURE INDEX OF COMPANIES erapeutics c (advisory c royalties) Other Financial Interest Interest Financial Other (specify) (advisory PRD, Merck boards) Embera NeuroTh Scientifi board) (travel Neuronetics support, 2007) Aventis zer Financial Options Financial Sanofi zer, zer, zer zer Aventis, Sepracor, Sepracor, Aventis, zer, Abbott Labs., GSK, Abbott zer, Wyeth-Ayerst, zer, zer zer Forest Labs. Forest Jazz, Pfi Jazz, BMS Pfi Eisai, BMS, Lilly Research Labs., BMS, Lilly Research Ortho McNeil AZ, BMS, Eli Lundbeck, Cilag, Otsuka Janssen Lilly, Pfi Lilly Labs., Eli Forest Lilly, Jazz, AZ, Forest, Pfi Nove, McNeil, Sanofi Takeda Pfi AZ Cyberonics, Dev., UCB Pharma Dev., BMS, Otsuka Pfi zer, zer, zer, Lilly zer, zer Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Merck, Hythiam, Eli Lilly Eli Hythiam, Merck, BMS, Ortho Janssen, Pfi McNeil, Labs. Research Labs., GSK, Forest Abbott Labs., Wyeth-Ayerst & Johnson Johnson Pfi NIMH, Cyberonics, UCB Pharma, Sepracor, NARSAD Eli Lilly Eli Employee Deutschland zer Merck Labs., Ortho McNeil, Wyeth-Ayerst Lilly, Labs., Eli Forest Marinus Ovation, Novartis, Medtronics, Wyeth-Ayerst, Labs., BMS, Abbott Sepracor, Cyberonics, Pfi Cephalon Shire Pharm. Dev., Dev., Pharm. Shire Novartis omas E. Lilly, Labs., Eli Abbott C eld, Robert N, Stanley Pfi Clayton, Paula J Clayton, Paula ACohen, Judith NIH (book Publ. Guilford Choi-Kain, Lois WChoi-Kain, Lois Chung, Henry NIMH Name Consultant Full-Time Adler, Mats MA Mats Adler, Alsuwaidan, Mohammad AntonioAndreoli, Anton, Raymond F.Arnsten, Amy F Rahn KBailey, Labs., Lilly Research Marinus Shire, BMS, Lilly Research JolieBrams, Bransfi Research Wyeth-Ayerst Novartis Caroff Linda LCarpenter, Neuronetics, T William Carpenter, Wyeth-Ayerst, Casey, David A David Casey, Brady, KathleenBrady, Labs., GSK, Abbott Anderson, Allan A A David Baron, Julian Beezhold, W. Donald Black, CarlosBlanco-Jerez, GBoess, Frank Lilly Eli Labs. Forest Jazz, Medivation Th Brown, Labs. NIMH, Forest NIDA Lilly, Eli Labs., Novartis Forest Lilly Pfi Pfi GSK, NIMH, NIDA Lilly Eli Buckingham, U. DianeBuckingham, AlexanderBystritsky, E William Callahan, Shire EnriqueCamarena, Campbell, William H. Jazz Neuronetics, Janssen-Cilag Jazz Pharm. Shire Novartis,
XXVI WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES zer zer relative is full-time relative Pfi employee), Alzheimers (employed); of Foundation America and Advanstar Communications (honoraria) Other Financial Interest Interest Financial Other (specify) Lilly, AZ, BMS, Eli Otsuka, Organon, Vanda Supernus, Solvay., (advisory boards) Merck Financial Options Financial
zer, GSK zer, zer, Wyeth- zer, Aventis, Eli Lilly Eli Aventis, zer zer Jazz, GSK, Sepracor, GSK, Sepracor, Jazz, Boehringer Takeda, Sanofi Ingelheim, McNei Cyberonics, Shire Ayerst, Forest Labs. Forest Ayerst, Eisai, Novartis, Forest Forest Novartis, Eisai, Labs., Pfi Janssen, AZ, BMS, Otsuka, AZ, BMS, Otsuka, Janssen, Lilly Eli AZ, Sanofi Canada Lundbeck Lilly Eli BMS, AZ, Pfi zer, zer, zer Lilly, Forest Labs., McNeil, Labs., McNeil, Forest Lilly, Medtronic Eli Lilly, Novartis, Ono Ono Novartis, Lilly, Eli Pharma Grant/Research SupportGrant/Research Bureau Speaker’s Pfi Supernus, Stock/Other Abbott Labs., AZ, Eli Labs., AZ, Eli Abbott Pfi Janssen, Shire, Lilly, BMS, NARSAD, Somerset, NIDA, NIMH Johnson Employee
zer, zer, zer, Abbott Labs., Abbott zer, zer Sepracor, Takeda, Takeda, Sepracor, BMS, GSK, Sanofi Cephalon, GSK, Merck, Medivation, Schering, Neurochem, Takeda Pfi BMS, NIDA, GSK y, Farifteh F Farifteh y, APIRE Desai, Abhilash K Abhilash Desai, RiadDirani, Labs. Forest & Johnson Novartis Doghramji, KarlDoghramji, Ortho McNeil, Edinger, Jack D. Jack Edinger, M James Ellison, Philips NIMH, NIH, Philips GSK Pfi Lilly, Eli Dougherty, Darin D Darin Dougherty, L Robert Doyle, Duff Novartis Shire, Eli Cephalon, Cyberonics, Novartis, McNeil, Janssen, Faison, Warachal Faison, AmyFarabaugh, R Martin Farlow, Pfi Myriad Organon, NARSAD GSK (1st degree Name Consultant Full-Time Cohen, Lisa J O David Conant-Norville, Christoph UCorrell, JovitaCrasta, Labs., GSK, Forest Otsuka, Lilly, AZ, BMS, Eli BMS Novartis McNeil, Croft, HarryCroft, Scott JCrow, DaleD’Mello, JD Jon Davine, Deborah Deas, MelissaDelBello, Shire BMS AZ, Pfi Lilly, Eli Takeda Lilly, GSK, Forest, Pfi
162ND ANNUAL MEETING XXVII DISCLOSURE INDEX OF COMPANIES zer, GSK, zer, Otsuka (speaking fees) Otsuka Other Financial Interest Interest Financial Other (specify) Behavioral Pediatric (owner) Health (royalties) Publ. Guilford AZ, BMS, Organon, funds (travel and Otsuka or to attend research educational meeting with no honoraria) Financial Options Financial MedAvante, Compellis zer, zer, zer zer, Cephalon, Reckitt Cephalon, Reckitt zer, zer, Novartis, Janssen Novartis, zer, Pfi Forest Somaxon, Benckiser, Labs. AZ, Boehringer Ingelheim, AZ, Boehringer Ingelheim, BMS, Cephalon, Eli Labs., GSK, Forest Lilly, Pfi Organon, Novartis, Wyeth-Ayerst Pharmastar, Labs. Pfi - zer, Pharmavite, Roche Roche Pharmavite, zer, GSK zer, AZ, Lilly, Labs., Eli Abbott GSK zer, Pfi Lilly, Eli Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Synthelabo, BMS, Johnson BMS, Johnson Synthelabo, PRD, Abbott & Johnson Labs., Alkermes, Aspect AZ, Systems, Medical Forest Lilly, Cephalon, Eli Labs., GSK, Lichtwer GmbH, Lorex, Pharma Organon, Novartis, Pfi Sanofi Biosciences, Wyeth- Solvay, Synthelabo, Labs., Labs., Abbott Ayerst Lab BMS, Pam AZ, Organon, Lilly, Eli Otsuka, BMS, Organon, GSK Employee - zer, zer, Amarin, Auspex, Amarin, Auspex, Compellis, Trascept, MedAvante, EPIX, Vanda, Somaxon, Synthelabo, Cephalon, Tetragenex, Lilly, Eli Cypress, Labs., GSK, Forest Johnson Jazz, Janssen, PRD, & Johnson Knoll, Lundbeck, Neuronetics, Merck, Nutrition, Novartis, Pfi Organon, Pharmastar, Roche Pharmavite, Aspect Biosciences, AZ, Systems, Medical Biovail AG, Bayer Labs., BMS, Sanofi Sepracor, Synthelabo, Somerset, Solvay, Wyeth-Ayerst Takeda, Labs., BrainCells, Phar, Fabre-Kramer GmBH, Grunenthal Human Precision Pam Biolaboratory, Lorex Lab, BMS Frank, EllenFrank, NIMH Servier (advisory board), Name Consultant Full-Time Fava, Maurizio Fava, (cont’d.) Maurizio Fava, W Timothy Fong, P Brent Forester, MarkFrye, A. Toshiaki Furukawa, Labs., BMS, Abbott Pfi Pfi Ferrando, Stephen J Stephen Ferrando, Caroline Fisher, Abbott AZ AZ, Pfi
XXVIII WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES zer (Clinical Trial Trial (Clinical zer Labs. (CME activities/ talks) sponsored Safety Adjudication Adjudication Safety Wyeth-Ayerst Board), Safety Labs. (Data Board) Monitoring Other Financial Interest Interest Financial Other (specify) Janssen Lilly, AZ, Eli Cilag (symposium Wyeth-Ayerst, speaker); Cilag Janssen Lilly, Eli (advisory boards) zer Johnson & Johnson & Johnson Johnson PRD Johnson & Johnson & Johnson Johnson Labs. PRD, Forest Financial Options Financial zer, BMS, zer, zer zer, Eli Lilly Eli zer, zer zer, Prempharm, Janssen Prempharm, zer, NMHAC AZ Janssen Cilag, Pfi Janssen AZ Pfi Aventis, Aventis, zer zer Pfi zer, Wyeth-Ayerst Wyeth-Ayerst zer, zer, BMS, AZ zer, zerPfi AZ, zer, Sanofi zer, Cyberonics, Eli Lilly Eli Cyberonics, GSK GSK, Pfi Abbott Labs., Elan, Forest Forest Labs., Elan, Abbott Myriad Institute, Research Eisai, Novartis, Genetics, Pfi Labs. Forest Ono, Research, Pfi NIMH Solvay, Takeda, Pfi Janssen, Pharm. Dev. Pharm. Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Cortex, GSK, Stanley Cortex, GSK, Stanley Institute, Research Medical NIMH Pfi Sepracor Targasept, zer Pfi Employee zer, Solvay, Solvay, zer, zer, AZ, Eli Lilly, Lilly, AZ, Eli zer, zer, Organon Organon zer, zer zer, Prempharm, Prempharm, zer, Wyeth-Ayerst, GSK Wyeth-Ayerst, Genetics, Novartis, Novartis, Genetics, Pfi USA, Wyeth-Ayerst, Janssen-Ortho, BMS, Forest Research, Labs., Takeda Wyeth-Ayerst BMS, Janssen, Eli Eli BMS, Janssen, Novartis Solvay, Lilly, Medical Systems, Systems, Medical Neuronetics Janssen nger, Stephen M. Stephen nger, Teva Pfi Janssen, C, Donald Lilly Xenoport, Eli Pfi Janssen, Hermann, Richard C Richard Hermann, K John Hines, AZ Hendren, Robert L Robert Hendren, Barry KHerman, Pfi Labs., BMS, Janssen Forest Gonzalez, GerardoGonzalez, KarlGoodkin, FrederickGoodwin, Nicholas IV, Greco Alan I.Green, Pfi Janssen Lilly, Eli Labs. Abbott BMS UCB Pharma, AZ, Lundbeck, Janssen, Merck GSK, Janssen, Benckiser Reckitt Labs. Abbott Greenberg, Benjamin D. Benjamin Greenberg, T George Grossberg, Jazz Medtronic, Labs., Myriad Abbott Medtronic Jazz Gupta, Nitin Gupta, G Paul Hammerness, PhilipHarvey, PeterHauser, T David Healy, C David Henderson, Labs., AZ, Abbott BMS, Pfi Servier Shire Janssen Shire AZ, Jazz AZ Abbott McNeil, Shire, (legal expert) Teva Goldfi Ghaemi, S. NassirGhaemi, AlexanderGlassman, IraGlick, Goff Pfi Pfi Shire Solvay, BMS, Glaxo, Name Consultant Full-Time Gaebel, Wolfgang Gaebel, N. Bradley Gaynes, S. Mark George, BMS Aspect Cyberonics, Novartis George, Tony P Tony George, Pfi 162ND ANNUAL MEETING XXIX DISCLOSURE INDEX OF COMPANIES Johnson & Johnson & Johnson Johnson PRD (spouse employee) Other Financial Interest Interest Financial Other (specify) Republic Czech Board, Financial Options Financial zer zer Aventis, Takeda, Takeda, Aventis, GSK, Janssen AZ Novartis BMS, Janssen Dev. Pharm. Shire AZ Labs. AZ, Wyeth-Ayerst Abbott Labs., AZ, Eli Lilly, Lilly, Labs., AZ, Eli Abbott GSK, Pfi Labs. MA), Forest Sanofi Cephalon Janssen, Pfi Janssen, Aventis, Aventis, zer, GSK zer, Aventis, Sepracor, Sepracor, Aventis, Nancy Pritzker Network, Network, Pritzker Nancy Sanofi Novartis, NIMH Abbott Labs., AZ, BMS, Abbott Wyeth- Lilly, Cephalon, Eli Pfi Ayerst, BMSOrtho McNeil, Alkermes (Cambridge, Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Sanofi Organon Abbott, Takeda Somaxon Solvay, McNeil, Ortho McNeil Otsuka, Neuronetics, BMS Neuronetics, Otsuka, Labs., AZ, BMS, Abbott Employee
zer, zer, airs, LLC airs, zer Labs., Forest Lilly, Eli c Aff c -Synthelabo -Synthelabo Cephalon, Merck, Vanda, Scientifi Labs., Eli Lilly, Pfi Lilly, Labs., Eli Wyeth-Ayerst Abbott Labs., GSK, Abbott Novartis, Jazz, Janssen, Wyeth-Ayerst Solvay, NIEHS, NIND, EPA Solvay, Aventis, Alkermes (Cambridge, MA), BMS, Forest Labs., Lundbeck Neuronetics Jayaram, Geetha Jayaram, D Michael Jibson, A Bankole Johnson, Janssen Ortho-McNeil Kahan, Kara L Kane, John MKane, John Abbott BMS, Janssen, Kaplan, Gabriel ATerence Ketter, G Kingdon, David D Herbert Kleber, Lilly, AZ, BMS, Eli JamesKocsis, Alkermes RobertKohn, ScottKollins, CoMentis, Addrenex, Benckiser Reckitt Labs., AZ, NIDA, Forest NIH Labs. Forest Kranzler, Henry R.Kranzler, Sanofi Ortho McNeil, Name Consultant Full-Time Hirshkowitz, MaxHirshkowitz, Sanofi I James Hudson, Pfi Lilly, Eli Hodgkins, PaulHodgkins, EricHollander, CyrilHoschl, G Philip Janicak, Servier BMS, AZ, Janssen, Shire Labs., Ortho Abbott BMS Lilly, Eli Lundbeck, Shire Cilag Advisory Janssen XXX WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES BMS, Otsuka BMS, Otsuka (honoraria) Oxford Press, Psychiatric Elsevier U Press, Other Financial Interest Interest Financial Other (specify) (royalties/ Publ. Guilford patient, other income) Systems Financial Options Financial zer, Wyeth- zer, zer, AZ, Cephalon, zer, Eli Lilly, Wyeth-Ayerst Lilly, Eli Aspect Medical Pfi Takeda Labs., Forest AZ Pfi Lilly, Eli Ayerst Labs. AZ, Wyeth-Ayerst BMS Consumer Healthcare, Shire Sepracor, Novartis,
zer, zer, zer, zer, zer Aventis, Eli Lilly Eli Aventis, Aventis, Sepracor, Sepracor, Aventis, zer Sanofi Eli Systems, Aspect Medical Novartis, MedAvante, Lilly, Pfi Neuromodulation Cyberonics, Systems, NIH, NARSAD, Stanley Foundation Research AZ, Forest Institute BMS, AZ, Sanofi Janssen, Pfi Merck, Aventis, Lundbeck Wyeth-Ayerst, Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Cephalon, GSK, Merck, Cephalon, GSK, Merck, Biosciences, Neurocrine NIH, Pfi Neuronetics, Sanofi Takeda Somaxon, NIMH Employee , zer, zer, zer, zer, zer, AZ zer, AZ, GSK, Pfi Aventis, BMS, Aventis, Aventis Aventis, Sanofi Aventis, zer Eli Lilly, Janssen, Janssen, Lilly, Eli & Johnson Johnson PRD, Lundbeck, Pfi Lilly, Eli Systems, Novartis Solvay, Roche Labs., Roche Solvay, GSK, Wyeth-Ayerst, Sanofi Cephalon, Eli Lilly, Lilly, Cephalon, Eli & Johnson GSK, Jazz, PRD, King, Johnson Neurocrine Merck, Novartis, Biosciences, Pfi Organon, Institute, Research Biosciences, Roche Sanofi Somaxon, Sepracor, Takeda Leucht, Stefan F Andrew Leuchter, Sanofi Aspect Medical C John Markowitz, NIMH Books, American Basic Levounis, Petros Levounis, Licinio, Julio F Lim, Russell H Sarah Lisanby, Lilly Eli Maria Llorente, I Shari Lusskin, RajnishMago, AliceMao, R. Stephen Marder, Vanda Pfi BMS, Otsuka, Novartis Lilly, Eli Advanced Neuronetics, NARSAD, Lilly, GSK, Eli McNeil Lilly, AZ, BMS, Eli Name Consultant Full-Time Krystal, D Andrew AZ, BMS, Arena, Lazarus, Arthur LLerman, Caryn GSK, Pfi AZ AZ Kupfer, David J David Kupfer, Servier Institute, Research Forest
162ND ANNUAL MEETING XXXI DISCLOSURE INDEX OF COMPANIES c erapeutics, Other Financial Interest Interest Financial Other (specify) (author) Elsevier NARSAD, AZ, Forest NARSAD, AZ, Forest Labs., Quintiles, (scientifi Janssen-Ortho advisory boards) Th Tikvah Vivus erapeutics Financial Options Financial EEG Spectrum International & Johnson Johnson Th zer zer, zer, zer, Servier, Servier, zer, zer zer(honorarium) Lundbeck zer Janssen Pfi Janssen, Lilly, AZ, Eli Wyeth-Ayerst Forest Lilly AZ, Eli Janssen, Novartis, Shire Novartis, AZ, Eli Lilly, Pfi Lilly, AZ, Eli Wyeth-Ayerst Alkermes Alkermes Labs., GSK, Pfi BMS, Pfi Benckiser Reckitt Cephalon, BMS, Pfi GSK, Lilly, AZ, BMS, Eli Pfi zer BMS, NIMH, Pam zer, Forest Lilly, AZ, BMS, Eli zer, BMS, GSK, Forest BMS, GSK, Forest zer, Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Neuronetics, Boehringer Neuronetics, Wyeth- GSK, Ingelheim, Ayerst Advanced Advanced Neuromodulation Medical Stanley Systems, NIMH, Institute, Research Cyberonics Neuronetics, Labs. McNeil, Eli Lilly, Shire, Shire, Lilly, Eli McNeil, Novartis AZ, Eli Lilly, GSK, Wyeth- GSK, Lilly, AZ, Eli Labs., Stanley Ayerst Institute Research Medical Pfi Lab Labs., Titan, Labs., Titan, Organon, Cephalon Merck, Employee zer, zer, airs zer zer, Wyeth- zer, zer c Aff c Janssen MA), Eli Lilly MA), Eli BMS, Janssen Shire, Novartis, Novartis, Shire, Cortex, Pfi Lilly, GSK, Pfi Lilly, Servier Ayerst, BMS, Eli Lilly, Lilly, BMS, Eli Ayerst, Shire Lab, Pam Jazz, McNeil Janssen Janssen McNeil Scientifi GSK, Pfi H.rey Lilly, Eli McNeil, , Charles B NIH Corcept Name Consultant Full-Time Marks, Glenn GM Glenn Marks, M.William McDonald, Genetics, Myriad M Jacqueline Melonas, DavidMischoulon, A Jerome Motto, Lab BMS, Pam PRMS Lab Pam Mason, Barbara J Barbara Mason, Malia McCarthy, R James McKay, Labs. Forest R Philip Muskin, Alkermes (Cambridge, HusainMustafa, Labs. Forest Labs., AZ, Abbott Lilly, AZ, BMS, Eli Jazz, McLean, Andrew J Andrew McLean, Myrick, HughMyrick, MeeraNarasimhan, Nemeroff BMS John Newcomer, Jeff Newcorn, Forest AZ, BMS, Janssen, Forest Abbott, Alkermes, Cephalon, BMS, Nolen, Willem WA Willem Nolen, AZ, Eli Cyberonics, Nunes, Edward V Edward Nunes, LenOchs, J Michael Ostacher, I George Papakostas, J Joseph Parks, GSK, Pfi Labs, Inc Ochs Ortho- Lilly, Eli Pfi Labs, Inc Ochs Patkar, Ashwin A.Patkar, Pfi Perlis, Roy H Roy Perlis, Lilly, AZ, BMS, Eli
XXXII WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES nancial interest) column (wrote Epocrates on ADHD) GSK MGH Psychiatry (CME Academy support)program Other Financial Interest Interest Financial Other (specify) MedAvante Financial Options Financial zer, zer, , Takeda Takeda , zer, BMS, Novartis zer, zer zer, Forest Labs. Forest zer, BMS, Forest Labs., GSK, BMS, Forest Pfi Lilly, Eli Janssen, Wyeth-Ayerst Solvay, AZ, Pfi Janssen Alza/McNeil, AZ Benckiser Reckitt Novartis Cephalon, Sanofi Abbott Pfi Lilly, Eli Pediatrics, McNeil BMS Pfi , zer zer, BMS, zer, zer, Sanofi zer, -Synthelabo, Solvay, Solvay, -Synthelabo, AZ, BMS, Cephalon, Labs., Forest Cyberonics, Lilly, Eli GSK, Janssen, NARSAD, NIDA, NIMH Sanofi Allergan, AZ, BMS, Lilly Labs., Forest Research Mitsubishi Labs., Janssen, Ono, Novartis, Pharma, Pfi Otsuka, Organon, Cephalon, GSK, Aventis, Pfi Neurocrine, Takeda Somaxon, Sepracor, Wyeth-Ayerst Abbott, Labs., Xenoport Labs., Eli Lilly, Merck Lilly, Labs., Eli Labs., NIHForest Pfi GSK, Otsuka, Sepracor, Supernus, Forest, NIMH, NICHO Janssen, (fi Somaxon Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Employee , zer, Roche Roche zer, Abbott Labs., McNeil Abbott Forest Labs., GSK, Forest Eli Jazz, Janssen, MedAvante, Lilly, Novartis, Neurocrine, Otsuka AZ, BMS, Janssen, Organon, Novartis, Pfi Otsuka, Labs. Cephalon, Cypress Eli Elan, Bioscience, Pharma, Purdue Lilly, Labs., Sanofi Roche Schering, Sepracor, Shire, Servier, Takeda Somaxon, Wyeth-Ayerst Abbott, Labs., Xenoport, Alza, Ancile, Acadia, Alkermes, AZ, BMS Aventis, Somaxon BMS, Forest, Merck Lundbeck, erson B Shire, Novartis, omasLabs., Abbott Pollack, Mark H Mark Pollack, AZ, BMS, Cephalon, G Steven Potkin, Arena, Acadia, Annelle BPrimm, Jeff Prince, Lilly Eli V Barbara Romberg, Sarah Romeo, Th Roth, Potenza, Marc N Marc Potenza, Boehringer Ingelheim, J Andres Pumariega, Rathod, Shanaya Varinder Rathore, Maurice Wm Redden, Lilly Eli A Darrel Regier, AdelaideRobb, Lilly, Eli Otsuka, APIRE Pettinati, Helen M Helen Pettinati, HT Edmond Pi, Merck Lilly, Eli Alkermes, Cephalon, Forest Name Consultant Full-Time Peselow, Eric D Eric Peselow,
162ND ANNUAL MEETING XXXIII DISCLOSURE INDEX OF COMPANIES Other Financial Interest Interest Financial Other (specify) (distributor) NeuroTek Solutions Satiety (founder and principal) Labs., Merck Forest (advisory boards) zer erapeutics, Forest Forest erapeutics, Financial Options Financial Corcept Merck, Th Labs., Neurocrine, Pfi Aventis, Abbott Abbott Aventis, Aventis zer, Novartis zer, Labs., Schering Corp. AZ, BMS, GSK, Eli Lilly, Lilly, AZ, BMS, GSK, Eli Wyeth-Ayerst Sanofi Labs. Sanofi Cilag, Janssen Janssen Labs. Canada, Roche zer, zer, Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Cyberonics, Takeda Cyberonics, Labs., GSK, Abbott Memory Janssen, Wyeth- Pharmaceuticals, Labs. Ayerst Labs., AZ, Abbott Sciences, Abuse Drug Pharmaceuticals, LIPHA OyContral, Alkermes, Ortho McNeil Stanley Pharma, Wyeth-Ayerst, Foundation, NIMH, NIDA, NARSAD, of Institute Fujisawa America AZ, BMS, Ortho McNeil, Lilly Eli Pfi Labs., GSK, Jazz, Quintiles & Johnson Employee , erapeutics, zer, GSK, Eli Lilly, Lilly, GSK, Eli zer, Forest Labs. Forest Neuronetics, Lilly, Eli GSK Wyeth-Ayerst, PRD, Abbott PRD, Abbott Labs., AZ, BMS, GSK, Lilly, Eli Memory Janssen, Pharmaceuticals, Sanofi Novartis, Wyeth-Ayerst Shire, Labs., Cephalon, AZ USA, Organon Schering- Janssen, France Plough, Name Consultant Full-Time Rothschild, Anthony JRothschild, Pfi GarySachs, & Johnson Johnson M Ihsan Salloum, Labs., Forest Abbott J Andrew Saxon, IngoSchäfer, Schatzberg, Alan F NinaSchooler, Th Corcept Ortho McNeil, Janssen-Ortho BMS Lilly, Eli Cephalon, Alkermes, Forest Pfi Ruano, GualbertoRuano, A Beverly Rubik, FloydSallee, Genomas M Shirlene Sampson, P2D Inc. AkiraSawa, Neuronetics Neuronetics C Shawn Shea, V David Sheehan, HongShen, K.A Amresh Shrivastava, America, Mitsubishi Eisai Lilly Eli LinmarieSikich, I Robert Simon, YusufSivrioglu, Novartis Forest Lilly, AZ, BMS, Eli Labs. Cilag, Roche Janssen Lilly, AZ Canada, AZ, Eli Labs., Johnson BMS, Forest Seaside Novartis Novartis Neuropharm
XXXIV WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES Other Financial Interest Interest Financial Other (specify) MGH Psychiatry (CME Academy support)program (CME honoraria) Financial Options Financial MedAvante, Guilford Publications
zer, Forest Labs. Forest zer, BMS, Pfi GSK, AZ GSK, Sanofi Cyberonics, Aventis, Wyeth-Ayerst Wyeth-Ayerst Aventis, Labs., Schering-Plough, France zer Lilly AZ, Eli NIM Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other BenckiserReckitt Benckiser Reckitt Foundation, Forest Labs., Forest Foundation, Pharm. AZ, BMS, Shire & Johnson Johnson Dev., PRD, NIMH NIH Lilly, Eli Sepracor Lilly, Eli Lilly, AZ, BMS, Eli BMS, AZ Employee zer zer Research Janssen Lilly, Eli Lilly Benckiser, Reckitt Dev., Pharm. Shire Titan, Schering Corp., GSK Forest Labs., Myriad Labs., Myriad Forest Novartis, Genetics, Pfi Ortho McNeil, Labs. Forest Cyberonics, Eli Lilly, Lilly, Eli Cyberonics, Research Forest GSK, Institute, MedAvante, Janssen, Novartis, Neuronetics, Sepracor, Organon, Supernus, Shire, Labs. Wyeth-Ayerst E ase, Michael AZ, BMS, Cephalon, Stewart, Donna E Donna Stewart, C Eric Strain, Eli Wyeth-Ayerst, GmBH, Grunenthal Name Consultant Full-Time Stigler, Kimberly AStigler, Janssen, Lilly, BMS, Eli Skodol, Andrew E Andrew Skodol, W Gary Small, Shilpa Srinivasan, Labs., Eisai, Abbott M Stephen Strakowski, Pfi Lilly, Eli NIMH Marvin S.Swartz, A Holly Swartz, M Robert Swift, Lilly Eli BMS TransOral, Alkermes, Lilly Eli BMS AZ, Servier Lilly, Eli Soares, Jair C Jair Soares, Shire Organon, GSK, Pfi Suo, Shannon Suo, Kelly Sutton-Skinner, Th H Mark Townsend, G Martin Tracy, AZ, Jazz PRMS Otsuka, Janssen, Lilly, Eli
162ND ANNUAL MEETING XXXV DISCLOSURE INDEX OF COMPANIES Other Financial Interest Interest Financial Other (specify) Financial Options Financial zer, Wyeth-Ayerst zer, zer zer, Akzo-Nobel, Akzo-Nobel, zer, zer, Wyeth-Ayerst, Eli Eli Wyeth-Ayerst, zer, zer AZ, Eli Lilly, Forest Labs., Forest Lilly, AZ, Eli Wyeth- GSK, Novartis, Labs. Forest Ayerst, Pfi Pfi AZ, Johnson & Johnson & Johnson AZ, Johnson PRD, Neuronetics, Pfi BMS, Cephalon, Janssen, Forest Lilly, Eli Cyberonics, & Labs., GSK, Pharmacia Wyeth- Solvay, Upjohn, Labs. Ayerst Labs., Lilly Research Benckiser Reckitt Janssen, Pfi Lilly Pfi zer, zer, zer, zer, ective Disorders, Disorders, ective zer, NIH, Pharmacia & NIH, Pharmacia zer, erapeutics, GSK, erapeutics, Research Institute, Pfi Institute, Research Sepracor, Wyeth-Ayerst, Wyeth-Ayerst, Sepracor, Institute, Research Forest Laboratories, AZ, Berlex GSK Beechum Lilly, Eli Janssen, Pharmaceuticals, NIMH Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other NIMH, NIDA, BMS, Cephalon, Corcept Th Forest Lilly, Eli Cyberonics, Merck, Labs., Janssen, Pfi Wyeth- Solvay, Upjohn, Labs., NIMH, Ayerst Alliance for National in Schizophrenia Research and Aff Novartis Labs. Lilly Research UCB Pharma, Sepracor, Sepracor, UCB Pharma, Medtronic Employee Labs. zer, zer, Akzo-Nobel, Akzo-Nobel, Corp., AZ, Bayer BMS, Cephalon, Lilly, Eli Cyberonics, Labs., GSK, Forest Johnson Janssen, PRD, & Johnson Neuronetics, Solvay, Pfi Parke-Davis, & Upjohn, Pharmacia Wyeth- Sepracor, Labs., Novartis Ayerst Eli LillyEli Cilag Janssen Viguera, AdeleViguera, Medical NARSAD, Stanley Wancata, JohannesWancata, D Elyse Weiner, Janssen Name Consultant Full-Time Trivedi, Madhukar H Madhukar Trivedi, Labs., Abbott Garry M Vickar, Trzepacz, PaulaTrzepacz, W John Tsuang, R Audrey Tyrka, Lilly Research Pfi Cyberonics, Unwalla, Khushro Unwalla, J Rutger der Gaag, Van Wijngaarden-Cremers, van J Patricia Lilly Eli Cilag Janssen Vanderpool, DonnaVanderpool, Vijoy Varma, PRMS
XXXVI WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES (study medication zer Other Financial Interest Interest Financial Other (specify) for NIMH trial) zer, zer, Johnson & Johnson & Johnson Johnson PRD Financial Options Financial Pfi Merck, BMS, Cortex Noven zer, zer,
zer, Wyeth- zer, zer Mindstreet zer Abbott Labs., AZ, BMS, Abbott GSK, Lilly, Eli Cyberonics, Pfi Lab, Pam Labs. Ayerst AZ, Pfi Solvay, Wyeth-Ayerst, GSK, Wyeth-Ayerst, Solvay, AZ, Cephalon, Lilly, Eli Labs., Abbott Biovail Labs., BMS, Labs., Forest Pfi Dev., Pharm. Shire Sanofi Organon, Eli Lilly, Ortho McNeil, Ortho McNeil, Lilly, Eli Shire Novartis, Pfi Aventis, Aventis, zer, Sanofi zer, -Synthelabo, NIMH, -Synthelabo, zer, Eli Lilly, GSK, Lilly, Eli zer, erapeutics, McNeil, McNeil, erapeutics, Takeda Grant/Research SupportGrant/Research Bureau Speaker’s Stock/Other Systems, Aspect Medical AZ, BMS, Cephalon, Labs., GSK, Forest Eli NARSAD, Lichtwer, Bioscien Roche Lorex, Lilly, Pfi Labs., Merck, Abbott Wyeth-Ayerst, Organon, SmithKline Upjohn, Pharm. Shire Beecham, Solvay, AZ, Janssen, Dev., Schwabe, BMS, Novartis, Synaptic, Pharm., TAP UCB Pharma, Eisai, Cephalon, Lundbeck, Labs., Pharmacia Forest Neurochem, & Upjohn, Corp., Ciba Geigy Division, Pharmaceutical Sanofi Labs., Sandoz, Biovail Corcept Parke-Davis, Vela, Th Burroughs-Wellcome, PRD & Johnson Johnson AZ, BMS, Cephalon, Lilly, Eli Cyberonics, Labs., GSK, NIMH, Forest Pam Novartis, McNeil, Pfi Lab, Abbott Labs., Merck, Labs., Merck, Abbott Lilly, Eli Ortho McNeil, NIDA, Shire Employee zer, Takeda zer, -Synthelabo, -Synthelabo, zer, GSK, Organon, GSK, Organon, zer, erapeutics, Abbott Abbott erapeutics, BMS, Biovail BMS, Biovail Laboratories, Eli Labs., Forest Lilly, Shire Wyeth-Ayerst, Solvay, Dev., Pharm. Pfi Sanofi & Johnson Johnson PRD, Novartis, Corcept Otsuka, Th Labs. Ortho McNeil, Eli Eli Ortho McNeil, NIDA, Merck, Lilly, Novartis Labs., Biovail Abbott Lilly, Labs., BMS, Eli Pam Otsuka, Novartis, Pfi Lab, Xiang, Yingqiang Monique Yohanan, KimberlyYonkers, Janssen Lilly Eli Pfi Name Consultant Full-Time Weisler, Richard Weisler, (cont’d.) Richard Weisler, M Janet Witte, H Jesse Wright, Raymond Zablotny, Labs., Alkermes, Abbott Westgate, HarlandWestgate, ETimothy Wilens, Labs., Abbott Shire, PRMS JohnZajecka, Labs., Wyeth-Ayerst Williams, Jill M Jill Williams, 162ND ANNUAL MEETING XXXVII DISCLOSURE INDEX OF COMPANIES
NOTES
XXXVIII WWW.PSYCH.ORG DISCLOSURE INDEX
PRESENTERS WITH NOTHING Benedek, David M Capitanio, John P. Benedek, Elissa P. Caring, Joanne TO DISCLOSE Benjelloun, Hind Carino, Anthony Bergman, Gretchen Carlson, Stephan Abbasi, Farha Z Berkowitz, Ellen Carney, Colleen E Abdel-Wahab, Nancy Berman, Karen Faith Caselli, Monica T Abel, Gene G Bhandari, Tarun Casey, Patricia P Abouallaban, Yousef Bialer, Philip A Castellanos, Daniel Aboul-Fotouh, Frieda Bienenfeld, David Castro, Anthony M Abrams, Karen M Binder, Renee L. Ceccherini-Nelli, Alfonso A Adams, Jr., Curtis N. Birkholm, Molly Cefalu, Charles A Adelson, Stewart L Bisaga, Adam Chaffi n, Jennifer A Ahmed, Sadaf Bittner, Stephen J Chaisson, Anne-Marie Ahmed, Iqbal Bjork, James M Chamberlain, Samuel R Akil, Huda Blaise, Aguirre A Chan, Carlyle H Akiyama, Tsuyoshi Blaustein, Mel I Chanen, Andrew M Albrecht, Suzanne A Blendy, Julie Phd Chang, Jacquelyn Alfonso, Cesar A Blum, Nancee S Chase-Eldridge, Warene Ali, Shirin Blumenfi eld, Michael Chaudhry, Haroon Alkhouri, Iyad Bockting, Claudi CLH Chen, Chiao-Chicy Allison, Rebecca Boehnlein, James K Chien, Peter L Andermann, Lisa F Bohus, Martin Christianson, Amy L Anderson III, Otis Bokarius, Vladimir Ciccocioppo, Roberto RC Andrea, Helene Book, Howard E Clarkin, John F Anglin, Rebecca Booty, Andrew Cobb, Robert Anzia, Joan M Bostwick, John M Coconcea, Cristinel M Appelbaum, Paul S Boust, Susan J Coffey, M. Justin Arboleda-Florez, Julio E Brada, Kay Cohen, Mitchell JM Arean, Patricia A Breiling, James P Cohen, Michael Armstead, Ron E Breitbart, Willaim Cohen, Carl I. Armstrong, Scott C Brendel, David H. Collins, Pamela Aron, Laudan Y Brod, Thomas M. Compton III, Wilson M Arroyo, William Brodkey, Amy C Condon, Timothy P Astruc, Bernard Brooks, Kristen Coopey, Adrienne Atkins, Robert Brooks, Beth Ann Courchesne, Eric Auger, R. Robert Broquet, Karen Cournos, Francine Austin, Jehannine C Brown, Sandra A. Critchfi eld, Kenneth L. Baker, Allison S Brown, Richard A Cureton, Janetta Ballon, Jacob S. Brown, Richard P Cutler, Janis Barak, Yoram Bruce, Travis O Cyr, Alan A Bark, Nigel Buchanan, Alec W D’Souza, Russell Barnes, Donna H Buckley, Peter Daley, Christopher T Bartlett, Selena E Bullock, Karen Dallam, Deborah Bassuk, Ellen Bunt, Gregory C Dannon, Pinhas N Bateman, Anthony W Burd, Ronald M Daroff, Robert Jr Batki, Steven Burke, Mary G Dauenhauer, Laura E Batten, Sonja V Burpee, Stacey Davae, Umee A Baum, Antonia L Cabaj, Robert P David, Anthony Beck, Judith S Cabrejos, Claudio David, Daniella Becker, Judith V Cahill, Larry F Davidoff, Donald A Becker, Daniel F Caligor, Eve Davidson, Kate M Bedregal, Luis E Campbell, Jamae C Davies, Emily Beeber, Alan R Campbell, Nioaka N Davis, Jeri Beer, Jennifer Campbell, Frank R Daviss, Steven R Begum, Millia Ms
162ND ANNUAL MEETING XXXIX DISCLOSURE INDEX
De Blécourt, Carel C.V. Foelsch, Pamela Guynn, Robert E. De Jonghe, Frans F Fonagy, Peter Hafter Gray, Sheila De Maat, Saskia S Forstein, Marshall Hales, Deborah De Wit, Harriet Francis, Andrew J Hales, Robert E Defrancisci Lis, Lea Frank, Julia B Hall, Ryan C Dekker, Jack J Frankel, Debra MS Haller, Ellen Del Rosario, Salvador R Franklin, Teresa Halmi, Katherine A Demaso, David R. Fung, Kenneth Dr. Hameed, Noumana Desmeules, Marie Gabbard, Glen O Harlow, Michael Devlin, Michael J Galanter, Marc Harrow, Martin Dewan, Mantosh J Galynker, Igor Harvey, Steven Diamond, Milton Ph.D. Ganzini, Linda Hasan, Nidal NH Diaz-Granados, Natalia Garcia, Mai-Ling J Hatti, Shivkumar S Dickstein, Leah J. Garrett, Michael Healy, David T Dimaggio, Giuseppe, Giancarlo Gask, Linda Hendriksen, Mariëlle Dimeff, Linda A Gaudiano, Brandon A Herbert, Sarah E Donatilla, Mukamana Gelernter, Joel Hercher, Laura S Dooley-Sammuli, Margaret Geller, Ruth E. Herie, Marilyn Douaihy, Antoine Geller, Jeffrey Herrman, Helen E Dowling, Gayathri George, David T Hersh, Richard G. Downey, Jennifer I Gerbarg, Patricia L Heru, Alison M. Drescher, Jack Germain, Anne Hickson, Gerald Dunn, Jeffrey Gers, Seymour Hien, Denise Dunn, Laura B Gers, Glenn Higgins, Brian D. Ecker, Sidney W Gessesse, Hiruy Hilty, Don Edelheit, Phyllis B Ghadiali, Nafi sa Hines, Kevin Edenberg, Howard J Ghitza, Udi E Hinterhuber, Hartman Ehrensaft, Diane Glantz, Meyer D. Hippman, Catriona Ehret, Megan J Gleason, Ondria OG Hira-Brar, Shabneet Elliott, Glen R Glover, Karinn Hoffman, Perry D Elsayed, Yasser A Goethe, John W Hoge, Steven K Esguerra, Chris E Goin, Marcia K. Hoglend, Per Essex, Marilyn J Goldman, Marina Hollon, Steven Everett, Anita S Goldman, Howard H Hommer, Rebecca E Fahrer, Rodolfo Goldman, Morris B. Hoop, Jinger G Fairweather, Amy Goldstein, Rita Hopkinson, Marta J Falzone, Richard L Goodman, Marianne S Horgan, Constance M Farkas, Marianne D Gopal, Arun Horowitz, Mardi J. Fartacek, Reinhold Gordon, Harold W Houston, Michael Faulkner, Larry R Gordy, Tracy R Hsiung, Robert C Fauman, Susan Gorelick, David A Huebner, Robert Fauman, Beverly Grady-Weliky, Tana A Huffi ne, Charles W Fawcett, Jan Granacher, Robert P Huguelet, Philippe Feenstra, Dineke Grant, Steven Hung, Erick Feijen, Rudolf R.A.M. Grant, Jon E Huremovic, Damir Fernandez, Antony Green, Stephen Hurley, Robin A Ferranti, Jessica Greenwald, Phyllis Hurwitz, Thomas D Fewer, Sandra L Gregory, Simon Husain, Arshad Fine, Carla Gregory, Robert J Hutsebaut, Joost Finlayson, Reid Grewal, Arvinder K Ibe, Aloysius C Finn, Christine T Greydanus, Donald E Ignacio, Luis Faustino Fishel, Tobi Groen, Wouter Indest, David W Fishkind, Avrim B Guarino, Kathleen Iren Akbiyik , Derya Fitelson, Elizabeth M Gunderson, John G Irigoyen, Fructuoso R Fochtmann, Laura Gutheil, Thomas G Irwin, Michael R XL WWW.PSYCH.ORG DISCLOSURE INDEX
Isaacs, Julian JI Larson, Justine Martens, Elisabeth J Ivanov, Iliyan Lee, Eugene Martinez, Humberto L. Jabbarpour, Yad M Lee, Allison M.R. Marumoto, Megan Janofsky, Jeffrey Lee, Elliott K. Marzani-Nissen, Gabrielle Javed, Afzal Leigh, Hoyle Massie, Mary Jane Jenkins, Rachel Levander, Eric Matharu, Yogi Jensen, Peter Levav, Itzhak Matorin, Anu A. Jimerson, David C Levenson, Hanna May, Alison C. Johnson, Bradley R Levin , Edmund C May, Catherine S Johnson, Jeffrey Levin, Frances R McCabe, Sean E Joiner, Lasa Levine, Stephen B McCann, Una D Jorgenson, Linda M Levy, Matthew D McCarthy, Richard H Kaitin, Kenneth Levy, Norman B McClung, Colleen A Kang, Shimi Lewis, Jerry L McCormick, Laurie M Kaplan, Sandra J Lewis, Stephen McDonald, Scott Katherine , Shear Lewis Harris, Treniece McFarland, Bentson H Katz, Craig I Lewy, Alfred J McFarr, Lynn Katz-Bearnot, Sherry P. Liberman, Robert P McGee, Michael D Kay, Jerald Lieberman, Alicia F McGlashan, Thomas H Kaye, Walter H Lin, Chieh-Hsin McHugh, Paul R Kazim, Batool Linden, Michael McIntyre, Kathryn Keitner, Gabor I Lipsitt, Don R McNicholas, Laura F Kellner, Charles Litten, Raye Z. McVoy, Molly K Kennedy, Robert S Liu, Shirley Medina Mora, Maria. Elena Kent, Laura K Livesley, John Mee-Lee, David Kernberg, Otto F. Llorca , Pierre Michel Mehl-Madrona, Lewis Kertzner, Robert M Llorente, Maria Melissa, Brymer J Khan, Sarah Lo, Ted Menezes, Paulo Kim, Borah Loo, Colleen K Menvielle, Edgardo J Kim, Eugene Lowenkopf, Eugene L Merikangas, James R Kirsch, Andrew Loza, Nasser N Messing, Robert O Klein, Carolina A Lu, Francis G Meyerson, David A Klin, Ami Luby, Joan L. Micevski, Aleksandar Knight, Sara J Luce, John M Michaels, M Koivukangas, Jenni Lukas, Scott E Michaels, Laura Koob, George F. Luo, John Miettunen, Jouko Kool, Simone S Lynch, Wendy J Mikalac, Cecilia M Koopman, Cheryl Lynch, Minda R Minoletti, Alberto Kosten, Thomas R Lynch, Katherine L Minter, Shannon P Koyanagi, Chad Y Madaan, Vishal Mintz, David L Kraemer, Helena C. Maercker, Andreas Miotto, Karen A Krakowski, Menahem I. Maj, Mario Mishra, Asha S Kramer, Milton Maki, Pirjo H. Mitchell, James E. Kramer, Elizabeth J Malaspina, Dolores Mittal, Sukriti Krueger, Robert Malison, Robert T Moeller, Kristen Kua, Ee-Heok Ehk Malmquist, Carl P. Mohamed, Zahurin Kung, Simon Malphurs, Julie E Mohandessi, Soroush Kuo, Felicia Y Mangurian, Christina V Moncrieff, Joanna Kuo, Irving Manring, John Montenegro , Roger M Kuzenko, Nina Marazziti, Donatella Morairty, Zach Laboy, Phd , Felicity L. Marchionni, Christine Morciglio, April H Laje, Gonzalo Markov, Dimitri D Morey, Leslie C Lamb, William K Marks, Tracey I Mrazek, David A Landau, Judith Marks, Saul I Mucic, Davor MD Lane, Richard 162ND ANNUAL MEETING XLI DISCLOSURE INDEX
Munoz, Rodrigo A. Peeters, Frenk Robinson, Robert G. Munyandamutsa, Naasson MN Perry, Christopher T Robinson, Gail E Musher, Jeremy S Pessar, Linda F Robinson, David Myers, Wade Peteet, John R Rodriguez-Suarez, Mercedes M Myers, Michael F Petrakis, Ismene L Roessel, Mary H Nace, David K Pfl anz, Steven E Roman, Brenda J.B. Nadelson, Carol Phillips, James Romanoski, Alan J Nader, Michael A Phillips, Robert Rondon, Marta B. Najavits, Lisa M. Pilotte, Nancy S Rone, Lisa A. Nand, Surinder S Pini, Stefano SP Rose, Diana Napoli, Joseph C Plakun, Eric M Rosenberg, Stanley D. Nardi, Antonio E Pleak, Richard R Rosenburg, Zack Narrow, William E Pollack, David A Rosenquist, Peter B. Nash, Sara S Pontius, Edward Rosenstock, Jason B Nasky, Kevin M Ponton, Lynn Roskes, Erik Nau, Melissa Pope, Kayla Ross, Stephen Navin, Natarajan A Postlethwaite, Alejandra Rube, David M Nelson, Charles G Powsner, Seth Ruiz, Pedro Nemat, Ali Prabhakar, Deepak DP Russakoff, L. Mark Neufeld, Ronald E Preda, Adrian Rutter, Joni L Newmark, Thomas S Preven, David Ryan, Elizabeth Ng, Anthony T Price, Marilyn Ryan, Caitlin Norko, Michael Puchalski, Christina Ryan, Deirdre Northcott, Colleen J. Qian, Yifang Rychik, Abe M Notman, Malkah T Quadrio, Carolyn Saavedra, Javier E Nyhus, Nadine J Rabow, Michael W Sadre-Chirazi-Stark, Michael F O’Brien, Charles Radke, Alan Q Saeed, Sy A O’Brien, Moira P Ragins, Mark Sahler, Olle Jane O’Leary, Paul J Ramani, Meena Samenow, Charles Obatusin, Tayo Ramchandani, Vijay A Sanchez, Francis Oele, Bastiaan B. Ramirez, Luis F Sanders, Kathy M Ogundipe, Kehinde A Randall, Carrie L Santiago, Patcho Okasha, Ahmed Ranz, Jules Sareen, Jitender Okpaku, Samuel O Rao, Nyapati R Sartorius, Norman Oldham, John M Rasic, Daniel T Sattar, Syed Oms, Juan D Ratliff, Brenda M Saucedo, Catherine J Ong, Jason C Ravindranath, Divy Saxena, Shekhar Ongur, Dost Raynor, Jeffrey D Schnaas, Francisco J Ortiz Fragola, Alfredo A Reardon, Claudia L Schneidman, Barbara S Osinski, Alphonse D Recupero, Patricia R Schoener, Gary R Oslin, David Rego, Mark D Schroeder, Steve A Osofsky, Howard J Reich, James H Schubmehl, James Q Osofsky, Joy D Reid, William H Schummer, Gary J Palmer, Christina G Reifl er, Burton V Scimeca, Michael M Pandya, Anand Reliford, Aaron Scott, Charles Parikh, Rajesh M Resnick, Phillip J Scott, Marcia Paris, Joel Reus, Victor I Seritan, Andreea L Parish, Brooke Reyes, Raymond M Sevilla, Brett J Parnham, George J. Riba, Michelle B. Sexson, Sandra B Parry, Peter I Richeimer, Steven Shanfi eld, Stephen B Pato, Michele T Richman, Jennifer Shapiro, Edward Robert Payne, James O. Rifai, Muhamad Aly Sharfstein, Steven S Peay, Holly L Rigaud, Marie-Claude Shaw, Kailie Pecora, Peter Ritchie, Elspeth C Shea, Tracie Peele, Roger Robinowitz, Carolyn B. Shihabuddin, Lina XLII WWW.PSYCH.ORG DISCLOSURE INDEX
Shinfuku , Naotaka Tillman, Jane G Wise, Robert Shumay, Dianne M. Tong, Lowell D Wise, Michael Jan Siever, Larry J Toomey, R.P.N., Jennifer Wolf, Robert Silberman, Edward K Torres, Michael A. Wood, William C Silberschatz, George Treisman, Glenn J Woolley, Stephen B Silk, Kenneth R. Tschan, Werner Worley, Jena Silver, Jonathan Tse, Wing Wynn, Gary Simmons, Chantelle M Tsuang, Ming T Xie, Yuhuan Simon, Witold Tuerk, Catherine L. Yager, Joel Sinclair, Beryle D Turkington, Douglas Yellowlees, Peter M Sitzer, Lauren Turner, Erick H Yen, Jennifer L Sizoo, Bram B Tyrer, Peter Yen, Shirley Slattery, Marcia J Tzuang, Dan Yeomans, Frank E Smith, Eric G Udomratn, Pichet Yeung, Albert Sonawalla, Shamsah B. Un, Hyong Yoo, Tai P Song, Suzan Unutzer, Jurgen Young, Tina Sorel, Eliot Ursano, Amy M Young, Jeffrey E Spack, Norman Ursano, Robert J Young, John Q Speller, Heather K Vaillant, George Yudofsky, Stuart C Spencer, C. Edgar Van, Henricus Zainal, Nor Z Sperber, Jacob E Van Horn, Patricia J Zanarini, Mary C Srabstein, Jorge C Van Nieuwenhuizen, Adrienne O Zangen, Abraham Srivastava, Shefali Varma, Sudeepta SV Zaretsky, Ari E Stahle, Galen W Veijola, Juha M. Zatzick, Douglas F Stanley, Barbara H Vela, Ricardo M Zeller, Scott L Starcevic, Vladan Verhalen, Nisha Zhu, Ziqing Steele, Annie K Vianin, Pascal Ziedonis, Douglas M Steinglass, Peter Victor, Lisa Ziegler, Penelope P Stevens, Michael C Vincent, Kathy M. Zubieta, Jon-Kar Stewart, Caroline Viron, Mark Zucker, Robert A Stolar, Andrea Vogel-Scibilia, Suzanne E. Zurowski, Mateusz Stone, Michael Volberding, Paul Zweben , Allen Stone, Walter N Volkow, Nora D Stotland, Eve Wagner, Eric F Stotland, Nada L. Walker, Sandra C Strain, James J Warshaw, Carole L. Strauss, David H Webb, Roger T Streltzer, Jon Weerasekera, Priyanthy Stroeh, Oliver Weiner, Richard Sudak, Donna M Weinstock, Robert Sukumaran, Anand Weisner, Constance M Sullivan, Maria Weissman, Sidney Summers, Richard F Welch, Kristen U Susman, Virginia L. Wetherington, Cora Lee Sutcliffe, James Whelan, Gerald P Swiggart, William H White, Stephen G Szarek, Bonnie L White, Leigh Anne Szigethy, Eva White-Labora, Deborah Taintor, Zebulon Whyte, Doug DW Talbott, John A Willenbring, Mark Tandon, Rajiv Williams, Eric R Temporini, Humberto D Wills, Marketa Terhakopian, Artin Windle, Michael Terilli, Dale Winick, Bruce J Tiainen, Anne AT Winters, Kelley 162ND ANNUAL MEETING XLIII DISCLOSURE INDEX
NOTES
XLIV WWW.PSYCH.ORG Saturday, May 16, 2009
8:00 A.M. SESSIONS IMPORTANT REMINDER: COURSE 1 8:00 A.M. -12 NOON PROGRAM CHANGES ARE PRINTED EACH DAY IN Room 111, Exhibit Level, Moscone Center THE DAILY BULLETIN - A COPY MAY BE OBTAINED BY ATTENDEES THROUGHOUT THE MOSCONE BRAIN STIMULATION THERAPIES IN CONVENTION CENTER PSYCHIATRY Director: Ziad H. Nahas, M.D. Faculty: Linda Carpenter, M.D., Special Course Event Darin Dougherty, M.D., Mustafa Hussain, M.D.
COURSE 2 8:00 A.M. -12 NOON BOARD REVIEW: ABPN PART 1 Room 131, Exhibit Level, Moscone Center INTERPERSONAL PSYCHOTHERAPY BDRV 9:00 AM- 4:00PM Director: John C. Markowitz, M.D. Gateway Ballroom 104, Exhibit Level, Moscone Center DIRECTOR: JAMES BOURGEOIS, O.D., M.D. COURSE 3 8:00 A.M. -12 NOON Room 226, Mezzanine Level, Moscone Center Faculty: Jaesu Han, M.D., Cameron Quanbeck, M.D., Glen Xiong, M.D., Martin Leamon, M.D., PSYCHIATRIC CONSULTATION IN LONG TERM Andreea Seritan, M.D., Alan Koike, M.D., CARE: BASIC COURSE Mark Servis, M.D., Charles Scott, M.D., Directors: Abhilash K. Desai, M.D., Humberto Temporini, M.D., Robert McCarron, D.O. George T. Grossberg, M.D. Seperate Fee Required - Textbook included 9:00 A.M. SESSIONS
COURSES 4-10
NEW CLINICAL KNOWLEDGE AND COURSE 4 9:00 A.M. - 4:00 P.M. SKILLS (CKS) MASTER COURSE SERIES Room 125, Exhibit Level, Moscone Center HOPE FOR THE DISTRESSED AND DISRUPTIVE PHYSICIAN: THE GOOD, THE BAD AND THE MASTER COURSE: UGLY Director: William H. Swiggart, M.S. PRACTICAL COGNITIVE Faculty: Charles Samenow, M.D., M.P.H., BEHAVIOR THERAPY Tobi Fishel, Ph.D., Gerald Hickson, M.D., Ronald Neufeld, B.S., Reid Finlayson, M.D. CKS01 9:00 AM- 4:00PM Gateway Ballroom 103, Exhibit Level, Moscone Center COURSE 5 9:00 A.M. - 4:00 P.M. Room 112, Exhibit Level, Moscone Center DIRECTOR: JESSE WRIGHT, M.D., PH.D. Faculty: Judith Beck,M.D., CHILD AND ADOLESCENT PSYCHIATRY FOR THE Robert Goisman, M.D., Donna Sudak, M.D. GENERAL PSYCHIATRIST Seperate Fee Required - Textbook included Director: Robert L. Hendren, D.O. Faculty: Malia McCarthy, M.D., Yuhuan Xie, M.D.
COURSE 6 9:00 A.M. - 4:00 P.M. Room 130, Exhibit Level, Moscone Center
Course descriptions are available in the Course Brochure HOW TO BLOG, FRIEND, AND FLY: 21ST CENTU- included in your registration materials. Admission to all RY INTERNET TECHNOLOGIES FOR BEGINNERS courses is by ticket only. Director: Robert C. Hsiung, M.D. Faculty: Jerald Block, M.D., Steven Davis, M.D.
162ND ANNUAL MEETING 1 Saturday, May 16, 2009
COURSE 7 9:00 A.M.- 4:00 P.M. COURSE 12 1:00 P.M. - 5:00 P.M. Room 220, Mezzanine Level, Moscone Center Room 309, Esplanade Level, Moscone Center BASIC CONCEPTS IN ADMINISTRATIVE MANAGING MALPRACTICE RISK FOR PSYCHIATRY I PSYCHIATRISTS: THE BASICS AND BEYOND Directors: Barry K. Herman, M.D., Directors: Jacqueline M. Melonas, J.D., R.N., Douglas M. Brandt, M.D. Donna Vanderpool, J.D., M.B.A. Faculty: L. Mark Russakoff, M.D., LECTURE 01 Shivkumar Hatti, M.D., M.B.A., David Nace, M.D., Sy Saeed, M.D., M.S. LECTURE 01 1:00 P.M.-2:30 P.M. COURSE 8 9:00 A.M.- 4:00 P.M. Grand Ballroom A, Third Floor, Intercontinental Room 222, Mezzanine Level, Moscone Center San Francisco SPIRITUALITY IN PSYCHIATRY PREVALENCE, CORRELATES, AND RISK OF POST TRAUMATIC STRESS DISORDER: Director: Michael D. McGee, M.D. HOW LATINOS FARE COMPARED TO NON- Faculty: Christina Puchalski, M.D. LATINO WHITES, ASIANS, AFRICAN-AMERICAN, AND AFRO-CARRIBEAN COURSE 9 9:00 A.M. - 4:00 P.M. Margarita Alegria, Ph.D. Room 224, Mezzanine Level, Moscone Center Simon Bolivar Award Lecture A PRACTICAL APPROACH TO RISK ASSESSMENT Chp.: Andres J. Pumariega, M.D.
Director: William H. Campbell, M.D., M.B.A. argarita Alegría, Ph.D., is the Director of the MCenter for Multicultural Mental Health Research COURSE 10 9:00 A.M. - 4:00 P.M. at the Cambridge Health Alliance. She is a professor of Room 276, Mezzanine Level, Moscone Center psychology in the Department of Psychiatry at Harvard Medical School and currently serves as the Principal INTERPERSONAL AND SOCIAL RHYTHM Investigator of three National Institutes of Health-fund- THERAPY ed research studies. Dr. Alegría’s published work focuses on how to improve services delivery for diverse racial and Directors: Ellen Frank, Ph.D., Holly A. Swartz, M.D. ethnic populations; conceptual and methodological Faculty: Debra Frankel, L.C.S.W. issues with multicultural populations; and how to bring the community’s perspective in the design and implementa- tion of health services. Dr. Alegría also conducts research that will contribute to an understanding of the factors infl uencing NOW OPEN service disparities, and testing interventions aimed at reduc- EXHIBIT HALL ing disparities for ethnic and racial minority groups. Dr. Alegría APA MEMBER CENTER received the 2003 Mental Health Section Award of the Ameri- PUBLISHERS’ BOOKFAIR can Public Health Association and the 2006 Greenwood Award for Research Excellence. In 2007, she was honored with the HOURS OF OPERATION fi rst Latino Mental Health Scientifi c Leadership Award. She 10:00 A.M. -5:00 P.M. is also recipient of the Carl Taube Award, given by the Men- tal Health Section of the American Public Health Association. She serves on several boards, including the National Acad- 1:00 P.M. SESSIONS emy of State Health Policy, Health Services Research Journal. COURSES 11-12 COURSE 11 1:00 P.M. - 5:00 P.M. Room 131, Exhibit Level, Moscone Center PSYCHOPHARMACOLOGIC, ECT AND PSYCHOTHERAPEUTIC TREATMENT OF PSYCHOTIC (DELUSIONAL) DEPRESSION Director: Anthony J. Rothschild, M.D. Faculty: Brandon Gaudiano, Ph.D.
2 WWW.PSYCH.ORG Sunday, May 17, 2009
9:00 A.M. SESSIONS IMPORTANT REMINDER: PROGRAM CHANGES ARE PRINTED EACH DAY IN NEW CLINICAL KNOWLEDGE AND SKILLS THE DAILY BULLETIN - A COPY MAY BE OBTAINED MASTER COURSE SERIES BY ATTENDEES THROUGHOUT THE MOSCONE CONVENTION CENTER PRACTICAL PSYCHODYNAMIC Course descriptions are available in the Course Brochure PSYCHOTHERAPY included in your registration packet. Admission to all courses is by ticket only. CKS02 9:00 A.M.- 4:00 P.M. Gateway Ballroom 103, Exhibit Level, Moscone Center 8:00 A.M. SESSIONS DIRECTOR: GLEN O. GABBARD, M.D. COURSES 13-17 Faculty: Barbara Milrod, M.D., John Gunderson, M.D., Thomas Gutheil, M.D., Funmilayo Rachal, M.D. COURSE 13 8:00 A.M.-12 NOON Room 111, Exhibit Level, Moscone Center Seperate fee required - textbook included. PSYCHIATRIC ROLES IN ASSESSING AND TREAT- ING ADULT AND ADOLESCENT SEX OFFENDERS COURSES 18-27 Directors: Bradley R. Johnson, M.D., Judith V. Becker, Ph.D. COURSE 18 9:00 A.M.- 4:00 P.M. Room 222, Mezzanine Level, Moscone Center COURSE 14 8:00 A.M.-12 NOON LOVE, INTIMACY, DESIRE AND INFIDELITY Room 120, Exhibit Level, Moscone Center Director: Stephen B. Levine, M.D. MOOD DISORDERS IN LATER LIFE Directors: James M. Ellison, M.D., M.P.H., COURSE 19 9:00 A.M.- 4:00 P.M. Yusuf Sivrioglu, M.D. Room 112, Exhibit Level, Moscone Center Faculty: Brent Forester, M.D., James Ellison, M.D., THE IMG INSTITUTE M.P.H., Donald Davidoff, Ph.D., Patricia Arean, Ph.D. Directors: Nyapati R. Rao, M.D., M.S., Deborah Hales, M.D. COURSE 15 8:00 A.M.-12 NOON Faculty: Mantosh Dewan, M.D., Jacob Sperber, M.D., Room 125, Exhibit Level, Moscone Center Priyanthy Weerasekera, M.D., John Manring, M.D., PSYCHIATRIC INTERVENTIONS IN DISASTERS Peter Buckley, Joan Anzia, M.D. AND PUBLIC HEALTH EMERGENCIES: THEORY TO PRACTICE COURSE 20 9:00 A.M.- 4:00 P.M. Room 113, Exhibit Level, Moscone Center Directors: Anand Pandya, M.D., Craig I. Katz, M.D. Faculty: Judith Cohen, M.D. BASIC CONCEPTS IN ADMINISTRATIVE PSYCHIATRY II COURSE 16 8:00 A.M.-12 NOON Directors: Douglas M. Brandt, M.D., Barry K. Herman, Room 226, Mezzanine Level, Moscone Center M.D. PSYCHIATRIC CONSULTATION IN LONG-TERM Faculty: Alan Axelson, M.D., Robert Atkins, M.D., CARE: ADVANCED COURSE Arthur Lazarus, M.D., M.B.A., Jeri Davis, M.B.A., William Reid, M.D., M.P.H. Directors: Abhilash K. Desai, M.D., George T. Grossberg, M.D. COURSE 21 9:00 A.M.- 4:00 P.M. Room 114, Exhibit Level, Moscone Center COURSE 17 8:00 A.M.-12 NOON Room 310, Esplanade Level, Moscone Center WHAT IS PSYCHIATRY? PHILOSOPHIES AND PRACTICES HOW TO GIVE A MORE EFFECTIVE LECTURE: PUNCH, PASSION AND POLISH Directors: S. Nassir Ghaemi, M.D., M.P.H., David H. Brendel, M.D. Director: Phillip J. Resnick, M.D.
162ND ANNUAL MEETING 3 Sunday, May 17, 2009
COURSE 22 9:00 A.M.- 4:00 P.M. Room 121, Exhibit Level, Moscone Center NOW OPEN EXHIBIT HALL TRAUMATIC BRAIN INJURY: APA MEMBER CENTER NEUROPSYCHIATRIC ASSESSMENT PUBLISHERS’ BOOKFAIR Director: Robert P. Granacher, M.D., M.B.A. HOURS OF OPERATION: 10:00 A.M. -4:30 P.M. COURSE 23 9:00 A.M.- 4:00 P.M. Room 122, Exhibit Level, Moscone Center 12:00 NOON SESSIONS AUTISM SPECTRUM DISORDERS OVER THE LIFESPAN: DIAGNOSTIC CLASSIFICATION, INDUSTRY-SUPPORTED LUNCHEON NEUROBIOLOGY, BIOPSYCHOSOCIAL SYMPOSIA INTERVENTIONS AND PHARMACOLOGIC MANAGEMENT ISS 12:30 P.M. -2:30 P.M. Directors: Kimberly A. Stigler, M.D., Alice Mao, M.D. Grand Ballroom Salon B, Grand Ballroom Level, Faculty: James Sutcliffe, Ph.D., Kara Kahan, M.D., Hilton San Francisco Jolie Brams, Ph.D., Eric Courchesne, Frieda Aboul-Fotouh, DEVELOPMENT OF NEW AGENTS FOR THE Robert Doyle, D.D.S, M.D. TREATMENT OF SCHIZOPHRENIA Supported by Dainippon Sumitomo Pharma America, Inc. COURSE 24 9:00 A.M.- 4:00 P.M. Room 131, Exhibit Level, Moscone Center Chp.: Steven Potkin, M.D. ESSENTIALS OF ASSESSING & TREATING 1. Unmet Needs in Schizophrenia Adrian Preda, M.D. ATTENTION DEFICIT HYPERACTIVITY DISOR- DER IN ADULTS AND CHILDREN 2. Drug Development in Psychiatry: Issues and Trends Amir Kalali, M.D. Director: Thomas E. Brown, Ph.D. Faculty: Jefferson Prince, M.D. 3. New Targets for Drug Development Philip Harvey, Ph.D. COURSE 25 9:00 A.M.- 4:00 P.M. Room 133, Exhibit Level, Moscone Center ISS 12:30 P.M. -2:30 P.M. COGNITIVE-BEHAVIOR THERAPY FOR SEVERE Salons 7 & 8, Lower B-2 Level, Marriott San Francisco MENTAL ILLNESS EFFECTIVE TREATMENT OF ALZHEIMER’S Director: Jesse H. Wright, M.D., Ph.D. DISEASE – TRANSLATING GUIDELINES INTO Faculty: Douglas Turkington, M.D., Michael Thase, M.D., PRACTICE: AN INTERACTIVE PANEL David Kingdon, M.D. DISCUSSION Supported by Forest Laboratories, Inc.
COURSE 26 9:00 A.M.- 4:00 P.M. Chp.: George Grossberg, M.D. Room 276, Mezzanine Level, Moscone Center 1. Putting Practice Recommendations for AD Patients SEEING THE FOREST AND THE TREES: AN AP- into Practice: Confusion for Clinicians PROACH TO BIOPSYCHOSOCIAL FORMULATION Maurice Redden, M.D. Director: William H. Campbell, M.D., M.B.A. 2. Practice Recommendations from the American COURSE 27 9:00 A.M.- 4:00 P.M. Association for Geriatric Psychiatry Gary Small, M.D. Room 309, Esplanade Level, Moscone Center 3. Management of Dementia: An Evidence-based PSYCHOTHERAPY FOR BORDERLINE Review from the American Academy of Neurology PERSONALITY Martin Farlow, M.D. Directors: Frank E. Yeomans, M.D., Ph.D., 4. Current Pharmacologic Treatment of Dementia: Otto F. Kernberg, M.D. Practice Guidelines from the American College of Faculty: Eve Caligor, M.D., John Clarkin, Ph.D. Physicians and the American Academy of Family Physicians 10:00 A.M. SESSIONS Charles Cefalu, M.D.
4 WWW.PSYCH.ORG Sunday, May 17, 2009
ISS 12:30 P.M. -2:30 P.M. COURSE 32 1:00 P.M. - 5:00 P.M. Continental Ballroom 4/5/6, Hilton San Francisco Room 300, Esplanade Level, Moscone Center DELIVERING OPTIMAL CARE FOR COMPLEX MANAGEMENT OF PSYCHIATRIC DISORDERS IN BIPOLAR PATIENTS: AN AUDIENCE GUIDED PREGNANT AND POSTPARTUM WOMEN SYMPOSIUM Director: Arvinder K. Grewal, M.A. Supported by AstraZeneca Pharmaceuticals Faculty: Shari Lusskin, M.D., Diana Carter, M.D., Chp.: Gary Sachs, M.D. Deirdre Ryan, M.D.
1. What Defi nes Quality of Care In Bipolar Disorder? COURSE 33 1:00 P.M. - 5:00 P.M. Richard Hermann, M.D. Room 310, Esplanade Level, Moscone Center 2. What Does the Payor’s Data on Quality of Care NEUROANATOMY OF EMOTIONS Tell Us? Phyllis Greenwald, M.D. Director: Ricardo M. Vela, M.D. 3. How Do We Know If Medications Are Working? 2:00 P.M. SESSION Michael Ostacher, M.D. 4. How Do We Care For Complex Bipolar Patients? LECTURE 02 Gary Sachs, M.D. LECTURE 02 2:00 P.M. -3:00 P.M. 1:00 P.M. SESSIONS Gateway Ballroom 102, Exhibit Level, Moscone Center COURSES 28-33 PSYCHOPATHIC DISORDERS WITHOUT BORDERS COURSE 28 1:00 P.M.- 5:00 P.M. Alan R. Felthous, M.D. and Henning Sass, M.D. Room 111, Exhibit Level, Moscone Center Manfred Guttmacher Award Lecture LOSING A PATIENT TO SUICIDE Chp.: Marilyn Price, M.D. Director: Michael F. Myers, M.D. Faculty: Carla Fine, M.S., lan R. Felthous, M.D., is Professor and Director Frank Campbell, Ph.D., L.C.S.W. Aof Forensic Psychiatry, Department of Neurology and Psychiatry, Saint Louis University School of Medicine. COURSE 29 1:00 P.M.- 5:00 P.M. He received his bachelors degree from the University of Room 120, Exhibit Level, Moscone Center Washington and his medical doctorate from the Univer- MELATONIN AND LIGHT TREATMENT OF SAD, sity of Louisville; he interned at Roosevelt Hospital (New York) with residency training at McLean Hospital and SLEEP AND OTHER BODY CLOCK DISORDERS Harvard Medical School. Previously, Dr. Felthous held Director: Alfred J. Lewy, M.D., Ph.D. positions at the Naval Regional Medical Center in Oak land; the Menninger Foundation; the Department of COURSE 30 1:00 P.M. - 5:00 P.M. Psychiatry and Behavioral Sciences at the University of Room 220, Mezzanine Level, Moscone Center Texas Medical Branch in Galveston, where he was Chief of Forensic Services and the Marie B. Gale Centen- CREATIVE USE OF BOUNDARY CROSSINGS IN nial Professor of Psychiatry; and Southern Illinois Univer- THERAPY sity, where he was Director of Forensic Psychiatry and Medical Director of Chester Mental Health Center, Director: Gail E. Robinson, M.D., D.P.H. Illinois’ maximum security forensic hospital. Dr. Felthous Faculty: Gary Schoener, M.A., Linda Jorgenson, J.D., is a past president of the American Academy of Psychia- Howard Book, M.D. try and the Law and the American Board of Forensic Psychiatry, and is the senior editor of Behavioral Sciences and the Law. His research, COURSE 31 1:00 P.M. - 5:00 P.M. scholarly and teaching interests focus on clinical aggression, the psy- Room 272, Mezzanine Level, Moscone Center chopathology of criminal behavior, legal requirements of clinicians in managing potentially violent patients, and jail and prison suicide. SHORT-TERM PSYCHODYNAMIC SUPPORTIVE PSYCHOTHERAPY FOR DEPRESSION enning Sass, M.D., is currently Medical Director and Chair- Director: Henricus Van, M.D. Hman of the Board of Directors at the University Hospital of Faculty: Mariëlle Hendriksen, M.A., the University of Technology (RWTH) in Aachen/Aix-la-Chapelle, Germany. He studied medicine at the universities of Kiel, Vienna Annemieke Nooteboom, Ph.D., Jack J. Dekker, Ph.D., Frans and Mainz. After passing the state examination in Kiel and re de Jonghe, M.D., Ph.D., Simone Kool, Ph.D., M.D. 162ND ANNUAL MEETING 5 Sunday, May 17, 2009
ceiving his medical doctorate in Mainz, he was a resident in the 1. Neurobiology, Correlates and Measurement of Department of Psychiatry at the University of Heidelberg. Having Antipsychotic Non-response in Schizophrenia completed his training in clinical psychiatry and in psychotherapy, John Kane, M.D. he concentrated on forensic psychiatry, general psychopathology, diagnostic research and personality disorders. His habilitation on 2. Early Prediction of Antipsychotic Non-Response Psychopathie, Soziopathie, and Dissozialitat (Psychopathy, Soci- in Schizophrenia opathy and Dissocial Behaviors) was published by Springer (1987). Stefan Leucht, M.D. Previously, he was Professor of by Springer (1987). Previously, he was Professor of Forensic Psychiatry at the Ludwig-Maximilians 3. Therapeutic Management of Antipsychotic University in Munich, after which he was the Chair of Psy- Non-Response in Patients with Schizophrenia chiatry and Psychotherapy at the medical faculty in Aachen Christoph Correll, M.D. for 10 years. His research interest is forensic psychiatry, especially personality disorders. He is past president of the ISS 05 7:00 P.M.- 9:00 P.M. German Society for Psychiatry, Psychotherapy and Ner- Grand Ballroom Salon B, Grand Ballroom Level, vous Diseases (DGPPN) and the Association of European Hilton San Francisco Psychiatrists (AEP). He is editor of several scientifi c journals and member of numerous boards of scientifi c organizations in- THE PATHOPHYSIOLOGY OF ADHD: cluding the European Brain Council and the Research Council IMPLICATIONS FOR TREATMENT of the German Ministry for Science, Research and technology. Supported by Shire US, Inc. Chp.: Timothy Wilens, M.D. 5:00 P.M. SESSION 1. The Neurobiology of ADHD: Overview of the OFFICAL OPENING SESSION 5:00 - 6:30 P.M. Rm 134/135, Exhibit Hall E, Moscone Center Mechanisms of Effi cacious Agents Paul Hammerness, M.D. CALL TO ORDER Nada L. Stotland, M.D., M.P.H., President 2. Role of Dopamine in ADHD Darin Dougherty, M.D. INTRODUCTION OF STAGE GUESTS 3. Alpha-2A Agonists Strengthen Prefrontal Cortex INTRODUCTION OF SCIENTIFIC PROGRAM Function COMMITTEE Amy Arnsten, Ph.D. Josepha Cheong, M.D., Chairperson 4. Nicotinic Receptors and Agonists in ADHD INTRODUCTION OF VISITING DIGNITARIES Timothy Wilens, M.D. (List of Presidents of Allied Organization follows this page) PRESIDENTIAL ADDRESS ISS 06 7:00 P.M. -9:00 P.M. Nada L. Stotland, M.D., M.P.H. Salon 7/8, Lower B-2 Level, Marriott San Francisco AUGMENTATION STRATEGIES FOR MAJOR RESPONSE OF THE PRESIDENT ELECT DEPRESSIVE DISORDER: THE EVIDENCE FOR Alan F. Schatzberg, M.D. EFFECTIVE CLINICAL DECISION-MAKING IN ADJOURNMENT IMPROVING PATIENT CARE Supported by Bristol-Myers Squibb Chp.: Madhukar Trivedi, M.D. 7:00 P.M. SESSIONS 1. Atypical Antipsychotics as Augmentation Agents INDUSTRY-SUPPORTED DINNER for Major Depressive Disorder: Effi cacy and SYMPOSIA 4-6 Tolerability George Papakostas, M.D. ISS 04 7:00 P.M.-9:00 P.M. 2. Inadequate Treatment Response in Major Depressive Continental Ballroom 4/5/6, Ballroom Level, Tower 3, Disorder: Predictors and Strategies for Selecting Hilton San Francisco Next-Step Treatments NEUROBIOLOGY, PREDICTION AND MANAGE- Roy Perlis, M.D. MENT OF ANTIPSYCHOTIC NON-RESPONSE IN 3. Effective Management of Treatment-Resistant PATIENTS WITH SCHIZOPHRENIA Depression: Evidence-Based Approaches Beyond Supported by Lilly USA, LLC First-Line Antidepressant Monotherapy Chp.: Christoph Correll, M.D. Madhukar Trivedi, M.D.
6 WWW.PSYCH.ORG 2009 Presidents of Allied Organizations
Albanian Psychiatric Association Psychiatric Association of Bosnia- Egyptian Psychiatric Association Prof. Afrim Dangëllia Herzegovina Prof. Ahmed Okasha Prof. Marija Burgic-Radmanovic Algerian Psychiatric Association Salvadorean Association Prof. Farid Kacha Brazilian Association of Psychiatry of Psychiatry Dr. João Alberto Carvalho Dra. Claudia Beatriz Barahona Argentinean Association of Navarrete Psychiatrists (AAP) Psychiatric Association of Rio de Dr. Nestor F. Marchant Janeiro State (Brazil) Estonian Psychiatric Association Dr. Fatima Vasconcellos Dr. Andres Lehtmets Association of Argentinean Psychiatrists (APSA) Society of Psychiatry of Rio Grande Ethiopian Psychiatric Association Prof. Juan Carlos Stagnaro do Sul (Brazil) Dr. Mesfi n Araya Dr. Fernando Lejderman Foundation for Interdisciplinary Finnish Psychiatric Association Investigation of Communication Bulgarian Psychiatric Association Prof. Jyrki Korkeila (Argentina) Prof. Peter Marinov Prof. Miguel Angel Materazzi French Association of Psychiatrists Canadian Psychiatric Association in Private Practice Armenian Association of Psychia- Dr. Susan Abbey Dr. Olivier Schmitt trists and Narcologists Prof. Marietta Melik-Pashayan Society of Neurology, Psychiatry French Association of Psychiatry and Neurosurgery (Chile) Prof. Bernard Gibello The Royal Australian and New Dr. Juan Maass Zealand College of Psychistrists French Psychiatric Information Prof. Ken Kirkby Chinese Society of Psychiatry Society Prof. Dongfeng Zhou Dr. Nicole Garret-Gloanec Austrian Association for Psychiatry and Psychotherapy Hong Kong College of Psychiatrists International Society of Prof. Michael Musalek Dr. SF Hung Psychopathology of Expression (France) Colombian Psychiatric Association Azerbaijan Psychiatric Association Prof. J. G. Veyrat Prof. Nadir Ismayilov Dr. Carlos Alberto Miranda Bastidas Medical Psychologic Society (France) Costa Rican Psychiatric Association Arab Gulf Psychiatric Association Prof. J.D. Guelfi Prof. Mohamed Al-Haddad Dra. Yanira Obando Salazar The Psychiatric Evolution (France) Croatian Psychiatric Association Bangladesh Association of Dr. Yves Thoret Psychiatrists Prof. Ljubomir Hotujac Prof. Abdus Sobhan Society of Georgian Psychiatrists Cuban Society of Psychiatry Prof. George Naneishvili Barbados Association of Psychiatrists Dr. Miguel Valdes Mier Dr. Sharon Harvey German Society of Psychiatry, Cyprus Psychiatric Association Psychotherapy and Neurology Dr. Neophytos Papaneophytou Byelorussian Psychiatric Association Prof. Wolfgang Gaebel Prof. Roman A. Evsegneev Czech Psychiatric Association Ghana Psychiatric Association Prof. Mudr Jiri Raboch Royal Society of Mental Medicine Dr. Sammy Ohene of Belgium Danish Psychiatric Association Hellenic Psychiatric Association Prof. Jean Bertrand Dr. Anders Fink-Jensen (Greece) Society of Flemish Neurologists and Dominican Society of Psychiatry Prof. Nikolaos Tzavaras Psychiatrists (Belgium) Dr. Fior Solis de Mendez Prof. Bernard Sabbe Hellenic Society of Neurology and Ecuadorian Association of Psychiatry Psychiatry (Greece) Bolivian Society of Psychiatry Dr. José Cruz Dueñas Prof. Costas Stefanis Dr. Maria Rosario Del Carpio O
162ND ANNUAL MEETING a 2009 Presidents of Allied Organizations
Guatemalan Psychiatric Association Kuwait Psychiatric Association Netherlands Psychiatric Association Dr. See King Emilio Quinto Prof. Essam A. Al-Ansari Prof. Rutger Jan van der Gaag Honduran Society of Psychiatry Kyrgyz Psychiatric Association Nicaraguan Psychiatric Association Dr. Mario Mendoza Dr. Abjalal Begmatov Dr. Luis Aleman Hungarian Psychiatric Association Latvian Psychiatric Association Association of Psychiatrists in Prof. Janos Harmatta Prof. Raisa Andrezina Nigeria Prof. Oye Gureje Icelandic Psychiatric Association Lebanese Psychiatric Society Dr. Magnus Haraldsson Dr. Nabil Mikati Norwegian Psychiatric Association Dr. Jan Olav Johannessen Indian Association for Social Libyan Association of Psychiatry, Psychiatry Neurology and Neurosurgery Pakistan Psychiatric Society Prof. Roy Abraham Kallivayalil Dr. Aburkes Abduraouf Prof. Muhammad Riaz Bhatti Indian Psychiatric Society Lithuanian Psychiatric Association Palestinian Psychiatric Association Prof. Priyavadan Chandrashankar Prof. Algirdas Dembinskas Dr. Bassam Ashhab Shastri Luxembourguese Society of Panamanian Society of Psychiatry Indonesian Psychiatric Association Psychiatry, Neurology and Dr. Miguel Angel Cedeno Tello Prof. HM. Syamsul Hadi Psychotherapy Dr. Chretien Jacoby Papua New Guinea Psychiatric Iranian Psychiatric Association Association Dr. S. Ahmad Jalili Psychiatric Association of Macedonia Dr. Umadevi Ambihaipahar (Republic of Macedonia, FYROM) Iraqi Society of Psychiatrists Prof. Antoni Novotni Paraguayan Society of Psychiatry Dr. Muhammed Lafta Dr. José Britez Cantero Malaysian Psychiatric Association Irish College of Psychiatrists Dr. Yen Teck Hoe Peruvian Psychiatric Association Dr. Consilia Walsh Prof. Jorge Anibal Castro Morales Mauritius Psychiatric Association Israeli Psychiatric Association Dr. Mridula Suresh Naga Philippine Psychiatric Association Prof. Avi Bleich Dr. Imelda Batar Mexican Psychiatric Association Italian Association for Research Prof. Martha P. Ontivero Uribe Polish Psychiatric Association in Schizophrenia Prof. Aleksander Araszkiewicz Prof. Carlo Lorenzo Cazzullo Mexican Society of Neurology and Psychiatry Portuguese Association of Psychiatry Italian Psychiatric Association Dr. Juan Ignacio Rosales Prof. Jose C. Dias Cordeiro Dr. Mariano Bassi League for Mental Health from Portuguese Society of Psychiatry Jamaica Psychiatric Association Republic of Moldova and Mental Health Dr. Roger Gibson Dr. Mihail Hotineanu Prof. Adriano Vaz-Serra Japanese Society of Psychiatry Mongolian Mental Health Association of Free Psychiatrists and Neurology Association of Romania Prof. Takuya Kojima Dr. Bayankhuu Ayushjav Prof. Aurel Romila Jordan Association of Psychiatrists Montenegrin Psychiatric Association Romanian Psychiatric Association Dr. Tawfi k Daradkeh Dr. Lidija Injac-Stevovic Prof. Dan Prelipceanu Kazakh Association of Psychiatrists Moroccan Society of Psychiatry Independent Psychiatric Association and Narcologists Prof. M.F. Benchekroun of Russia Prof. Saltanat A. Nurmagambetova Prof. Yury Savenko Myanmar Medico-Psychological Kenya Psychiatric Association Society Russian Society of Psychiatrists Prof. Frank G. Njenga Prof. Sao Sai Lon Prof. Valery N. Krasnov Psychiatrists’ Association of Nepal Saudi Psychiatric Association Korean Neuropsychiatric Association Dr. Surendra Sherchan Dr. Mahdi S. Abumadini Dr. Soo-Churl Cho
b WWW.PSYCH.ORG 2009 Presidents of Allied Organizations
Society of Psychopathology and Mental Hygiene of Dakar (Senegal) Uganda Psychiatric Association Prof. Omar Sylla Dr. Fred Kigozi Association of Psychiatric Ukraine Scientifi c Society of Institutions of Serbia - UPUS Neurologists, Psychiatrists and Dr. Tanja Voskresenski Narcologists Prof. Petro V. Voloshyn Serbian Psychiatric Association Prof. Miroslava Jasovic Gasic Ukrainian Psychiatric Association Prof. Victor Shumlyansky Singapore Psychiatric Association Dr. Alex Su The Royal College of Psychiatrists Prof. Dinesh Bhugra Slovak Psychiatric Association Prof. Livia Vavrusova Society of Psychiatry of Uruguay Dr. Vicente Pardo Psychiatric Association of Slovenia Prof. Slavko Ziherl Association of Psychiatrists of Uzbekistan South African Society of Prof. Ulugbek Alimov Psychiatrists (SASOP) Dr. Jan Chabalala Venezuelan Society of Psychiatry Dr. Néstor Macías Spanish Association of Neuropsychiatry Yemen Psychiatrists and Neurologists Prof. Alberto Fernandez Liria Association Prof. Abdelmagid S. Al-Khulaidi Spanish Society of Psychiatry Prof. Jeronimo Saiz Sri Lanka College of Psychiatrists Dr. Balapuwadige Jayan Medis Sudanese Association of Psychiatrists Dr. Abdullah Abdelrahman Swedish Psychiatric Association Dr. Christina Spjut Swiss Society of Psychiatry Dr. Hans Kurt Syrian Arab Association of Psychiatrists Prof. Pierre Chiniara Taiwanese Society of Psychiatry Prof. Cheng-Chung Chen Psychiatric Association of Thailand Prof. Udomratn Pichet Tunisian Society of Psychiatry Dr. Essedik Jeddi Psychiatric Association of Turkey Prof. Seref Ozer Turkish Neuro-Psychiatric Association Prof. Peykan G. Gökalp 162ND ANNUAL MEETING c 2009 Presidents of Allied Organizations
NOTES
d WWW.PSYCH.ORG Monday, May 18, 2009
8:00 A.M. SESSIONS IMPORTANT REMINDER: COURSES 34-41 PROGRAM CHANGES ARE PRINTED EACH DAY IN THE DAILY BULLETIN - A COPY MAY BE OBTAINED COURSE 34 8:00 A.M. -12 NOON BY ATTENDEES THROUGHOUT THE MOSCONE Continental Ballroom 8, Ballroom Level, Tower 3, CONVENTION CENTER Hilton San Francisco 7:00A.M. SESSIONS EXPLORING TECHNOLOGIES IN PSYCHIATRY American Association for Technology in Psychiatry INDUSTRY-SUPPORTED BREAKFAST SYMPOSIA 7-8 Directors: Robert S. Kennedy, M.D., John Luo, M.D. Faculty: Carlyle Chan, M.D. ISS 07 7:00 A.M. -9:00 A.M. Grand Ballroom Salon B, Grand Ballroom Level, COURSE 35 8:00 A.M. - 12 NOON Tower 2, Hilton San Francisco Continental Ballroom 9, Ballroom Level, Tower 3, Hilton San Francisco AUGMENTATION STRATEGIES FOR MAJOR DEPRESSIVE DISORDER: THE EVIDENCE FOR TREATING MEDICAL STUDENTS AND EFFECTIVE CLINICAL DECISION-MAKING IN PHYSICIANS IMPROVING PATIENT CARE Directors: Michael F. Myers, M.D., Supported by: AstraZeneca Pharmaceuticals Leah J. Dickstein, M.D., M.A. Chp.: Madhukar Trivedi, M.D. Faculty: Penelope Ziegler, M.D. 1. Atypical Antipsychotics as Augmentation Agents COURSE 36 8:00 A.M. - 12 NOON for MDD: Effi cacy and Tolerability Franciscan Room A, Ballroom Level, Tower 1, George Papakostas, M.D. Hilton San Francisco 2. Inadequate Treatment Response in MDD: Predictors TREATING PHYSICIANS INVOLVED IN SEXUAL and Strategies for Selecting Next-Step Treatments MISCONDUCT Roy Perlis, M.D. Directors: Tracey I. Marks, M.D., Gene G. Abel, M.D. 3. Effective Management of Treatment-Resistant Depression: Evidence-Based Approaches Beyond COURSE 37 8:00 A.M. - 12 NOON First-Line Antidepressant Monotherapy Imperial Ballroom A, Ballroom Level, Tower 2, Madhukar Trivedi, M.D. Hilton San Francisco
ISS 08 7:00 A.M. -9:00 A.M. ADVANCED ASSESSMENT AND TREATMENT Yerba Buena Ballrooms 7 & 8, Lower B-2 Level, Marriott OF ADHD San Francisco Director: Thomas E. Brown, Ph.D. ADHD FAQS: PRACTICAL ANSWERS FOR THE Faculty: Jefferson Prince, M.D. OFFICE-BASED PRACTITIONER Supported by Shire US, Inc. COURSE 38 8:00 A.M. - 12 NOON Yosemite Room B, Ballroom Level, Tower 2, Chp.: Gabriel Kaplan, M.D. Hilton San Francisco 1. How Do I Identify and Treat Adult ADHD? Gabriel Kaplan, M.D. THE DETECTION OF MALINGERED MENTAL ILLNESS 2. Cardiovascular Effects of Stimulants--Is There Cause for Concern? Director: Phillip J. Resnick, M.D. Donald Greydanus, M.D. COURSE 39 8:00 A.M. - 12 NOON 3. How Do I Approach the Bipolar vs. ADHD Issue? Union Square Rooms 3/4, Fourth Floor, Tower 3, Jeffrey H. Newcorn, M.D. Hilton San Francisco 4. How Do I Manage the ADHD/SUD Comorbidity? IMPROVE YOUR PRESENTATION SKILLS: A Iliyan Ivanov, M.D. COACHING APPROACH Director: Luis F. Ramirez, M.D. 162ND ANNUAL MEETING 7 Monday, May 18, 2009
COURSE 40 8:00 A.M. - 12 NOON ankole A. Johnson, M.D., is Chairman of the Union Square Rooms 17/18, Fourth Floor, Tower 3, BDepartment of Psychiatry and Neurobehavioral Sci- ences at the University of Virginia, where he is also a pro- Hilton San Francisco fessor in the Departments of Neuroscience and Medicine. RESEARCH AND PUBLISHING ON A SHOESTRING Dr. Johnson graduated from Glasgow University with a degree BUDGET in medicine and trained in psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals. He trained in re- Director: Mantosh J. Dewan, M.D. search at the Institute of Psychiatry (University of London) and Faculty: Michele Pato, M.D., Edward Silberman, M.D. at Oxford University and earned his doctoral degree in Psycho- pharmacology from Glasgow University. His primary area of COURSE 41 8:00 A.M. - 12 NOON research expertise is the psychopharmacology of medications for Union Square Room 10, Fourth Floor, Tower 3, treating addictions; his clinical expertise is in addiction, biologi- Hilton San Francisco cal, and forensic psychiatry. He was the 2001 recipient of the Dan Anderson Research Award and received the Distinguished Senior APPLIED CULTURAL PSYCHIATRY: HOW THE Scholar of Distinction Award in 2002 from the National Medical DSM-IV-TR OUTLINE FOR CULTURAL FORMULA- Association. In 2006 he received the American Psychiatric As- TION CAN INFORM THE CLINICAL INTERVIEW sociation’s Distinguished Psychiatrist Lecturer Award. In 2007, he was named as a Fellow in the Royal College of Psychiatrists, Directors: Russell F. Lim, M.D., Francis G. Lu, M.D. and in 2008 he was elected to the status of Distinguished Fellow of the American Psychiatric Association. Dr. Johnson is on the 9:00 A.M. SESSIONS editorial board of The International Journal of Neuropsychophar- macology, has over 200 publications, and has edited two books. FOCUS LIVE! LECTURE 04 9:00 A.M. - 10:30 A.M. FOCUS LIVE 1 9:00 A.M. - 10:30 A.M. Gateway Ballroom 104, Exhibit Level, Moscone Center Room 130/131, Exhibit Level North, Moscone Center FOCUS LIVE! PSYCHIATRIC DIAGNOSIS AND PSYCHIATRISTS ROLE IN PREVENTION AND ASSESSMENT IN OLDER ADULTS INTERVENTION IN DOMESTIC VIOLENCE AMONG SOUTH ASIANS Presented by: Barry D. Lebowitz, Ph.D. Surinder Sucha Nand, M.D. he biological processes of aging are surprisingly not well Alexandra Symonds Award Tunderstood. Aging brings important changes, and some of these changes are often diffi cult to distinguish from the patho- Chp.: Asha S. Mishra, M.D. physiologically-based signs and symptoms of diseases common urinder S. Nand, M.D., is professor of Clinical Psychiatry and in older persons. The dynamics that have resulted in the growth Associate Director, Psychiatry Residency Training in the De- of the older population in general have also contributed to the in- S partment of Psychiatry at the University of Illinois at Chicago. creased prevalence of chronic conditions. Age of onset assumes a She served as the Director of the Mental Health Service Line at greater importance of diagnosis of the older patient. Co-morbid- the Jesse Brown VA Medical Center until May 2005. In 1991, she ity of psychiatric illness, acute physical illnesses, and other brain was appointed Director, Psychiatry Residency Training Program at disorders represent a second area of clinical signifi cance. This University of Illinois. She is a Distinguished Fellow of the Ameri- multiple-choice question based presentation will provide par- can Psychiatric Association (APA). She was elected President of ticipants with an opportunity to test their knowledge about diag- the Illinois Psychiatric Society (IPS) in 2005-2006. She has been nosis and treatment of older patients. In FOCUS Live! sessions, active in the American Psychiatric Association and served as the expert clinicians lead lively multiple choice question-based dis- Chair of the Asian-American Psychiatrists Committee of the APA cussions. Participants test their knowledge with an interactive from 2005-2007. She has been appointed as a member of the Sci- audience response system, which instantly presents the audience entifi c Program Committee of the APA from 2007-2011. Dr. Nand responses as a histogram on the screen. Questions cover existing became a member of The American College of Psychiatrists in knowledge on a clinical topic important to practicing general psy- 2001. She is currently President of the Indo American Psychia- chiatrists, including diagnosis, treatment, and new developments trists Association (IAPA). She volunteers her time for issues re- LECTURES 3-6 lated to suicide, domestic violence and homelessness. At present, she is Co-Vice President of the Board and Interim Executive Direc- tor [volunteer] of Apna Ghar [Our Home], an organization which LECTURE 03 9:00 A.M. - 10:30 A.M. provides services and programs for victims of domestic violence Gateway Ballroom 102, Exhibit Level, Moscone Center among South Asian and immigrant communities in Chicago. PILLS TO TREAT ALCOHOLISM The Association of Women Psychiatrists/APA Committee on Bankole A. Johnson, M.D., Ph.D., D.Sc. Women Solomon Carter Fuller Award Lecture Chp.: Michele Reid, M.D.
8 WWW.PSYCH.ORG Monday, May 18, 2009
LECTURE 05 9:00 A.M. - 10:30 A.M. kins Mood Disorders Center in the Department of Psychiatry. The Room 132/133, Exhibit Level North, Moscone Center primary focus of Dr. Potash’s research is the genetic basis of mood disorders. He has received major grants from the National Institute PSYCHIATRIC GENETICS: A CURRENT of Mental Health studying the genetics of bipolar disorder and major PERSPECTIVE depression, and the epigenetics of major depression. His two areas Kenneth Kendler, M.D. of research specialty have been the genetic basis of the psychotic Distinguished Psychiatrist Lecture form of bipolar disorder and the epigenetics of mood disorders. The author of numerous scientifi c papers, he has also collaborated on a Chp.: Julio Licino, M.D. revision of the textbook, Manic-Depressive Illness. He received Vice-Chp.: Srijan Sen, M.D., Ph.D. American Psychopathological Association’s Robins/Guze Award for Research Excellence in 2003. Dr. Potash has collaborated close- ly with Dr. Andrew Feinberg, Director of the Epigenetics Center of enneth Kendler, M.D., is the Rachel Brown Banks Distin- the Institute for Basic Biomedical Science at Johns Hopkins, and a Kguished Professor of Psychiatry and Professor of Human world leader in epigenetics. Drs. Potash and Feinberg co-direct an Genetics at the Medical College of Virginia of Virginia Common- Epigenetics Core Facility within the Johns Hopkins Brain Sciences wealth University. He also directs, along with Dr. Lindon Eaves, Institute. The Center is currently studying the epigenetics of major the Virginia Institute for Psychiatric and Behavioral Genetics. He depression, bipolar disorder, schizophrenia and autism. Dr. Potash has received a number of prestigious awards, including: the Lieber also has an Independent Investigator Award from the National Alli- Prize for Outstanding Research on Schizophrenia (1995); First ance for Research on Schizophrenia and Depression (NARSAD) to Prize from the Anna-Monika-Foundation for outstanding contribu- study the epigenetics of antidepressant response in an animal mod- tions to resarch on depression (1997); the Stanley R. Dean Award el. In addition to his research efforts, Dr. Potash is also an active cli- from the American College of Psychiatrists, for major contributions nician who sees patients in the Mood Disorders Consultation Clinic to the understanding of schizophrenic disorders (1998), and the and the Mood Disorders Inpatient Service at Johns Hopkins Hospital. Kurt Schneider Scientifi c Award for exceptional scientifi c achieve- ment in schizophrenia (1998). He has received an Honorary Doctor POSTER SESSION 1: of Science from the University of Birmingham, England, and is a NEW RESEARCH/YOUNG INVESTIGATORS member of the Institute of Medicine of the National Academy of For information on New Research Poster Sessions, please refer to Sciences. He was selected by Science Watch 2000 as the second most frequently cited author of high-impact papers in Psychiatry the New Research Program section in the back of this publication. for the years 1990-98 and was given the Edward Strecker Award (2000) for outstanding contributions to psychiatric care and treat- CASE CONFERENCES 1-2 ment. In 2001, he received two awards — the Fundacion Castillo del Pino 2001 Award in Spain for achievement in Psychiatry and THESE SESSSIONS ARE OPEN TO APA MEMBERS the Edward J. Sachar 2001 Award for outstanding contributions ONLY. A MEMBER REGISTRATION BADGE OR to psychiatric research. In 2002, he received the Rema Lapouse CURRENT APA MEMBERSHIP CARD IS REQUIRED Award for signifi cant contributions to the scientifi c understand- FOR ADMITTANCE. ing of epidemiology and control of mental disorders from the American Public Health Association. In 2003, he was awarded the Erik Stromgren Medal by the Stromgren Foundation in Den- mark, in 2006 the Judd Marmor Award from the American Psychi- CASE CONFERENCE 01 9:00 A.M. - 12:00 P.M. atric Association and in 2007, the 12th Howard P. Rome Lecturer Room 120, Exhibit Level North, Moscone Center Award from the Mayo Clinic, Mayo Clinic College of Medicine. PSYCHOANALYTIC CASE LECTURE 06 9:00 A.M. - 10:30 A.M. Chp.: Deborah Spitz, M.D. Room 303/305, Esplanade Level, Moscone Center Presented by Melvin Lansky, M.D. ETIOLOGY IN PSYCHIATRY: PHENOMES, GENOMES AND EPIGENOMES CASE CONFERENCE 02 9:00 A.M. - 10:30 A.M. James Potash, M.D., M.P.H. Room 121, Exhibit Level North, Moscone Center Frontiers of Science Lecture A POPULATION-BASED CASE CONFERENCE Chp.: David A. Mrazek, M.D. ILLUSTRATING THE IMPLEMENTATION OF AN EVIDENCED -BASED PREVENTION, INTERVEN- ames Potash, M.D., M.P.H., is a graduate of Yale College, where Jhe majored in English and was managing editor of the Yale Daily TION IN A COUNTRY WITH 200,000 PEOPLE News. Following graduation he served in the Peace Corps in West Africa, and there decided to become a physician. He received an Presented by Carl C. Bell, M.D. MPH and MD from Johns Hopkins University. He completed his psychiatry residency training at Hopkins as well, and in 1998 joined the faculty. He is currently the Arlene and Robert Kogod Associate Professor, and Director of Research Programs for the Johns Hop- 162ND ANNUAL MEETING 9 Monday, May 18, 2009
COMPONENT WORKSHOPS 1-6 Chp.: M. Justin Coffey, M.D. Participants: Kayla Pope, M.D., J.D., CW 1 9:00 A.M. -10:30 A.M. Mohammad Alsuwaidan, M.D., Claudia Reardon, M.D., Room 114, Exhibit Level North, Moscone Center Stacey Burpee, D.O., M.P.H. HIGH-RISK STUDENT POPULATIONS: INNOVA- TIVE APPROACHES TO TREATMENT AND ISSUE WORKSHOPS 1-13 OUTREACH Chp.: Jerald Kay, M.D. IW 1 9:00 A.M.-10:30 A.M. Participants: Marta Hopkinson, M.D., Room 111, Exhibit Level, Moscone Center Leigh Anne White, M.D., Beverly Fauman, M.D. INCREASING CULTURAL COMPETENCY TO CW 2 9:00 A.M.-10:30 A.M. ASSESS AND AMELIORATE DISTRESS OF DI- VERSE PATIENTS: EXAMPLE FROM THE CARE Room 220, Mezzanine Level, Moscone Center OF ASIAN VICTIM OF SPOUSAL ABUSE LOST AND NOT FOUND: DEPRESSION AND Co-Chps.: Jacob E. Sperber, M.D., Nyapati R. Rao, M.D., M.S. SUICIDE IN ELDERLY ASIAN AMERICANS Participant: Sadaf Ahmed, M.D. APA Committee of Asian-American Psychiatrists Chp.: Jacquelyn Chang, M.D. IW 2 9:00 A.M.-10:30 A.M. Participants: Dan Tzuang, M.D. Room 112, Exhibit Level, Moscone Center Megan Marumoto, M.D., Iqbal Ahmed, M.D. PRACTICAL PHARMACOTHERAPY FOR THE CW 3 9:00 A.M.-10:30 A.M. TREATMENT OF ALCOHOL DEPENDENCE National Institute on Alcohol Abuse and Alcoholism WITHDRAWN Co-Chps.: Robert M. Swift, M.D., Ph.D., CW 4 9:00 A.M.-10:30 A.M. Allen Zweben, D.S.W. Room 224, Mezzanine Level, Moscone Center INTERNATIONAL DISASTERS: CHALLENGES AND IW 3 9:00 A.M.-10:30 A.M. OPPORTUNITIES TO CONTRIBUTE Room 113, Exhibit Level, Moscone Center APA Committee on Psychiatric Dimensions of Disaster INCEST - A CULTURAL PERSPECTIVE Co-Chps.: Shirley Liu, M.D., APA Council on Global Psychiatry and the APA Council Patcho Santiago, M.D., M.P.H. on Children, Adolescents, and Their Families Participants: Joseph Napoli, M.D., Arshad Husain, M.D., Co-Chps.: Rodrigo A. Munoz, M.D. Robert Ursano, M.D., Artin Terhakopian, M.D., M.P.H. IW 4 9:00 A.M.-10:30 A.M. CW 5 9:00 A.M.-10:30 A.M. Room 122, Exhibit Level, Moscone Center Room 226, Mezzanine Level, Moscone Center PLAYING IN THE BIG LEAGUE: RESIDENT CAREER ADVANCEMENT IN ADMINISTRATIVE LEADERSHIP IN THE APA BOARD OF TRUSTEES PSYCHIATRY FOR EARLY CAREER Co-Chps.: Molly K. McVoy, M.D., Lauren Sitzer, M.D. PSYCHIATRISTS Participants: Otis Anderson III, M.D., APA Assembly Committee of Early Career Psychiatrists Carolyn B. Robinowitz, M.D., Pedro Ruiz, M.D. Co-Chps.: Dimitri D. Markov, M.D., IW 5 9:00 A.M.-10:30 A.M. Marina Goldman, M.D. Participants: Barry Herman, M.D., Room 125, Exhibit Level, Moscone Center Thomas Newmark, M.D., Shivkumar Hatti, M.D., M.B.A. RISK MANAGEMENT ISSUES IN PSYCHIATRIC PRACTICE CW 6 9:00 A.M.-10:30 A.M. Co-Chps.: Martin G. Tracy, J.D., Room 310, Esplanade Level, Moscone Center Jacqueline M. Melonas, J.D., R.N. SHOW ME THE MONEY! SUSTAINABLE FUNDING Participant: Harland Westgate, J.D. FOR EDUCATION IN PSYCHIATRY APA/GlaxoSmithKline Fellows
10 WWW.PSYCH.ORG Monday, May 18, 2009
IW 6 9:00 A.M.-10:30 A.M. Co-Chps.: Salvador R. del Rosario, M.D., Rooms 272, Mezzanine Level West, Moscone Center Tai P. Yoo, M.D., M.B.A., Susan Fauman
ETHICAL, CLINICAL AND LEGAL CHALLENGES IW 12 9:00 A.M.-10:30 A.M. CREATED BY INFORMATION TECHNOLOGY Room 308, Esplanade Level, Moscone Center Co-Chps.: Malkah T. Notman, M.D., Linda M. Jorgenson, J.D. USING THE DSM-IV-TR CULTURAL FORMULA- Participants: Elissa Benedek, M.D., Lea DeFrancisci, M.D., Carl Malmquist, M.D. TION FOR CULTURAL COMPETENCE SKILL BUILDING AMONG PSYCHIATRY RESIDENTS IW 7 9:00 A.M.-10:30 A.M. Co-Chps.: Treniece Lewis Harris, Ph.D., Room 300, Esplanade Level, Moscone Center Marshall Forstein, M.D. TECHNOLOGY AND PSYCHIATRY: PRACTICAL AND CLINICAL TIPS FOR USING IW 13 9:00 A.M.-10:30 A.M. TELEPSYCHIATRY Room 309, Esplanade Level, Moscone Center (For Residents Only) DIVERSION OF PRESCRIPTION STIMULANTS Co-Chps.: Jena Worley, M.D., Michael Houston, M.D. National Institute on Drug Abuse Participants: Don Hilty, M.D., Chad Koyanagi, M.D., Co-Chps.: Moira P. O’Brien, M.P.H., Peter Yellowlees, M.D. Wilson M. Compton III, M.D. IW 8 9:00 A.M.-10:30 A.M. Participants: Sean McCabe, Ph.D., Timothy Wilens, M.D. Room 301, Esplanade Level, Moscone Center MINDFUL PRACTICE: UNDERSTANDING ITS SMALL INTERACTIVE SESSION ROLE IN PSYCHIATRY AND PSYCHIATRIC TRAINING SI01 9:00 A.M. - 10:30 A.M. Room 216, Mezzanine Level East, Moscone Center Chp.: Tana A. Grady-Weliky, M.D. Participants: Scott McDonald, M.D., SAFETY ISSUES IN CHILD Jennifer Richman, M.D. PSYCHOPHARMACOLOGY IW 9 9:00 A.M.-10:30 A.M. Chp.: Barbara Coffey, M.D. Room 302, Esplanade Level, Moscone Center NEED TO REFORMULATE “RISK” AND ITS ADVANCES IN RESEARCH “ASSESSMENT” IN CLINICAL PRACTICE World Psychiatric Association ADVANCES IN RESEARCH 01 WITHDRAWN Chp.: Amresh K. A. Shrivastava, M.D., D.P.M. Participant: Charles Nelson, Ph.D. MEDIA WORKSHOPS 1-2 IW 10 9:00 A.M.-10:30 A.M. MW 1 9:00 A.M.-12:30 P.M. Room 304, Esplanade Level, Moscone Center Room 123, Exhibit Level, Moscone Center IMAGING INSIGHT: BASIC DEFINITIONS, READY? OK! A FILM ABOUT CHILDHOOD MEASURES, AND RELEVANCE TO GENDER VARIANCE PSYCHOPATHOLOGY American Academy of Child and Adolescent Psychiatry National Institute on Drug Abuse Chps.: Richard R. Pleak, M.D., Sarah E. Herbert, M.D., M.S.W. Co-Chps.: Steven Grant, Ph.D., Rita Goldstein Participant: Edgardo Menvielle, M.D. Participants: Jennifer Beer, Ph.D., Richard Lane, Nora D. Volkow, M.D. MW 2 9:00 A.M.-12:30 P.M. Room 124, Exhibit Level, Moscone Center IW 11 9:00 A.M.-10:30 A.M. Room 306, Esplanade Level, Moscone Center SILVER SPURS SEVERE AND CHRONIC MENTAL ILLNESS, AND LIFE IN A RESIDENTIAL CARE IMPLEMENTING A TELEPSYCHIATRY PROGRAM FACILITY IN THE KERN COUNTY MENTAL HEALTH SYSTEM IN RURAL CALIFORNIA: PART 2 Co-Chps.: Steven Harvey, M.D., Doug Whyte, B.S. 162ND ANNUAL MEETING 11 Monday, May 18, 2009
NEW CLINICAL KNOWLEDGE AND SKILLS COURSE 46 9:00 A.M.- 4:00 P.M. MASTER COURSE SERIES Union Square Room 14, Fourth Floor, Tower 3, Hilton San Francisco ADVANCES IN MONEY MATTERS I: USING THEORY IN NEUROPSYCHIATRY CLINICAL PRACTICE CKS03 9:00 AM- 4:00PM Director: Cecilia M. Mikalac, M.D. Grand Ballroom, Salon A Level, Tower 2 Hilton San Francisco COURSE 47 9:00 A.M.- 4:00 P.M. DIRECTOR: C. EDWARD COFFEY, M.D. Union Square Rooms 15/16 Fourth Floor, Tower 3, Faculty: Jeffrey L. Cummings, M.D., Hilton San Francisco Mark S. George, M.D., Nancy Minshew, M.D., TREATING BORDERLINE PERSONALTY Randolph Schiffer, M.D. DISORDERS WITH THE STEPPS MODEL Separate fee required: Textbook Included Director: Donald W. Black, M.D. Faculty: Nancee Blum, M.S.W., L.C.S.W. COURSES 42-49 COURSE 48 9:00 A.M.- 4:00 P.M. COURSE 42 9:00 A.M.- 4:00 P.M. Union Square Rooms 19/20, Fourth Floor, Tower 3, Continental Ballroom 1, Ballroom Level, Tower 3, Hilton San Francisco Hilton San Francisco A DEVELOPMENTAL APPROACH TO UNDERSTANDING THE PERSON BEHIND THE CONTEMPORARY ISSUES IN PSYCHOTHERAPY ILLNESS: AN APPROACH TO PSYCHODYNAMIC WITH GAY MEN FORMULATION Directors: Robert M. Kertzner, M.D., Marshall Forstein, M.D. Director: William H. Campbell, M.D., M.B.A. Faculty: Stewart Adelson, M.D. COURSE 43 9:00 A.M.- 4:00 P.M. COURSE 49 9:00 A.M.- 4:00 P.M. Continental Ballroom 2, Ballroom Level, Tower 3, Union Square Rooms 23/24, Fourth Floor, Tower 3, Hilton San Francisco Hilton San Francisco DAVANLOO’S INTENSIVE SHORT-TERM DYNAM- THERAPEUTIC INTERVENTIONS IN EATING IC PSYCHOTHERAPY IN CLINICAL PRACTICE DISORDERS: BASIC PRINCIPLES Directors: James Q. Schubmehl, M.D., Alan R. Beeber, M.D. Director: David C. Jimerson, M.D. Faculty: Joel Yager, M.D., Katherine Halmi, M.D., COURSE 44 9:00 A.M.- 4:00 P.M. Michael Devlin, M.D., James Mitchell, M.D. Imperial Ballroom B, Ballroom Level, Tower 2, Hilton San Francisco DRUG INTERACTION PRINCIPLES COURSE: UPDATE 2009 Academy of Psychosomatic Medicine NOW OPEN Directors: Scott C. Armstrong, M.D., Gary Wynn, M.D. EXHIBIT HALL APA MEMBER CENTER COURSE 45 9:00 A.M.- 4:00 P.M. PUBLISHER’S BOOK FAIR Yosemite Room A, Ballroom Level, Tower 2, HOURS OF OPERATION Hilton San Francisco 10:00 A.M. - 5:00 P.M. GOING FROM THE BIO-BIO-BIO MODEL FOR- WARD TO BIO-PSYCHO-SOCIAL REASONING Director: Paul R. McHugh, M.D. Faculty: Alan Romanoski, M.D., M.P.H., 11:00 A.M. SESSIONS Glenn Treisman, M.D., Ph.D.
12 WWW.PSYCH.ORG Monday, May 18, 2009
11:00 A.M. SESSIONS Chp.: Kenneth Silk, M.D. Participants: Don Hilty, M.D., Philip Muskin, M.D., M.A., ADVANCES IN MEDICINE James Scully, Jr., M.D., Josepha Cheong, M.D., Srijan Sen, M.D., Kelli Harding, M.D., Ken Silk, M.D. ADVANCES IN MEDICINE 01 11:00 A.M. - 12:30 P.M. FORUM 03 11:00 A.M. - 12:30 P.M. Room 300, Esplanade Level, Moscone Center Room 306, Esplanade Level, Moscone Center THE TOP 10 MEDICAL ARTICLES OF 2008: A DEVELOPING THE NEXT GENERATION OF COMPREHENSIVE AND PRACTICAL REVIEW OF CLINICAL TRANSLATIONAL RESEARCHERS: WHAT WE NEED TO KNOW INNOVATION IN AN ACADEMIC DEPARTMENT OF Chp.: Monique Yohanan, M.D. PSYCHIATRY Chp.: Renee Binder, M.D. FOCUS LIVE! Participants: Renee Binder, M.D., Daniel Mathalon, Ph.D., FOCUS LIVE 2 11:00 A.M. - 12:30 P.M. M.D., Kristine Yaffe, M.D. Gateway Ballroom 104, Exhibit Level, Moscone Center FORUM 04 11:00 A.M. - 12:30 P.M. FOCUS LIVE! PTSD AND DISASTER PSYCHIATRY Room 307, Esplanade Level, Moscone Center
Presented by: Anand Pandya, M.D. WOMEN WITH ALCOHOL DISORDERS: RE- SEARCH UPDATES FOR TREATMENT INOVATION n the seven years since the 9-11 attacks and the four years since IHurricane Katrina, American psychiatry has developed an in- Chp.: Grace Chang, M.D. creased interest in the psychiatric sequellae to disasters. This has Participants: Chang Grace, M.D., M.P.H., Nancy Goler, helped the fi eld to develop greater sophistication in epidemiology M.D., Shelly F. Greenfi eld, M.D., M.P.H., and in the treatment of individuals affected by disasters. Large scale Lee Ann Kaskutas, Ph.D. tragedies underscore the increasing role that psychiatrists play in aiding survivors, emergency workers, and broader communities to LECTURES 7-9 cope with disaster. The fi eld of disaster psychiatry, itself, needs to be understood in relationship to other areas of psychiatry such as trauma psychiatry and military psychiatry. Reactions to stress occur LECTURE 07 11:00 A.M. - 12:30 P.M. in stages, each one characterized by a specifi c psychological mecha- Room 130/131, Exhibit Level North, Moscone Center nism. This multiple-choice question based presentation will pro- vide participants with an opportunity to test their knowledge about PSYCHIATRIC EDUCATION ACROSS diagnosis and treatment of PTSD and about Disaster Psychiatry. In CIVILIZATIONS: THE SEARCH FOR A FOCUS Live sessions, expert clinicians lead lively multiple choice GURU AND THE IMG question-based discussions. Participants test their knowledge with Nyapati R. Rao, M.D., M.S. an interactive audience response system, which instantly presents the George Tarjan Award Lecture audience responses as a histogram on the screen. Questions cover existing knowledge on a clinical topic important to practicing general Chp.: Marie Claude Rigaud, M.D. psychiatrists, including diagnosis, treatment, and new developments. Nyapati R. Rao, M.D., is the chair of the Department of Psy- FORUMS 1-4 chiatry and Behavioral Sciences at Nassau University Medi- FORUM 01 TIME CHANGED 12-1:30 P.M. cal Center in Long Island. He was born and completed his Gateway Ballroom 102, Exhibit Level, Moscone Center medical education in India. Interested in a career in psychia- try in the United States, Dr. Rao completed his postgradu- DSM-V: PROGRESS IN RESEARCH AND ate training at the Brookdale Hospital Medical Center in DEVELOPMENT (DSM Track 01) Brooklyn. In 1987, he became the Director of Residency Chp.: Darrel Regier, M.D. Training at Brookdale. In 2000, Dr.Rao accepted the resi- Participants: Darrel A. Regier, M.D., David Kupfer, M.D., dency training director position at SUNY-Downstate Medi- Norman Sartorius, M.D., Ph.D. cal Center, in Brooklyn. He also is the Director of residency Training at NUMC, where he assumed the chair in 2006. FORUM 02 11:00 A.M. - 12:30 P.M. He continues to maintain his appointment as Professor of Room 301, Esplanade Level, Moscone Center Clinical Psychiatry at SUNY-Downstate. Throughout his career, Dr. Rao has worked to address the issues faced by THE RELATIONSHIP BETWEEN APA AND THE IMGs a priority of psychiatric education.Dr. Rao chaired PHARMACEUTICAL INDUSTRY: HISTORICAL the APA Council on Medical Education and Life Long AND CURRENT PERSPECTIVES AND ISSUES Learning from 2000-2004 and recently completed his term 162ND ANNUAL MEETING 13 Monday, May 18, 2009
as the president of Brooklyn Psychiatric Society. He is the health, having published four books and more than two dozen arti- founding chair of the Committee on IMGs at GAP, a member of cles. Current projects include empirical studies on informed consent ACP, and a consultant to the AMA- IMG Governing Council. and competency. Professor Saks is an elected member of the Amer- Dr. Rao’s contributions for IMGs include creation of the IMG ican Law Institute and has been awarded numerous awards, includ- Award and mentorship program at AADPRT, creating an APA- ing USC’s 2004 Associates Award for Creativity in Research and supported Diagnostic Evaluation Program for psychiatrists un- Scholarship and 2004 and 2007 Phi Kappa Phi Faculty Recognition able to pass the Oral Board exam, and recently organizing the Award; The Books for a Better Life Inspirational Memoir Award; IMG Resident Institute at the APA Annual Meeting, which helps and Top Ten Nonfi ction Book of the Year from Time Magazine. IMG residents orient to US psychiatry . Dr. Rao is a Distin- Professor Saks is on the board of several mental health nonprofi ts, guished Fellow of the APA, and last year received the Educator including the Bazelon Center for Mental Health Law in Washing- of the Year Award from the Association of Academic Psychiatry. ton, D.C., and Mental Health Advocacy Services in Los Angeles.
LECTURE 08 11:00 A.M. - 12:30 P.M. SCIENTIFIC AND CLINICAL REPORT Room 132/133, Exhibit Level North, Moscone Center SESSIONS 1-8 MENTAL HEALTH IN THE NEW ERA OF COST SCR 01 11:00 A.M. - 12:30 A.M. CONTAINMENT Room 111, Exhibit Level, Moscone Center Richard Frank, Ph.D. Frontiers of Science Lecture FORENSIC PSYCHIATRY
Chp.: Renato D. Alarcon, M.D., M.P.H. Chp.: Dan Coleman, M.D. 1. Characteristics of Mentally Ill Offenders From 100 Richard G. Frank, Ph.D., is the Margaret T. Morris Professor of Psychiatric Court Reports Health Economics in the Department of Health Care Policy at Yasser Elsayed, M.D. Harvard Medical School. He is also a Research Associate with the National Bureau of Economic Research. Dr. Frank is engaged in 2. Homicide During the First Episode of Psychotic research in three general areas: 1) the economics of mental health Illness care; 2) the economics of the pharmaceutical industry; and 3) pay- Olav Nielssen, M.B.B.S ment policy and physician practices. Dr. Frank served on the Con- gressional Citizen’s Working Group on Health Care. He advises 3. Differences Between Men and Women Found Not several state mental health and substance abuse agencies on issues Guilty By Reason of Insanity for Homicide Offenses related to managed care and fi nancing of care. Frank serves as Co- at Napa State Hospital Editor of the Journal of Health Economics. In 1997 He was elected Jessica Ferranti, M.D. to the Institute of Medicine. Dr. Frank was awarded the Georgescu- Roegen prize from the Southern Economic Association for his col- SCR 2 11:00 A.M. - 12:30 A.M. laborative work on drug pricing, the Carl A. Taube Award from the Room 112, Exhibit Level, Moscone Center American Public Health Association for outstanding contributions to mental health services and economics research, and the Emily MEASUREMENT OF PERSONALITY DISORDER Mumford Medal from Columbia University’s Department of Psy- SEVERITY chiatry. Dr Frank received the John Eisberg Mentorship Award from National Research Service Awards. He and Sherry Glied recently Chp.: Adel Gabriel, M.D. published the book Better but Not Well (Johns Hopkins Press.) 4. The Severity Indices of Personality Problems - A New Dimensional Questionnaire for Measuring LECTURE 09 11:00 A.M. - 12:30 P.M. (mal) Adaptive Personality Functioning Room 303/305, Esplanade Level, Moscone Center Helene Andrea, Ph.D. THE CENTER CANNOT HOLD: 5. Severity Indices of Personality Problems (SIPP-118) MY JOURNEY THROUGH MADNESS in Adolescents: Factor Structure and Validity Elyn Saks, J.D. Joost Hutsebaut, Ph.D. Chp.: Dillip Jeste, M.D. 6. The Severity Indices of Personality Problems (SIPP-118) as a Clinical Instrument Elyn R. Saks is Orrin B. Evans Professor of Law, Psychology, and Psychiatry and the Behavioral Sciences at the University of South- Dineke Feenstra, M.A. ern California Gould School of Law. She is also Associate Dean for SCR 3 11:00 A.M. - 12:30 P.M. Research at the USC Law School; Adjunct Professor of Psychia- try, University of California, San Diego, School of Medicine; and Room 113, Exhibit Level, Moscone Center Research Clinical Associate at the New Center for Psychoanalysis. GENETIC, NEUROIMAGING, AND NEUROPSY- Professor Saks received her BA from Vanderbilt University; an CHOLOGICAL STUDIES IN SCHIZOPHRENIA M.Litt,. in philosophy from Oxford University; and a J.D. from Yale Chp.: Anna Molofsky, M.D. Law School. She writes extensively in the area of law and mental 14 WWW.PSYCH.ORG Monday, May 18, 2009
7. Does Aberrant Stimulus Salience Lead to Psychosis 16. Who Receives Guideline-Based Pharma in Schizophrenia? A 20-Year Longitudinal Study cotherapy for Bipolar Depression? Martin Harrow, Ph.D. Megan Ehret, Pharm.D. 8. Association of G-1438A Polymorphism of 5HT2A 17. Psychiatric Admissions and Hospital Receptor With Schizophrenia in Three Ethnic ization Costs in Bipolar Disorder in Groups in Malaysia Sweden Zahurin Mohamed, B.S.C., Ph.D. Anne Tiainen, M.P.H. 9. MEG Analysis of Early Processing of Facial 18. Symptoms and Treatment of Bipolar Expressions in Schizophrenia and Controls Disorder in Sweden Mats Adler, M.D. Stephen Lewis, M.D. SCR 4 11:00 A.M. - 12:30 P.M. SCR 7 11:00 A.M. - 12:30 P.M. Room 114, Exhibit Level, Moscone Center Room 122, Exhibit Level, Moscone Center ADJUNCTIVE TREATMENT AND COMORBIDITY THE BROAD REACH OF PSYCHIATRY: IN SCHIZOPHRENIA STUDYING HISTORY, PEACEKEEPING & THE Chp.: Susan Stabinsky, M.D. ROLE OF SPIRITUALITY IN SCHIZOPHRENIA 10. Effects of Adjunctive Treatment With Armodafi nil Chp.: Derya Akibiyik, M.D. in Schizophrenia 19. The Modern History of American Psychiatry: Ashwin A. Patkar, M.D. Unintended Consequences 11. Prevalence of Alcohol Use Disorders Milton Kramer, M.D. in Schizophrenia: A Systematic Review and Meta- 20. Is Peacekeeping Peaceful? A Systematic Review Analysis Jitender Sareen, M.D. Jouko Miettunen, Ph.D. 21. Spiritual and Religious Coping in Schizophrenia: 12. Zolpidem in Treatment-Resistant Catatonia: Case Clinical Implications Reports and Literature Review Philippe Huguelet, M.D. Cristinel Coconcea, M.D. SCR 5 11:00 A.M. - 12:30 P.M. SCR 08 11:00 A.M. - 12:30 P.M. Room 234, Mezzanine Level, Moscone Center Rooms 272/274/276, Mezzanine Level West, Moscone Center PSYCHOPHARMACOLOGY, PSYCHOSTIMU- LANTS AND ANTIDEPRESSANT SIDE EFFECTS STUDIES IN PSYCHOTHERAPY Chp.: Merra Vasawni, M.D. Chp: Waguih Ishak, M.D. 13. Linking ADHD Ratings and Clinical Global 22. Follow-Up Psychotherapy Outcome of Patients Impressions Scores in Studies of Lisdexamfetamine With Dependent, Avoidant and Obsessive- Dimesylate in ADHD Compulsive Personality Disorders: Richard Weisler, M.D. A Meta-Analytic Review Witold Simon M.D. 14. Antidepressant-Induced Excessive Sweating (ADIES): Measurement and Treatment 23. The Effectiveness of Evidence-Based Treatments Rajnish Mago, M.D. for MDD in a Routine Clinical Setting; Results From an Observational Study 15. Armodafi nil Once Daily Sustains Wakefulness Frenk Peeters M.D., Ph.D. Throughout the Day in Patients With Excessive Sleepiness Associated With Narcolepsy 24. The Effectiveness of a Group-Oriented Inpatient Thomas Roth, Ph.D. CBT Program Katherine Lynch, Ph.D. SCR 6 11:00 A.M. - 12:30 P.M. Room 121, Exhibit Level, Moscone Center Bipolar Disorder Chp.: Vivek Singh, M.D.
162ND ANNUAL MEETING 15 Monday, May 18, 2009
SMALL INTERACTIVE SESSION IW 15 11:00 A.M.-12:30 P.M. Room 224, Mezzanine Level, Moscone Center SI 02 11:00 A.M. - 12:30 P.M. Room 216, Mezzanine Level East, Moscone Center MAN AND NON-MAN MADE DISASTERS IN ASIA: THE ROLE OF RESILIENCE PSYCHIATRIC ISSUES RELATED TO RETURNING VETERANS FROM IRAQ Chp.: Pedro Ruiz, M.D. Participants: Tsuyoshi Akiyama, M.D., Chp.: Charles Hoge, M.D. Haroon Chaudhry, M.B.B.S., Chiao-Chicy Chen, M.D., Russell D’Souza, M.D. COMPONENT WORKSHOP SESSIONS 7-9 CW 7 11:00A.M.-12:30 P.M. IW 16 Room 220, Mezzanine Level, Moscone Center WITHDRAWN
REVITALIZING SERVICE: STRATEGIC PLANNING IW 17 11:00 A.M.-12:30 P.M. SUCCESS WITHIN DISTRICT BRANCHES AND Room 304, Esplanade Level, Moscone Center STATE ASSOCIATIONS APA Council on Member and District Branch Relations CAN DISCLOSURE OF A DIAGNOSIS OF BPD HELP GUIDE TREATMENT FOR CLINICIANS, PATIENTS Chp.: Nioaka N. Campbell, M.D. AND FAMILIES? Participants: Lasa Joiner, Laura Michaels, J.D., Warene Chase-Eldridge Chp.: Richard G. Hersh, M.D. CW 8 11:00 A.M.-12:30 P.M. Participants: Perry Hoffman, Ph.D., Dale Terilli, B.A. Room 222, Mezzanine Level, Moscone Center IW 18 11:00 A.M.-12:30 P.M. COMBAT TO COMMUNITY: NEEDS AND Room 308, Esplanade Level, Moscone Center RESOURCES FOR POST-SEPTEMBER 11TH VETERANS AND THEIR FAMILIES APPLICATION OF CULTURAL VARIABLES FOR APA Alliance THE PRACTICE OF EFFECTIVE PSYCHOTHERA- PY OF INDIANS SETTLED IN USA Chp.: Kay Brada Participants: Mai-Ling Garcia, B.A., Amy Fairweather, J.D. Co-Chps.: Nitin Gupta, M.D., Vijoy Varma, M.D.
CW 9 11:00 A.M.-12:30 P.M. IW 19 11:00 A.M.-12:30 P.M. Room 226, Mezzanine Level, Moscone Center Room 309, Esplanade Level, Moscone Center BECOMING A PUBLIC PSYCHIATRY LEADER: COGNITIVE THERAPY FOR PSYCHOSIS IN PRAC- MENTORING MODELS FOR EVERYONE, FROM TICE BY PSYCHIATRISTS: BASIC TECHNIQUES RESIDENTS TO MEDICAL DIRECTORS Co-Chps.: Shanaya Rathod, M.D., APA Council on Social Issues and Public Psychiatry Douglas Turkington, M.D. Chp.: Peter L. Chien, M.D., M.A. Participant: David Kingdon, M.D. Participants: Susan Boust, M.D., David Pollack, M.D., Anita Everett, M.D., Annelle Primm, M.D., M.P.H. IW 20 11:00 A.M.-12:30 P.M. Room 310, Esplanade Level, Moscone Center ISSUE WORKSHOPS 14-20 RESIDENT WELLNESS SURVEY RESULTS AND DISCUSSION IW 14 11:00 A.M.-12:30 P.M. Room 125, Exhibit Level, Moscone Center Co-Chps.: Paul J. O’Leary, M.D., Hind Benjelloun, M.D. Participant: Leah Dickstein, M.D. CHALLENGING STIGMAS & STEREOTYPES: INTEGRATED THERAPY FOR PATIENTS WITH 12:00 NOON SESSION MULTIDIAGNOSED ADDICTION COMBINING IN- NOVATIVE WITH TRADITIONAL APPROACHES FORUM 01 12:00 NOON -1:30 P.M. Chp.: Michael M. Scimeca, M.D. Gateway Ballroom 102, Exhibit Level, Moscone Center Participants: Felicity L. LaBoy, Ph.D., DSM-V: PROGRESS IN RESEARCH AND Brian D. Higgins, Ph.D., Beryl D. Sinclair, NP DEVELOPMENT (DSM Track 01)
16 WWW.PSYCH.ORG Monday, May 18, 2009
12:30 P.M. SESSION 2:00 P.M. SESSIONS
NEW RESEARCH POSTER SESSION 2: FOCUS LIVE! YOUNG INVESTIGATORS FOCUS LIVE 3 2:00 P.M. - 3:30 P.M. See New Research Program section in back of this book. PANIC AND SOCIAL ANXIETY DISORDER
1:00 P.M. SESSIONS Moderators: Deborah Hales, M.D., Presenter: Mark Rapaport, M.D. COURSES 50-54 COURSE 50 1:00 P.M.- 5:00 P.M. Anxiety disorders are among the most common mental health problems in the United States, affecting 18% of adults in a giv- Continental Ballroom 9, Ballroom Level, Tower 3, en year and almost 30% at some point during their lifetime. They Hilton San Francisco are associated with a wide range of distressing psychological and somatic symptomatology, as well as disability across broad do- DEVELOPMENT OF INTEGRATED CARE MODELS mains of work, social and family function. There are a number FOR PATIENTS WITH HEPATITIS C AND of effective pharmacological and psychosocial interventions with COMORBID PSYCHIATRIC AND SUBSTANCE USE which to treat individuals affected by social anxiety disorder and DISORDERS panic disorder, although there remains a signifi cant unmet need for more effective, well-tolerated, and readily administered interven- Director: Muhamad Aly Rifai, M.D., Peter Hauser, M.D. tions that can move more patients from symptomatic to remitted Faculty: Ondria Gleason, M.D., David Indest, Psy.D., status. This multiple-choice question based presentation will pro- Eric Dieperink, M.D. vide participants with an opportunity to test their knowledge about diagnosis and treatment of these disorders. In FOCUS Live! ses- COURSE 51 1:00 P.M.- 5:00 P.M. sions, expert clinicians lead lively multiple choice question-based Imperial Ballroom A, Ballroom Level, Tower 2, discussions. Participants test their knowledge with an interactive Hilton San Francisco audience response system, which instantly presents the audience responses as a histogram on the screen. Questions cover existing MULTIDISCIPLINARY TREATMENT OF CHRONIC knowledge on a clinical topic important to practicing general psy- PAIN chiatrists, including diagnosis, treatment, and new developments. Directors: Vladimir Bokarius, M.D., Ph.D., Steven Richeimer, M.D. LECTURE 10 Faculty: Tina Young, O.T., OTR/L, Lisa Victor, Ph.D., Yogi Matharu, D.P.M., Ali Nemat, M.D. LECTURE 10 2:00 P.M. - 3:30 P.M. Room 130/131, Exhibit Level, Moscone Center COURSE 52 1:00 P.M.- 5:00 P.M. Franciscan Room A, Ballroom Level, Tower 1, SUCCESSFUL AGING AND WISDOM: Hilton San Francisco ARE THESE FOR REAL? Dilip Jeste, M.D. CURRENT PROCEDURAL TERMINOLOGY Distinguished Psychiatrist Lecture CODING AND DOCUMENTATION Chp.: Iqbal Ahmed, M.D. Directors: Chester W. Schmidt, M.D., Tracy R. Gordy, M.D. Vice-Chp.: Josepha Cheong, M.D. Faculty: Ronald Burd, M.D., David Nace, M.D., Jeremy Musher, M.D., Allan Anderson, M.D. ilip Jeste, M.D., is Estelle and Edgar Levi Chair in Aging, DDirector of the Stein Institute for Research on Aging, and COURSE 53 1:00 P.M.- 5:00 P.M. Distinguished Professor of Psychiatry and Neurosciences, Univer- Yosemite Room B, Ballroom Level, Tower 2, sity of California, San Diego and VA San Diego. He is Director of the NIMH-funded Advanced Center for Innovation in Services Hilton San Francisco and Intervention Research, and of the John A. Hartford Center of THE PSYCHIATRIST AS EXPERT WITNESS Excellence in Geriatric Psychiatry. He has received APA’s Award for Research in Psychiatry, Jack Weinberg Memorial Award, and Director: Phillip J. Resnick, M.D. George Tarjan Award, and has been listed in “The Best Doc- tors in America.” He has published nine books and over 500 COURSE 54 1:00 P.M.- 5:00 P.M. articles, and received a number of federal grants. He is a mem- Union Square Rooms 3/4, Fourth Floor, Tower 3, ber of the Institute of Medicine of the National Academy of Sci- Hilton San Francisco ences, and Editor of the American Journal of Geriatric Psychiatry. He is in the ISI list of “world’s most cited authors” comprising REEL PSYCHIATRY less than 0.5% of all publishing researchers of last two decades. Directors: Luis F. Ramirez, M.D., David Robinson, M.D. 162ND ANNUAL MEETING 17 Monday, May 18, 2009
ADVANCES IN SERIES 1-3 Laura F. McNicholas, M.D., Ph.D. 4. Treatment of Tobacco Addiction: Integration with ADVANCES IN 01 2:00 P.M.-5:00 P.M. Psychiatric Care for People with Mental Health and Gateway Ballroom 102, Exhibit Level, Moscone Center Addictive Disorders ADVANCES IN NEUROPSYCHIATRY AND Tony P. George, M.D. CLINICAL NEUROSCIENCES 5. Treating Addiction with Alcoholics Anonymous Chp.: Stuart Yudofsky, M.D. Marc Galanter, M.D. Co-Chp.: Robert E. Hales, M.D., M.B.A. DSM TRACK 1. Windows to the Brain: Clinical and Functional DSM SYMPOSIUM 2:00 P.M. -5:00 P.M. Imaging in Psychiatry Room 132/133, Exhibit Level, Moscone Center Robin A. Hurley, M.D. EVOLUTION OF THE DSM-V CONCEPTUAL 2. Current Controversies and Research Oportunities FRAMEWORK: DEVELOPMENT, DIMENSIONS, in the Neuropsychiatric Aspects of Delirium DISABILITY, SPECTRA AND GENDER/CULTURE Paula Trzepacz, M.D. Chair: Darrel Regier, M.D. 3. Neuropsychiatry of Traumatic Brain Injury Jonathan Silver, M.D. 1. Incorporating Developmental Variations of Disorder Expression Across the Lifespan: The Signifi cance of 4. Advances in Neuropsychiatric Disorders Associated Later Life With Cerebrovascular Disease Warachal Faison, M.D. Robert G. Robinson, M.D. 2. Diagnostic Parity: Incorporating Gender Issues Parity ADVANCES IN 02 2:00 P.M.-5:00 P.M. in the DSM-V Text and Categories Gateway Ballroom 103, Exhibit Level, Moscone Center Kimberly Yonkers, M.D. ADVANCES IN PSYCHOPHARMACOLOGY 3. One Way Forward for Psychiatric Nomenclature: The Example of the Spectrum Project Chp.: Alan Schatzberg, M.D., Charles Nemeroff, M.D Ellen Frank, Ph.D. 1. Personalized, Quantitative, Evidence-Based Treat- 4. Clinical Signifi cance and Disorder Thresholds in DSM-V: The Role of Disability and Distress ment for Bipolar Disorders William E. Narrow, M.D. Terence Ketter, M.D. 5. Enhancing Research and Treatment of Mental 2. ECT and Other Non-Pharmacological Treatments Disorders with Dimensional Concepts: A DSM-V William M. McDonald, M.D. Agenda 3. Pharmacotherapy Options for TRD Robert Krueger, Ph.D. Linda Carpenter, M.D. PRESIDENTIAL SYMPOSIA 1-2 4. An Update on Pharmacological Treatment of PS 1 2:00 P.M. - 5:00 P.M. Schizophrenia Room 300, Esplanade Level, Moscone Center Alan I. Green, M.D. 5. Perinatal Mood Disorders: Risk Appraisal & Risk IS PSYCHIATRY BETTER FOR PATIENTS AND Management PHYSICIANS IN A REAL HEALTH CARE SYSTEM? D. Jeffrey Newport, M.D., M.S., M.Div. Chair: Gisele Apter, M.D., Ph.D. ADVANCES IN 03 2:00 P.M.-5:00 P.M. 1. The U.S. Non-System Room 303/305, Esplanade Level, Moscone Center Steven Shafestein, M.D. ADVANCES IN SUBSTANCE ABUSE 2. National Health Service in the United Kingdom Dinesh Bhugra, M.B.B.S Chp.: Mark Galanter, M.D., Herbert Kleber, M.D 3. The Australian Mental Health System: A Complex 1. Treating Opioid and Marijuana Addiction Mix Moving Forward. Mark Kleberm, M.D. Beverley Raphael, M.D 2. Pharmacologic Treatment of Alcoholism 4. The Fench National Health System: How Much Care Hugh Myrick, M.D. for All and For How Long? 3. Treating Prescription Drug Abuse Gisele Apter, M.D.
18 WWW.PSYCH.ORG Monday, May 18, 2009
PS2 2:00 P.M. - 5:00 P.M. SYMPOSIUM 02 2:00 P.M.- 5:00 P.M. Room 301, Esplanade Level, Moscone Center Room 112, Exhibit Level, Moscone Center THE PSYCHIATRIST RELATIONSHIP WITH ADJUSTMENT DISORDERS: PROBLEMS IN INDUSTRY CONCEPTUALIZATION, CONUNDRUMS IN CLASSIFICATION Chair: Paul Appelbaum, M.D. Co-Chair: Laura Roberts, M.D. Co-Chp.: Patricia P Casey, M.D., M.Psy., 1. Relationships with Industry: What the Data Say Andreas Maercker, M.D., Ph.D. Paul S. Appelbaum, M.D. 1. Adjustment Disorders and the DSM-V: 2. Ethics and Overlapping Roles: Safeguarding Confl icts Considerations for Dimensional (Spectrum of Interest Diagnoses) Versus Categorial Laura W. Roberts, M.D. James J. Strain, M.D. 3. Industry and the Individual Physician 2. Recent Advances in the Study of Adjustment Jonathan L. Weker, M.D. Disorders Andreas Maercker, M.D. 4. Medical Education Meets Industry: Moving Ahead Joel Yager, M.D. 3. Can Adjustment Disorder and Depressive Episode Be Distinguished? Results From the ODIN Study 5. Relationships With Industry: Academic Departments Patricia P. Casey, M.D. of Psychiatry David A. Baron, D.O. 4. Post-Traumatic Embitterment Disorder Michael Linden, M.D. Discussant: Nada L. Stotland, M.D., M. P. H. Discussant: Katherine Shear, M.D. SYMPOSIA 1-18 SYMPOSIUM 03 2:00 P.M.- 5:00 P.M. SYMPOSIUM 01 2:00 P.M.- 5:00 P.M. Room 113, Exhibit Level, Moscone Center Room 111, Exhibit Level, Moscone Center DELIVERING PSYCHIATRY IN RURAL PERU: THE SPOTTING THE WOLF IN SHEEP’S CLOTHING: AYACUCHO MENTAL HEALTH PROJECT CLINICAL CHALLENGES IDENTIFYING AND Chp.: James Phillips, M.D. TREATING UNPRESENTED CO-MORBIDITY National Institute on Drug Abuse 1. The Ayacucho Mental Health Project James Phillips, M.D. Co-Chp.: Wilson M. Compton, M.D., Meyer D. Glantz, Ph.D. 2. Constructing a Formulary for a Psychiatric Clinic 1. The Prevalence of Substance Use Disorders Among in the Developing World Populations With Psychiatric Disorders Mark D. Rego, M.D. Carlos Blanco-Jerez, M.D. 3. Psychiatric Treatment in a Trilingual Setting 2. Screening for Substance Use Disorder Among Stephen J. Bittner, M.D. Individuals With Severe Mental Illness Stanley D. Rosenberg, Ph.D. 4. The Use of Skype by the Ayacucho Team in Follow- up, Supervision and Other Contacts with Patients 3. Motivational Interviewing for Substance Abuse and Staff Among Adolescents With Psychiatric Comorbidity Galen W. Stahle, M.D. Richard A Brown, Ph.D. 5. Evaluation of Change in Indicators of Mental Health 4. Diagnosis Challenges for Co-Occurring ADHD and in an Andean Region of Peru Substance Use Disorders Luis E. Bedregal, Ph.D. Frances Levin, M.D. 5. The Treatment of Co-Occurring Mood and Anxiety SYMPOSIUM 04 2:00 P.M.- 5:00 P.M. Disorders in Addictions Room 114, Exhibit Level, Moscone Center Kathleen Brady, M.D. STALKING: RISK MANAGEMENT AND TREAT- Discussant: Charles O’Brien, M.D., Ph.D. MENT OF OFFENDERS AND VICTIMS Chp.: Gail E. Robinson, M.D.
162ND ANNUAL MEETING 19 Monday, May 18, 2009
1. A Comprehensive Approach to the Treatment of 3. Aligning Bodies With Minds: The Case For Medical Stalking Victims and Surgical Treatment of Gender Dysphoria Gail E. Robinson, M.D. Rebecca Allison, M.D. 2. Stalking of Healthcare Professionals 4. The Role of Medical and Psychological Discourse in Karen M. Abrams, M.D. Legal and Policy Advocacy for Transgender Persons 3. Treatment of Stalking-Offenders in the U.S. Werner Tschan, M.D. Shannon P. Minter, J.D. 4. Workplace Assessment of Violence Risk Stephen G. White, Ph.D. SYMPOSIUM 07 2:00 P.M.- 5:00 P.M. Room 122, Exhibit Level, Moscone Center 5. Stalking Threat Management Jeffrey Dunn, M.D. RELATIONSHIP OF SUBTHRESHOLD PSYCHIA- TRY TO AXIS II PERSONALITY DISORDERS SYMPOSIUM 05 2:00 P.M.- 5:00 P.M. Room 120, Exhibit Level, Moscone Center Chp.: Ahmed Okasha, M.D., Ph.D. UNDERSTANDING AND ADDRESSING 1. Relationship of Subthreshold Psychiatry To ADOLESCENT ALCOHOL CONSUMPTION AND Personality Disorders ALCOHOL USE DISORDERS IN THE CONTEXT OF Ahmed Okasha, M.D. OVERALL DEVELOPMENT 2. Personality Disorders, Their Thresholds and Public National Institute on Alcohol Abuse and Alcoholism Health Chp.: Vivian B Faden, Ph.D. Norman Sartorius, M.D. 1. Early Development and Continuity of Risk for 3. Schizophrenia /Schizotaxia: A Genetic Predisposition Early Drinking, Problem Drinking, and Alcoholism of Schizophrenia from Early Childhood to Adulthood Ming T. Tsuang, M.D. Robert A. Zucker, Ph.D. 4. On the Shared Diathesis of Borderline Personality 2. Applying a Developmental Framework to Alcohol- Disorder And Bipolar Disorder Related Behaviors: Ages 10 – 15 Hagop S. Akiskal, M.D. Michael Windle, Ph.D. 5. Generalized Anxiety Disorder and Avoidant 3. Applying a Developmental Framework to Alcohol- Personality Disorder Related Behaviors from Middle to Late Adolescence Juan J. Lopez-Ibor, M.D. Sandra A. Brown, Ph.D. Discussant: Mario Maj, M.D., Ph.D. 4. Developmentally Informed Research on the Effectiveness of Clinical Trials (DIRECT) in SYMPOSIUM 08 2:00 P.M.- 5:00 P.M. Adolescents With Alcohol Addiction Problems Room 123, Exhibit Level, Moscone Center Eric F. Wagner, Ph.D. EDUCATING A NEW GENERATION OF PHYSI- 5. Evidenced-Based Treatments for Adolescents With CIANS IN PSYCHIATRY: REPORTS FROM WIN- Alcohol Use Disorders NERS OF APA INNOVATIVE TEACHING GRANTS Deborah Deas, M.D., M.P.H. APA Corresponding Committee on Medical Student Education SYMPOSIUM 06 2:00 P.M.- 5:00 P.M. Room 121, Exhibit Level, Moscone Center Co-Chp.: Linda F. Pessar, M.D., Amy C. Brodkey, M.D. “IN OR OUT?”: A DISCUSSION ABOUT GENDER 1. Changing Perspectives: Reducing the Stigma of IDENTITY DIAGNOSES AND THE DSM Mental Illness in Medical Students Through the Living Museum Project Co-Chp.: Jack Drescher, M.D., William E. Narrow, M.D., M.P.H. Janis Cutler, M.D. 1. The DSM-V Revision Process: Principles and 2. A School-Based Medical Student Curriculum for Progress Education in Child and Adolescent Psychiatry William E. Narrow, M.D. Justine Larson, M.D. 2. Beyond Conundrum: Strategies for Diagnostic 3. Teaching Third Year Medical Students Brief Harm Reduction Kelley Winters, Ph.D. Motivational Interviewing Skills to Use in Counseling 20 WWW.PSYCH.ORG Monday, May 18, 2009
Patients With Mental Illness on Smoking Cessation 4. Psychopharmacology Brenda J.B. Roman, M.D. Gabrielle Marzani-Nissen, M.D.
4. Preventing and Managing Metabolic Syndrome SYMPOSIUM 12 2:00 P.M.- 5:00 P.M. Among the Seriously Mentally Ill: Teaching Room 302, Esplanade Level, Moscone Center Behavioral Medicine to Medical Students Jason B. Rosenstock, M.D. THE OBSESSIVE COMPULSIVE SPECTRUM IN THE ATHLETE: PSYCHOPATHOLOGY OR SYMPOSIUM 09 2:00 P.M.- 5:00 P.M. COMPETITIVE EDGE? Room 124, Exhibit Level, Moscone Center International Society for Sport Psychiatry EFFECTIVE ASSESSMENT AND TREATMENT OF Chp.: Antonia L. Baum, M.D., M.D. SEXUAL DYSFUNCTION IN ADULTS AND THE ELDERLY 1. An International Level Athlete’s Struggle With Obsessive Compulsive Disorder Co-Chp.: Travis O. Bruce, M.D., Meera Narasimhan, M.D. David O. Conant-Norville, M.D. 1. Clinical Presentation and Assessment of Sexual 2. Athletes and Superstition Dysfunction in Patients with Psychiatric Illness Thomas S. Newmark, M.D. Jeffrey D. Raynor, M.D. 3. The Obsessive Compulsive Spectrum in the Athlete: 2. Treatment of Psychotropic-Induced Sexual Psychopathology or Competitive Edge Dysfunction Saul I. Marks, M.D. Travis O. Bruce, M.D. SYMPOSIUM 13 3. Sexual Dysfunction in Late-Life: WITHDRAWN Beyond “Vitamin V” Shilpa Srinivasan, M.D. SYMPOSIUM 14 2:00 P.M.- 5:00 P.M. Room 306, Esplanade Level, Moscone Center SYMPOSIUM 10 2:00 P.M.- 5:00 P.M. Room 125, Exhibit Level, Moscone Center INCREASING THE LIKELIHOOD OF ACHIEVING REMISSION IN DEPRESSION THE NEUROBIOLOGICAL EVIDENCE FOR TRANSGENDERISM Co-Chp.: Andrew F. Leuchter, M.D., Maurizio Fava, M.D. Chp.: Sidney W. Ecker, M.D. 1. Medication Algorithms for Antidepressant Treatment: Lessons Learned from STAR*D and 1. Brain Gender Identity Other Practical Clinical Trials Sidney W. Ecker, M.D. Madhukar H. Trivedi, M.D. 2. Transsexuality as an Intersex Condition 2. Strategies for Medication Management of Treatment Milton Diamond, Ph.D. Resistance: Lessons from STAR*D 3. Novel Approaches to Endocrine Treatment of Maurizio Fava, M.D. Transgender Adolescents and Adults 3. Use of EEG Biomarkers to Direct Selection of Norman Spack, M.D. Antidepressant Medication SYMPOSIUM 11 2:00 P.M.- 5:00 P.M. Andrew F. Leuchter, M.D. Rooms 272/274/276, Mezzanine Level West, 4. Collaborative Care Approaches to Depression Moscone Center Jurgen Unutzer, M.D. COMPREHENSIVE HIV PSYCHIATRY UPDATE 5. Can Genetic Biomarkers Help Direct Treatment for Depression? Chp.: Marshall Forstein, M.D. Gonzalo Laje, M.D. 1. HIV/AIDS Medical Update SYMPOSIUM 15 2:00 P.M. - 5:00 P.M. Paul Volberding, M.D. Room 307, Esplanade Level, Moscone Center 2. Neuropsychiatric Overview of HIV/AIDS THE TRANSMISSION OF BORDERLINE PERSON- Robert Daroff, Jr., M.D. ALITY DISORDER 3. Neurocognitive Decline Chp.: John G. Gunderson, M.D. Karl Goodkin, M.D. 1. The Aggregation of DIB-R and DSM-IV BPD 162ND ANNUAL MEETING 21 Monday, May 18, 2009
Mary C. Zanarini, Ed.D. Middle And High Income Countries Natalia Diaz-Granados, M.S.C. 2. Familial Coaggregation of BPD with Axis I Disorders James I. Hudson, M.D. 3. Socio-demographic Factors Affect Mental Illness Rates Differently Across Countries 3. Familial Aggregation of Attachment in BPD Marta B. Rondon, M.D. Lois W. Choi-Kain, M.D. 4. Factors Associated With Inequities In Mental Health 4. Familiality of BPD’s Component Phenotypes Care Use in a Developing Country John G. Gunderson, M.D. Javier E. Saavedra, M.D. 5. An Endophenotypic Approach to BPD 5. Income-Related Inequity in Mental Health Service Larry J. Siever, M.D. Utilization in Colombia and Canada SYMPOSIUM 16 2:00 P.M.- 5:00 P.M. Marie DesMeules, M.S.C. Room 308, Esplanade Level, Moscone Center SYMPOSIUM 18 2:00 P.M.- 5:00 P.M. CONTRIBUTIONS OF NEUROSCIENCE TO Room 310, Esplanade Level, Moscone Center MEDICATION DEVELOPMENT FOR ALCOHOL RECOVERY AND REHABILITATION FROM THE USE DISORDER PROVIDER AND PATIENTS POINTS OF VIEW IN National Institute on Alcohol Abuse and Alcoholism FRANCE AND THE US: VIVE LA DIFFERENCE! Chp.: Vijay A. Ramchandani, Ph.D. Chp.: John A. Talbott, M.D. 1. Novel Targets From The Dark Side of Dependence 1. Recovery From Disability of Serious Mental on Alcohol: Focus on CRF, Norepinephrine and Disorders: A Phase-Linked Rehabilitation Process Vasopressin Robert P. Liberman, M.D. George F. Koob, Ph.D. 2. Can We Implement “Recovery” and Rehabilitation?: 2. Activation of the Nociceptin/Orphanin FQ System What Do We Know and What Are the Implications Reduces Alcohol Abuse Related Behaviors in Rats for Services? With Innate Predisposition to Excessive Alcohol Marianne D. Farkas, Sc.D. Intake and Elevated Anxiety Roberto RC Ciccocioppo, Ph.D. 3. An Individualized Cognitive Remediation Therapy for Patients With Schizophrenia : The RECOS 3. N-Type Calcium Channel Blockers for Alcohol Use Program Disorders: From Cells to People Pascal Vianin, Ph.D. Robert O. Messing, M.D. 4. Functional Remission in Schizophrenia: A Specifi c 4. New Array of Potential Treatments for Alcohol Use Tool for Evaluation Disorders: From Drosophila to Electophysiology and Pierre Michel Llocra, M.D. More Predictive Animal Models Selena E. Bartlett, Pharm.D. Discussant: Alexandra McLean, M.D. 5. The Emerging Role of Pharmacogenetics in Medications Development for Alcoholism: The Case SPECIAL EVENT 2:00 P.M. -5:00 P.M. of the Mu-Opioid Receptor Room 304, Esplanade Level, Moscone Center Vijay A. Ramchandani, Ph.D. NORTHERN CALIFORNIA PSYCHIATRIC SYMPOSIUM 17 2:00 P.M. - 5:00 P.M. SOCIETY PRESENTS: BREAKING THE BARRIERS This session focuses on landmark cultural changes in soci- Room 309, Esplanade Level, Moscone Center ety and the APA from 1970 to 1992 MONITORING EQUITY IN MENTAL HEALTH Panelists: Carol Nadelson, M.D., FROM A CROSS-NATIONAL PERSPECTIVE Lawrence Hartmann, M.D., Melvin Sabshin, M.D., Chp.: Donna E. Stewart, M.D. Anne Kronenberg, Michael Blumfi eld, M.D. Jeannine Yeoman, Alfred Freeman, M.D. 1. Equity in Determinants of Health and Health
Policies Infl uencing Mental Health: A Cross- Closing Remarks: Nada Stotland, M.D., M.P.H. National Perspective Donna E. Stewart, M.D. 2. Monitoring Equity in Mental Health In Lower, 3:00 P.M. SESSIONS 22 WWW.PSYCH.ORG Monday, May 18, 2009
NEW RESEARCH/YOUNG INVESTIGATORS APIRE/Kempf Fund Awards for Research SESSION 3 Development in Psychobiological Psychiatry For information on New Research sessions, please refer Human Rights Awards to the New Research Program section in the back of this Blanche F. Ittleson Award for Research in Child Psychiatry publication. Agnes Purcell McGavin Awards Isaac Ray Award Jack Weinberg Memorial Award for Geriatric Psychiatry 5:30 P.M. SESSION CONVOCATION OF WILLIAM C. MENNINGER MEMORIAL CONVOCATION LECTURE DISTINGUISHED FELLOWS Abraham Verghese, M.D. 5:30 P.M.-6:30 P.M. Lecture 10 Hall E, Exhibit Level, Moscone Convention Center Abraham Verghese, M.D., attended the Iowa Writers Workshop in ALL DISTINGUISHED LIFE FELLOWS, 1990 at the University of Iowa, where he obtained a Master of Fine DISTINGUISHED FELLOWS, LIFE FELLOWS, Arts degree, taking a sabbatical from an active AIDS practice. His INTERNATIONAL FELLOWS, MEMBERS, AND fi rst book, My Own Country, about AIDS in rural Tennessee, was REGISTERED GUESTS ARE INVITED. a fi nalist for the National Book Critics Circle Award for 1994 and Presiding: Nada L. Stotland, M.D., M.P.H., President was made into a movie. His second book, The Tennis Partner, was a New York Times Notable Book and a national bestseller. Dr. Ver- Grand Marshals: Robert L. Okin, M.D., ghese’s fi rst novel, Cutting for Stone, published by Knopf, appeared Lenore C. Terr, M.D. in bookstores last February – described as “intensely suspenseful, deeply moving, and unexpectedly funny – it is both an unforgettable Marshals: Helen Haller, M.D., Francis G. Lu, M.D. journey into one man’s astonishing life, and a story about the power, intimacy, and curious beauty in the work of healing others.” He has INTRODUCTION OF DISTINGUISHED published extensively in the medical literature, and his writing has LIFE FELLOWS appeared in The New Yorker, Sports Illustrated, The Atlantic, Es- Alan F. Schatzberg, M.D., President-Elect quire, Granta, The New York Times Magazine, The Wall Street Jour- INDUCTION OF DISTINGUISHED FELLOWS nal. Dr. Verghese is now Senior Associate Chair and Professor of the Theory and Practice of Medicine in the Department of Medicine at Alan F. Schatzberg, M.D. Stanford University. From 2002 to 2007, he was the Director of The INTRODUCTION OF FIFTY-YEAR DISTINGUISHED Center for Medical Humanities & Ethics at the University of Texas LIFE FELLOWS, FIFTY-YEAR LIFE MEMBERS, Health Science Center San Antonio (UTHSCSA), where he held the AND INTERNATIONAL FELLOWS Joaquin Cigarroa Jr. Chair in Medicine and was the Marvin Forland Distinguished Professor of Ethics. He maintains an appointment as Nada L. Stotland, M.D., M.P.H. an adjunct Professor at UTHSCSA. From 1991 to 2002, he was a INTRODUCTION OF FELLOWS professor of medicine at the Texas Tech University Health Sciences Nada L. Stotland, M.D., M.P.H. Center, El Paso where he held the Grover E. Murray Distinguished Professorship. Board certifi ed in internal medicine, pulmonary PRESENTATION OF THE HONORARY diseases, and infectious diseases, he serves on the Board of Direc- FELLOWSHIP MEDALLION tors of the American Board of Internal Medicine. He is acclaimed Nada L. Stotland, M.D., M.P.H. as a dedicated and inspiring teacher of medicine at the bedside.
PRESENTATION OF SPECIAL PRESIDENTIAL 7:00 P.M. SESSIONS COMMENDATIONS Nada L. Stotland, M.D., M.P.H. INDUSTRY-SUPPORTED DINNER SYMPOSIA 9-10 PRESENTATION OF DISTINGUISHED SERVICE AWARDS ISS 09 7:00 P.M. -9:00 P.M. Nada L. Stotland, M.D., M.P.H. Continental Ballroom 4, Ballroom Level, Hilton INTRODUCTION OF THE MEMBERSHIP San Francisco COMMITTEE CHAIRPERSON AND AWARD ANXIOUS DEPRESSION: DIAGNOSTIC AND BOARD CHAIRPERSONS TREATMENT ISSUES Nada L. Stotland, M.D., M.P.H. Supported by Takeda Pharmaceuticals PRESENTATION OF AWARDS Chp.: Maurizio Fava, M.D. Nada L. Stotland, M.D., M.P.H. 1. How Do We Defi ne Anxious Depression? John Zajecka, M.D. APA/Lilly Resident Research Awards 2. Neurobiology of Anxious Depression 162ND ANNUAL MEETING 23 Monday, May 18, 2009
Audrey Tyrka, M.D. 3. Pharmacotherapeutic Strategies in the Treatment of Anxious Depression Maurizio Fava, M.D. 4. Psychotherapeutic Approaches to Anxious Depression Amy Farabaugh, Ph.D.
INDUSTRY-SUPPORTED SYMPOSIUM 10
BIPOLAR DISORDER THROUGHOUT THE LIFE CYCLE: TREATMENTS AND TREATMENT EXPERIENCE Supported by Pfi zer Chp.: Joseph R. Calabrese, M.D. 1. Understanding the Challenges of Reproductive Mental Health: Pregnancy and Lactation Adele Viguera, M.D., MPH 2. Treatments and Treatment Experience: From Adult to Late Life Martha Sajatovic,M M.D. O V E D 3. Management of Metabolic Syndrome Across the Life Cycle in Bipolar Disorder David Kemp MOVED TO TUESDAY, MAY 19, 2009 7:00 - 9:00 A.M. YERBA BUENA BALLROOM, SALON 7/8 MARRIOTT
24 WWW.PSYCH.ORG Tuesday, May 19, 2009
8:00 A.M. SESSIONS COURSE 61 8:00 A.M.-12 NOON Union Square Room 22, Fourth Floor, Tower 3, COURSES 55-61 Hilton San Francisco COURSE 55 8:00 A.M.-12 NOON DISASTER PSYCHIATRY: TERRORISM, TRAUMA Continental Ballroom 1, Ballroom Level, Tower 3, AND THINGS TO DO Hilton San Francisco Director: Joseph C. Napoli, M.D. SYSTEMIC THERAPIES FOR SUBSTANCE ABUSE Faculty: Michael Blumenfi eld, M.D. DISORDERS Directors: Peter Steinglass, M.D., Marc Galanter, M.D. 9:00 A.M. SESSIONS COURSE 56 8:00 A.M. - 12 NOON ADVANCES IN SERIES 4-5 Yosemite Room B, Ballroom Level, Tower 2, Hilton San Francisco ADVANCES IN SERIES 4 9:00 A.M. -12 NOON Gateway Ballroom 102, Exhibit Level, Moscone Center RISK ASSESSMENT FOR VIOLENCE Director: Phillip J. Resnick, M.D. PSYCHOSOMATIC MEDICINE Chp.: James L. Levenson, M.D. COURSE 57 8:00 A.M.-12 NOON Union Square Rooms 3/4, Fourth Floor, Tower 3, 1. Update on Heart Disease and Psychiatry Hilton San Francisco Peter A. Shapiro, M.D. TIME-LIMITED DYNAMIC PSYCHOTHERAPY: 2. Update on Psychopharmacology in GI Disease A PSYCHODYNAMIC/RELATIONAL/ Catherine Crone, M.D. EXPERIENTIAL APPROACH 3. Legal Issue for Psychiatrists in Medical Settings Director: Hanna Levenson, Ph.D. James L Levenson, M.D. COURSE 58 8:00 A.M.-12 NOON 4. Psychopharmacology in the Medically Ill Union Square Room 14, Fourth Floor, Tower 3, Stephen J. Ferrando, M.D. Hilton San Francisco 5. Severe Drug Reactions MONEY MATTERS II: ADVANCED CLINICAL AD Stanley N. Caroff. M.D. HOC SEMINAR Director: Cecilia M. Mikalac, M.D. ADVANCES IN SERIES 5 9:00 A.M. -12 NOON Gateway Ballroom 103, Exhibit Level, Moscone Center COURSE 59 8:00 A.M.-12 NOON Union Square Rooms 15/16 Fourth Floor, Tower 3, PSYCHOTHERAPEUTIC PSYCHIATRY Hilton San Francisco Chp.: Glen O. Gabbard, M.D. TREATING THE CHRONICALLY DEPRESSED PATIENT USING CBASP 1. How Does Psychodynamic Psychotherapy Work? Glen Gabbard, M.D. Director: Eric Levander, M.D., M.P.H. 2. Neural Circuits of Psychotherapy Faculty: Toshiaki A. Furukawa, M.D., Ph.D., Bernard D. Beitman, M.D. Lynn McFarr, Ph.D. 3. Mentalizing: Some Theory and Some Practice COURSE 60 8:00 A.M.-12 NOON Anthony Bateman, M.D. Union Square Rooms 19/20, Fourth Floor, Tower 3, Hilton San Francisco 4. Cognitive-Behavior Therapy Methods Jesse Wright, M.D. IT’S NOT JUST IN YOUR HEAD: MEDICAL PROBLEMS IN PEOPLE WITH MENTAL HEALTH 5. Interpersonal Psychotherapy CONDITIONS John Markowitz, M.D. Directors: Monique Yohanan, M.D., Michele T. Pato, M.D. Faculty: Hiruy Gessesse, M.D., Robert Cobb, M.D., Amy Christianson, M.D., M.B.A.
162ND ANNUAL MEETING 25 Tuesday, May 19, 2009
to development of human well-being through initiatives in health CASE CONFERENCE 3 care and education. He is widely cited and honored for his inno- THIS SESSSION IS OPEN TO APA MEMBERS ONLY. A vative biopsychosocial research that spans the genetics, neurobiol- MEMBER REGISTRATION BADGE OR APA MEMBERSHIP ogy, development, psychology, brain imaging, and assessment of personality and psychopathology. His personality inventories have CARD IS REQUIRED FOR ADMITTANCE. been used in more than 4000 peer-reviewed publications around the world. He received his B.A. with High Honors and Special CASE CONFERENCE 3 9:00 A.M. - 10:30 A.M. Honors in Philosophy, Psychology, and Anthropology from the Room 120, Exhibit Level, Moscone Center University of Texas at Austin, 1966. He received his M.D. from ISSUES IN THE DIFFERENTIAL DIAGNOSIS OF Washington University in 1970 and an Honorary Doctorate from MILD TBI, PCS, AND PTSD IN SERVICE MEMBERS the University of Umea, Sweden in 1983. Dr. Cloninger has pub- lished nine books and 400 articles in psychiatry, psychology, and AFTER BLAST EXPOSURE IN COMBAT genetics. His recent books include Feeling Good: The Science of Well-Being by Oxford University Press and Personality and Psy- Chp.: Marvin Oleshansky, M.D. chopathology by American Psychiatric Press. Among his many awards, Dr. Cloninger has received the American Psychiatric Asso- CASE CONFERENCE 4 ciation’s Adolf Meyer Award in psychobiology (1993) and lifetime WITHDRAWN achievement awards from the American Society of Addiction Medi- cine (2000) and the International Society of Psychiatric Genetics DEBATE/ROUNDTABLE 1-2 (2003). He is a Distinguished Life Fellow of the APA, a fellow of the American Academy for the Advancement of Science, and a DR 01 9:00 A.M. - 10:30 A.M. member of the Institute of Medicine of the National Academy of Room 303/305 Esplanade Level, Moscone Center Sciences. The Institute of Scientifi c Information ranks him among the most highly cited psychiatrists and psychologists in the world. APA-OUR RELATIONSHIPS TO *This award is endowed by the estate of Judd Marmor, M.D. PHARMACEUTICAL COMPANIES: THE PROS AND CONS OF REFORM LECTURE 14 9:00 A.M. - 10:30 A.M. Room 132/133, Exhibit Level, Moscone Center Moderator: Paul McHugh, M.D. Pro-side: Glenn Triesman, M.D. Ph.D. BORDERLINE PERSONALITY DISORDER: THE Con-side: Thomas Finucane, M.D. BIRTH PAINS OF THE STILL NEW DIAGNOSIS John G. Gunderson, M.D. DR 02 9:00 A.M. - 10:30 A.M. Distinguished Psychiatrist Lecture Room307, Esplanade Level, Moscone Center Chp.: Kenneth Silk, M.D. PSYCHIATRY SHOULD EMBRACE MEASUREMENT BASED CARE ohn G. Gunderson, M.D., is Professor of Psychiatry at Har- Jvard Medical School, Boston, Massachusetts. At McLean Moderator: John McIntrye, M.D. Hospital in Belmont, Massachusetts, he serves as Director Pro-side: Madhukar Trivedi, M.D., David Katzelnick, M.D. of Psychosocial and Personality Research and of the Border- Con-side: Robert Michaels, M.D., Harold Eist, M.D. line Personality Disorder Center. Dr. Gunderson has been in- tegrally involved in the diagnosis and treatment of borderline LECTURES 12-14 personality disorder since 1969. His studies helped to defi ne the diagnosis of borderline personality disorder and edstablished LECTURE 12 an empirical standard for evaluating treatment of this disorder. WITHDRAWN MEDICAL UPDATE 1 LECTURE 13 9:00 A.M. - 10:30 A.M. MEDICAL UPDATE 1 9:00 A.M. - 10:30 A.M. Room 130/131, Exhibit Level, Moscone Center Room 300, Esplanade Level, Moscone Center MODULES OF THE MIND: DEVELOPING A 21ST CENTURY ECT – UPDATING THE APA POSITIVE PSYCHIATRY OF THE PERSON RECOMMENDATIONS ON ECT C. Robert Cloninger, M.D. Task Force to Revise the Practice of ECT Therapy Judd Marmor Award Lecture Co-Chps.: Sarah H. Lisanby, M.D., Richard Weiner, M.D., Ph.D. Chp.: Stuart Yudofsky, M.D. Participants: William M. McDonald, M.D., Pamela Sul- . Robert Cloninger, M.D., is Wallace Renard Profes-sor of Psy- livan, M.D., Andrew Krystal, M.D., Husain Mustafa, M.D., Cchiatry, Professor of Psychology and Genetics, and Director of Charles Kellner, M.D. the Sansone Family Center for Well-Being at Washington Univer- sity School of Medicine in St. Louis. He is also Scientifi c Direc- tor of the Anthropedia Institute, a non-profi t organization dedicated 26 WWW.PSYCH.ORG Tuesday, May 19, 2009
SMALL INTERACTIVE SESSIONS 3-5 OUTPATIENT FORENSIC SERVICES AND INTERVENTIONS TO IMPROVE CLINICAL SI 03 9:00 A.M. -10:30 A.M. OUTCOMES AND REDUCE RECIDIVISM Room 216, Mezzanine Level East, Moscone Center APA Task Force on Forensic Outpatient Services A DISCUSSION ABOUT DRUG INTERACTIONS Co-Chps.: Steven K. Hoge, M.D., M.B.A., Chp.: Gary H. Wynn, M.D. Alec W. Buchanan, Ph.D., M.D. Participants: Erik Roskes, M.D. SI 04 9:00 A.M. -10:30 A.M. Room 218, Mezzanine Level East, Moscone Center CW 14 9:00 A.M.-10:30 A.M. Room 306, Esplanade Level, Moscone Center NEUROPSYCHIATRIC ASSESSMENT FOR GENERAL PSYCHIATRISTS NATIONAL SECURITY, THE HIPPOCRATIC OATH, AND THE WAR ON TERROR Chp.: Sheldon Benjamin, M.D. APA Council on Global Psychiatry SI 05 9:00 A.M. -10:30 A.M. Co-Chps.: Shirin Ali, M.D., Karinn Glover, M.D., M.P.H. Room 266, Mezzanine Level West, Moscone Center Participants: Alan Cyr, M.D., Jeffrey Janofsky, M.D., Eliot Sorel, M.D., Elspeth Ritchie, M.D., M.P.H. PALLIAIVE CARE AND PSYCHIATRIC ISSUES AT THE END OF LIFE ISSUE WORKSHOPS 21-32 Chp.: William Breitbart, M.D. IW 21 9:00 A.M.-10:30 A.M. COMPONENT WORKSHOPS 10-14 Room 112, Exhibit Level, Moscone Center CW 10 9:00 A.M.-10:30 A.M. TIPS FOR EFFECTIVE COMMUNICATION ABOUT Room 111, Exhibit Level, Moscone Center GENETICS AND MENTAL ILLNESS WITH PATIENTS AND THEIR FAMILIES BIRACIAL AMERICANS: “CHECK ONE BOX ONLY” AND THE DEVELOPMENT OF Co-Chps.: Jehannine C. Austin, Ph.D., M.S.C., MULTIRACIAL IDENTITY Holly L. Peay, M.S. APA Council on Minority Mental Health and Health Disparities Participants: Christine Finn, M.D., Laura Hercher, M.S., Catriona Hippman, M.S.C., Christina Palmer, M.S. Co-Chps.: Jacquelyn Chang, M.D., Kehinde A. Ogundipe, M.D. Participants: Brett Sevilla, M.D., Sandra Walker, M.D., IW 22 9:00 A.M.-10:30 A.M. U. Diane Buckingham, M.D., B.S.N. Room 114, Exhibit Level, Moscone Center CW 11 9:00 A.M.-10:30 A.M. CLINICAL AND FORENSIC ISSUES CONCERNING Room 113, Exhibit Level, Moscone Center INFANTICIDE, THE MURDER OF A CHILD IN THE FIRST YEAR OF LIFE BY ITS MOTHER RECOGNITION AND TREATMENT OF DEMENTIA IN A CHANGING AMERICA Co-Chps.: Malkah T. Notman, M.D., Carl P. Malmquist, M.D. APA Committee on Ethnic Minority Elderly Participants: Elissa Benedek, M.D., George Parnham, J.D., Margaret Spinelli, M.D. Co-Chps.: Maria llorente, M.D., Khushro Unwalla, M.D. Participants: Khushro Unwalla, M.D., Irving Kuo, M.D., IW 23 9:00 A.M.-10:30 A.M. Deborah Dallam, M.D., Carl I. Cohen, M.D., Maria llorente, M.D. Room 122, Exhibit Level, Moscone Center CW 12 9:00 A.M.-10:30 A.M. EXTENDED TREATMENTS FOR ALCOHOL USE Room 224, Mezzanine Level, Moscone Center DISORDERS National Institute on Alcohol Abuse and Alcoholism HOW GENERAL PSYCHIATRISTS CAN Chp.: James R. McKay, Ph.D. EFFECTIVELY SCREEN & TREAT SUBSTANCE Participant: David Oslin, M.D. USE DISORDERS APA Corresponding Committee on Treatment Services for Patients IW 24 9:00 A.M.-10:30 A.M. with Addictive Disorders Room 125, Exhibit Level, Moscone Center Co-Chps.: Varinder Rathore, M.D., COGNITIVE THERAPY FOR PERSONALITY Petros Levounis, M.D., M.A. DISORDERS CW 13 9:00 A.M.-10:30 A.M. Room 226, Mezzanine Level, Moscone Center Chp.: Judith S. Beck, Ph.D. 162ND ANNUAL MEETING 27 Tuesday, May 19, 2009
IW 25 9:00 A.M.-10:30 A.M. IW 31 9:00 A.M.-10:30 A.M. Room 220, Mezzanine Level, Moscone Center Room 309, Esplanade Level, Moscone Center THE IMPACT OF MEDITATION AS A NON- ASSESSMENT AND TREATMENT OF SLEEP PHARMACOLOGICAL INTERVENTION FOR DISORDERS IN ALCOHOL-DEPENDENT PATIENTS VETERANS WITH MENTAL HEALTH DISORDERS WITH ADHD AND OTHER CO-OCCURRING DISORDERS Co-Chps.: Julie E. Malphurs, Ph.D., National Institute on Alcohol Abuse and Alcoholism Daniella David, M.D., M.S.C. Participant: Molly Birkholm, M.D. Co-Chps.: Kirk J. Brower, M.D., Iyad Alkhouri, M.D.
IW 26 9:00 A.M.-10:30 A.M. IW 32 9:00 A.M.-10:30 A.M. Room 222, Mezzanine Level, Moscone Center Room 310, Esplanade Level, Moscone Center ASSESSMENT OF CAPACITY: DEVELOPMENTS, DOING IT RIGHT THE FIRST TIME: DOCUMENTATION & DEFENDABILITY RECOGNIZING, MAINTAINING, AND SUPPORTING WORKPLACE FUNCTION Co-Chps.: Michael Jan Wise, M.B.B.S, M.S.C., Julian APA Corresponding Committee on Psychiatry in the Workplace Beezhold, M.D. Chp.: Andrea Stolar, M.D. IW 27 9:00 A.M.-10:30 A.M. Participants: Marilyn Price, M.D., Room 301, Esplanade Level, Moscone Center Marie-Claude Rigaud, M.D., Marcia Scott, M.D.
LESSONS LEARNED ABOUT RESILIENCE AND MEDIA WORKSHOPS 3-4 RECOVERY FOLLOWING DISASTERS Chp.: Howard J. Osofsky, M.D., Ph.D. Participants: Melissa Brymer, Ph.D., MEDIA WORKSHOP 3 9:00 A.M.-12:30 P.M. Jose Calderon-Abbo, M.D., Alicia Lieberman, Ph.D., Room 123, Exhibit Level, Moscone Center Joy Osofsky, Ph.D., Zack Rosenburg THE JOY LUCK CLUB: UNIVERSAL STORIES ABOUT MOTHERS AND DAUGHTERS FROM IW 28 9:00 A.M.-10:30 A.M. CHINA Room 302, Esplanade Level, Moscone Center Chp.: Francis G. Lu, M.D. WHEN PSYCHIATRY RESIDENTS TREAT MEDIA WORKSHOP 4 9:00 A.M.-12:30 P.M. MEDICAL STUDENTS: SOME CHALLENGES Room 124, Exhibit Level, Moscone Center Chp.: Michael F. Myers, M.D. PROVOKED: COMBATING DOMESTIC VIOLENCE Participants: Michael Garrett, M.D., Carolina Klein, M.D., Indo-American Psychiatric Association Anand Sukumaran Co-Chps.: Vishal Madaan, M.D., M.B.B.S., IW 29 9:00 A.M.-10:30 A.M. Surinder S. Nand, M.D. Room 304, Esplanade Level, Moscone Center Participants: Sarah Khan
BOOTCAMP FOR BURNOUT COURSES 62-66 Association of Women Psychiatrists Chp.: Tana A. Grady-Weliky, M.D. Participant: Eva Szigethy, M.D. COURSE 62 9:00 A.M.- 4:00 P.M. Continental Ballroom 9, Ballroom Level, Tower 3, IW 30 9:00 A.M.-10:30 A.M. Hilton San Francisco Room 308, Esplanade Level, Moscone Center A PSYCHODYNAMIC APPROACH TO TREATMENT LESSONS FROM THE POST-RESIDENCY ROAD: RESISTANT MOOD DISORDERS: BREAKING FOUR CAREER JOURNEYS SINCE RESIDENCY THROUGH COMPLEX COMORBID TREATMENT GRADUATION IN 2004 WITH INSIGHTS FROM RESISTANCE BY FOCUSING ON AXIS II OUR TRAINING DIRECTOR Director: Eric M. Plakun, M.D. Co-Chps.: William C. Wood, M.D., Kathy M. Sanders, M.D. Faculty: Edward Shapiro, M.A., M.D., David Mintz, M.D. Participants: Richard Falzone, M.D., Dost Ongur, M.D., Marketa Wills, M.D.
28 WWW.PSYCH.ORG Tuesday, May 19, 2009
COURSE 63 9:00 A.M.- 4:00 P.M. FORUMS 5-7 Imperial Ballroom A, Ballroom Level, Tower 2, Hilton San Francisco FORUM 5 11:00 A.M.-12:30 P.M. Room 301, Esplanade Level, Moscone Center HERBS, NUTRIENTS, AND YOGA FOR ANXIETY, PTSD, DEPRESSION, BIPOLAR, COGNITIVE ANXIETY IN PATIENTS WITH HIV: IMPORTANCE, ENHANCEMENT, BRAIN INJURY, ADD, SCHIZO- DIAGNOSTIC AND TREATMENT CHALLENGES PHRENIA, AND SEXUAL ENHANCEMENT Chair: Ramaswany Viswanathan, M.D. Directors: Patricia L. Gerbarg, M.D., Richard P. Brown, M.D. Participants: Maria Tiamson-Kassab, M.D., Aparna Dole, Faculty: Monica Vermani, M.A., Psy.D., Martin Katzman, M.D. M.D., Philip Bialer, M.D.
COURSE 64 9:00 A.M.- 4:00 P.M. FORUM 6 11:00 A.M.-12:30 P.M. Yosemite Room A, Ballroom Level, Tower 2, Room 306, Esplanade Level, Moscone Center Hilton San Francisco BRIDGES AND BARRIERS TO CARE: ADVANCED INTERVIEWING TECHNIQUES CURRENT STRATEGIES WITH UNDERSERVED POPULATIONS Director: Shawn C. Shea, M.D. Chair: Mark Townsend, M.D. COURSE 65 9:00 A.M.- 4:00 P.M. Participants: Khushro Unwalla, M.D., Yosemite Room C, Ballroom Level, Tower 2, Jagannathan Srinivasaraghavan, M.D., Rahn Bailey, M.D. Hilton San Francisco FORUM 7 11:00 A.M.-12:30 P.M. TREATMENT OF SCHIZOPHRENIA Room 307, Esplanade Level, Moscone Center Director: Philip G. Janicak, M.D. NEW PERSPECTIVES ON CULTURAL ISSUES IN Faculty: Morris B. Goldman, M.D., Stephen R. Marder, M.D., ALCOHOL TREATMENT Rajiv Tandon, M.D., Philip Janicak, M.D. Chair: Barbara McCrady, M.D.
COURSE 66 9:00 A.M.- 4:00 P.M. LECTURES 15-17 Imperial Ballroom B, Ballroom Level, Tower 2, Hilton San Francisco LECTURE 15 11:00 A.M. -12:30 P.M. Room 130/131, Exhibit Level , Moscone Convention Center AN OVERVIEW OF SLEEP MEDICINE FOR THE MENTAL HEALTH PROVIDER CROSS-CULTURAL PSYCHOPHARMACOLOGY: SHAPING OUR FUTURE VIA BRIDGING Directors: R. Robert Auger, M.D., Thomas D. Hurwitz, M.D. SCIENCE AND SERVICE Faculty: Elliott Lee, M.D., Max Hirshkowitz, Ph.D. Edmond Pi, M.D. Kun-Po Soo Award 11:00 A.M. SESSIONS Chp.: Jacquelyn Chang, M.D. NOW OPEN! dmond Hsin-tung Pi, M.D., has taken an active role in EXHIBIT HALL ensuring equal psychiatric care for the ethnic minority commu- APA MEMBER CENTER E nity. A Professor of Clinical Psychiatry at the University of Southern PUBLISHERS’ BOOKFAIR California (USC) Keck School of Medicine since 1988, he is also HOURS OF OPERATION Professor of Psychiatry at the Charles R. Drew University of Medi- 10:OO A.M. -3:00 P.M. cine and Science, Clinical Professor of Psychiatry at the University of California Los Angeles (UCLA) David Geffen School of Medi- cine, and a Visiting Professor of Psychiatry at the Tsinghua Uni- ADVANCES IN MEDICINE 2 versity in Beijing, China. An accomplished researcher in the fi eld of cross-cultural psychiatry, psychopharmacology, and movement ADV IN MEDICINE 2 11:00 A.M.-12:30 P.M. disorders, Dr. Pi has more than 100 publications, 23 book chapters, Room 300, Esplanade Level, Moscone Center and one book. He served as Chairperson of the Committee of Asian CURRENT ETHICAL CHALLENGES IN ASSISTED American Psychiatrists of the APA, President of the Association of Chinese American Psychiatrists, a member of the Organizing- REPRODUCTIVE TECHNOLOGY: A PANEL Liaison Committee of the First World Congress of Cultural Psy- DISCUSSION chiatry, and a member of the International Advisory Committee of Chp.: Elena Gates, M.D. World Psychiatric Association (WPA) Regional Meetings for Seoul, Shanghai, Paris, and Granada. Dr. Pi is a former Visiting Scholar, 162ND ANNUAL MEETING 29 Tuesday, May 19, 2009
Committee on Scholarly Communication with the People’s Repub- LECTURE 17 11:00 A.M. -12:30 P.M. lic of China (CSCPRC), sponsored by the U.S. National Academy Room 303/305, Esplanade Level, Moscone Center of Sciences, American Council of Learned Societies, and Social Science Research Council. Dr. Pi served as Medical Director of WHEN POLITICS DISTORTS SCIENCE: the Department of Mental Health (DMH) of the State of California. A PSYCHIATRIST REPORTS FROM THE Currently, Dr. Pi is Associate Chair for Clinical Affairs, Department TRENCHES OF THE CULTURE WARS of Psychiatry at the USC Keck School of Medicine and Director of Jack Drescher, M.D. Psychiatric Consultation-Liaison Service at Los Angeles County & Distinguished Psychiatrist USC Medical Center. An active contributor to the commu- nity and advocate of people with disabilities, he has served Chp.: Annette Matthews, M.D. on the Board of Directors of China AIDS Fund, the Com- mittee of 100, the American Red Cross, San Gabriel Chap- ack Drescher, M.D., is a psychiatrist and psychoanalyst in pri- ter, the Mental Health Association of Los Angeles County, Jvate practice in New York City. He is a Distinguished Fellow and the Executive Board of the California Governor’s of the American Psychiatric Association, and currently serves as Committee for Employment of People with Disabilities. a consultant to the APA Committee on Public Affairs. A member of the DSM-V Workgroup on Sexual and Gender Identity Disor- ders, past chair of APA’s Committee on GLB Issues, he is also a past president of APA’s New York County District Branch, where LECTURE 16 11:00 A.M. -12:30 P.M. he is presently the editor of their newsletter “AppleSource”. Dr. Room 132/133, Exhibit Level, Moscone Center Drescher is on the Board of the Group for the Advancement of Psychiatry and a past trustee of both the Accreditation Council for HOW ALCOHOLISM DEVELOPS: Psychoanalytic Education and the American Academy of Psycho- IDENTIFICATION analysis and Dynamic Psychiatry. He is a member of the American OF GENETIC AND ENVIRONMENTAL College of Psychiatrists and the New York Academy of Medi- INFLUENCES IN 25 YEAR LONGITUDINAL STUDY cine. A teacher and educator, he is a Training and Supervis- Marc Shuckit, M.D. ing Analyst at the William Alanson White Institute in New Adolf Meyer Award York, Adjunct Clinical Assistant Professor at NYU’s Postdoc- toral Program in Psychotherapy and Psychoanalysis, and Clini- Chp.: Marian Fireman, M.D. cal Assistant Professor of Psychiatry at New York Medical College and SUNY Downstate. The author of Psychoana- r. Schuckit’s research has focused on evaluating the lytic Therapy and the Gay Man (the Analytic Press), Dr. Dimportance of genetic infl uences in alcoholism, and Drescher has edited twenty books dealing with gender, sexu- the biological factors that interact with the environment ality and the health and mental health of LGBT communities. to produce a vulnerability toward heavy drinking and al- Emeritus editor of the Journal of Gay and Lesbian Men- cohol problems. Other research efforts include a search tal Health, he has authored numerous articles and book chap- for the optimal diagnostic criteria for substance abuse or ters, including the chapter “Homosexuality, Gay and Lesbian dependence, which lead to his contributions to the DSM- Identities and Homosexual Behavior” in the 8th and forthcom- IV and DSM-V process. He has also studied the relationship ing 9th edition of Kaplan and Sadok’s Comprehensive Text- between alcoholism or drug use disorders and psychiatric syn- book of Psychiatry. His media appearances include Good dromes, especially depression, states of anxiety, or psychoses. He Morning America, 20/20, Nightline, CBS Sunday Morning, has published almost 600 papers and written over 10 books, includ- In the Life (PBS), the O’Reilly Factor, NPR and interviews ing the recent sixth edition of Drug and Alcohol Abuse. Dr. Schuckit with Wolf Blitzer, Paula Zahn, and Anderson Cooper. He is of- is a Distinguished Professor of Psychiatry at the University of Cali- ten quoted in national print media, including the New York fornia, San Diego School of Medicine, and serves as the Director Times, the Washington Post, Time, Newsweek and many others. of the Alcohol and Drug Treatment Program and of the Alcohol Research Center at the Veterans Affairs San Diego Healthcare Sys- SMALL INTERACTIVE SESSIONS 6-8 tem. He is Editor of the Journal of Studies on Alcohol and Drugs, and has been a member of the editorial boards of many major SI 6 11:00 A.M.-12:30 P.M. alcohol and drug journals in the United States and Europe. Room 216, Mezzanine Level, Moscone Center In addition, he is Director of the Alcohol Medical Scholars Program. He has received a number of awards in the alco- THE PHYSICIAN AS PATIENT: A CLINICAL HAND- holism fi eld including the Middleton Award for the best re- BOOK FOR MENTAL HEALTH PROFESSIONALS search within the VA system, the American Psychiatric Asso- Chp.: Michael Myers, M.D. ciation’s Hoffheimer Award for Research in Psychiatry (now the President’s Prize), the Gold Medal Award for lifetime SI 7 11:00 A.M.-12:30 P.M. achievement from the Society of Biological Psychiatry, the Room 218, Mezzanine Level, Moscone Center Distinguished Scientist Award, as well as the Seixas Award from the Research Society on Alcoholism and the Jellinek Award. APPROACH TO THE PSYCHIATRIC PATIENT Chp.: John W. Barnhill, M.D. SI 8 WITHDRAWN 11:00 A.M.-12:30 P.M. 30 WWW.PSYCH.ORG Tuesday, May 19, 2009
SCIENTIFIC AND CLINICAL REPORT METABOLISM, METABOLIC SYNDROME, AND SCR 09 11:00 A.M. - 12:30 P.M. CARDIOVASCULAR DISEASE IN SCHIZOPHRENIA Room 111, Exhibit Level, Moscone Center Chp.: Merra Vaswani, M.D. CHILD AND ADOLESCENT PSYCHIATRY 34. Schizophrenia-Spectrum Disorders Were Associated Chp.: Vishal Madaan, M.D. With Cardiovascular Disease Symptoms, 25. Medication Trends in New-Onset Pediatric Bipolar Independent of Known Risk Factors for Symptoms Disorder among Medicaid-Insured Youth Stephen Woolley, D.Sc. Aloysius Ibe, B.S. 35. Ultra Rapid Metabolizers Are in a Pilot Study in 26. Physical Activity and Fitness in Adolescents at Risk Two Different Clinics Overrepresented in Court- for Psychosis Ordered Psychotic Patients Carel de Blécourt, M.D. Jenni Koivukangas, B.Med. 36. Oatmeal vs. Donuts: Treating Metabolic Syndrome/ 27. Metabolic Symptoms in Adolescent Psychiatric Obesity Using CBT/DBT in an Inner City SPMI Inpatients Population Michael Stevens, Ph.D. Joanne Caring, M.D. SCIENTIFIC AND CLINICAL REPORTS SCIENTIFIC AND CLINICAL REPORTS SCR 10 11:00 A.M. - 12:30 P.M. SCR 13 11:00 A.M. - 12:30 P.M. Room 112, Exhibit Level, Moscone Center Room 120, Exhibit Level, Moscone Center CROSS-CULTURAL PSYCHIATRY DIAGNOSTIC ISSUES IN THE SCHIZOPHRENIA Chp.: Derya Akibiyik, M.D. SPECTRUM 28. Genes, Memes, Migration, and Mental Illness Chp.: Adel Gabriel, M.D. Hoyle Leigh, M.D. 37. Is Schizoaffective Disorder a Distinct Clinical Entity? 29. One-Year Follow-Up Study of the Culturally John Goethe, M.D. Sensitive Collaborative Treatment (CSCT) for Chinese Americans with Depression 38. Diagnostic Stability in Patients with Schizoaffective Adrienne van Nieuwenhuizen, B.A. Disorder Compared to Schizophrenia and Bipolar Disorder 30. Prevalence of Childhood Trauma in Psychiatric Bonnie Szarek, R.N. and Primary Care Clinics in Cities Along the U.S.-Mexico Border 39. Depression and Its Treatment in Patients Presenting With Late-Onset Delusional Disorder (LODD) Alejandra Postlethwaite, M.D. Rebecca Anglin, M.D. SCIENTIFIC AND CLINICAL REPORTS SCIENTIFIC AND CLINICAL REPORTS SCR 11 11:00 A.M. - 12:30 P.M. SCR 14 11:00 A.M. - 12:30 P.M. Room 113, Exhibit Level, Moscone Center Room 121, Exhibit Level, Moscone Center DIAGNOSTIC ISSUES PSYCHIATRIC ISSUES RELATED TO PREGNANCY Chp.: Sanjay Yaswani, M.D. AND BREAST FEEDING 31. Heterogeneity of the Jealousy Phenomenon in the Chp.: Alison May, M.D. General Population An Italian Study 40. Postpartum Depression and Breast Feeding in an Donatella Marazziti, M.D. Urban Population of Women in Malaysia 32. Olfactory Reference Syndrome (ORS): A Systematic Nor Zainal, M.B.B.S. Review of the World Literature 41. Psychotic Denial of Pregnancy: Ethical and Legal Millia Begum, M.B.B.S. Considerations for Treating Physicians 33. Dimensionality and Etiology in Psychiatric Research Melissa Nau, M.D. Stephen Shanfi eld, M.D. 42. Posttraumatic Growth and Quality of Life in SCR 12 11:00 A.M. - 12:30 P.M. Breast Cancer Patients Room 114, Exhibit Level, Moscone Center Derya Iren Akbiyik, M.D. 162ND ANNUAL MEETING 31 Tuesday, May 19, 2009
SCIENTIFIC AND CLINICAL REPORTS Participants: Robert Weinstock, M.D., SCR 15 11:00 A.M. - 12:30 P.M. Steven Hoge, M.D., M.B.A. Room 122, Exhibit Level, Moscone Center CW 16 11:00 A.M.-12:30 P.M. EXPLORING SUICIDALITY: ASSESSMENT AND Room 224, Mezzanine Level, Moscone Center THE IMPACT OF SPIRITUALITY AND ECONOMIC CONDITIONS INDICATIONS FOR THE USE OF COMBINED TALKING THERAPY AND PHARMACOTHERAPY Chp.: Nitin Gupta, M.D. AND HOW TO TEACH IN RESIDENCY 43. Meeting the Challenge of Risk Assessment: Corresponding Committee on Graduate Education Towards a New Scale of Suicide Assessment: Chp.: Sidney Weissman, M.D. The Scale for Impact of Suicidality: Management Participants: Edward Silberman, M.D., and Assessment David Preven, Ryan Hall, M.D. Amresh K. Shrivastava, M.D. CW 17 11:00 A.M.-12:30 P.M. 44. Economic Factors and Suicide Rates - Associations Room 302, Esplanade Level, Moscone Center Over Time in Four Countries Alfonso Ceccherini-Nelli, M.D. MEDICAL ISSUES FOR PSYCHIATRISTS IN DISASTERS 45. Religion, Spirituality and Suicide in a Large APA Committee on Psychiatric Dimensions of Disaster Community Sample Daniel Rasic, B.S. Co-Chps.: Mark Viron, M.D., Nidal NH. Hasan, M.D., M.P.H. SCIENTIFIC AND CLINICAL REPORTS Participants: Brooke Parish, M.D. SCR 16 11:00 A.M. - 12:30 P.M. Catherine May, M.D., Elspeth Ritchie, M.D., M.P.H. Rooms 272/274/276, Mezzanine Level West, Moscone Center CW 18 11:00 A.M.-12:30 P.M. PANIC AND ANXIETY DISORDER Room 304, Esplanade Level, Moscone Center Chp.: Britta Ostermeyer, M.D. ETHICAL DILEMMAS IN PSYCHIATRIC 46. Frequency and Clinical Correlates of Adult Separa- PRACTICE tion Anxiety Disorder in 508 Outpatients With Mood APA Ethics Committee and Anxiety Disorders Chp.: Wade Myers, M.D. Stefano Pini, M.D. 47. Long-Term Treatment of Panic Disorder with Participants: Burton V. Reifl er, M.D., Clonazepam or Paroxetine: a Randomized Natural- Stephen Green, M.D., Lea DeFrancisci Lis, M.D., istic Open Study Elissa Benedek, M.D. Antonio Nardi, M.D. ISSUE WORKSHOPS 33-38 48. Effectiveness of a Mindfulness-Based Cognitive Therapy Program as an Adjunct to Pharma- IW 33 11:00 A.M.-12:30 P.M. cotherapy in Patients With Panic Disorder Room 125, Exhibit Level, Moscone Center Borah Kim, M.D. THE USE OF RESEARCH MEASURES IN CLINICAL COMPONENT WORKSHOPS 15-18 PRACTICE CW 15 11:00 A.M.-12:30 P.M. Chp.: Joan Busner, Ph.D. Room 222, Mezzanine Level, Moscone Center Participants:Nicholas Greco IV, M.S., Stuart Kaplan, M.D. CURRENT TOPICS IN FORENSIC PSYCHIATRY: UPDATE FROM THE COUNCIL ON PSYCHIATRY IW 34 11:00 A.M.-12:30 P.M. AND LAW AND THE COMMITTEE ON JUDICIAL Room 220, Mezzanine Level, Moscone Center ACTION FFT-HPI AND FIT: TWO DIFFERENT APPROACHES APA Council on Psychiatry and Law and APA Committee TO FAMILY-INVOLVED TREATMENT FOR on Judicial Action BIPOLAR DISORDER Co-Chps.: Patricia R. Recupero, M.D., J.D., Chp.: Igor Galynker, M.D., Ph.D. Jeffrey Janofsky, M.D. Participants: Lisa Cohen, Ph.D., Allison Lee, M.D., Annie Steele, B.A., Nisha VerHalen, M.A. 32 WWW.PSYCH.ORG Tuesday, May 19, 2009
IW 35 11:00 A.M.-12:30 P.M. COURSE 68 1:00 P.M.- 5:00 P.M. Room 226, Mezzanine Level, Moscone Center Yosemite Room B, Ballroom Level, T2,Hilton San Francisco OUTPATIENT MASTECTOMIES: OVERVIEW OF A PRIMER ON ACCEPTANCE AND COMMITMENT PSYCHOSOCIAL ISSUES THERAPY Co-Chps.: Zach Morairty, M.D., Michelle B. Riba, M.D. Directors: Kenneth Dr. Fung, M.D., M.S., Mateusz Participant: Mary Jane Massie, M.D. Zurowski, M.D., M.S.
IW 36 11:00 A.M.-12:30 P.M. COURSE 69 1:00 P.M.- 5:00 P.M. Room 308, Esplanade Level, Moscone Center Union Square Rooms 19/20, Fourth Floor, Tower 3, EVALUATION AND MANAGEMENT OF PATIENTS Hilton San Francisco WITH EXCESSIVE DAYTIME SLEEPINESS IN STREET DRUGS AND MENTAL DISORDERS: PSYCHIATRIC PRACTICE OVERVIEW AND TREATMENT Chp.: Dimitri D. Markov, M.D. Director: John W. Tsuang, M.D. Participants: Karl Doghramji, M.D., Faculty: Timothy Fong, M.D., Stephen Ross, M.D., Karen Christine Marchionni, M.D. Miotto, M.D. IW 37 11:00 A.M.-12:30 P.M. Room 309, Esplanade Level, Moscone Center COURSE 70 1:00 P.M.- 5:00 P.M. Union Square Room 22, Fourth Floor, Tower 3, THE PORTRAYAL OF PSYCHIATRY IN RECENT Hilton San Francisco AMERICAN FILM MOTIVATIONAL THERAPY FOR INDIVIDUALS Chp.: Steven E. Pfl anz, M.D. WITH CONCURRENT DISORDERS IW 38 11:00 A.M.-12:30 P.M. Director: Shimi Kang, M.D. Room 310, Esplanade Level, Moscone Center Faculty: Marilyn Herie, Ph.D., Jennifer Toomey, R.P.N.
THE CHANGING MANAGED CARE LANDSCAPE 2:00 P.M. SESSIONS FOR BEHAVIORAL HEALTH SERVICES National Institute on Alcohol Abuse and Alcoholism ADVANCES IN SERIES 6-7 Co-Chps.: Constance M. Horgan, Sc.D., ADVANCES IN 06 2:00 P.M. -5:00 P.M. Mark Willenbring, M.D. Gateway Ballroom 103, Moscone Center Participants: Hyong Un, M.D., Constance Weisner, D.P.H. PERSONALITY DISORDER 12:00 NOON SESSIONS Chp.: John Oldham, M.D. NEW RESEARCH POSTER SESSION 4: For further information on New Research submissions, 1. How Neurobiology Informs Psychotherapy of please refer to the New Research Program section in the Personality Disorders back of this publication. Glen O. Gabbard, M.D. 2. Neurobiology of Personality Disorders 1:00 P.M. SESSIONS Larry J. Siever, M.D COURSES 67-70 3. Attachment and Personality Disorder: A Mentalization Based Approach COURSE 67 1:00 P.M.- 5:00 P.M. Peter Fonagy, Ph.D. Continental Ballroom 1, Ballroom Level, Tower 3, Hilton San Francisco 4. Levels of Care John G. Gunderson, M.D ENGAGING RESISTANT AND DIFFICULT-TO- TREAT PATIENTS IN COLLABORATIVE 5. Essentials of Pharmacotherapy in the PD Patient: An TREATMENT Update Paul H. Soloff, M.D. Director: David Mee-Lee, M.D. 6. Future Directions: Toward DSM-V Andrew E. Skodol, M.D.
162ND ANNUAL MEETING 33 Tuesday, May 19, 2009
ADVANCES IN 07 2:00 P.M. -5:00 P.M. LECTURE 19 2:00 P.M. -3:30 P.M. Room 132/133 Exhibit Level North, Moscone Center Room 303/305, Esplanade Level, Moscone Center FORENSIC PSYCHIATRY TRANSLATIONAL NEUROSCIENCE Chp.: Robert I. Simon, M.D., Lisa Gold, M.D. FOR SCHIZOPHRENIA Akira Sawa, M.D., Ph.D. 1. Managing of Clinical Legal Dilemmas Frontiers of Science Robert Simon, M.D. Chp.: Julio Licinio, M.D. 2. Disability Evaluations Lisa Gold, M.D., DFAPA kira Sawa, M.D., Ph.D., received his medical degree 3. Assessment and Management of Students at Risk for Afrom the University of Tokyo in 1990. He completed Violence at School residency in psychiatry in Japan and also received Ph.D. Peter Ash, M.D. from University of Tokyo. He enjoys working at Johns Hopkins University in Maryland, where he is the Director 4. Standards of Care in Correctional Settings of the Program in Molecular Psychiatry. His program is Jeffery Matenik, M.D. directed translational neuroscience in which both basic and 5. The Changing Law of Family Dissolution clinical researches are synergistically combined, towards Daniel Shuman, M.D. understanding the pathogenesis of neuropsychiatric illnesses at the molecular level. Since 2007, Dr. Sawa is the director of Silvio O. Conte Center grant for translational neurosci- LECTURES 18-19 ence at Johns Hopkins University to study molecular patho- genesis of schizophrenia. His awards and honors include in LECTURE 18 2:00 P.M. -3:30 P.M. 1998 Brain Science Research Award (Japan); he was the 2002 Room 130/131, Exhibit Level, Moscone Center and 2004 NARSAD Young Investigator Award recipient. An award presented to provide support for the most prom- THE MOVEMENT FOR GLOBAL MENTAL ising young scientists conducting neurobiological research; HEALTH: WHY YOU SHOULD JOIN in 2007 he was awarded the NARSAD and Staglin Family Vikram Patel M.SC., M.R.C.Psych, Ph.D. Award and the Efron Award from American College of Neu- International Lecture ropsychopharmacology; in 2008 he received the NARSAD Chp.: Geetha Jayaram, M.D. Freedman Award honorable mention. Dr. Sawa is a widely published researcher having been published in over 130 peer ikram Patel is a Professor of International Mental reviewed journals either as lead or corresponding author. VHealth and Wellcome Trust Senior Clinical Research Fellow at the London School of Hygiene & Tropical Medi- DSM TRACK cine, London. He serves on a number of international and national committees including the WHO Expert Advisory DSM TRACK 2:00 P.M. -5:00 P.M. Group for Mental Health. His recent books include Where Room 301, Esplanade Level, Moscone Center There Is No Psychiatrist (Gaskell, 2003) which has become PUBLIC HEALTH ASPECTS OF DIAGNOSIS AND a widely used manual for community mental health in de- CLASSIFICATION OF MENTAL DISORDERS: A veloping countries. He was an editor of the recent Lancet DSM-V RESEARCH AGENDA Series on Global Mental Health (2007). He led the efforts to set up the Movement for Global Mental Health which was Chp.: Norman Sartorius, M.D. launched on October 10th, 2008 (www.globalmentalhealth. 1. Public Health Aspects of Mental Disorders Classi org). He is based in Goa, India, where he serves on the boards fi cations: The WHO-APIRE Conference and Further of three community based NGOs including Sangath, a com- Thoughts munity mental health NGO (www.sangath.com) which he Shekhar Saxena, M.D. founded and which won the MacArthur Foundation’s Inter- national Prize for Creative and Effective Institutions in 2008. 2. Economic Consequences Revising the Diagnostic Nomenclature for Mental Disorders Howard Goldman, M.D. 3. Capturing Complexity: The Case for a New Classifi ca tion System for Mental Disorders in Primary Care Linda Gask, Ph.D.
34 WWW.PSYCH.ORG Tuesday, May 19, 2009
4. What are Consumers’ Views on Diagnosis and Can 5. Ethics in Suicide Which Is not Associated with They be Involved in the Development Classifi cations? Psychiatric Illness Diana Rose, Ph.D. James J. Strain, M.D. 5. Translating Psychiatric Diagnostic and Classifi cation into Public Health Usage SYMPOSIUM 20 2:00 P.M.- 5:00 P.M. Alberto Minoletti, M.D. Room 111, Exhibit Level, Moscone Center
PRESIDENTIAL SYMPOSIUM 3 BIOLOGICAL BASIS OF SEX DIFFERENCES IN DRUG ADDICTION: TRANSLATIONAL PS 3 2:00 P.M.-5:00 P.M. PERSPECTIVES Room 300, Esplanade Level, Moscone Center National Institute on Drug Abuse PSYCHIATRY AND THE CONTROL OF FERTILITY Co-Chp.: Cora Lee Wetherington, Ph.D., Wendy J. Lynch, Ph.D. Chp.: Nada Stotland, M.D. Co-Chps.: Nancy Adler, Ph.D.Gail E. Robinson, M.D., 1. Sex Differences in Biological Sensitivity to the Gisele Apter, M.D., Carole E. Joffe, Ph.D., Reinforcing Effects of Drugs of Abuse in Preclinical Michael F. Myers, M.D. Models of Acquisition, Escalation, and Relapse Wendy J. Lynch, Ph.D. 1. Is There an Abortion Trauma Syndrome? 2. The Role of Dopamine in Sex Differences in Drug Nancy Adler, Ph.D. Abuse 2. Critiquing the Evidence Jill B. Becker, Ph.D. Gail E. Robinson, M.D. 3. Gonadal Steroid Hormones and Neural Mechanisms 3. The Marginality of the Abortion Provider in the of Cognition and Emotion in Women United States Karen Faith Berman, M.D. Carole E. Joffe, Ph.D. 4. Sex Differences in MRI Correlates of Stress and 4. Contraception, Abortion and Men Drug Cues in Cocaine Dependence Michael F. Myers, M.D. Marc N. Potenza, M.D. 5. Abortion in France: High Availability Best European 5. Sex Differences in Amygdala-Based Emotional Fecundity Memory Processes: Relevance for Addiction Gisele Apter, M.D. Larry F. Cahill, Ph.D.
SYMPOSIA 19-36 SYMPOSIUM 21 2:00 P.M.- 5:00 P.M. Room 112, Exhibit Level, Moscone Center SYMPOSIUM 19 2:00 P.M.- 5:00 P.M. Gateway Ballroom 102, Exhibit Level, Moscone Center CO-OCCURRING DISORDERS IN HIV POSITIVE PATIENTS SUICIDE WITHOUT A PSYCHIATRIC DISORDER Chp.: Marshall Forstein, M.D. Chp.: Norman B. Levy, M.D. 1. HIV and Hepatitis C Co-Infection 1. Had Gary Powers Killed Himself Elizabeth Ryan, M.D. Norman B. Levy, M.D. 2. Metabolic Disease and HIV 2. Differentiating Suicide from Other Life-Ending Acts: Marshall Forstein, M.D. A Model Illustrated with Chronic Kidney Disease 3. PTSD and HIV and Dialysis Antoine Douaihy, M.D. John M. Bostwick, M.D. 4. Update on Severe Mental Illness and HIV 3. Oregon’s Death with Dignity Act: Who Chooses Francine Cournos, M.D. Physician Assisted Suicide Linda Ganzini, M.D. 5. Substance Use Disorders and HIV Steven Batki, M.D. 4. Desire for Death in Terminally Ill Cancer and AIDS Patients: Hopelessness and Loss of Meaning as Contributing Factors, Independent of Depression William Breitbart, M.D. 162ND ANNUAL MEETING 35 Tuesday, May 19, 2009
SYMPOSIUM 22 2:00 P.M.- 5:00 P.M. 4. An Analysis of Two Promising Medications, Room 113, Exhibit Level, Moscone Center Topiramate and Ondansetron, for Treating Alcohol Dependence: Results from Recent Large-Scale STARTING OUT ON THE RIGHT FOOT: SECURING Clinical Trials YOUR FIRST JOB AND ESTABLISHING A Bankole A. Johnson, M.D., Ph.D.. DSc PSYCHIATRIC PRACTICE APA Committee of Residents and Fellows 5. Pharmacogenetics and Alcohol Dependence Henry R. Kranzler, M.A. Co-Chp.: Molly K. McVoy, M.D., William H. Campbell, M.D., M.B.A. SYMPOSIUM 25 2:00 P.M.-5:00 P.M. Room 121, Exhibit Level, Moscone Center SYMPOSIUM 23 2:00 P.M.- 5:00 P.M. AUTISM IN ADULTS TOWARDS A BETTER CLINI- Room 114, Exhibit Level, Moscone Center CAL APPROACH THROUGH UNDERSTANDING: SOCIAL STRESS INCREASES VULNERABILITY TO RECENT INSIGHTS FROM RESEARCH DRUG ABUSE AND DISEASE Chp.: Rutger J. Van der Gaag, M.D., Ph.D. National Institute on Drug Abuse 1. Neurodevelopmental Correlates of Social Chp.: Nancy S. Pilotte, Ph.D. Impairment in Autism: From Infancy to Adulthood 1. Adverse Effects of Stress on Drug Addiction Ami Klin, Ph.D. Julie Blendy, Ph.D. 2. Diffusion Tensor Imaging in Autism and Asperger 2. Social Stress and Vulnerability to Substance Abuse: Syndrome: Evidence for Impairment of Long Range Genes, Environment and Neural Correlates White Matter Integrity Huda Akil, Ph.D. Wouter Groen, M.D. 3. Interactions of Social Stressors and Enrichment 3. Neurocognitive Correlates of Substance Use Disorder With Social Rank on Dopamine D2 Receptors and in Adults With Autism Spectrum Disorder or ADHD the Reinforcing Strength of Cocaine in Monkeys Bram B. Sizoo, M.D. Michael A. Nader, Ph.D. 4. Comorbidity in Adults with ASD Evidence From Data From Cross-Sectional and Prospective Case 4. Social Stress and Simian Immunodefi ciency Virus Controlled Cohort Samples Disease: Behavioral and Physiological Mechanisms Patricia J. van Wijngaarden-Cremers, M.D. That Affect Disease Progression John P. Capitanio, Ph.D. 5. ASD in Parents and Siblings of Early Diagnosed Infants With ASD SYMPOSIUM 24 2:00 P.M.-5:00 P.M. Rutger J. Van der Gaag, M.D. Room 120, Exhibit Level, Moscone Center SYMPOSIUM 26 2:00 P.M.-5:00 P.M. WHAT’S NEW IN PHARMACOTHERAPY FOR Room 122, Exhibit Level, Moscone Center ALCOHOL DEPENDENCE? National Institute on Alcohol Abuse and Alcoholism THE EFFECTS OF CITY LIFE ON MENTAL HEALTH AROUND THE WORLD Chp.: David T. George, M.D. The Royal College of Psychiatrists 1. Neurokinin 1 Receptor (NK1R) Antagonism: A Co-Chp.: Nigel Bark, M.D., Rachel Jenkins, M.D. Novel Anti-Stress Mechanism for the Treatment of Alcoholism 1. The Impact of Urban Living on Mental Health David T. George, M.D. and Illness in Egypt Nasser N. Loza, M.D. 2. Human Laboratory and Clinical Trial Evidence for Gabapentin Treatment of Alcohol Dependence 2. Mental Disorders and Quality of Life in Large Barbara J. Mason, Ph.D. Metropolitan Areas in Mexico Maria Elena Medina Mora, Psy.D., Ph.D. 3. Update on New Clinical Trials for Alcohol Dependence: Opiate, Dopamine and GABA/ 3. Metro-Urban Mental Health in Developing Glutamate Acting Medications Countries: From Origins to Outcome: An Indian Raymond F. Anton, M.D. Experience Amresh K. A. Shrivastava, M.D.
36 WWW.PSYCH.ORG Tuesday, May 19, 2009
4. A Population-Based Study of First Episode Psychosis 3. Nonresponse to CBT and Antidepressants in the in São Paulo, Brazil Treatment of Depression in Myocardial Infarction Paulo Menezes, M.D. Patients Elizabeth Martens, M.D. 5. Chinese Elderly in Singapore : Comparing the Mental Health of an Urban and a Suburban 4. How Well Do We Treat MDD? Population Claudi CLH Bockting, Ph.D., M.S.C. Ee-Heok Ehk Kua, M.B.B.S. Discussant: Steven Hollon, Ph.D. 6. The Practice of Mental Health Promotion in Urban Planning and City Administration SYMPOSIUM 29 2:00 P.M.-5:00 P.M. Rooms 272/274/276, Mezzanine Level West, Helen E. Herrman, M.B., M.D. Moscone Center Discussant: Rachel Jenkins, M.D. BORDERLINE PERSONALITY DISORDER: THE SYMPOSIUM 27 2:00 P.M.-5:00 P.M. ROLE OF NEUROBIOLOGY AND GENES Room 124, Exhibit Level, Moscone Center Co-Chp.: Barbara H. Stanley, Ph.D., Larry J. Siever, M.D. RECENT RESEARCH IN EATING DISORDERS 1. Opioid Receptor and Oxytocin Genotypes in BPD Chp.: James E. Mitchell, M.D. Larry J. Siever, M.D. 1. Psychopathology and Eating Pathology in Bariatric 2. Dysregulation of Endogenous Opioid System Surgery Candidates Function in Borderline Personality Disorder James E. Mitchell, M.D. Jon-Kar Zubieta, M.D. 2. Disordered Eating and Psychiatric Symptoms in 3. Pain Processing in Borderline Personality Disorder: Adolescents Presenting for Bariatric Surgery Functional and Genetic Approach Michael J. Devlin, M.D. Martin Bohus, M.D. 4. Neurobiology of Self Injury in Borderline 3. Recent Mortality Studies in Eating Disorders Personality Disorder Scott J. Crow, M.D. Barbara H. Stanley, Ph.D. 4. A Model of Allostasis for Conceptualizing Eating Discussant: Peter Fonagy, Ph.D. Disorders Katherine A. Halmi, M.D. SYMPOSIUM 30 2:00 P.M.-5:00 P.M. 5. Are Anorexia Nervosa and Bulimia Nervosa Room 302, Esplanade Level, Moscone Center Really Eating Disorders: New Understanding of CURRENT AND FUTURE OF THE EMERGENT Puzzling Symptoms FIELD OF THERAPEUTIC BRAIN STIMULATION Walter H. Kaye, M.D. AND NEUROMODULATION IN PSYCHIATRY SYMPOSIUM 28 2:00 P.M.-5:00 P.M. Co-Chp.: Alexander Bystritsky, M.D., Ph.D., Room 125, Exhibit Level, Moscone Center Mark S. George, M.D. PUBLICATION BIAS AND THE EFFECTIVENESS 1. Neurosurgery for OCD: Focus on Deep Brain OF ANTIDEPRESSANT TREATMENT AND Stimulation PSYCHOLOGICAL INTERVENTIONS IN Benjamin D. Greenberg, M.D. DEPRESSION: SHOULD WE CARE? 2. Feasibility Study of an Implantable Cortical Co-Chp.: Claudi C.L.H. Bockting, Ph.D., M.S.C., Stimulation System for Patients With Major Steven Hollon, Ph.D. Depressive Disorder Darin D. Dougherty, M.D. 1. Selective Publication of Antidepressant Trials and Its Infl uence on Apparent Effi cacy 3. Deep Transcranial Magnetic Stimulation: Compari Erick H. Turner, M.D. son Between Effects of Unilateral and Bilateral Pre- frontal Cortex Stimulation in Depressive Patients 2. Publication Bias Is Not Restricted to Reporting Abraham Zangen, Ph.D. Outcomes of Pharmacotherapy Trials Willem W.A.Nolen, M.D. 4. Current and Future Therapeutic Uses of TMS Mark S. George, M.D. 162ND ANNUAL MEETING 37 Tuesday, May 19, 2009
5. Current and Future of Other Brain Stimulating 1. Evidence-Based Versus Effectiveness Studies: Techniques The Randomized Controlled Trial and Psycho- Alexander Bystritsky, M.D. therapy Research Discussant: Laura B. Dunn, M.D. Kenneth R. Silk, M.D. 2. Mentalization Based Treatment: a Discussion of SYMPOSIUM 31 2:00 P.M.-5:00 P.M. Theory and Evidence. Room 304, Esplanade Level, Moscone Center Anthony W. Bateman, M.R.C. PEDIATRIC BIPOLAR DISORDER: A CRITICAL 3. Transference-Focused Psychotherapy for BPD: LOOK AT AN AMERICAN PHENOMENON. Aiming for Change in Personality Structure Chp.: Peter I. Parry, M.B.B.S. Frank E. Yeomans, M.D. 1. Australian and New Zealand’s Child & Adolescent 4. Dialectical Behavior Therapy for Complex, Multi- Psychiatrists’ Views on Bipolar Disorder Prevalence Diagnostic Patients – A Review of DBT’s Evidence and on Rates of Pediatric Bipolar Disorder in the Base to Date USA. Linda A. Dimeff, Ph.D. Peter I. Parry, M.B.B.S. 5. CBT for Personality Disorders (CBT-PD) 2. Changing the Treatment Culture in a Residential Kate M. Davidson, Ph.D. Agency for Youth: Broadening the Role of Psychiatry 6. Schema Therapy for Borderline Personality Disorder Edmund C. Levin , M.D. Jeffrey E. Young, Ph.D. 3. Pediatric Bipolar Disorder: A Dispassionate Review Discussant: John G. Gunderson, M.D. of the Literature Glen R. Elliott, M.D. SYMPOSIUM 34 4. Bioethics and “Pediatric Bipolar Disorder” WITHDRAWN . Mary G. Burke, M.D. SYMPOSIUM 35 2:00 P.M.-5:00 P.M. SYMPOSIUM 32 2:00 P.M.-5:00 P.M. Room 309, Esplanade Level, Moscone Center Room 306, Esplanade Level, Moscone Center PTSD AND ALCOHOL USE DISORDER (WITH WORKING WITH LAWYERS SPECIAL EMPHASIS ON RETURNING VETERANS) National Institute on Alcohol Abuse and Alcoholism Co-Chp.: Lawrence K. Richards, M.D., Roger Peele, M.D. Chp.: Lisa M. Najavits, Ph.D. 1. Values of Medicine and the Law Roger Peele, M.D. 1. Psychotherapy Treatments for PTSD and Alcohol Use Disorder 2. Brownlee Versus Me: A Good Lawyer Directs the Lisa M. Najavits, Ph.D. Process and Gets a Favorable Summary Judgement Lawrence K. Richards, M.D. 2. Neurobiological Determinants of the Comorbidity of PTSD and Substance Abuse 3. New Opportunities for Attorney/Psychiatrist Collaborations Thomas R. Kosten, M.D. Bruce J. Winick, J.D. 3. Pharmacotherapeutic Treatment of PTSD and 4. Beyond “Get the Money up Front” Co-Occurring Alcohol Use Disorders Thomas G. Gutheil, M.D. Kathleen Brady, M.D. 5. Working With Lawyers 4. Outcomes for Alcohol Misusing Women with PTSD Harold I. Eist, M.D. in the Women and Trauma Multisite Study in NIDA’s Clinical Trials Network SYMPOSIUM 33 2:00 P.M.-5:00 P.M. Denise Hien, Ph.D. Room 307, Esplanade Level, Moscone Center 5. Impact of Childhood Trauma on Hypothalamic- EMPIRICALLY VALIDATED AND EFFECTIVE Pituitary-Adrenocorticol (HPA) Activity in Alcohol PSYCHOTHERAPIES FOR BORDERLINE Dependent Patients PERSONALITY DISORDER Ingo Schäfer, M.D. Co-Chp.: Kenneth R. Silk, M.D., John G. Gunderson, M.D.
38 WWW.PSYCH.ORG Tuesday, May 19, 2009
SYMPOSIUM 36 2:00 P.M.-5:00 P.M. INDUSTRY-SUPPORTED SYMPOSIA 11 Room 310, Esplanade Level, Moscone Center PSYCHIATRIC PATIENTS OVERCROWDING ISS 11 7:00 P.M. - 9:00 P.M. IN EMERGENCY DEPARTMENTS: A CALL FOR Continental Ballroom 4/5/6, Ballroom Level, Hilton S.F. ACTIONS NOVEL APPROACHES TO ASSESSING AND APA Council on Healthcare Systems and Financing TREATING DEPRESSION IN THE MEDICALLY ILL Chp.: Anthony T. Ng, M.D. Supported by Lilly USA, LLC 1. Overview of Psychiatric Patient Overcrowding in Chp.: Bradley Gaynes, M.D. Emergency Departments 1. Assessing Mood and Somatic Symptoms in the Scott L. Zeller, M.D. Medically-Ill, Depressed Patient Simon Gregory, M.D. 2. HealthCare Delivery System Infl uences and Impacts Strategies for Improvement 2. Pathophysiology of Somatic Symptoms and Joseph J. Parks, M.D. Medical Illness in Major Depressive Disorder Janet Witte, M.D. 3. Innovative Methods To Decrease Psychiatric Patient Overcrowding of Medical Emergency Departments 3. An Evidence-Based Guide for Treating Avrim B. Fishkind, M.D. Depression in the Medically Ill Bradley N. Gaynes, M.D. 4. Behavioral Health Service Gaps and the Role of Emergency Departments 4. Management of Treatment-Resistant Patients With Somatic Symptoms and Medical Illness Alan Q. Radke, M.D. Maurizio Fava, M.D. Discussant: Anita S. Everett, M.D.
3:00 P.M. SESSION
NEW RESEARCH POSTER SESSION 5: For further information on New Research Poster sessions, please refer to the New Research Program section in the back of this publication.
5:00 P.M. SESSION
MIND GAMES 5:00 P.M. -6:00 P.M. Gateway Ballroom 104, Moscone Center Our Host and Moderator: Glen O. Gabbard, M.D. Mind Games is a national team competition for residents at the APA Annual Meeting. The game pits top game scoring residency programs against each other in a fi nal competition testing the depth and breadth of their knowledge of psychiatry. FINALISTS FOR THE 2009 CHAMPIONSHIP ARE: Albert Einstein Healthcare Network University of Pennsylvania University of Texas at Houston
7:00 P.M. SESSION
162ND ANNUAL MEETING 39 Wednesday, May 20, 2009
8:00 A.M. SESSIONS COURSE 76 8:00 A.M.-12 NOON Union Square Rooms 15/16 Fourth Floor, Tower 3, COURSES 71-76 AND 80 Hilton San Francisco COURSE 71 8:00 A.M. -12 NOON A MODEL OF GROUP PSYCHOTHERAPY FOR Continental Ballroom 1, Ballroom Level, Tower 3, PERSONS WITH CHRONIC MENTAL ILLNESS Hilton San Francisco American Group Psychotherapy Association
MENTALIZATION BASED TREATMENT (MBT) Director: Walter N. Stone, B.A., M.D. FOR BORDERLINE PERSONALITY DISORDER (BPD): INTRODUCTION TO CLINICAL PRACTICE COURSE 80 8:00 A.M.- 5:00 P.M. Directors: Anthony W. Bateman, M.R.C., Peter Fonagy, Ph.D. Yosemite Room C, Ballroom Level, Tower 2, Hilton San Francisco COURSE 72 8:00 A.M.-12 NOON Continental Ballroom 2, Ballroom Level, Tower 3, OFFICE-BASED BUPRENORPHINE TREATMENT Hilton San Francisco OF OPIOID-DEPENDENT PATIENTS FROM TRAUMATIC STRESS TO TRAUMA-IN- Director: Gerardo Gonzalez, M.D. FORMED CARE: STRATEGIES FOR PROVIDING Faculty: Andrew Saxon, M.D., Eric Strain, M.D., SERVICES TO PEOPLE WHO ARE HOMELESS Laura McNicholas, M.D., Ph.D. Director: Kathleen Guarino, B.A., M.A. 9:00 A.M. SESSIONS Faculty: Ellen K. Bassu, M.D. LECTURE 20 9:00 A.M. -10:30 A.M. COURSE 73 8:00 A.M.-12 NOON Room 130/131, Exhibit Level, Moscone Center Continental Ballroom 9, Ballroom Level, Tower 3, Hilton San Francisco OVERCOMING THE TERROR OF DEATH Irvin D. Yalom, M.D. COGNITIVE BEHAVIORAL THERAPY FOR Distinguished Psychiatrist INSOMNIA CO-MORBID WITH DEPRESSIVE AND ANXIETY DISORDERS Chp.: Cathy Crone, M.D. Vice-Chair: Josepha A. Cheong, M.D. Director: Rachel Manber, Ph.D. Faculty: Anne Germain, Ph.D., Jack Edinger, Ph.D., rvin Yalom was born in Washington DC, attended Boston Uni- Colleen Carney, Ph.D., Rachel Manber, Ph.D., Iversity Medical School, interned at Mount Sinai Hospital in NY, Jason Ong, Ph.D. and took his psychiatric residency training at Johns Hopkins. His textbooks include: The Theory and Practice of Group Psychothera- COURSE 74 8:00 A.M.-12 NOON py, Existential Psychotherapy, and Inpatient Group Psychotherapy. Imperial Ballroom A, Ballroom Level, Tower 2, Books of stories and novels that teach psychotherapy include Love’s Hilton San Francisco Executioner, Momma and the Meaning of Life, When Nietzche Wept, Lying on the Couch, The Schopenhauer Cure. His most re- INTRODUCING CULTURE INTO PSYCHIATRIC cent book is Staring at the Sun: Overcoming the Terror of Death. PRACTICE SMALL INTERACTIVE SESSION 9 Directors: Kenneth Fung, M.D., M.S., Lisa F. Andermann, M.D. SI 9 9:00 A.M.-10:30 A.M. Faculty: Ari Zaretsky, M.D., Ted Lo, M.B.B.S, M.R.C. Room 218, Mezzanine Level, Moscone Center COURSE 75 8:00 A.M.-12 NOON CLINICAL MANUAL FOR THE DIAGNOSIS AND Yosemite Room B, Ballroom Level, Tower 2, TREATMENT OF PSYCHOTIC DEPRESSION Hilton San Francisco Chp.: Anthony Rothschild, M.D. (Meet the Author) ECT PRACTICE UPDATE FOR THE GENERAL PSYCHIATRIST COMPONENT WORKSHOPS 19-23 APA Corresponding Committee on ECT and Other Electro- CW 19 9:00 A.M.-10:30 A.M. magnetic Therapies Room 111, Exhibit Level, Moscone Center Director: Jerry L. Lewis, M.D., M.S. Faculty: Laurie McCormick, M.D., Peter Rosenquist, M.D., IMMIGRANT MENTAL HEALTH: CHALLENGES Andrew Krystal, M.D., Charles Kellner, M.D. AND CONSIDERATIONS 40 WWW.PSYCH.ORG Wednesday, May 20, 2009
APA/SAMHSA and APA/AstraZeneca Minority Fellowships INTERACTION Co-Chps.: Shirin Ali, M.D., Felicia Y. Kuo, B.A., M.D. Co-Chps.: Divy Ravindranath, M.D., M.S., Participants: Chris Esguerra, M.D., Farha Abbasi, M.D., Erick Hung, M.D. Arun Gopal, M.D., Suzan Song, M.D., M.P.H., Participant: Michelle Riba, M.D., Kristen Brooks, M.D., Batool Kazim, M.D. Jewel Shim, M.D. CW 20 9:00 A.M.-10:30 A.M. IW 40 9:00 A.M.-10:30 A.M. Room 125, Exhibit Level, Moscone Center Room 114, Exhibit Level, Moscone Center NATIONAL TRENDS IN PSYCHOTHERAPY BY PATIENT SUICIDE DURING PSYCHIATRY PSYCHIATRISTS RESIDENCY: A WORKSHOP DISCUSSION APA Committee on Psychotherapy by Psychiatrists Co-Chps.: Christina V. Mangurian, M.D., Chp.: Eric M. Plakun, M.D. Andrew Booty, M.D. Participants: Ramin Mojtabai, M.D., Ph.D., Participants: Emily Davies, M.D., Kristen Brooks, M.D., Glen Gabbard, M.D., Nada L. Stotland, M.D., M.P.H. Aaron Reliford, M.D., Laura Dauenhauer, M.D., Francine Cournos, M.D. CW 21 9:00 A.M.-10:30 A.M. Room 222, Mezzanine Level, Moscone Center IW 41 9:00 A.M.-10:30 A.M. Room 122, Exhibit Level, Moscone Center TRADITIONAL AND PSYCHIATRIC HEALERS IN NORTH AMERICA PEDIATRIC GRIEF AND BEREAVEMENT: APA Committee of American Indian, Alaska Native, STRATEGIES TO HELP KIDS AND PARENTS COPE and Native Hawaiian Psychiatrists Co-Chps.: Ruth E. Geller, M.D., M.Ed., Chp.: Mary H. Roessel, M.D. Eva Szigethy, M.D., Ph.D. Participants: Ruth Geller, M.D., M.Ed., CW 22 9:00 A.M.-10:30 A.M. Olle Jane Sahler, M.D., David R. DeMaso, M.D. Room 302, Esplanade Level, Moscone Center IW 42 9:00 A.M.-10:30 A.M. SCHOOL BULLYING: PSYCHIATRIC AND Room 224, Mezzanine Level, Moscone Center PHYSICAL HEALTH RISKS, AND TREATMENT INTERVENTIONS PRACTICAL MODELS FOR INCORPORATING APA Corresponding Committee on Mental Health and Schools EBM INTO ACADEMIC CLINICAL PRACTICES Chp.: Marcia J. Slattery, M.D. Chp.: John Q. Young, M.D., M.P.P. Participants: Jorge Srabstein, M.D., Hong Shen, M.D. Participants: Melissa Nau, M.D., Alison May, M.D., Christopher Daley, M.D., Monica Caselli, M.D., CW 23 9:00 A.M.-10:30A.M. Lowell Tong, M.D. Room 304, Esplanade Level, Moscone Center IW 43 9:00 A.M.-10:30 A.M. BREAKING THROUGH A SHATTER-PROOF Room 226, Mezzanine Level, Moscone Center GLASS CEILING: WHAT KEEPS WOMEN PSYCHIATRISTS FROM REACHING THEIR PROMOTING SCHOLARSHIP & LEADERSHIP LEADERSHIP GOALS? DURING RESIDENCY TRAINING APA Committee on Women Co-Chps.: Anu A. Matorin, M.D., Sandra B Sexson, M.D. Co-Chps.: Claudia L. Reardon, M.D., Participants: Jennifer Yen, M.D., Deborah Hales, M.D., Stacey Burpee, D.O., M.P.H. Pedro Ruiz, M.D. Participants: Dolores Malaspina, M.D., Carol Nadelson, M.D., Gail Robinson, M.D. IW 44 9:00 A.M.-10:30 A.M. Rooms 272-276, Mezzanine Level W, Moscone Center ISSUE WORKSHOPS 39-50 BEYOND DOCTOR-PATIENT RELATIONSHIP IN CYBERSPACE: PITFALLS, TRANSGRESSIONS, IW 39 9:00 A.M.-10:30 A.M. AND GUIDELINES (WHEN THERAPISTS AND Room 113, Exhibit Level, Moscone Center PATIENTS GOOGLE EACH OTHER) SUPERVISION IN THE PSYCHIATRIC Co-Chps.: Damir Huremovic, M.D., M.P.P., EMERGENCY DEPARTMENT: TECHNIQUES FOR Nyapati R. Rao, M.D., M.S. MAXIMIZING THE SUPERVISOR-TRAINEE Participants: Shabneet Hira-Brar, M.D., Jacob Sperber, M.D. 162ND ANNUAL MEETING 41 Wednesday, May 20, 2009
IW 45 9:00 A.M.-10:30 A.M. SPECIAL EVENT 9:00 A.M. - 11:00 A.M. Room 300, Esplanade Level, Moscone Center Gateway Ballroom 102 Exhibit Level, Moscone Center OLDER ADULTS AND THE NEUROBIOLOGY OF PSYCHOLOGICAL EFFECTS OF THE LONG WAR: SUBSTANCE ABUSE STRATEGIES FOR MITIGATION National Institute on Drug Abuse Co-Chairs: Brigadier General Loree Sutton, M.D., Chp.: Timothy P. Condon, Ph.D. Colonel Elspeth Ritchie, M.D. Participants: David Oslin, M.D., Gayathri Dowling, Ph.D. Presenters: Captain Paul Hammer, M.D., Captain Ed Simmer, M.D. IW 46 9:00 A.M.-10:30 A.M. Room 301, Esplanade Level, Moscone Center 1. Updates on the Defense Center of Excellence Brigadier General Loree Sutton, M.D. AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY UPDATE: CERTIFICATION IN 2. Suicide and Psychological Issues in the United PSYCHIATRY AND ITS SUBSPECIALTIES States Army Colonel Elspeth Ritchie, M.D. Co-Chps.: Larry R. Faulkner, M.D., Naleen N. Andrade, M.D. 3. Psychological Issues for the Unites States Navy Participants: Kailie Shaw, M.D., Robert Guynn, B.A., Captain Paul Hammer, M.D. M.D., Barbara Schneidman, M.D., M.P.H., Beth Ann 4. Best Practice: Update from DCOE Brooks, M.D., Victor Reus, M.D., David Mrazek, M.D. Captain Ed Simmer, M.D. IW 47 9:00 A.M.-10:30 A.M. Discussant: Robert Ursano, M.D. Room 306, Esplanade Level, Moscone Center ADVANCES IN SERIES THE COBBLER’S CHILDREN: DEALING WITH PSYCHIATRIC PROBLEMS IN OUR OWN ADVANCES IN SERIES 8 9:00 A.M.-12 NOON FAMILIES Gateway Ballroom 103, Exhibit Level, Moscone Center Chp.: Julia B. Frank, M.D. HOSPITAL PSYCHIATRY Participants: Mitchell Cohen, M.D., Kathryn McIntyre, M.D. Chp.: Steven Sharfstein, M.D. IW 48 9:00 A.M.-10:30 A.M. 1. A New Model for Acute Psychiatric Hospitalization Room 308, Esplanade Level, Moscone Center Ira D. Glick, M.D., Harold I. Schwartz, M.D. ORAL BOARDS BOOT CAMP-2009 2. Core Requirements for an Inpatient Co-Occurring Co-Chps.: Elyse D. Weiner, M.D., Eric D. Peselow, M.D. Disorders Unit Patricia R. Recupero, J.D., M.D., John M. Oldham, M.D. IW 49 9:00 A.M.-10:30 A.M. 3. Information Systems and the Electronic Medical Room 309, Esplanade Level, Moscone Center Record HOW TO LAUNCH A SUCCESSFUL PRIVATE John J. Boronow, M.D. PRACTICE (PART I) 4. Financing of Hospital-Based Psychiatry Chp.: William E. Callahan, M.D. Benjamin Liptzin, M.D. Participants: Donna Vanderpool, J.D., M.B.A., 5. Working with Families of Patients with Serious Martin Tracy, J.D. Mental Illness in the Inpatient Setting IW 50 9:00 A.M.-10:30 A.M. Lisa B. Dixon, M.D., M.P.H. Room 310, Esplanade Level, Moscone Center MEDIA WORKSHOPS 5-6 PSYCHIATRISTS WHO HAVE HAD A PSYCHIATRIC ILLNESS: THEIR STORIES MEDIA WORKSHOP 5 9:00 A.M.-12 NOON Room 123, Exhibit Level, Moscone Center Co-Chps.: Michael F. Myers, M.D., Leah J. Dickstein, M.D., M.A. THE BRIDGE (A DOCUMENTARY FILM ABOUT Participants: Alphonse Osinski, M.D., Raymond Reyes, M.D., SUICIDE FROM THE GOLDEN GATE BRIDGE; Suzanne E. Vogel-Scibilia, M.D., Francine Cournos, M.D. DISCUSSION WITH THE FILM’S DIRECTOR AND A BRIDGE JUMP SURVIVOR) APA Northern California Psychiatric Society
42 WWW.PSYCH.ORG Wednesday, May 20, 2009
Co-Chps.: Mel I. Blaustein, M.D., Raymond Zablotny, M.D. 11:00 A.M. SESSIONS Participant: Patrick Hines, Kevin Hines ADVANCES IN MEDICINE 03 MEDIA WORKSHOP 6 9:00 A.M.-12:00 NOON Room 124, Exhibit Level, Moscone Center ADV IN MEDICINE 11:00 A.M.-12:30 P.M. Gateway Ballroom 104, Exhibit Level, Moscone Center disFIGURED – A MOVIE ABOUT WOMEN AND WEIGHT: THE IMPACT OF APPEARANCE ON MEDICAL UPDATES AND CONTROVERSIES: COPING WITH LIFE WHAT PSYCHIATRISTS SHOULD KNOW Co-Chps.: Katherine A. Halmi, M.D., Seymour Gers, M.D. Chp.: Robert McCarron, D.O. Participants: Glen L. Xiong, M.D., John C. Onate, M.D., COURSES 77-79 James A. Bourgeois, O.D., M.D. COURSE 77 9:00 A.M.- 4:00 P.M. FORUMS 8-10 Imperial Ballroom B, Ballroom Level, Tower 2, FORUM 8 11:30 A.M.-12:30 P.M. Hilton San Francisco Room 301, Esplanade Level, moscone Center YOGA OF THE EAST AND WEST: INTEGRATING BREATH WORK AND MEDITATION INTO CLINI- HOW TO CHOOSE A TOPIC AND SUBMIT CAL PRACTICE SUCCESSFULLY TO THE APA ANNUAL MEETING: UNDERSTANDING MEMBERS’ INTERESTS AND Directors: Patricia L. Gerbarg, M.D., Richard P. Brown, M.D. DIFFERENT FORMATS Faculty: Monica Vermani, M.A., Psy.D., Martin Katzman, M.D. Chairs.: Donald Hilty, M.D., Deborah Spitz, M.D. Presenters: Robert Boland, M.D., Michele Pato, M.D., COURSE 78 9:00 A.M.- 4:00 P.M. Ken Silk, M.D., Anand Pandya, M.D., Don Hilty, M.D. Union Square Room 22, Fourth Floor, Tower 3, FORUM 9 12:00 A.M.-1:30 P.M. Hilton San Francisco Room 306, Esplanade Level, Moscone Center EEG FEEDBACK IN PSYCHIATRY: CLINICAL PSYCHIATRY IN AMERICA: AN EUROPEAN APPLICATIONS PERSPECTIVE Directors: Thomas M. Brod, M.D., Michael Cohen, M.D. Chair: Pedro Ruiz, M.D. Faculty: Julian Isaacs, B.A., Ph.D., Gary Schummer, Ph.D., Presenters: Livia Vaburosa, M.D., Cyril Holsch, M.D., Beverly Rubik, B.S., Ph.D., Glenn Marks, Ph.D., Wolfgang Gaebel, M.D., Michael Musaleck, M.D. Len Ochs, M.D. FORUM 10 11:00 A.M.-12:30 P.M. COURSE 79 9:00 A.M.- 4:00 P.M. Room 307, Esplanade Level, Moscone Center Union Square Rooms 17/18, Fourth Floor, Tower 3, THE MILESTONES OF RECOVERY SCALE: Hilton San Francisco TRACKING RECOVERY AND GUIDING SERVICES NARRATIVE PSYCHIATRY: AN INDIGENOUS- Chair: Mark Ragins, M.D. FRIENDLY APPROACH FOR CROSS-CULTURAL Participants: Leonard Miller, Ph.D., Dave Pilon, Ph.D., PSYCHOTHERAPY Lisa S. Miller, M.D. Director: Lewis Mehl-Madrona, M.D., Ph.D. Faculty: Anne-Marie Chaisson, M.D., M.P.H. LECTURE 21 LECTURE 21 11:00 A.M. -12:30 P.M. Room 130/131, Exhibit Level, Moscone Center 10:00 A.M. SESSIONS DEVELOPMENTS IN MENTAL HEALTH NOW OPEN SERVICES IN INDIA EXHIBIT HALL Mathew Varghese, M.D. APA MEMBER CENTER International Lecture PUBLISHERS’ BOOKFAIR Chp.: Geetha Jayaram, M.D. HOURS OF OPERATION: Vice-Chair: Srijan Sen, M.D. 10:00 A.M. -5:00 P.M.
162ND ANNUAL MEETING 43 Wednesday, May 20, 2009
r Mathew Varghese is Professor of Psychiatry at the National Depression Care on College Campuses DInstitute of Mental Health and NeuroSciences (NIMHANS) at Henry Chung, M.D. Bangalore, India. He trained in Medicine at the St John’s Medi- 53. CBASP and Brief Supportive Psychotherapy for cal College, Bangalore and specialized in psychiatry at NIMHANS Augmentation of Antidepressant Nonresponse in in 1984. For 25 years he has served on the psychiatry faculty at Chronic Depression NIMHANS, where he provides clinical service on the adult, geri- James Kocsis, M.D. atric and family psychiatry services as well as postgraduate teach- ing, research and administration. A visiting faculty and examiner 54. Can Clinicians Improve Antidepressant Remission in mental health, he is also on the governing boards of the World Rates With Better Treatment Algorithms? Association for Psychosocial Rehabilitation, the Alzheimer’s Richard Metzner, M.D. Disease International Association, and the Medical Pastoral As- sociation. Dr Varghese’s research interests are in the area of fam- ily interventions with psychiatric disorders, social psychiatry and SCIENTIFIC AND CLINICAL REPORT rehabilitation. He does research on dementia and is one of the SCR 19 11:00 A.M.- 12:30 P.M. founding members of the international “10/66 Dementia Research Room 113, Exhibit Level, Moscone Center Group”. He has developed family intervention manuals for use with caregivers of persons with dementia and schizophrenia. He stud- PREMORBID FACTORS AND COURSE IN ies resource needs for mental health care in developing countries. SCHIZOPHRENIA He was a co-investigator and author of the National Human Rights Chp.: Haldun Soygur, M.D. Commission project on “Quality Assurance in Mental Health” in 1999. He was the principle investigator for the Bangalore cen- 55. Remission in Schizophrenia: A National Survey of ter on the multi-site World Mental Health Survey in India. Dr. Clinical and Psychosocial Aspects Varghese was the recipient of a Fulbright Alumni Exchange fel- Yoram Barak, M.D. lowship in geriatric psychiatry at the Robert Wood Johnson Medical School, New Jersey in 2001, and a Fogarty International 56. Schizophrenia in the Offspring of Ante-natally Center Visiting Fellowship at the ADRC at Washington Univer- Depressed Mothers in the Northern Finland 1966 sity School of Medicine, St Louis, in 2008. His research proj- Birth Cohort – A Gene X Environment Interaction ects supported have been supported by Fogarty International Pirjo H. Maki, M.D., Ph.D. Center (FIRCA & ICOHRTA), the Ministry of Health, the ICMR, the Dept of Science & Technology, the Dept of Biotechnology. 57. Child and Adolescent Symptoms Predicting He has over 60 publications in journals, books and monographs. Psychosis Juha M. Veijola, M.D. SCIENTIFIC AND CLINICAL REPORTS 17-24 SCIENTIFIC AND CLINICAL REPORTS SCR 17 11:00 A.M.- 12:30 P.M. SCR 20 11:00 A.M.- 12:30 P.M. Room 111, Exhibit Level, Moscone Center Room 114, Exhibit Level, Moscone Center BORDERLINE PERSONALITY DISORDER TRAUMA AND PTSD Chp.: Karla Compton, M.D. Chp.: Brigette Apfel, M.D. 49. Parental Viewpoints of Trajectories to Borderline Personality Disorder 58. The USS Cole Bombing: Analysis of Preexisting Marianne Goodman, M.D. Factors as Predictors for Development of PTSD Kevin Nasky, D.O. 50. Lifetime Patterns of Psychotherapy and Medication Utilization in Females with Borderline Personality 59. Emotional Distress and Other Health-Related Disorder- Results of an On-line Parental Survey Dimensions Among Elderly Survivors of the Shoa Marianne Goodman, M.D. Living in the Community Robert Kohn, M.D. 51. Is Borderline Personality Disorder Underdiagnosed? David Meyerson, B.A. 60. Psychopathology Among Holocaust Survivors Sixty Years Thereafter SCIENTIFIC AND CLINICAL REPORT Itzhak Levav, M.D. SCR 18 11:00 A.M.- 12:30 P.M. Room 112, Exhibit Level, Moscone Center SCIENTIFIC AND CLINICAL REPORTS SCR 21 11:00 A.M.- 12:30 P.M. ALGORITHMS AND OTHER MODELS IN THE Room 120, Exhibit Level, Moscone Center TREATMENT OF DEPRESSION Chp.: Nitin Gupta, M.D. SUICIDE IN SPECIALLY DEFINED POPULATIONS 52. Using the Chronic Care Model to Improve Chp.: Sanjay Vaswani, M.D. 44 WWW.PSYCH.ORG Wednesday, May 20, 2009
61. Suicide Among Female Veterans During 2005: METABOLIC EFFECTS OF PSYCHOTROPIC Findings From the National Violent Death Reporting MEDICATION System Bentson McFarland, M.D., Ph.D. Chp.: Julio Licinio, M.D. 62. A Multi-Site Study of the Incidence and Nature of 70. Do Cardiovascular Risk Factors Impede Anti- Inpatient Suicide Attempts depressant Treatment Response? Virginia L. Susman, M.D. Dale D’Mello M.D. 63. Association Between Antidepressant Half-Life and 71. Depressive Symptoms and Risk for 10-Year the Risk of Suicidal Ideation or Behavior Among Cardiovascular Morbidity and Mortality Hannu Koponen M.D., Ph.D. Children and Adolescents Eric Smith M.D. 72. Weight Gain and Increases in Cholesterol, Triglyceride, and Glucose Levels in Schizophenic SCIENTIFIC AND CLINICAL REPORTS Patients Treated With Clozapine, Olanzapine and SCR 22 11:00 A.M.- 12:30 P.M. Haloperidol Room 121, Exhibit Level, Moscone Center Menahem Krakowski M.D., Ph.D.
SUBSTANCE USE DISORDER IN PSYCHOSIS AND SMALL INTERACTIVE SESSIONS 10-11 BIPOLAR DISORDER Chp.: Merra Vaswani, M.D. SI 10 11:00 A.M.-12:30 P.M. Room 216, Mezzanine Level, Moscone Convention Ctr 64. Cannabis Withdrawal in People With Schizophrenia HOW TO RESEARCH A CLINICAL QUESTION David Gorelick, M.D., Ph.D. Chp.: Ranga Krishnan, M.D. 65. Is Use of Illegal Non-Cannabinoid Substances Associated With Psychotic Symptoms? SI 11 11:00 A.M.-12:30 P.M. Nina Kuzenko, M.D. Room 218, Mezzanine Level, Moscone Convention Ctr 66. Comorbid Anxiety and Substance Use Disorders HOW TO TREAT BEHAVIORAL SYMPTOMS IN Confound the Clinical Diagnosis of Bipolar I But DEMENTIA Not II: Implication for Mood Stabilizer Use Keming Gao, M.D., Ph.D. Chp.: Marc E. Agronin, M.D. SCIENTIFIC AND CLINICAL REPORTS COMPONENT WORKSHOPS 24-26 SCR 23 11:00 A.M.- 12:30 P.M. Room 122, Exhibit Level, Moscone Center CW 24 11:00 A.M.-12:30 P.M. Room 125, Exhibit Level, Moscone Center EPIDEMIOLOGY I PSYCHIATRIC RESIDENCY TRAINING NEEDS Chp.: Derya Akibiyik, M.D. FOR INTERNATIONAL MEDICAL GRADUATES 67. Survey of World Psychiatric Association (WPA) APA Committee on International Medical Graduates Member Societies on Child Sexual Abuse and Co-Chps.: Antony Fernandez, M.D. Physician-Patient Sexual Relations Participants: Marie-Claude Rigaud, M.D., Donna Stewart M.D., Ph.D. Fructuoso Irigoyen, Milton Kramer, M.D. 68. Parental Mental Illness and Sudden Infant Death Syndrome: The Role of Maternal Smoking, Obstetric CW 25 11:00 A.M.-12:30 P.M. Risk Factors and Social Adversity Room 222, Mezzanine Level, Moscone Center Roger Webb Ph.D., M.S.C. MOTIVATING THE MOTIVATORS: MOTIVATION- 69. SMI, SPMI, SED, FMD: Why Can’t We Use Only AL ENHANCEMENT THERAPY MADE EASY One Mental Health Indicator? APA Corresponding Committee on Training and Education Deepak Prabhakar M.D., M.P.H. in Addiction Psychiatry Chp.: Syed Sattar, M.D. SCIENTIFIC AND CLINICAL REPORTS Participants: Tayo Obatusin, M.D., SCR 24 11:00 A.M. - 12:30 P.M. Petros Levounis, M.D., M.A. Rooms 272-276, Mezzanine Level W, Moscone Center
162ND ANNUAL MEETING 45 Wednesday, May 20, 2009
CW 26 11:00 A.M.-12:30 P.M. Deborah White-Labora, B.S., J.D., Janetta Cureton, Room 304, Esplanade Level, Moscone Center Anthony Castro, Psy.D., Ph.D. THE ASSESSMENT OF VIOLENCE RISK APA Council on Psychiatry and Law IW 56 11:00 A.M.-12:30 P.M. Room 310, Esplanade Level, Moscone Center Chp.: Alec W. Buchanan, Ph.D., M.D. Participants: Michael Norko, M.D., Renee Binder, M.D., “DOCTOR, IS THAT A BABY YOU ARE CARRY- Marvin S. Swartz, M.D., Alec Buchanan, Ph.D., M.D. ING?”: IMPACT OF PHYSICIAN PREGNANCY ON THE THERAPEUTIC ALLIANCE ISSUE WORKSHOPS 51-56 Co-Chps.: Sudeepta SV Varma, M.D., IW 51 11:00 A.M.-12:30 P.M. Jamae C. Campbell, M.D. Room 224, Mezzanine Level, Moscone Center Participants: Kathy Vincent, M.D., M.S., Asha Mishra, M.D., Nioaka Campbell, M.D., THE POST 9-11 ERA: UNDERSTANDING THE April Morciglio, M.D. CULTURAL ISSUES IN THE PSYCHIATRIC TREATMENT OF MUSLIM PATIENTS 12 NOON SESSIONS APA Illinois Psychiatric Society NEW RESEARCH POSTERS SESSION 6: Co-Chps.: Nancy Abdel-Wahab, M.D., Nafi sa Ghadiali, M.D. For further information on New Research sessions, please Participant: Surinder Nand, M.D. refer to the New Research Program section in the back of IW 52 11:00 A.M.-12:30 P.M. this publication. Room 226, Mezzanine Level, Moscone Center 2:00 P.M. SESSIONS VISUAL RECOGNITION OF CATATONIA: VIDEO TEACHING SESSION LECTURE 22 Chp.: Andrew J. Francis, M.D., Ph.D. Participants: Gregory Fricchione, M.D., LECTURE 22 2:00 P.M.-3:30 P.M. Stanley Caroff, M.D. Room 130/131, Exhibit Level, Moscone Center WHAT RESEARCH TELLS US ABOUT SUICIDE IW 53 11:00 A.M.-12:30 P.M. Paula J. Clayton, M.D. Rooms 302, Esplanade Level, Moscone Center Distinguished Psychiatrist Lecture WATCHING THE MOVIES, BEATING THE Chp.: Michael F. Myers, M.D. STIGMAS Vice-Chair: David Baron, M.S.Ed., D.O. Chp.: Rudolf R.A.M. Feijen, M.D. Participants: Rudolf Feijen, M.D., Bastiaan Oele, M.D. r. Clayton is the Medical Director of the American Founda- Dtion for Suicide Prevention in New York City. In this position, IW 54 11:00 A.M.-12:30 P.M. she oversees grant funding and educational projects for both pro- Room 308, Esplanade Level, Moscone Center fessionals and the public. The foundation recently produced Strug- gling in Silence: Physician Depression and Suicide, an educational PSYCHOTHERAPY UPDATE: A REVIEW OF THE fi lm that was awarded the 2008 FREDDIE Award in the category CURRENT LITERATURE FOR THE PRACTICING of psychiatry. The fi lm was aired on over 300 public television sta- PSYCHIATRIST tions nationwide. She graduated AOA from Washington Univer- sity School of Medicine in St. Louis, Missouri in 1960. She did Co-Chps.: Priyanthy Weerasekera, M.D., M.Ed., her psychiatric residency there and joined the staff in 1965. She John Manring, M.D. became a full professor in 1976. In September of 1980, she was appointed Professor and the Head of the Department of Psychia- IW 55 11:00 A.M.-12:30 P.M. try at the University of Minnesota School of Medicine, where she Room 309, Esplanade Level, Moscone Center served until her retirement in 1999. Later, she was a Professor of Psychiatry at the University of New Mexico School of Medicine DEVELOPING A M.H.COURT FOR DOMESTIC from 2001 to 2005. Her fi rst paper, in 1965, defi ned mania. She VIOLENCE PERPETRATORS: A NEW JUDICIAL received her fi rst clinical grant from NIMH in 1967 to study the MODEL recently widowed, to defi ne their responses and compare them to Co-Chps.: Lawrence K. Richards, M.D., those of psychiatric patients with major depression. She published her fi rst paper on that work in 1968 and multiple manuscripts fol- Bruce J. Winick, J.D. lowed. In 1968 she published a paper, borrowing from European Participants: Juan Oms, M.D., Bruce Winick, J.D., psychiatry, that defi ned the schizoaffective disorders. In 1969, 46 WWW.PSYCH.ORG Wednesday, May 20, 2009
she published, with Drs. Winokur and Reich, the fi rst textbook on 1. Special Needs of Women and Children mania entitled Manic-Depressive Illness. She published three ad- Carolyn B. Robinowitz, M.D. ditional books, more than 160 papers and 20 book chapters. Her textbook The Medical Basis of Psychiatry is now in its third re- 2. Hidden Wounds of War vision. Her areas of expertise and research are mood disorders, Barbara Van Dahlen Romberg, Ph.D. particularly bipolar and unipolar illness, and bereavement. 3. Treatment of Post-traumatic Stress Disorder (PTSD) She is a member of many editorial boards, psychiatric soci- Robert Ursano, M.D. eties, has served on study sections, and has been on many other governmental and nongovernmental committees. In 4. The Role of VA and the Development of DOD/State 1985, she received the Athena Award from the University of and Community Partnerships Michigan as the outstanding woman alumna of the year. She Harold Kudler, M.D. also received a Distinguished Alumnae Award from Wash- ington University in 1985 and in 1993, the First Aphrodite PS 6 2:00 P.M.-5:00 P.M. Jannapaula Hofsommer Award from Washington University. Room 301, Esplanade Level, Moscone Center THE GRANDKIDS OF THE 1967 FLOWER PRESIDENTIAL SYMPOSIA 4-7 CHILDREN: LESSONS FROM HAIGHT-ASHBURY PS 4 2:00 P.M.-5:00 P.M. AND FROM TREATMENT AND RECOVERY Rooms 132/133, Exhibit Level North, Moscone Center Chp.: Mark S. Gold, M.D. WHEN THE TREATMENT FAILS THE PATIENT: 1. Epidemiology of Drug Use, Abuse, Misuse PSYCHODYNAMIC CONTRIBUTIONS TO THE and Death From the 60s to Today TREATMENT OF TREATMENT REFRACTORY Bruce A. Goldberger, Ph.D. PATIENTS American Academy of Psychoanalysis and Dynamic 2. Lessons from Four Decades of Drug Abuse Psychiatry Robert L. Dupont, M.D. Chp.: Sherry P. Katz-Bearnot, M.D. 3. Summer of Love: 40 Years Later David E. Smith, M.D. 1. When the Patient Is a Mother: Addressing Parenting Issues in Psychotherapy, Promises and Pitfalls PS 7 2:00 P.M.-5:00 P.M. Jennifer I. Downey, M.D. Room 303/305, Esplanade Level, Moscone Center 2. Challenges Presenting in Transference and SUICIDE AND THE GOLDEN GATE BRIDGE Counter-transference in the Psychotherapy of a Military Service Member Chp.: Mel I. Blaustein, M.D. Eugene Kim, M.D. 1. A History of Golden Gate Bridge Barrier Campaigns 3. Treatment Resistant Patients in Psychotherapy Eve Meyer, MSW Michael Stone, M.D. 2. Perspective from a Family Memeber 4. Improving Adherence to Treatment – Contributions John Brooks of Attachment Theory to our Understanding of 3. Suicide Deterrents Non-Compliance Ann Fleming, M.D. Cesar A. Alfonso, M.D. 4. The Coroner Reports on Bridge Suicide 5. Psychodynamic Psychopharmacology: An Approach Ken Holmes to Pharmacologic Treatment Resistance David L. Mintz, M.D. SYMPOSIA 37-55 Discussant: Philip R. Muskin, M.D., M.A. SYMPOSIUM 37 2:00 P.M.-5:00 P.M. Gateway Ballroom 102, Exhibit Level, Moscone Center PS 5 2:00 P.M.-5:00 P.M. Room 300, Esplanade Level, Moscone Center DISABILITY REDUCTION AND REHABILITATION OF IRAQI AND AFGHANISTAN WAR VETERANS: THE INVISIBLE WOUNDS OF WAR: MENTAL THE ROLE OF CIVILIAN MENTAL HEALTH HEALTH NEEDS OF RETURNING MILITARY AND PROVIDERS THEIR FAMILIES Chp.: Samuel O. Okpaku, M.D., Ph.D. Chp.: Carolyn B. Robinowitz, M.D.
162ND ANNUAL MEETING 47 Wednesday, May 20, 2009
1. Suicide Prevention Among Returning Soldiers of 1. Treatment of Co-Occurring PTSD and Substance War Use Disorders: Exposure-Based Therapy and Donna H. Barnes, Ph.D. Medication Management 2. Meeting the Needs of Post-Deployment Soldiers: An Kathleen Brady, M.D. Interagency Approach 2. Stepped Collaborative Care Targeting PTSD and James K. Boehnlein, M.D. Co-Occurring Substance Use Disorders Douglas F. Zatzick, M.D. 3. Civilian Assessment of Veterans of Iraqi and 3. Seeking Safety: An Evidence-Based Model for PTSD Afghanistan Wars and/or Substance Abuse Samuel O. Okpaku, M.D. Lisa M. Najavits, Ph.D. 4. Psychological Effects of Persistent Confl ict: Strategies 4. Integrating Treatment for Smoking Cessation and for Mitigation and Collaboration with Civilians PTSD Elspeth C. Ritchie, M.D. Andrew J. Saxon, M.D. 5. Traumatic Brain Injury, Treatment and 5. Pharmacologic Management of PTSD and Comorbid Rehabilitation Alcohol Dependence James R. Merikangas, M.D. Ismene L. Petrakis, M.D. 6. Integrated Treatment for PTSD and Substance Use 6. The War on Terrorism: Rethinking Systems and Disorders in Veterans Services for Iraq and Afghanistan Combat Soldiers Sonja V. Batten, Ph.D. and Their Families Ron E. Armstead, L.C.S.W. SYMPOSIUM 40 2:00 P.M.-5:00 P.M. Room 112, Exhibit Level, Moscone Center SYMPOSIUM 38 2:00 P.M.-5:00 P.M. IMPULSE CONTROL DISORDERS: RECOGNITION Gateway Ballroom 104, Exhibit Level, Moscone Center AND CLINICAL MANAGEMENT IN-RESIDENCY CLINICAL SKILLS ASSESSMENT: Chp.: Jon E. Grant, M.D., J.D. TRAINING FOR FACULTY EVALUATORS APA Council on Medical Education and Lifelong Learning 1. Overview of Impulse Control Disorders and Their Neurobiology Chp.: Michael D. Jibson, M.D., Ph.D. Eric Hollander, M.D. 1. Rationale for a Change in the Live-Patient Exam and 2. Compulsive Shopping Disorder: A Review Program Requirements for the in-Residency Clinical Donald W. Black, M.D. Skills Assessment Sandra B. Sexson, M.D. 3. Update on the Clinical Features and Treatment of Kleptomania 2. What the Research on Direct Observation of Clinical Jon E. Grant, M.D. Skills Tells Us Joan M. Anzia, M.D. 4. Trichotillomania and Skin Picking - Clinical Features and Treatment 3. Clinical Skills Assessment: Competencies, Skills, Samuel R. Chamberlain, M.D. Forms, and Anchor Points Richard F. Summers, M.D. 5. Etiology, Identifi cation, and Treatment of Pathological Gambling 4. Setting Up a Curriculum for Faculty on Clinical Marc N. Potenza, M.D. Skills Assessment Karen Broquet, M.D. SYMPOSIUM 41 2:00 P.M.-5:00 P.M. SYMPOSIUM 39 2:00 P.M.-5:00 P.M. Room 114, Exhibit Level, Moscone Center Room 111, Exhibit Level, Moscone Center RECENT DEVELOPMENTS IN CROSS-CULTURAL, ETHNIC AND ETHNOPSYCHOPHARMACOLOGI- INTEGRATING TREATMENT FOR SUBSTANCE CAL ASPECTS OF MOOD DISORDERS: A GLOBAL USE AND POST-TRAUMATIC STRESS DISORDERS PERSPECTIVE IN PATIENTS WITH CO-OCCURRING CONDITIONS Co-Chp.: Rajesh M. Parikh, M.D., National Institute on Drug Abuse David Mischoulon, M.D., Ph.D. Co-Chp.: Udi E. Ghitza, Ph.D., Andrew J. Saxon, M.D.
48 WWW.PSYCH.ORG Wednesday, May 20, 2009
1. Ethnopsychopharmacology Update 2. Practical Approaches to Violence Risk Assessment David C. Henderson, M.D. Marvin S. Swartz, M.D. 2. Psychiatric Management of Hispanic Patients: Cross 3. SAFE-T Suicide Assessment Five-Step Evaluation Cultural Issues and Ethnopsychopharmacology and Triage David Mischoulon, M.D. Jefferson B. Prince, M.D. 3. Culturally Sensitive Collaborative Treatment (CSCT) 4. Suicide Risk Management: Research and Practice for Chinese Americans with Depression in an Inpatient Department of Suicide Prevention Albert Yeung, M.D. (Psychiatric University Clinic Salzburg – Austria) 4. Mood Disorders in the Asian-Indian Population: Reinhold Fartacek, M.D. Effects of Culture, Globalization & Ethnopsycho- 5. The Joint Commission’s View of the Response pharmacology and Prevention of Suicide and Aggression Rajesh M. Parikh, M.D. Robert Wise, M.D. 5. Mood Disorders In Women: The Interaction of Discussant: Paul S. Appelbaum, M.D. Culture and Biopsychosocial Factors Shamsah B. Sonawalla, M.D. SYMPOSIUM 44 2:00 P.M.-5:00 P.M. Discussant: Shamsah B. Sonawalla, M.D. Room 122, Exhibit Level, Moscone Center SYMPOSIUM 42 2:00 P.M.-5:00 P.M. THE ROLE OF FORENSIC PSYCHIATRY IN Room 120, Exhibit Level, Moscone Center EVALUATING PROBLEMATIC INTERNET BEHAVIORS: UNTANGLING WEBS OF DECEIT CHOOSING THE RIGHT TREATMENT FOR FROM MURDER TO MALPRACTICE SUBSTANCE ABUSE Chp.: Charles Scott, M.D. Co-Chp.: Herbert D. Kleber, M.D., Frances R. Levin, M.D. 1. Forensic Aspects of “Internet Addiction” 1. Choosing the Right Treatment for Cocaine Michael Harlow, M.D. Dependence Adam Bisaga, M.D. 2. Psychiatric Evaluations of Defendents Charged with Internet Pornography Possession 2. Choosing Treatment for Cannabis Dependence Humberto D. Temporini, M.D. Frances R. Levin, M.D. 3. The Internet and Child and Adolescent Victimization 3. Integrating Psychosocial Interventions with Jennifer A. Chaffi n, M.D. Medications in the Treatment of Substance Dependence 4. The Internet and Cyberstalking Edward V. Nunes, M.D. Soroush Mohandessi, M.D. 4. Pain and Addiction: Implications of Substance 5. Mental Health Treatment via the Internet Use Disorders for Opioid Therapy Charles Scott, M.D. Maria Sullivan, M.D. SYMPOSIUM 45 2:00 P.M.-5:00 P.M. 5. Choosing the Right Treatment for Opioid Room 123, Exhibit Level, Moscone Center Dependence DROP “SCHIZOPHRENIA”? INTERNATIONAL Herbert D. Kleber, M.D. PERSPECTIVES SYMPOSIUM 43 2:00 P.M.-5:00 P.M. World Psychiatric Association’s Section on Rehabilitation Room 121, Exhibit Level, Moscone Center and Section for Psychosocial Rehabilitation SUICIDE AND AGGRESSION: A PRACTICAL Co-Chp.: Zebulon Taintor, M.D., Gregory C. Bunt, M.D. TOOLKIT FROM RISK ASSESSMENT TO JOINT COMMISSION TO THE PATIENT 1. Should We Abandon the Term Schizophrenia APA Committee on Patient Safety After All These Years? John A. Talbott, M.D. Chp.: Yad M. Jabbarpour, M.D. 2. Beyond the Term Schizophrenia 1. From Rules to Protocols: Suicide Risk Assessment Afzal Javed, M.B.B.S in Everyday Practice Geetha Jayaram, M.D. 162ND ANNUAL MEETING 49 Wednesday, May 20, 2009
3. Japan: Experience Since Schizophrenia 3. Childhood Abuse and Neglect Associated with Was Renamed in 2002 Personality Disorders Naotaka Shinfuku , M.D. Jeffrey Johnson, Ph.D. 4. Western Pacifi c Perspectives on Schizophrenia 4. Empirically-Derived Mental Disorder Spectrums and Luis Faustino Ignacio, M.D. Case Conceptualization: The Role of Personality in Linking Axes I and II 5. Schizophrenia Robert Krueger, Ph.D. Russell D’Souza, M.D. Discussant: Wilson M. Compton III, M.D. 6. Subtypes, Electrophysiological Data Point to Several Different Diseases Zebulon Taintor, M.D. SYMPOSIUM 48 2:00 P.M.-5:00 P.M. Discussant: Michael F. Sadre-Chirazi-Stark, M.D., Ph.D. Rooms 272/274/276, Mezzanine Level West, Moscone Center SYMPOSIUM 46 2:00 P.M.-5:00 P.M. Room 124, Exhibit Level, Moscone Center SPIRITUALLY INTEGRATED TREATMENT LESBIAN, GAY, BISEXUAL AND TRANSGENDER Chp.: John R. Peteet, M.D. YOUTH: FAMILY APPROACHES 1. Therapeutic Uses of a Shared Tradition to Address Chp.: Edgardo J. Menvielle, M.D., M.S., Darryl Hill Problematic Faith Nadine J. Nyhus, M.D. 1. Psychopathology and Gender Variance in a Clinical 2. Spiritually Integrated Treatment Sample of Children Yousef Abouallaban, M.D. Edgardo J. Menvielle, M.D. 3. Mental Health Promotion in the African American 3. Gender Made, Gender Nurtured, Gender Bent: Faith Community The Child Shapes the Parent as the Parent Shapes Michael A. Torres, M.D. the Child in Families with a Gender Variant Child Diane Ehrensaft, Ph.D. 4. Spiritual Interventions in the Treatment of Depression 4. Three Integrated Family Interventions for Children John R. Peteet, M.D. With Gender-Variant Behaviors: Face-To-Face Groups, Online Discussions and Multi-Family Gatherings SYMPOSIUM 49 2:00 P.M.-5:00 P.M. Catherine L. Tuerk, M.A. Room 302, Esplanade Level, Moscone Center 5. Raising the Gender-Varian Boy: A Parent’s HOW TO APPROACH THE PREGNANT PATIENT Perspective FROM A MENTAL HEALTH STANDPOINT Sarah Hoffman Co-Chp.: Allison S. Baker, M.D., Christina V. Mangurian, M.D. SYMPOSIUM 47 2:00 P.M.-5:00 P.M. 1. Diagnosis and Prognosis of Mood Disorders During Pregnancy and the Postpartum Period Room 125, Exhibit Level, Moscone Center Adele Viguera, M.D. PERSONALITY DISORDERS IN THE U.S.A.: 2. Prevention and Treatment of Psychiatric Disorders RELATIONSHIP TO EARLY EXPERIENCES During Pregnancy OCCURRENCE AND COURSE OF AXIS I Gail E. Robinson, M.D. DISORDERS National Institute on Alcohol Abuse and Alcoholism 3. Medicating the Depressed Pregnant Woman: Risk Benefi t Discussions and the Informed Consent Co-Chp.: Deborah S. Hasin, Ph.D., Andrew E. Skodol, M.D. Process 1. Relationship of Personality Disorders to Course of Margaret Spinelli, M.D. Mood and Anxiety Disorders in a National Sample 4. Staying Informed and Afl oat: The Importance of Andrew E. Skodol, M.D. Evidence-Based Clinical Practice in The Treatment of 2. Personality Disorders: Their Impact on the Course Mentally ill Patients During and After Pregnancy of Alcohol and Drug Dependence in the U.S. General Elizabeth M. Fitelson, M.D. Population Deborah S. Hasin, Ph.D. 50 WWW.PSYCH.ORG Wednesday, May 20, 2009
SYMPOSIUM 50 2:00 P.M.-5:00 P.M. William T. Carpenter, M.D. Room 304, Esplanade Level, Moscone Center 2. Diagnosis and Treatment of Bipolar Disorder ADVANCES IN ELECTROCONVULSIVE THERAPY Frederick Goodwin, M.D. APA Corresponding Committee on ECT and Other Electro- 3. Pharmacology Leading to the Current Debates magnetic Therapies about Old and New Psychotropics Chp.: Shirlene M. Sampson, M.D., M.S. Alan F. Schatzberg, M.D. 1. Ultra-Brief Pulse ECT: Effi cacy and Cognitive 4. Concept of “Me-Too” Medications on Public Policies Impact-Findings From the United States Roger Peele, M.D. Joan Prudic, M.D. 5. Pharmacologic Treatment of Depression 2. Ultra-brief Pulse ECT: Effi cacy and Cognitive Impact Jan Fawcett, M.D. Findings From a Larger Clinical Sample (Sydney) Discussant: M Michaels, M.D. Colleen K. Loo, M.B.B.S. SYMPOSIUM 53 2:00 P.M.-5:00 P.M. 3. Comparing Bifrontal, Bitemporal, and Right Unilateral Electrode Placement in ECT: A Room 308, Esplanade Level, Moscone Center Multisite Study From the Consortium for Research END OF LIFE CARE: A MULTIDISCIPLINARY in ECT (CORE) CLINICAL AND RESEARCH UPDATE Charles Kellner, M.D. Chp.: Laura B. Dunn, M.D. 4. An Update on Continuation-ECT Mustafa Husain, M.D. 1. Psychiatry and Palliative Medicine Collaboration at the End of Life SYMPOSIUM 51 2:00 P.M.-5:00 P.M. Michael W. Rabow, M.D. Room 306, Esplanade Level, Moscone Center 2. Issues Facing Caregivers and Family at the End INTEGRATED TREATMENT OF PERSONALITY of Life DISORDER: PRINCIPLES AND TECHNIQUE Dianne M. Shumay, Ph.D. Co-Chp.: John Livesley, M.D., Giuseppe Giancarlo 3. Psychological Adjustment to End of Life Losses: Dimaggio, M.D. Application of the Reintegration Model to Advanced Cancer 1. Principles for Organizing Integrated Treatment Sara J. Knight, Ph.D. for Personality Disorder John Livesley, M.D. 4. End of Life Care in Dementia: A Research Update Laura B. Dunn, M.D. 2. Tailoring Common Treatment Principles to fi t Individual Personalities 5. Legal and Ethical Issues at the End of Life in Kenneth L. Critchfi eld, Ph.D. Chronically Mentally Ill Patients with HIV/AIDS Jeanne M. St. Pierre, M.D. 3. An Integrated View of Therapy Techniques for Personality Disorders SYMPOSIUM 54 2:00 P.M.-5:00 P.M. John F. Clarkin, Ph.D. Room 309, Esplanade Level, Moscone Center 4. Integrated Treatment for Personality Disorder with ENGAGING AND TREATING PERSONS WITH RE- Prominent Inhibited/Constricted Traits CENT ONSET SCHIZOPHRENIA: PRATICE BASED Giuseppe Giancarlo Dimaggio, M.D. EVIDENCE FROM THE CLINICAL TRENCHES American Association of Community Psychiatrists SYMPOSIUM 52 2:00 P.M.-5:00 P.M. Room 307, Esplanade Level, Moscone Center Chp.: Robert P. Liberman, M.D. “ME-TOO” MEDICATIONS, REALLY? 1. Working in the Trenches with 18 to 25-Year-Olds APA Council on Global Psychiatry and the APA Council on Mark Ragins, M.D. Children, Adolescents 2. Assisting the Transition from Child Mobile Co-Chp.: Rodrigo A. Munoz, M.D., Treatment to Adult ACT Services for Adolescents Amy M. Ursano, M.D., A.A. with Schizophrenia. Curtis N. Adams, Jr., M.D. 1. Barriers to Innovation in Psychopharmacology of Schizophrenia 162ND ANNUAL MEETING 51 Wednesday, May 20, 2009
3. The Dance of Engagement Connecting with Young Adults in the Pursuit of Mental Health Andrew J. McLean, M.D. 4. Early Assessment and Support Team: A Community Based Clinical Team Focused on Identfying, Engag ing and Treating Youth Who Are Developing Psychosis Robert Wolf, M.D. Discussant: Charles W. Huffi ne, M.D.
SYMPOSIUM 55 2:00 P.M.-5:00 P.M. Room 310, Esplanade Level, Moscone Center SLEEP DISTURBANCES AND CIRCADIAN DISRUP- TIONS AFFECTING, AND AFFECTED BY, ADDIC- TION TO DRUGS National Institute on Drug Abuse Chp.: Harold W. Gordon, Ph.D. 1. Differential Roles for Individual Circadian Genes in Bipolar Disorder and Drug Addiction Colleen A. McClung, Ph.D. 2. Disordered Sleep and Proinfl ammatory Cytokines in Cocaine Dependence: Clinical Implications Michael R. Irwin, M.D. 3. (+/-3,4-Methyleneldioxymethamphetamine (MDMA, Ecstasy) Use is Associated With Sleep-Disordered Breathing Una D. McCann, M.D. 4. Impact of Sleep Deprivation and Insomnia on the Development and Maintenance of Drug Addiction Scott E. Lukas, Ph.D. 5. “Occult insomnia” and Abstinence From Cocaine: Implications for Cognitive Function and the Clinical Treatment of Cocaine Dependence Robert T. Malison, M.D.
3:00 P.M. SESSIONS
NEW RESEARCH POSTER SESSION 7: For further information on New Research submissions, please refer to the New Research Program section in the back of this publication.
52 WWW.PSYCH.ORG Thursday, May 21, 2009
9:00 A.M. SESSIONS Edward Pontius, M.D., Suzanne Albrecht, M.D. MEDICAL UPDATE CW 30 9:00 A.M.-10:30 A.M. MEDICAL UPDATE 02 9:00 A.M.-10:30 A.M. Room 226, Mezzanine Level, Moscone Center Room 122, Exhibit Level, Moscone Center SCHIZOPHRENIA AND AGING: COGNITIVE, MEDICAL, SOCIAL AND PSYCHIATRIC ISSUES OPTIMIZING THE DELIVERY OF MENTAL APA Committee on Access and Effectiveness of Psychiatric HEALTH AND PRIMARY CARE SERVICES FOR Services for the Elderly PERSONS LIVING WITH HIV/AIDS Chp.: David A. Casey, M.D. Chp.: David E. Cohn, M.D. Participants: Mercedes Rodriguez-Suarez, M.D., Participants: Saul Perea, Shane Spicer, M.D. Colleen Northcott, Ph.D., M.D., Lina Shihabuddin, M.D., SMALL INTERACTIVE SESSION Chantelle Simmons, M.D., Garry Vickar, M.D. SI 12 9:00 A.M. - 10:30 A.M. CW 31 9:00 A.M.-10:30 A.M. Room 218, Mezzanine Level East, Moscone Center Room 310, Esplanade Level, Moscone Center ANTIPSYCHOTIC POLYPHARMACY: AN SCIENCE IN THE CLINIC: DOING RESEARCH AS EVIDENCE BASED PERSPECTIVE WE CARE FOR PATIENTS APA Lifers Chp.: Donald Goff, M.D. COMPONENT WORKSHOPS 27-31 Chp.: Sheila Hafter Gray, M.D. Participants: Christopher Perry, M.D., Pamela Foelsch, CW 27 9:00 A.M.-10:30 A.M. Ph.D., Milton Kramer, M.D., Mardi Horowitz, M.D. Room 113, Exhibit Level, Moscone Center ISSUE WORKSHOPS 57-68 IDENTIFYING CHILDREN AT RISK FOR MENTAL IW 57 9:00 A.M.-10:30 A.M. HEALTH PROBLEMS: EXPLORING HOW RISK FACTORS WORK TOGETHER IN THE EMER- Room 111, Exhibit Level, Moscone Center GENCE OF CHILDHOOD PSYCHOPATHOLOGY PHANTOMS OF THE MIND: THE ROLE OF NAR- APA Corresponding Committee on Infancy and CISSISM IN THERAPIST BOUNDARY-CROSSING Early Childhood Chp.: Howard E. Book, M.D. Chp.: William C. Wood, M.D. Participants: Gary Schoener, Psy.D., Participants: Joan Luby, M.D., Marilyn Essex, Ph.D., Carolyn Quadrio, M.D., Ph.D. Helena Kraemer, Ph.D. IW 58 9:00 A.M.-10:30 A.M. CW 28 9:00 A.M.-10:30 A.M. WITHDRAWN Room 114, Exhibit Level, Moscone Center IW 59 9:00 A.M.-10:30 A.M. OUT AND UP IN AGE: MENTAL HEALTH IN Room 123, Exhibit Level, Moscone Center LESBIAN, GAY, BISEXUAL AND TRANSGENDER RESEARCH WITH SUBJECTS WHO LACK OLDER ADULTS CAPACITY TO CONSENT: SURROGATE CONSENT, APA Committee on Gay, Lesbian, and Bisexual Issues ACCEPTABLE RISK, AND OTHER CLINICAL AND Chp.: Ellen Haller, M.D. ETHICAL CHALLENGES Participants: Stephan Carlson, M.D., Eric Williams, M.D., Chp.: David H. Strauss, M.D. Umee Davae, D.O., Philip Bialer, M.D. Participants: Paul Appelbaum, M.D., John Luce, M.D., CW 29 9:00 A.M.-10:30 A.M. Jason Karlawish, M.D., David Strauss, M.D., Room 224, Mezzanine Level, Moscone Center John Oldham, M.D., M.S. PROMISE AND PERILS OF ELECTRONIC HEALTH IW 60 9:00 A.M.-10:30 A.M. RECORD ADOPTION IN PRIVATE PRACTICE Room 124, Exhibit Level, Moscone Center PSYCHIATRY MAKING THE MOST OF YOUR CHIEF YEAR: APA Corresponding Committee on Electronic Health Records CHIEF RESIDENTS’ FORUM, PART I Chp.: Laura Fochtmann, M.D. Participants: Zebulon Taintor, M.D., Co-Chps.: Oliver Stroeh, M.D., Shefali Srivastava, M.D. Participants: Jacob Ballon, M.D., Melissa Nau, M.D. 162ND ANNUAL MEETING 53 Thursday, May 21, 2009
IW 61 9:00 A.M. -10:30 A.M. IW 68 9:00 A.M.-10:30 A.M. Room 125, Exhibit Level, Moscone Center Room 309, Esplanade Level, Moscone Center MALPRACTICE DEFENSE: WINNING HELPING PATIENTS WHO DRINK TOO MUCH: STRATEGIES USING THE NIAAA CLINICIAN’S GUIDE National Institute on Alcohol Abuse and Alcoholism Co-Chps.: Abe M. Rychik, J.D., Eugene L. Lowenkopf, M.D. Co-Chps.: Mark Willenbring, M.D., IW 62 9:00 A.M.-10:30 A.M. Robert Huebner, Ph.D. Room 222, Mezzanine Level, Moscone Center 11:00 A.M. SESSIONS SC PARTNERS IN BEHAVIORAL HEALTH EMERGENCY SERVICES: ACHIEVING FORUMS 11-13 TOMORROW, TODAY! FORUM 11 11:00 A.M. -12:30 P.M. Co-Chps.: Adrienne Coopey, D.O., Brenda M. Ratliff, M.D. Room 301, Esplanade Level, Moscone Center Participants: C. Edgar Spencer, Ed.M., M.S.W. FROM THE OTHER SIDE OF THE COUCH -A IW 63 9:00 A.M.-10:30 A.M. PSYCHIATRIST’S VIEW AS A BREAST CANCER Rooms 272/274/276, Mezzanine Level West, SURVIVOR Moscone Center Chp.: Ruksana Iftekhar, M.D. HOW TO LAUNCH A SUCCESSFUL PRIVATE Participants: Lloyd Alcera, M.D. PRACTICE (PART II) FORUM 12 11:00 A.M. -12:30 P.M. Chp.: William E. Callahan, M.D. Room 306, Esplanade Level, Moscone Center IW 64 9:00 A.M.-10:30 A.M. ACCULTURATION RELATED CHALLENGES IN WITHDRAWN MENTAL HEALTH IW 65 9:00 A.M.-10:30 A.M. Chp.: Meena Ramani, M.D. Room 301, Esplanade Level, Moscone Center Participants: Tarun Bhandari, M.D., Shivani Mehta, Jovita Crasta, Noumana Hameed, M.D. PSYCHIATRY IN THE AMERICAS: UPDATE FROM THE WORLD PSYCHIATRIC ASSOCIATION FORUM 13 11:00 A.M. -12:30 P.M. Chp.: Michelle B. Riba, M.D. Room 307, Esplanade Level, Moscone Center Participants: Alfredo Ortiz Fragola, M.D., NEW TOOLS AND TRENDS: SMOKING CESSATION Francisco Schnaas, M.D., Edgard Belfort, M.D., M.Ed., Rodolfo Fahrer, M.D., Roger Montenegro, M.D., Chp.: Steve Schroeder, M.D. Enrique Camarena, M.D. LECTURE 23 IW 66 9:00 A.M.-10:30 A.M. LECTURE 23 11:00A.M. -12:30 P.M. Room 302, Esplanade Level, Moscone Center Room 308, Esplanade Level, Moscone Center RESPONDING TO THE IMPACT OF SUICIDE ON THE POWER OF PERSONALIZED CLINICIANS LIFESTYLE CHANGES Dean Ornish, M.D. Chp.: Eric M. Plakun, M.D. Frontiers of Science Lecture Participants: Jane Tillman, Ph.D., Edward Shapiro, M.A., M.D. Chp.: Carolyn B. Robinowitz, M. D. IW 67 9:00 A.M.-10:30 A.M. ean Ornish, M.D., is a pioneer in the medicine of the Room 304, Esplanade Level, Moscone Center Dfuture. He is the founder and president of the non-profi t Preventive Medicine Research Institute in Sausalito, COGNITIVE AND BEHAVIORAL TECHNIQUES TO California and a Clinical Professor of Medicine at the IMPROVE BRIEF PHARMACOTHERAPY SESSIONS University of California, San Francisco. Dr. Ornish received his medical training in internal medicine from Chp.: Donna M. Sudak, M.D. the Baylor College of Medicine, Harvard Medical Participants: Judith Beck, Ph.D., School, and the Massachusetts General Hospital. He Jesse Wright, M.D., Ph.D. received a B.A. in Humanities summa cum laude from the University of Texas in Austin. For over 30 years, Dr. 54 WWW.PSYCH.ORG Thursday, May 21, 2009
Ornish has directed clinical research demonstrating, for 78. Ethnic Differences in Length of Stay and Choice the fi rst time, that comprehensive lifestyle changes may of Antipsychotic Medication Among In-Patients begin to reverse even severe coronary heart disease, with- Diagnosed With Schizophrenia out drugs or surgery. Recently, Medicare agreed to pro- Karen Bullock, Ph.D., M.S.W. vide coverage for this program, the fi rst time that Medi- care has covered a program of comprehensive life- SCIENTIFIC AND CLINICAL REPORTS style changes. He recently directed the fi rst randomized controlled trial demonstrating that comprehensive lifestyle changes SESSION 27 11:00 A.M. - 12:30 P.M. may stop or reverse the progression of prostate cancer. His current Room 112, Exhibit Level, Moscone Center research showed that comprehensive lifestyle changes affect gene GAMBLING, ADDICTIONS AND COMPULSIONS expression, “turning on” disease-preventing genes and “turning off” genes that promote cancer and heart disease. He is the author of Chp.: Merra Vaswani, M.D. fi ve books, including The Spectrum: A Scientifi cally Proven Pro- gram to Feel Better, Live Longer, Lose Weight & Gain Health; Dr. 79. Pathological Gambling: An Update on Neuro- Dean Ornish’s Program for Reversing Heart Disease; Eat More, pathophysiology and Pharmacotherapy Weigh Less; Everyday Cooking with Dr. Dean Ornish; and Love & Pinhas Dannon, M.D. Survival: The Scientifi c Basis for the Healing Power of Intimacy. 80. Psychiatric, Behavioral, and Attitudinal Correlates of Avoidant and Obsessive-Compulsive Personality SCIENTIFIC AND CLINICAL REPORTS 25-27 Pathology in Patients With Binge Eating Disorder SCR 25 11:00 A.M.- 12:30 P.M. Daniel Becker, M.D. Room 113, Exhibit Level, Moscone Center 81. Problem Video Game Use: Assessment and THE SETTINGS OF PSYCHIATRY: FROM TELE- Association With Dimensions of Psychopathology PSYCHIATRY TO THE EMERGENCY ROOM Vladan Starcevic, M.D., Ph.D.
Chp.: Derya Akibiyik, M.D. CWS 32-34 73. Telepsychiatry – New Approach in Treatment of CW 32 11:00 A.M. -12:30 P.M. Cross-Cultural Population: Patient Acceptability Study Room 120, Exhibit Level, Moscone Center Davor Mucic, M.D. SAVED BY THE INTERNET? PSYCHIATRIC 74. Videoconferencing for Delivering Group ADMINISTRATION AND GENERATION X Intervention to Reduce PTSD and Depression APA Committee on Psychiatric Administration in Women Living in Rural Communities and Management Cheryl Koopman, Ph.D. Chp.: L. Mark Russakoff, M.D. Participants: Brian Matthew Hepburn, M.D., 75. Gender Difference of Frequent Visitors in the James A. Greene, M.D., Susan Stabinsky, M.D., Lydia Psychiatric Emergency Room Weisser, MD Chieh-Hsin Lin, M.D. CW 33 11:00 A.M. -12:30 P.M. SCIENTIFIC AND CLINICAL REPORTS Room 122, Exhibit Level, Moscone Center SCR 26 11:00 A.M. - 12:30 P.M. Room 111, Exhibit Level, Moscone Center FORENSIC ISSUES AMONG HISPANICS APA Committee of Hispanic Psychiatrists ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA Co-Chps.: Humberto L. Martinez, M.D., Andres J. Pumariega, M.D., Susan Stabinsky, M.D. Chp.: Nitin Gupta, M.D. Participants: Humberto Martinez, M.D., Roberto Lewis-Fernandez, M.D., Daniel Castellanos, M.D., 76. Long-Term Treatment With Asenapine Versus Andres Pumariega, M.D. Olanzapine in Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia CW 34 11:00 A.M. -12:30 P.M. Nina Schooler, Ph.D. Room 222, Mezzanine Level, Moscone Center 77. Factors Associated With the Use of Atypical NEGOTIATION SKILLS FOR PSYCHIATRISTS Antipsychotics Among the Schizophrenic Population: APA Central California Psychiatric Society Generational and Disease Severity Effects Bernard Astruc, M.D. Chp.: Andreea L. Seritan, M.D. Participants: Shannon Suo, M.D. 162ND ANNUAL MEETING 55 Thursday, May 21, 2009
ISSUE WORKSHOPS 69-80 Co-Chps.: Rebecca E. Hommer, M.D., William C. Wood, M.D. Participants: James Bjork, Ph.D., Lynn Ponton, M.D. IW 69 11:00 A.M. -12:30 P.M. Room 114, Exhibit Level, Moscone Center IW 75 11:00 A.M. -12:30 P.M. MAKING THE MOST OF YOUR CHIEF YEAR: Room 226, Mezzanine Level, Moscone Center CHIEF RESIDENTS FORUM, PART II MAKING YOUR PRESENTATION MORE Co-Chps.: Oliver Stroeh, M.D., Shefali Srivastava, M.D. INTERACTIVE: THE BETTER WAY! Participants: Jacob Ballon, M.D., Melissa Nau, M.D. Chp.: Jon JD Davine, M.D.
IW 70 11:00 A.M. -12:30 P.M. IW 76 11:00 A.M. -12:30 P.M. Room 121, Exhibit Level, Moscone Center Rooms 272/274/276, Mezzanine Level West, THE NEW PUBLIC PSYCHIATRY: CREATING A Moscone Center FUTURE GENERATION OF PUBLIC PSYCHODYNAMIC THERAPY WITH PSYCHIATRISTS SELF-DESTRUCTIVE BORDERLINES Co-Chps.: Eugene Lee, M.D., Jules Ranz, M.D. Participants: Andrew Kirsch, M.D., M.A., Co-Chps.: Eric M. Plakun, M.D., Aleksandar Micevski, Matthew Levy, M.D., Edward Robert Shapiro, M.A., M.D. Anthony Carino, M.D. IW 77 11:00 A.M. -12:30 P.M. IW 71 11:00 A.M. -12:30 P.M. Room 302, Esplanade Level, Moscone Center Room 123, Exhibit Level, Moscone Center CHILDREN OF PSYCHIATRISTS CROSS-CULTURAL COMPARISONS OF SYSTEM Co-Chps.: Michelle B. Riba, M.D., APPROACHES TO PSYCHIATRIC Leah J. Dickstein, M.D., M.A. REHABILITATION: EXPERIENCES FROM CHINA Participants: Eve Stotland, Esq., Naomi Stotland, M.D., AND SAN FRANCISCO Heather Speller, Susan Fauman Chp.: Yifang Qian, M.D., Ph.D. Participants: Robert Cabaj, M.D., IW 78 11:00 A.M.-12:30 P.M. Yingqiang Xiang, M.D., Ph.D., Ziqing Zhu, Ph.D. Room 304, Esplanade Level, Moscone Center
IW 72 11:00 A.M. -12:30 P.M. THE PHYSICIAN AS PATIENT: AN INTERACTIVE WORKSHOP Room 124, Exhibit Level, Moscone Center Co-Chps.: Michael F. Myers, M.D., Glen O. Gabbard, M.D. SHOULD HIV TESTING BE ROUTINE FOR PSYCHIATRIC PATIENTS IN INPATIENT AND IW 79 11:00 A.M. -12:30 P.M. OUTPATIENT SETTINGS? WITHDRAWN Chp.: Robert B. Daroff, M.D. Participants: Peter Jensen, M.D., Marshall Forstein, M.D. IW 80 11:00 A.M. -12:30 P.M. Room 310, Esplanade Level, Moscone Center IW 73 11:00 A.M. -12:30 P.M. Room 125, Exhibit Level, Moscone Center INTEGRATING RESEARCH TRAINING AND EXPERIENCE INTO RESIDENCY TRAINING: PSYCHIATRY TRAINING FOR PRIMARY CARE A “HOW TO” GUIDE PHYSICIANS, AN ONGOING CHALLENGE Chp.: Ellen Berkowitz, M.D. Chp.: Hoyle Leigh, M.D. Participants: Mantosh Dewan, M.D., Participants: Jon Streltzer, M.D., Seth Powsner, M.D., Stephen M.Goldfi nger, M.D., Milton Kramer, M.D., Don Lipsitt, M.D., M.A., Hoyle Leigh, M.D. Michele Pato, M.D., Nina Schooler, Ph.D. IW 74 11:00 A.M. -12:30 P.M. Room 224, Mezzanine Level, Moscone Center 2:00 P.M. SESSIONS TEEN RISK-TAKING: TRANSLATING NEUROSCI- ENCE INTO REAL LIFE CHOICES 56 WWW.PSYCH.ORG Thursday, May 21, 2009
SYMPOSIA 56-72 5. Evaluating Evidence for the Effectiveness of SYMPOSIUM 56 2:00 P.M. -5:00 P.M. Psychodynamic Psychotherapy through Meta- Analytic Methods Room 111, Exhibit Level, Moscone Center William K. Lamb, Ph.D. THE ARCHITECTURAL ESSENTIAL BUILDING Discussant: Glen O. Gabbard, M.D. BLOCKS AND DESIGN ELEMENTS TOWARD A “GOOD ENOUGH” MENTAL HEALTH SYSTEM: NATIONAL AND INTERNATIONAL PERSPECTIVES SYMPOSIUM 58 2:00 P.M. -5:00 P.M. American Association of Psychiatric Administrators Room 113, Exhibit Level, Moscone Center Chp.: Yad M. Jabbarpour, M.D. OPTIMIZING TREATMENT OUTCOME IN AXIS 1 DISORDERS: AUGMENTATION WITH FAMILY 1. In the Nirvana Mental Health System We All Pay the INTERVENTIONS Same Jeffrey Geller, M.D. Chp.: Gabor I. Keitner, M.D. 2. Considering National Mental Healthcare Reform: 1. Family Intervention to Improve Effi cacy and Report from The APA Task Force on Systems of Care Effectiveness of Medication for Schizophrenia Anita S. Everett, M.D. Ira Glick, M.D. 3. Grading the States 2009: A Report to the Nation on 2. Family Systemic Models for Engaging Substance America’s Healthcare System for Serious Mental Abusers in Treatment Illness Judith Landau, M.D., D.P.M. Laudan Y. Aron, M.A. 3. The Effectiveness of Adjunctive Family Therapy 4. Canadian Innovations in Mental Health Care: Steps for Patients with Mood Disorders Towards an Optimal System Gabor I. Keitner, M.D. Jon JD Davine, M.D. 4. Adjunctive Family Interventions in Psychosomatic Medicine 5. Unmet Needs Among Schizophrenia Patients and Alison M. Heru, M.D. Their Family Caregivers – Selected Results From a European Perspective Discussant: Michael E. Thase, M.D. Hartman Hinterhuber, M.D. Discussant: Steven S. Sharfstein, M.D. SYMPOSIUM 59 2:00 P.M. -5:00 P.M. Room 114, Exhibit Level, Moscone Center SYMPOSIUM 57 2:00 P.M. -5:00 P.M. HEALING TRAUMATIC WOUNDS IN Room 112, Exhibit Level, Moscone Center POST-GENOCIDE RWANDA: PSYCHIATRIC PSYCHODYNAMIC PSYCHOTHERAPY: UPDATE TREATMENT AIDS THE PEACE DIALOGUE ON EMPIRICAL EVIDENCE Chp.: Lisa A. Rone, M.D. Chp.: Mardi J. Horowitz, M.D. 1. Healing Traumatic Wounds in Post-Genocide 1. Long Term Effects of Transference Interpretation in Rwanda: An Anthropological View of the Rwandan Dynamic Psychotherapy Genocide Per Hoglend, M.D. Kristen U. Welch, M.D. 2. Working-Out Traumatic Mourning: a Controlled 2. Healing Traumatic Wounds in Post-Genocide Evaluation of Psychodynamic Psychotherapy Among Rwanda: Psychiatric Disorders After Genocide Borderline Patients in a Suicidal Crisis Lisa A. Rone, M.D. Antonio Andreoli, M.D. 3. Healing Traumatic Wounds in Post-Genocide 3. Transference Formulations by CBT and Dynamic Rwanda: A View from the Inside Therapists Mukamana Donatilla, M.S.N. Mardi J. Horowitz, M.D. 4. Healing Traumatic Wounds in Post-Genocide 4. Predicting Outcome From Ratings of Therapist Rwanda: The Process of the Dialogue for Peace Interventions Naasson MN Munyandamutsa, M.D. George Silberschatz, Ph.D.
162ND ANNUAL MEETING 57 Thursday, May 21, 2009
SYMPOSIUM 60 2:00 P.M. -5:00 P.M. 1. The Axis I Comorbidity of Adolescent Onset Room 120, Exhibit Level, Moscone Center Borderline Personality Disorder Mary C. Zanarini, Ed.D. TREATMENT OF ALCOHOL AND CO-OCCURRING PSYCHIATRIC DISORDERS: WHAT DO WE KNOW, 2. Borderline Personality Disorder in Suicidal AND WHERE DO WE GO FROM HERE? Adolescents National Institute on Alcohol Abuse and Alcoholism Shirley Yen, Ph.D. Chp.: Carrie L. Randall, Ph.D. 3. Patterns of Mental Health Treatment Utilization in Adolescent Borderline Personality Disorder (BPD): 1. Treatment of Schizophrenia and Co-Occurring Does It Differ from Adult BPD? Alcoholism Marianne S. Goodman, M.D. Alan I. Green, M.D. 4. A Hospital Based Adolescent DBT Program for 2. Treatment of Alcoholism and Other Addictive Adolescent Girls with Borderline Personality Disorders with Co-Occurring Bipolar Disorder: Disorder Review of the Evidence Aguirre A. Blaise, M.D. Ihsan M. Salloum, M.D. 5. Early Intervention for Borderline Personality 3. Problems in Assessment and Treatment of Disorder in Adolescence: A Randomized Controlled Co-Occurring Depression and Alcohol Dependence Trial Helen M. Pettinati, Ph.D. Andrew M. Chanen, M.B.B.S. 4. Co-Occurring Alcohol Use Disorders and Social Discussant: Peter Fonagy, Ph.D. Anxiety Disorder Carrie L. Randall, Ph.D. SYMPOSIUM 63 2:00 P.M. -5:00 P.M. 5. PTSD and Co-Occurring Alcohol Use Disorders Room 123, Exhibit Level, Moscone Center Kathleen Brady, M.D. DIFFERENT EXPERTS APPROACH A CASE OF Discussant: Raye Z. Litten, Ph.D. BORDERLINE PERSONALITY DISORDER Association for Research in Personality Disorders SYMPOSIUM 61 2:00 P.M. -5:00 P.M. Chp.: James H. Reich, M.D., M.P.H. Room 121, Exhibit Level, Moscone Center 1. Dealing With Axis I Comorbidity in a Borderline UNDER THE BELL JAR: THE LIFE, WORKS, Personality Disorder Case PSYCHOPATHOLOGY AND TREATMENT OF James H. Reich, M.D. SYLVIA PLATH 2. A Dimensional/Vulnerability Approach to Borderline Chp.: Laura K. Kent, M.D. Personality Disorders (BPD) 1. Sylvia Plath: The Childhood years. Larry J. Siever, M.D. Allison S. Baker, M.D. 3. Short-term Psychodynamic Supportive Psycho- 2. Sylvia Plath: The College Years therapy (SPSP) for the Treatment of Borderline Laura K. Kent, M.D. Personality Disorder Simone Kool, Ph.D. 3. Sylvia Plath: The Cambridge Years Sara S. Nash, M.D. 4. Using Nidotherapy to Treat Personality Dysfunction Peter Tyrer, M.D. Discussant: Philip R. Muskin, M.D., M.A. 5. An Integrated Perspective on the Treatment of SYMPOSIUM 62 2:00 P.M. -5:00 P.M. Borderline Personality Disorder Room 122, Exhibit Level, Moscone Center John Livesley, M.D. BORDERLINE PERSONALITY DISORDER IN 6. Treating the Case of “Sam” with STEPPS* (Systems ADOLESCENCE: WHAT DOES IT LOOK LIKE AND Training for Emotional Predictability & Problem HOW IS IT TREATED? Solving) Nancee S. Blum, M.S.W. Co-Chps.: Marianne S. Goodman, M.D., Mary C. Zanarini, Ed.D.
58 WWW.PSYCH.ORG Thursday, May 21, 2009
SYMPOSIUM 64 2:00 P.M. -5:00 P.M. SYMPOSIUM 66 2:00 P.M. -5:00 P.M. Room 124, Exhibit Level, Moscone Center Rooms 272-276, Mezzanine Level W, Moscone Center BAD VERSUS MAD: THE FAILURE OF THE PENAL REASSESSING THE ACTION OF PSYCHIATRIC SYSTEM IN CALIFORNIA DRUGS APA Council on Global Psychiatry and the APA Council on Chp.: Joanna Moncrieff, M.D. Children, Adolescents, and Their Families 1. What Do Psychiatric Drugs Really Do? Co-Chps.: Rodrigo A. Munoz, M.D., Deconstructing Conventional Views of Psychiatric Marcia K. Goin, M.D., Ph.D. Drug Action Joanna Moncrieff, M.D. 1. Therapeutic Justice: Family Members Speak out to End Discrimination Against Individuals Struggling 2. Does Anything Stabilize Moods? to Recover From Addictive Illness David T. Healy, M.D. Gretchen Bergman 3. Hippocratic Psychopharmacology: A New Approach 2. Deconstructing Co-Dependence: Parents Need to Nassir Ghaemi, M.D. Shepherd Their Loved Ones Into Treatment Services and Away From Punitive Policies SYMPOSIUM 67 2:00 P.M. -5:00 P.M. Caroline Stewart Room 301, Esplanade Level, Moscone Center 3. New Treatments and Better Prognosis THE SUICIDAL PATIENT WITH BORDERLINE Claudio Cabrejos, M.D., M.P.H. PERSONALITY DISORDER 4. Treat or Shun Chp.: Robert J. Gregory, M.D. Kenneth A. Khoury, M.D. 1. Risk Factors for Suicidal Behavior in Borderline 5. California’s Nonviolent Offender Rehabilitation Act: Personality Disorder Reducing the Role of Addiction and Mental Illness in Paul H. Soloff, M.D. Prison Overcrowding 2. The Suicidal Borderline Patient: An Object Margaret Dooley-Sammuli Relations Approach Discussant: Robert Phillips, M.D., Ph.D. John F. Clarkin, Ph.D. SYMPOSIUM 65 2:00 P.M. -5:00 P.M. 3. Strategies and Interventions for Suicidal Individuals with Borderline Personality Disorder: DBT Room 125, Exhibit Level, Moscone Center Techniques and Beyond PREVENTION AND TREATMENT OF MENTAL Barbara H. Stanley, Ph.D. DISORDERS IN CHILDREN IN CARE 4. Dynamic Deconstructive Psychotherapy: A Novel APA Committee on Family Violence Treatment for Reducing Suicide Risk in Borderline and Abuse Personality Disorder Co-Chps.: Gail E. Robinson, M.D., D.P.H., Robert J. Gregory, M.D. Carole L. Warshaw, M.D. SYMPOSIUM 68 2:00 P.M.-5:00 P.M. 1. Helping Violence Exposed Children: A Curriculum Room 302, Esplanade Level, Moscone Center to Strengthen the Parent-Child Relationship Patricia J. Van Horn, Ph.D. EMERGING CLINICAL APPLICATIONS OF GENOTYPE-GUIDED PSYCHOTROPICS FOR 2. Increasing Access to Child Welfare and Mental DEPRESSIVE DISORDERS Health Systems by Reducing Stigma William Arroyo, M.D. Co-Chp.: Simon Kung, M.D., Gualberto Ruano, M.D., Ph.D. 3. The Effects of Enhanced Foster Care on the 1. Greater Utilization of Psychiatric Services Is Long-Term Physical and Mental Health of Foster Associated With Cyp450 Drug Metabolism Care Alumni Defi ciencies Peter Pecora, Ph.D. Gualberto Ruano, M.D. 4. Youth Empowerment Interventions and Foster 2. Cytochrome P-450 2D6, 2C19, and Serotonin Care Transporter Genotyping for Depressed Inpatients at Sandra J. Kaplan, M.D. the Mayo Clinic Mood Disorders Unit Simon Kung, M.D.
162ND ANNUAL MEETING 59 Thursday, May 21, 2009
3. Pharmacogenetic Testing in Psychiatry: Early 5. Genetics of Alcoholism and Related Endophenotypes Adopters’ Attitudes and Practices Howard J. Edenberg, Ph.D. Jinger G. Hoop, M.D. 4. The Serotonin Transporter Gene (SLC6A4): SYMPOSIUM 71 2:00 P.M.-5:00 P.M. Understanding Variability and Enhancing the Room 307, Esplanade Level, Moscone Center Clinical Utility of Genotyping THE COLLABORATIVE LONGITUDINAL David A. Mrazek, M.D. PERSONALITY DISORDERS STUDY: IMPLICATIONS FOR DSM-V SYMPOSIUM 69 2:00 P.M.-5:00 P.M. Co-Chp.: Andrew E. Skodol, M.D., John G. Gunderson, M.D. Room 304, Esplanade Level, Moscone Center 1. Associations of Personality Disorders and Axis I COMBATING STIGMA OF BORDERLINE Disorders Over Time: Implications for Spectrum PERSONALITY DISORDER Models Co-Chp.: Stuart C. Yudofsky, M.D., Perry D. Hoffman, Ph.D. Tracie Shea, Ph.D. 1. The Consequences of Stigma for Patients With 2. Traits and Symptomatic Behaviors: A Hybrid Model Borderline Personality Disorders of Personality Disorders George Vaillant, M.D. Thomas H. McGlashan, M.D. 2. Medical Care for Borderline Personality Disorder 3. Comparative Validity of Diagnostic Models for in Germany - A European Perspective Personality Disorders Martin Bohus, M.D. Leslie C. Morey, Ph.D. 3. Psychoeducation for Patients With Borderline 4. Impact of Personality Psychopathology on Course Personality Disorder and Their Families and Outcome of Axis I Disorders Joel Paris, M.D. Andrew E. Skodol, M.D. 4. Family and Consumer Advocacy to Congress: From 5. Perspectives on BPD: Lessons Learned From CLPS Stigma to Stability for Borderline Personality John G. Gunderson, M.D. Disorder Discussant: Kenneth R. Silk, M.D. James O. Payne, J.D. 5. Borderline Personality Disorder Research at NIMH SYMPOSIUM 72 2:00 P.M.-5:00 P.M. James P. Breiling, D.Phil. Room 308, Esplanade Level, Moscone Center SYMPOSIUM 70 2:00 P.M.-5:00 P.M. MATTERS OF THE HEART: DEPRESSION AND Room 306, Esplanade Level, Moscone Center CARDIOVASCULAR DISEASE GENETIC VULNERABILITIES FOR DRUG ABUSE Chp.: Carolyn B. Robinowitz, M.D. AND CO-MORBID MENTAL HEALTH DISORDERS Co-Chp: Charles B Nemeroff, M.D. Ph.D. National Institute on Drug Abuse 1. Autonomic Imbalance, Depression and CAD: Co-Chp.: Minda R Lynch, Ph.D., Joni L Rutter, Ph.D. Facing Our Scotoma Lawson Wulsin, M.D. 1. Subjective Drug Effects as Endophenotypes for Vulnerability 2. The Relationship Between Depressive Episodes and Harriet de Wit, Ph.D. Acute Coronary Syndrome (ACS) Alexander Glassman, M.D. 2. The Infl uence of Genetic Variance in the Dopamine Transporter on Brain and Behavioral Responses to 3. The AHA Scientifi c Perspective: Is Depression an Smoking Cues Independent Risk Factor for Cardiovascular Disease? Teresa Franklin, Ph.D. Erika Froelicher, RN
3. Interacting Effects of COMT Genotype and Nicotine * * * * Withdrawal on Brain Function and Cognition Don’t Miss the opportunity to submit Your presentation Caryn Lerman, Ph.D. for the the 2010 APA Annual meeting 4. Approaching Comorbidity in Addiction Genetics May 22-27, 2010 in New Orleans, LA Joel Gelernter, M.D. Watch for Updates and Infomation at www.psych.org
60 WWW.PSYCH.ORG TOPIC INDEX
FO5-Anxiety in Patients with HIV ...... 29 Addiction Psychiatry Lecture 20-Overcoming the Terror of Death ...... 40 S39-Integrating Treatment for Substance Use ...... 48 IW10-Imaging insight: Basic Defi nitions, Measures ...... 11 IW13-Diversion of Prescription Stimulants ...... 11 Attention Spectrum Disorders A03-Advances in Substance Abuse ...... 18 S01-Spotting the Wolf in Sheep’s Clothing ...... 19 C24-Essentials of Assessing & Treating ADHD ...... 4 CW12-How General Psychiatrists Can Effectively...... 27 ISS-05 The Pathophysiology of ADHD ...... 6 IW31-Assessment and Treatment of Sleep Disorders ...... 28 C37-Advanced Assessment and Treatment ...... 7 C70-Motivational Therapy for People ...... 33 ISS-08 ADHD FAQs: Practical Answers ...... 7 S20-Biological Basis of Sex Differences in Drug ...... 35 C80-Offi ce-based Buprenorphine: Treatment...... 40 Behavior and Cognitive Therapies CW25-Motivating the Motivators: Motivational ...... 45 PS6-The Grandkids of the 1967 Flower ...... 47 S42-Choosing the Right Treatment for Substance ...... 49 CKS01 Practical Cognitive Behavior Therapy ...... 1 FO13-New Tools and Trends: Smoking Cessation ...... 54 C25-CBT for Severe Mental Illness ...... 4 C33-Neuroanatomy of Emotions ...... 5 S60-Treatment of Alcohol and Co-Occurring ...... 58 IW19-Cognitive Therapy for Psychosis ...... 16 C59-Treating Chronically Depressed Patient with CB ...... 25 Aids and HIV Related Disorders IW24-Cognitive Therapy for Personality Disorders ...... 27 C67-Engaging Resistant and Diffi cult-to-Treat ...... 33 S11-Comprehensive HIV Psychiatry Update ...... 21 C68-A Primer on Acceptance and Commitment ...... 33 FO5-Anxiety in Patients with HIV ...... 29 IW67-Cognitive and Behavioral Techniques ...... 54 S21-Co-occurring Disorders in HIV Positive Patient ...... 35 IW72-Should HIV Testing be Routine for Psychiatric ...... 56 Biological Psychiatry and Neuroscience
Alcohol and Drug-Related Disorders S23-Social Stress Increases Vulnerability to Drug ...... 35 S30-Current and Future of the Emergent Field of ...... 37 Lecture 3-Pills to Treat Alcoholism ...... 8 S40-Impulse Control Disorders: Recognition ...... 48 IW02-Practical Pharmacotherapy For The Treatment ...... 10 FO4-Treating Women with Alcohol Use Disorders ...... 13 Child and Adolescent Psychiatry and Disorders IW14-Challenging Stigmas & Stereotypes: Integrated ...... 16 S05-Understanding and Addressing Adolescent ...... 20 C05-Child & Adol Psychiatry for General Psychiatrist ...... 1 S16-Contributions of Neuroscience to Medications...... 22 C23-Autism Spectrum Disorders Over the Lifespan ...... 4 C55-Systemic Therapies for Substance Abuse ...... 25 Small Interactive 1-Safety Issues in Child ...... 11 IW23-Extended Treatments for Alcohol Use ...... 27 MW1-Ready? OK! A Film About Childhood ...... 11 FO7-New Perspectives on Cultural Issues ...... 29 S05-Understanding and Addressing Adolescent ...... 20 Lecture 16-How Alcoholism Develops ...... 30 S31-Pediatric Bipolar Disorder: A Critical ...... 37 C69-Street Drugs & Mental Disorders Overview ...... 33 IW41-Pediatric Grief and Bereavement ...... 41 S23-Social Stress Increases Vulnerability to Drug ...... 35 CW22-School Bullying: Psychiatric and ...... 41 S24-What’s New in Pharmacotherapy for Alcohol ...... 36 S46-Lesbian, Gay, Bisexual and Transgender 5 ...... 0 S35-PTSD and Alcohol Use Disorder ...... 38 CW27-Identifying Children At Risk for Mental ...... 53 IW45-Older Adults and the Neurobiology of ...... 42 IW74-Teen Risk-Taking: Translating Neuroscience ...... 56 S39-Integrating Treatment for Substance Use ...... 48 IW77-Children of Psychiatrists ...... 56 IW68-Helping Patients Who Drink Too Much: ...... 54 S62-Borderline Personality Disorder ...... 58 S70-Genetic Vulnerabilities for Drug Abuse ...... 60 Cognitive Disorders Anxiety Disorders ISS-02 Effective Treatment of Alzheimers Disease ...... 4 Lecture 1-Prevalence, Correlates, and Risk of PTSD ...... 2 CW11-Recognition and Treatment of Dementia ...... 27 Focus Live 2-PTSD & Disaster Psychiatry ...... 13 Small Interactive 11-How to Treat Behavioral ...... 45 Focus Live 3-Panic & Social Anxiety Disorder ...... 17 S12-The OC Spectrum in the Athlete: ...... 21 162ND ANNUAL MEETING 61 TOPIC INDEX
IW65-Psychiatry in the Americas: Update ...... 54 Combined Pharmacotherapy and Psychotherapy IW71-Cross-Cultural Comparisons of System ...... 56 Diagnostic Issues C46-Money Matters I: Using Theory in Clinical ...... 12 C58-Money Matters II: Advanced Clinical Ad Hoc ...... 25 CW16-Indications for the Use of Combined Talking ...... 32 C26-Seeing the Forest and the Trees ...... 4 PS4 When the Treatment Fails the Patient: ...... 47 C42-Understanding the Person Behind ...... 12 IW67-Cognitive and Behavioral Techniques ...... 54 C45-Going From the Bio-Bio-Bio Model ...... 12 FO1-DSM-V: Progress in Research ...... 13 DSM - Evolution of the DSM ...... 18 Computers S06-“In or Out?”: A Discussion about DSM ...... 20 CC3-Issues in the Differential Diagnosis ...... 26 C34-Exploring Technologies in Psychiatry ...... 7 Lecture 13-Models of the Mind ...... 26 C64-Advanced Interviewing Techniques ...... 29 Couple and Family Therapies IW33-The Use of Research Measures ...... 32 DSM - Public Health Aspects of Diagnosis ...... 33 C18-Love, Intimacy, Desire, and Infi delity ...... 3 AM03-Medical Updates and Controversies ...... 43 S45-Drop “Schizophrenia”? International ...... 49 Creativity and the Arts S72-Matters of the Heart: Depression & Cardio ...... 60
C54-Reel Psychiatry ...... 17 Eating Disorders MW3-The Joy Luck Club: Universal Stories ...... 28 IW37-The Portrayal of Psychiatry in Recent...... 33 C49-Therapeutic Interventions in Eating Disorders ...... 12 IW53-Watching the Movies, Beating the Stigma’s ...... 46 S27-Recent Research In Eating Disorders ...... 36 S61-Under the Bell Jar: The life, Works ...... 58 MW6-disFIGURED – A Movie About Women ...... 43
Cross-Cultural and Minority Issues Electronic Medical Records
C19-The IMG Institute ...... 3 CW29-Promise and Perils of Electronic Health ...... 53 C41-Applied Cultural Psychiatry: How the DSM-IV ...... 8 CW02-Lost and Not Found: Depression ...... 10 Epidemiology IW01-Increasing Cultural Competency ...... 10 IW03-Incest - a Cultural Perspective ...... 10 Lecture 16-How Alcoholism Develops ...... 30 IW12-Using the DSM-IV-TR Cultural ...... 11 Lecture 18-The Movement for Global Mental ...... 34 Lecture 7-Psychiatric Education Across ...... 13 IW18-Application of Cultural Variables ...... 16 Ethics and Human Rights S17-Monitoring Equity In Mental Health ...... 22 S18-Recovery and Rehabilitation: From ...... 22 IW06-Ethical, Clinical and Legal Challenges ...... 10 CW10-Biracial Americans: “Check One Box Only” ...... 27 FO2-The Relationship Between the APA ...... 13 MW3-The Joy Luck Club: Universal Stories ...... 28 PS2-Psychiatrist Relationship with Industry ...... 19 FO6-Bridges and Barriers to Care ...... 29 DR01-APA: Our Relationships to Pharmaceutical ...... 26 FO7-New Perspectives on Cultural Issues ...... 29 CW14-National Security, the Hippocratic Oath ...... 27 Lecture 15-Cross-cultural Psychopharmacology ...... 29 AM02-Current Ethical Challenges in Assisted ...... 29 S26-The Effects of City Life on Mental Health ...... 36 CW18-Ethical Dilemmas in Psychiatric Practice ...... 32 C74-Introducing Culture Into Psychiatric Practice ...... 40 CW19-Immigrant Mental Health: Challenges ...... 40 CW21-Traditional and Psychiatric Healers ...... 41 Forensic Psychiatry C79-Narrative Psychiatry An Indigenous Friendly ...... 43 FO9-Psychiatry in America: An European ...... 43 C09-A Practical Approach to Risk Assessment ...... 2 Lecture 21-Developments in Mental Health ...... 43 C12-Malpractice Risk for Psychiatrists Basics & Be ...... 2 IW51-The Post 9-11 Era: Understanding ...... 46 C13-Psychiatric Roles in Assessing and Treating ...... 3 PS6-The Grandkids of the 1967 Flower Children ...... 47 Lecture 2-Psychopathic Disorders Without Borders ...... 5 S41-Recent Developments in Cross-Cultural ...... 48 C38-The Detection of Malingered Mental Illness ...... 7 FO12-Acculturation Related Challenges ...... 54 IW05-Risk Management Issues in Psychiatric ...... 10 C53-The Psychiatrist as Expert Witness ...... 17 62 WWW.PSYCH.ORG TOPIC INDEX
S04-Stalking: Risk Management and Treatment ...... 19 Individual Psychotherapies C56-Risk Assessment for Violence ...... 25 CW13-Outpatient Forensic Services and Intervention ...... 27 C04-Hope for the Distressed & Disruptive Physician ...... 1 IW22-Clinical and Forensic Issues Concerning Infan ...... 27 C02-Interpersonal Psychotherapy ...... 1 IW26-Assessment of Capacity: Developments ...... 28 C10-Interpersonal and Social Rhythm Therapy ...... 2 IW32-Doing it Right the First Time: Recognizing ...... 28 CKS02 Practical Psychodynamic Psychotherapy ...... 3 CW15-Current Topics in Forensic Psychiatry: Update ...... 32 C31-Short-Term Psychodynamic Supportive ...... 5 A07-Advances in Forensic Psychiatry ...... 33 C43-Davanloo’s Intensive Short-Term Dynamic ...... 12 S32-Working With Lawyers ...... 37 A05-Advances in Psychotherapuedic Psychiatry ...... 25 CW26-The Assessment of Violence Risk ...... 46 C57-Time-Limited Dynamic Psychotherapy ...... 25 S44-The Role of Forensic Psychiatry in Evaluating ...... 49 C62-A Psychodynamic Approach to Trmt ...... 28 IW59-Research With Subjects Who Lack Capacity ...... 53 C64-Advanced Interviewing Techniques ...... 29 IW61-Malpractice Defense: Winning Strategies ...... 54 CW20-National Trends in Psychotherapy ...... 41 CW33-Forensic Issues Among Hispanics ...... 55 IW54-Psychotherapy Update: A Review of ...... 46 S64-Bad v. Mad. The failure of the Penal System ...... 59 IW57-Phantoms of the Mind: The Role Of ...... 53 IW76-Psychodynamic Therapy With Self ...... 56 Gender Issues Internet MW1-Ready? OK! A Film About Childhood ...... 11 C06-How to Blog, Friend, & Fly: 21st Century ...... 1 Genetics IW44-Beyond Doctor-Patient Relationship ...... 41 S44-The Role of Forensic Psychiatry in Eval ...... 49 Lecture 5-Psychiatric Genetics A Current ...... 9 CW32-Saved by the Internet? Psychiatric Admin ...... 55 Lecture 6-Etiology in Psychiatry: Phenomes ...... 9 IW21-Tips for Effective Communication ...... 27 Lesbian/Gay/Bisexual/Transgender Issues S68-Emerging Clinical Applications of Genotype ...... 59 S70-Genetic Vulnerabilities for Drug Abuse ...... 60 C48-Developmental Approach to Contemporary ...... 12 Special Event - NCPS Presents Breaking the ...... 22 Geriatric Psychiatry S46-Lesbian, Gay, Bisexual and Transgender ...... 50 CW28-Out and Up in Age: Mental Health in ...... 53 C03-Psychiatric Consultation in Long-term Care ...... 1 C14-Mood Disorders in Later Life ...... 3 Managed Care and Health Care Funding C16-Psychiatric Consultation in Long-term Care ...... 3 Focus Live 1-Geriatric Psychiatry ...... 8 Lecture 8-Mental Health in the New Era of Cost ...... 14 Lecture 10-Successful Aging and Wisdom ...... 17 C52-CPT Coding and Documentation ...... 17 CW11-Recognition and Treatment of Dementia ...... 27 PS1-Psychiatry Better for Patients and Physicians ...... 18 Small Interactive 5-Palliative Care and Psychiatric ...... 27 IW38-The Changing Managed Care Landscape ...... 33 IW45-Older Adults and the Neurobiology of ...... 42 S53-End of Life Care: A Multidisciplinary Clinical ...... 51 CW28-Out and Up in Age: Mental Health in Lesbian ...... 53 Mood Disorders CW30-Schizophrenia and Aging: Cognitive, Medical ...... 53 C11-Psychopharmacologic ECT & Therapeutic ...... 2 Group Therapy C14-Mood Disorders in Later Life ...... 3 C29-Melatonin & Light Trtmt of SAD, ...... 5 ISS-03 Delivering Optimal Care for Complex ...... 5 C47-Treating BPD with the STEPPS* Model ...... 12 ISS-06 Augmentation Strategies for Major ...... 6 C76-Model of Group Psychotherapy for Persons ...... 40 ISS-07 Augmentation Strategies for Major ...... 7 CW02-Lost and Not Found: Depression ...... 10 Historical Questions S02-Adjustment Disorders: Problems in ...... 19 S14-Increasing the Likelihood of Achieving ...... 21 Special Event - NCPS Presents Breaking the Barriers ...... 22 ISS-09 Anxious Depression: Diagnostic and ...... 23 ISS-10 Bipolar Disorder Throughout the Life ...... 24 C62-A Psychodynamic Approach to Trmt ...... 28 162ND ANNUAL MEETING 63 TOPIC INDEX
IW34-FFT-HPI and FIT: Two Different Approaches ...... 32 S63-Different Experts Approach a Case of Borderline ...... 58 S28-Publication Bias and the Effectiveness ...... 37 S67-The Suicidal Patient with Borderline ...... 59 S31-Pediatric Bipolar Disorder: A Critical Look ...... 37 S69-Combating Stigma of Borderline ...... 60 ISS-11-Novel Approaches to Assessing and ...... 39 S71-The Collaborative Longitudinal ...... 60 Small Interactive 9-Clinical Manual for the Dx ...... 40 C73-CBT for Insomnia Co-morbid ...... 40 Political Questions IW41-Pediatric Grief and Bereavement ...... 41 S72-Matters of the Heart: Depression ...... 60 Lecture 17-When Politics Distorts Science ...... 30
Neuropsychiatry Presidential Theme
C22-Traumatic Brain Injury: Neuropsychiatric ...... 3 CW31-Science in the Clinic: Doing Research ...... 53 CKS03 Advances in Neuropsychiatry ...... 12 A01-Advances in Neuropsychiatry ...... 18 S16-Contributions of Neuroscience to Medications ...... 22 Professional and Personal Issues Small Interactive 4-Neuropsychiatric Assessment ...... 27 IW52-Visual Recognition of Catatonia: Video ...... 46 BDRV Board Review: ABPN Part 1 ...... 1 C04-Hope for the Distressed & Disruptive ...... 1 Other Somatic Therapies C12-Malpractice Risk for Psychiatrists Basics ...... 2 C28-Losing a Patient to Suicide ...... 5 C35-Treating Medical Students and Physicians ...... 7 C01-Brain Stimulation Therapies in Psychiatry ...... 1 C36-Treating Physicians Involved in Sexual ...... 7 C60-It’s Not Just in Your Head: Medical Problems ...... 25 IW05-Risk Management Issues in Psychiatric ...... 10 MU01-21st Century ECT – Updating the APA ...... 26 CW05-Career Advancement in Administrative ...... 10 C63-Herbs, Nutrients, & Yoga for Anxiety, PTSD ...... 28 FO2-The Relationship Between the APA ...... 13 IW25-The Impact of Meditation as a Non-Phar ...... 28 PS2-Psychiatrist Relationship with Industry ...... 19 Small Interactive 8-Brain Stimulation Therapies ...... 30 DR01-APA: Our Relationships to Pharma ...... 26 C75-ECT Practice Update for the General Psych ...... 40 IW28-When Psychiatry Residents Treat ...... 28 C78-EEG Feedback in Psychiatry: Clinical App ...... 43 IW29-Bootcamp for Burnout ...... 28 C77-Yoga of the East and West: Integrating ...... 43 Small Interactive 6-When a Physician ...... 30 S50-Advances in Electroconvulsive Therapy ...... 50 Small Interactive 7-Approach to the Psychiatric ...... 30 Lecture 23-The Power of Personalized Lifestyle ...... 54 CW23-Breaking through a Shatter-Proof Glass ...... 41 IW46-American Board of Psychiatry ...... 42 Pain Management IW47-The Cobbler’s Children: Dealing ...... 42 IW50-Psychiatrists Who Have Had ...... 42 C51-Multidisciplinary Treatment of Chronic Pain ...... 17 FO8-How to Submit to the Annual Meeting ...... 43 IW56-”Doctor, is That a Baby You Are ...... 46 IW57-Phantoms of the Mind: The Role ...... 53 Personality Disorders FO11-From the Other Side of the Couch ...... 54 CW34-Negotiation Skills for Psychiatrists ...... 55 C27-Psychotherapy for Borderline Personality ...... 4 IW77-Children of Psychiatrists ...... 56 C47-Treating BPD with the STEPPS* Model ...... 12 IW78-The Physician As Patient: ...... 56 IW17-Can Disclosure of a Diagnosis of Borderline ...... 16 S07-Relationship of Subthreshold Psychiatry ...... 20 Psychiatric Administration and Services: Public, S15-The Transmission of Borderline Personality ...... 21 Lecture 14-Borderline Personality Disorder ...... 26 Private, and University IW24-Cognitive Therapy for Personality Disorders ...... 27 A06-Advances in Personality Disorder ...... 33 C07-Basic Concepts in Admin Psychiatry ...... 2 S29-Borderline Personality Disorder: The Role ...... 37 C20-Basic Concepts in Administrative ...... 3 S33-Empirically Validated and Effective Psychotherapy ..... 38 CW05-Career Advancement in Administrative ...... 10 C71-Mentalization Based Treatment (MBT) for BPD ...... 40 CW07-Revitalizing Service: Strategic Planning ...... 16 S47-Personality Disorders in the United States ...... 50 A08-Advances in Hospital Psychiatry ...... 42 S51-Integrated Treatment of Personality Disorder ...... 51 Lecture 21-Developments in Mental Health ...... 43 S62-Borderline Personality Disorder in Adolescence ...... 58 CW32-Saved by the Internet? Psychiatric ...... 55 64 WWW.PSYCH.ORG TOPIC INDEX
IW70-The New Public Psychiatry: Creating ...... 56 IW35-Outpatient Mastectomies ...... 32 AM03-Medical Updates and Controversies ...... 43 S56-The Architectural Essential Building Blocks ...... 57 S53-End of Life Care: A Multidisciplinary Clinical ...... 51 S64-Bad v. Mad. The failure of the Penal System ...... 59 IW73-Psychiatry Training for Primary Care ...... 56
Psychiatric Education Religion, Spirituality, and Psychiatry
C19-The IMG Institute ...... 3 C08-Spirituality in Psychiatry ...... 2 C17-Give a More Effective Lecture Punch Passion ...... 3 IW51-The Post 9-11 Era: Understanding the Cultural ...... 46 C21-What is Psychiatry? Philosophies and Practice ...... 3 S48-Spiritually Integrated Treatment ...... 50 C39-Improve Your Presentation Skills ...... 7 CW06-Show Me the Money! Sustainable Funding ...... 10 Research Issues IW12-Using the DSM-IV-TR Cultural Formulation ...... 11 IW08-Mindful Practice: Understanding its Role ...... 11 Lecture 7-Psychiatric Education Across Civilizations ...... 13 C40-Research & Publishing on a Shoestring Budget ...... 8 AM01-The Top 10 Medical Articles of 2008 ...... 13 C41-Applied Cultural Psychiatry: How the DSM-IV-TR ...... 8 C54-Reel Psychiatry ...... 17 FO3-Developing the Next Generation of Clinical ...... 13 S08-Educating a New Generation of Physicians ...... 20 FO1-DSM-V: Progress in Research and Development ...... 13 IW21-Tips for Effective Communication ...... 27 IW33-The Use of Research Measures In Clinical ...... 32 Small Interactive 7-Approach to the Psychiatric ...... 30 S25-Autism in Adults Towards a Better Clinical ...... 36 IW39-Supervision in the Psychiatric Emergency ...... 41 S28-Publication Bias and the Effectiveness ...... 37 IW42-Practical Models for Incorporating EBM ...... 41 Small Interactive 10-How to Research a Clinical ...... 45 FO8-How to Submit to the Annual Meeting ...... 43 IW59-Research With Subjects Who Lack Capacity ...... 53 CW24-Psychiatric Residency Training Needs ...... 45 S38- In-Residency Clinical Skills Assessment ...... 48 Resident and Medical Student Concerns IW80-Training for All Psychiatric Residents ...... 56 IW75-Making Your Presentation More Interactive ...... 56 C35-Treating Medical Students and Physicians ...... 7 IW04-Playing in the Big League: Resident ...... 10 Psychoanalysis IW20-Resident Wellness Survey Results ...... 16 IW30-Lessons from the Post-Residency Road ...... 28 CC1-Psychoanalytic Case ...... 9 IW28-When Psychiatry Residents Treat Medical ...... 28 Lecture 20-Overcoming the Terror of Death ...... 40 S22-Starting Out on the Right Foot: Securing Your ...... 35 IW43-Promoting Scholarship & Leadership During ...... 41 IW40-Patient Suicide During Psychiatry Residency ...... 41 Psychopharmacology IW48-Oral Boards Boot Camp-2009 ...... 42 IW49-How to Launch a Successful Private Practice ...... 42 Small Interactive 1-Safety Issues in Child ...... 11 CW24-Psychiatric Residency Training ...... 45 C44-Drug Interaction Principles Course: Update 2009 ...... 12 S38- In-Residency Clinical Skills Assessment ...... 48 A02-Advances in Psychopharmacology ...... 18 IW60-Making the Most of Your Chief Year: ...... 53 S09-Effective Assessment and Treatment of Sexual ...... 21 IW63-How to Launch a Successful Private Practice ...... 54 Small Interactive 3-A Discussion about Drug ...... 27 IW69-Making the Most of Your Chief Year ...... 56 Lecture 15-Cross-cultural Psychopharmacology ...... 29 IW80-Training for All Psychiatric Residents ...... 56 S24-What’s New in Pharmacotherapy for Alcohol ...... 36 S52-”Me-too” Medications, Really? ...... 51 Schizophrenia and Other Psychotic Disorders Small Interactive 12-Antipsychotic Polypharmacy ...... 53 S66-Reassessing the Action of Psychiatric Drugs ...... 59 ISS-01 Development of New Agents for the ...... 4 ISS-04 Neurobiology: Predication and Manage ...... 6 Psychosomatic Medicine Lecture 9-The Center Cannot Hold: My Journey ...... 14 IW19-Cognitive Therapy for Psychosis in Practice ...... 16 C44-Drug Interaction Principles Course: Update 2009 ...... 12 C65-Treatment of Schizophrenia ...... 29 C50-Dev of Integrated Care Models for Patients ...... 17 Lecture 19-Translational Neuroscience ...... 34 A04Advances in Psychosomatic Medicine ...... 25 S45-Drop “Schizophrenia”? International Perspective ...... 49 CW17-Medical Issues for Psychiatrists in Disasters ...... 32 S54-Engaging and Treating Persons with Recent ...... 51 162ND ANNUAL MEETING 65 TOPIC INDEX
MW5-The Bridge(a Documentary Film ...... 42 Small Interactive 12-Antipsychotic Polypharmacy ...... 53 Lecture 22-What Research Tells us About Suicide ...... 46 CW30-Schizophrenia and Aging: Cognitive, Medical ...... 53 PS7-Suicide and the Golden Gate Bridge ...... 47 S43-Suicide and Aggression: A Practical Toolkit ...... 49 Sexual and Gender Identity Disorders IW66-Responding to the Impact of Suicide ...... 54 S67-The Suicidal Patient with Borderline Personality ...... 59 C13-Psychiatric Roles in Assessing and Treating ...... 3 C36-Treating Physicians Involved in Sexual Misconduct ...... 7 Telepsychiatry S10-The Neurobiological Evidence for Transgenderis ...... 21 S09-Effective Assessment and Treatment of Sexual ...... 21 IW07-Technology And Psychiatry: Practical ...... 11 IW11-Implementing a Telepsychiatry Program ...... 11 Sleep Disorders IW62-SC Partners in Behavioral Health Emergency ...... 54
C29-Melatonin & Light Trtmt of SAD, Sleep & Other ...... 5 Treatment Techniques and Outcome Studies IW31-Assessment and Treatment of Sleep Disorders ...... 28 C66-Overview - Sleep Medicine for Mental Hlth ...... 29 C30-Creative Use of Boundary Crossings in Therapy ...... 5 IW36-Evaluation and Management of Patients ...... 33 CW01-High Risk Student Populations: Innovative ...... 10 C73-CBT for Insomnia Co-morbid w/Depressive ...... 40 DR02-Psychiatry Should Embrace Measurement ...... 26 S55-Sleep Disturbances and Circadian Disruptions ...... 52 IW25-The Impact of Meditation as a Non-Pharm ...... 28 FO6-Bridges and Barriers to Care ...... 29 Social and Community Psychiatry S57-Psychodynamic Psychotherapy: Update ...... 57 S58-Optimizing Treatment Outcome in Axis ...... 57 Lecture 4-Psychiatrists Role in Prevention ...... 8 CC2-A Population-Based Case Conference ...... 9 Violence, Trauma, and Victimization CW08-Combat to Community: Needs and Resources ...... 16 CW09-Becoming a Public Psychiatry Leader: ...... 16 Lecture 1-Prevalence, Correlates, and Risk of PTSD ...... 2 S03-Delivering Psychiatry in Rural Peru: ...... 19 C15-Psychiatric Interventions in Disasters & Public ...... 3 Lecture 11- William C. Menninger Convocation ...... 23 Lecture 4-Psychiatrists Role in Prevention ...... 8 IW27-Lessons Learned About Resilience ...... 28 CW04-International Disasters: Challenges ...... 10 S36-Psychiatric Patients Overcrowding ...... 38 Focus Live 2-PTSD & Disaster Psychiatry ...... 13 FO10-The Milestones of Recovery Scale ...... 43 IW15-Man and Non-Man Made Disasters in Asia ...... 16 S37-Disability Reduction and Rehabilitation ...... 47 Small Interactive 2-Psychiatric Issues Related ...... 16 CW08-Combat to Community: Needs and Resources ...... 16 Stigma/Advocacy S04-Stalking: Risk Management and Treatment of Off ...... 19 C56-Risk Assessment for Violence ...... 25 MW2-Silver Spurs - Severe and Chronic Mental Illness ...... 11 C61-Disaster Psychiatry Terrorism Trauma & Things ...... 25 IW14-Challenging Stigmas & Stereotypes: Integrated ...... 16 CW14-National Security, the Hippocratic Oath ...... 27 IW53-Watching the Movies, Beating the Stigma’s ...... 46 MW4-Provoked: Combating Domestic Violence ...... 28 S65-Prevention and Treatment of Mental Disorders ...... 59 CW17-Medical Issues for Psychiatrists in Disasters ...... 32 S69-Combating Stigma of Borderline Personality ...... 60 C72-From Traumatic Stress to Trauma-Infor ...... 40 CW22-School Bullying: Psychiatric and Physical ...... 41 Stress Special Event - Psychological Effects of the ...... 42 CW26-The Assessment of Violence Risk ...... 46 IW55-Developing a M.H.Court for Domestic ...... 46 IW29-Bootcamp for Burnout ...... 28 PS5-The Invisible Wounds of War ...... 47 C77-Yoga of the East and West: Integrating Breath ...... 43 S43-Suicide and Aggression: A Practical ...... 49 S59-Healing Traumatic Wounds in Post-Genocide ...... 57 Suicide
C28-Losing a Patient to Suicide ...... 5 IW09-Need to Reformulate ‘Risk’ and Its ...... 11 S19-Suicide Without a Psychiatric Disorder ...... 35 IW40-Patient Suicide During Psychiatry ...... 41 66 WWW.PSYCH.ORG TOPIC INDEX
Women’s Health Issues
C32-Management of Psychiatric Disorders ...... 5 AM02-Current Ethical Challenges in Assisted ...... 29 PS3-Psychiatry and the Control of Fertility ...... 34 IW56-”Doctor, is That a Baby You Are Carrying?” ...... 46 S49-How to Approach the Pregnant Patient from ...... 50 FO11-From the Other Side of the Couch ...... 54 FO4-Treating Women with Alcohol Use ...... 13 IW35-Outpatient Mastectomies ...... 32 MW6-disFIGURED – A Movie About Women ...... 43
162ND ANNUAL MEETING 67 PRESENTER INDEX
A Bark, Nigel ...... 36 Barnes, Donna H...... 48 Abbasi, Farha ...... 41 Barnhill, John W...... 30 Abdel-Wahab, Nancy ...... 46 Baron, David A...... 19, 46 Abel, Gene G...... 7 Bartlett, Selena E...... 22 Abouallaban, Yousef ...... 50 Bassu, Ellen K...... 40 Aboul-Fotouh, Frieda ...... 4 Bateman, Anthony W...... 25, 38, 40 Abrams, Karen M...... 20 Batki, Steven ...... 35 Adams, Curtis N., Jr...... 51 Batten, Sonja V...... 48 Adelson, Stewart ...... 12 Baum, Antonia L...... 21 Adler, Mats ...... 15 Beck, Judith S...... 1, 27, 54 Adler, Nancy ...... 35 Becker, Daniel ...... 55 Agronin, Marc E...... 45 Becker, Jill B...... 35 Ahmed, Iqbal ...... 10, 17 Becker, Judith V...... 3 Ahmed, Sadaf ...... 10 Bedregal, Luis E...... 19 Akibiyik, Derya Iren ...... 15, 31, 45, 55 Beeber, Alan R...... 12 Akil, Huda ...... 36 Beer, Jennifer ...... 11 Akiskal, Hagop S...... 20 Beezhold, Julian ...... 28 Akiyama, Tsuyoshi ...... 16 Begum, Millia ...... 31 Alarcon, Renato D...... 14 Beitman, Bernard D...... 25 Albrecht, Suzanne ...... 53 Belfort, Edgard ...... 54 Alcera, Lloyd ...... 54 Bell, Carl C...... 9 Alegría, Margarita ...... 2 Benedek, Elissa ...... 11, 27, 32 Alfonso, Cesar A...... 47 Benjamin, Sheldon ...... 27 Ali, Shirin ...... 27, 41 Benjelloun, Hind ...... 16 Alkhouri, Iyad ...... 28 Bergman, Gretchen ...... 59 Allison, Rebecca ...... 20 Berkowitz, Ellen ...... 56 Alsuwaidan, Mohammad ...... 10 Berman, Karen Faith ...... 35 Andermann, Lisa F...... 40 Bhandari, Tarun ...... 54 Anderson, Allan ...... 17 Bhugra, Dinesh ...... 18 Anderson, Otis, III ...... 10 Bialer, Philip ...... 29, 53 Andrade, Naleen N...... 42 Binder, Renee ...... 13, 46 Andrea, Helene ...... 14 Birkholm, Molly ...... 28 Andreoli, Antonio ...... 57 Bisaga, Adam ...... 49 Anglin, Rebecca ...... 31 Bittner, Stephen J...... 19 Anton, Raymond F...... 36 Bjork, James ...... 56 Anzia, Joan M...... 3, 48 Black, Donald W...... 12, 48 Apfel, Brigette ...... 44 Blaise, Aguirre A...... 58 Appelbaum, Paul S...... 19, 49, 53 Blanco-Jerez, Carlos ...... 19 Apter, Gisele ...... 18, 34, 35 Blaustein, Mel I...... 42, 47 Arean, Patricia ...... 3 Blendy, Julie ...... 36 Armstead, Ron E...... 48 Block, Jerald ...... 1 Armstrong, Scott C...... 12 Blum, Nancee S...... 12, 58 Arnsten, Amy ...... 6 Blumenfi eld, Michael ...... 25 Aron, Laudan Y...... 57 Blumfi eld, Michael ...... 22 Arroyo, William ...... 59 Bockting, Claudi C.L.H...... 37 Ash, Peter ...... 34 Boehnlein, James K...... 48 Astruc, Bernard ...... 55 Bohus, Martin ...... 37, 60 Atkins, Robert ...... 3 Bokarius, Vladimir ...... 17 Auger, R. Robert ...... 29 Boland, Robert ...... 43 Austin, Jehannine C...... 27 Book, Howard E...... 5, 53 Axelson, Alan ...... 3 Booty, Andrew ...... 41 Boronow, John J...... 42 Bostwick, John M...... 35 B Bourgeois, James A...... 1, 43 Boust, Susan ...... 16 Bailey, Rahn ...... 29 Brada, Kay ...... 16 Baker, Allison S...... 50, 58 Brady, Kathleen ...... 19, 38, 48, 58 Ballon, Jacob ...... 54, 56 Brams, Jolie ...... 4 Barak, Yoram ...... 44 Brandt, Douglas M...... 2, 3
68 WWW.PSYCH.ORG PRESENTER INDEX
Breiling, James P...... 60 Chan, Carlyle ...... 7 Breitbart, William ...... 27, 35 Chanen, Andrew M...... 58 Brendel, David H...... 3 Chang, Grace ...... 13 Brod, Thomas M...... 43 Chang, Jacquelyn ...... 10, 27, 29 Brodkey, Amy C...... 20 Chase-Eldridge, Warene ...... 16 Brooks, Beth Ann ...... 42 Chaudhry, Haroon ...... 16 Brooks, John ...... 47 Chen, Chiao-Chicy ...... 16 Brooks, Kristen ...... 41 Cheong, Josepha A...... 13, 17, 40 Broquet, Karen ...... 48 Chien, Peter L...... 16 Brower, Kirk J...... 28 Choi-Kain, Louis W...... 22 Brown, Richard A...... 19 Christianson, Amy ...... 25 Brown, Richard P...... 29, 43 Chung, Henry ...... 44 Brown, Sandra A...... 20 Ciccocioppo, Roberto R. C...... 22 Brown, Thomas E...... 4, 7 Clarkin, John F...... 4, 51, 59 Bruce, Travis O...... 21 Clayton, Paula J...... 46–47 Brymer, Melissa ...... 28 Cloninger, C. Robert ...... 26 Buchanan, Alec W...... 27, 46 Cobb, Robert ...... 25 Buckingham, U. Diane ...... 27 Coconcea, Cristinel ...... 15 Buckley, Peter ...... 3 Coffey, Barbara ...... 11 Bullock, Karen ...... 55 Coffey, C. Edward ...... 12 Bunt, Gregory C...... 49 Coffey, Justin ...... 10 Burd, Ronald ...... 17 Cohen, Carl I...... 27 Burke, Mary G...... 38 Cohen, Judith ...... 3 Burpee, Stacey ...... 10, 41 Cohen, Lisa ...... 32 Busner, Joan ...... 32 Cohen, Michael ...... 43 Bystritsky, Alexander ...... 38 Cohen, Mitchell ...... 42 Cohn, David E...... 53 Coleman, Dan ...... 14 C Compton, Karla ...... 44 Compton, Wilson M., III ...... 11, 19, 50 Cabaj, Robert ...... 56 Conant-Norville, David O...... 21 Cabrejos, Claudio ...... 59 Condon, Timothy P...... 42 Cahill, Larry F...... 35 Coopey, Adrienne ...... 54 Calabrese, Joseph R...... 24 Correll, Christoph ...... 6 Calderon-Abbo, Jose ...... 28 Courchesne, Eric ...... 4 Caligor, Eve ...... 4 Cournos, Francine ...... 35, 41, 42 Callahan, William E...... 42, 54 Crasta, Jovita ...... 54 Camarena, Enrique ...... 54 Critchfi eld, Kenneth L...... 51 Campbell, Frank ...... 5 Crone, Catherine ...... 25, 40 Campbell, Jamae C...... 46 Crow, Scott J...... 37 Campbell, Nioaka N...... 16, 46 Cummings, Jeffrey L...... 12 Campbell, William H...... 2, 4, 12, 36 Cureton, Janetta ...... 46 Capitanio, John P...... 36 Cutler, Janis ...... 20 Caring, Joanne ...... 31 Cyr, Alan ...... 27 Carino, Anthony ...... 56 Carlson, Stephan ...... 53 Carney, Colleen ...... 40 D Caroff, Stanley N...... 25, 46 Carpenter, Linda ...... 1, 18 Daley, Christopher ...... 41 Carpenter, William T...... 51 Dallam, Deborah ...... 27 Carter, Diana ...... 5 Dannon, Pinhas ...... 55 Caselli, Monica ...... 41 Daroff, Robert, Jr...... 21 Casey, David A...... 53 Daroff, Robert B...... 56 Casey, Patricia P...... 19 Dauenhauer, Laura ...... 41 Castellanos, Daniel ...... 55 Davae, Umee ...... 53 Castro, Anthony ...... 46 David, Daniella ...... 28 Ceccherini-Nelli, Alfonso ...... 32 Davidoff, Donald ...... 3 Cefalu, Charles ...... 4 Davidson, Kate M...... 38 Chaffi n, Jennifer ...... 49 Davies, Emily ...... 41 Chaisson, Anne-Marie ...... 43 Davine, Jon J. D...... 56, 57 Chamberlain, Samuel R...... 48 Davis, Jeri ...... 3
162ND ANNUAL MEETING 69 PRESENTER INDEX
Davis, Steven ...... 1 Farkas, Marianne D...... 22 De Blécourt, Carel ...... 31 Farlow, Martin ...... 4 De Jonghe, Frans ...... 5 Fartacek, Reinhold ...... 49 De Wit, Harriet ...... 60 Faulkner, Larry R...... 42 Deas, Deborah ...... 20 Fauman, Beverly ...... 10 DeFrancisci, Lea ...... 11, 32 Fauman, Susan ...... 11, 56 Dekker, Jack J...... 5 Fava, Maurizio ...... 21, 23, 24, 39 Del Rosario, Salvador R...... 11 Fawcett, Jan ...... 51 DeMaso, David R...... 41 Feenstra, Dineke ...... 14 Desai, Abhilash K...... 1, 3 Feijen, Rudolf R.A.M...... 46 DesMeules, Marie ...... 22 Felthous, Alan R...... 5 Devlin, Michael J...... 12, 37 Fernandez, Antony ...... 45 Dewan, Mantosh J...... 3, 8, 56 Ferrando, Stephen J...... 25 Diamond, Milton ...... 21 Ferranti, Jessica ...... 14 Diaz-Granados, Natalia ...... 22 Fine, Carla ...... 5 Dickstein, Leah J...... 7, 16, 42, 56 Finlayson, Reid ...... 1 Dieperink, Eric ...... 17 Finn, Christine ...... 27 Dimaggio, Giuseppe Giancarlo ...... 51 Finucane, Thomas ...... 26 Dimeff, Linda A...... 38 Fireman, Marian ...... 30 Dixon, Lisa B...... 42 Fishel, Tobi ...... 1 D’Mello, Dale ...... 45 Fishkind, Avrim B...... 39 Doghramji, Karl ...... 33 Fitelson, Elizabeth M...... 50 Dole, Aparna ...... 29 Fleming, Ann ...... 47 Donatilla, Mukamana ...... 57 Fochtmann, Laura ...... 53 Dooley-Sammuli, Margaret ...... 59 Foelsch, Pamela ...... 53 Douaihy, Antoine ...... 35 Fonagy, Peter ...... 33, 37, 40, 58 Dougherty, Darin D...... 1, 6, 37 Fong, Timothy ...... 33 Dowling, Gayathri ...... 42 Forester, Brent ...... 3 Downey, Jennifer I...... 47 Forstein, Marshall ...... 11, 12, 21, 35, 56 Doyle, Robert ...... 4 Fragola, Alfredo Ortiz ...... 54 Drescher, Jack ...... 20, 30 Francis, Andrew J...... 46 D’Souza, Russell ...... 16, 50 Frank, Ellen ...... 2, 18 Dunn, Jeffrey ...... 20 Frank, Julia B...... 42 Dunn, Laura B...... 38, 51 Frank, Richard ...... 14 Dupont, Robert L...... 47 Frankel, Debra ...... 2 Franklin, Teresa ...... 60 Freeman, Alfred ...... 22 E Fricchione, Gregory ...... 46 Froelicher, Erika ...... 60 Ecker, Sidney W...... 21 Fung, Kenneth ...... 33, 40 Edenberg, Howard L...... 60 Furukawa, Toshiaki A...... 25 Edinger, Jack ...... 40 Ehrensaft, Diane ...... 50 Ehret, Megan ...... 15 G Eist, Harold I...... 26, 38 Elliott, Glen R...... 38 Gabbard, Glen O...... 3, 25, 33, 39, 41, 56, 57 Ellison, James M...... 3 Gabriel, Adel ...... 14, 31 Elsayed, Yasser ...... 14 Gaebel, Wolfgang ...... 43 Esguerra, Chris ...... 41 Galanter, Marc ...... 18, 25 Essex, Marilyn ...... 53 Galynker, Igor ...... 32 Everett, Anita S...... 16, 39, 57 Ganzini, Linda ...... 35 Gao, Keming ...... 45 Garcia, Mai-Ling ...... 16 F Garrett, Michael ...... 28 Gask, Linda ...... 34 Faden, Vivian B...... 20 Gates, Elena ...... 29 Fahrer, Rodolfo ...... 54 Gaudiano, Brandon ...... 2 Fairweather, Amy ...... 16 Gaynes, Bradley N...... 39 Faison, Warachal ...... 18 Gelernter, Joel ...... 60 Falzone, Richard ...... 28 Geller, Jeffrey ...... 57 Farabaugh, Amy ...... 24 Geller, Ruth E...... 41 70 WWW.PSYCH.ORG PRESENTER INDEX
George, David T...... 36 H George, Mark S...... 12, 37 George, Tony P...... 18 Hales, Deborah ...... 3, 17, 41 Gerbarg, Patricia L...... 29, 43 Hales, Robert E...... 18 Germain, Anne ...... 40 Hall, Ryan ...... 32 Gers, Seymour ...... 43 Haller, Ellen ...... 53 Gessesse, Hiruy ...... 25 Halmi, Katherine A...... 12, 37, 43 Ghadiali, Nafi sa ...... 46 Hameed, Noumana ...... 54 Ghaemi, S. Nassir ...... 3, 59 Hammer, Paul ...... 42 Ghitza, Udi E...... 48 Hammerness, Paul ...... 6 Glantz, Meyer D...... 19 Han, Jaesu ...... 1 Glassman, Alexander ...... 60 Harding, Kelli ...... 13 Gleason, Ondria ...... 17 Harlow, Michael ...... 49 Glick, Ira D...... 42, 57 Harris, Treniece Lewis ...... 11 Glover, Karinn ...... 27 Harrow, Martin ...... 15 Goethe, John ...... 31 Hartmann, Lawrence ...... 22 Goff, Donald ...... 53 Harvey, Philip ...... 4 Goin, Marcia K...... 59 Harvey, Steven ...... 11 Goisman, Robert ...... 1 Hasan, Nidal N. H...... 32 Gold, Lisa ...... 34 Hasin, Deborah S...... 50 Gold, Mark S...... 47 Hatti, Shivkumar ...... 2, 10 Goldberger, Bruce A...... 47 Hauser, Peter ...... 17 Goldfi nger, Stephen M...... 56 Healy, David T...... 59 Goldman, Howard ...... 34 Henderson, David C...... 49 Goldman, Marina ...... 10 Hendren, Robert L...... 1 Goldman, Morris B...... 29 Hendriksen, Mariëlle ...... 5 Goler, Nancy ...... 13 Hepburn, Brian Matthew ...... 55 Gonzalez, Gerardo ...... 40 Herbert, Sarah E...... 11 Goodkin, Karl ...... 21 Hercher, Laura ...... 27 Goodman, Marianne S...... 44, 58 Herie, Marilyn ...... 33 Goodwin, Frederick ...... 51 Herman, Barry K...... 2, 3, 10 Gopal, Arun ...... 41 Hermann, Richard ...... 5 Gordon, Harold W...... 52 Herrman, Helen E...... 37 Gordy, Tracy R...... 17 Hersh, Richard G...... 16 Gorelick, David ...... 45 Heru, Alison M...... 57 Grady-Weliky, Tana A...... 11, 28 Hickson, Gerald ...... 1 Granacher, Robert P...... 4 Hien, Denise ...... 38 Grant, Jon E...... 48 Higgins, Brian D...... 16 Grant, Steven ...... 11 Hill, Darryl ...... 50 Gray, Sheila Hafter ...... 53 Hilty, Donald ...... 11, 13, 43 Greco, Nicholas, IV ...... 32 Hines, Kevin ...... 43 Green, Alan I...... 18, 58 Hines, Patrick ...... 43 Green, Stephen ...... 32 Hinterhuber, Hartman ...... 57 Greenberg, Benjamin D...... 37 Hippman, Catriona ...... 27 Greene, James A...... 55 Hira-Brar, Shabneet ...... 42 Greenfi eld, Shelly F...... 13 Hirshkowitz, Max ...... 29 Greenwald, Phyllis ...... 5 Hoffman, Perry D...... 16, 60 Gregory, Robert J...... 59 Hoffman, Sarah ...... 50 Gregory, Simon ...... 39 Hoge, Charles ...... 16 Grewal, Arvinder K...... 5 Hoge, Steven K...... 27, 32 Greydanus, Donald ...... 7 Hoglend, Per ...... 57 Groen, Wouter ...... 36 Hollander, Eric ...... 48 Grossberg, George T...... 1, 3, 4 Hollon, Steven ...... 37 Guarino, Kathleen ...... 40 Holmes, Ken ...... 47 Gunderson, John G...... 3, 21, 22, 26, 33, 38, 60 Holsch, Cyril ...... 43 Gupta, Nitin ...... 16, 32, 44, 55 Hommer, Rebecca E...... 56 Gutheil, Thomas G...... 3, 38 Hoop, Jinger G...... 60 Guynn, Robert ...... 42 Hopkinson, Marta ...... 10 Horgan, Constance M...... 33 Horowitz, Mardi J...... 53, 57
162ND ANNUAL MEETING 71 PRESENTER INDEX
Houston, Michael ...... 11 Katz, Craig I...... 3 Hsiung, Robert C...... 1 Katz-Bearnot, Sherry P...... 47 Hudson, James I...... 22 Katzelnick, David ...... 26 Huebner, Robert ...... 54 Katzman, Martin ...... 29, 43 Huffi ne, Charles W...... 52 Kay, Jerald ...... 10 Huguelet, Philippe ...... 15 Kaye, Walter H...... 37 Hung, Erick ...... 41 Kazim, Batool ...... 41 Huremovic, Damir ...... 41 Keitner, Gabor I...... 57 Hurley, Robin A...... 18 Kellner, Charles ...... 26, 40, 51 Hurwitz, Thomas D...... 29 Kemp, David ...... 24 Husain, Arshad ...... 10 Kendler, Kenneth ...... 9 Husain, Mustafa ...... 51 Kennedy, Robert S...... 7 Hussain, Mustafa ...... 1 Kent, Laura K...... 58 Hutsebaut, Joost ...... 14 Kernberg, Otto F...... 4 Kertzner, Robert M...... 12 Ketter, Terence ...... 18 I Khan, Sarah ...... 28 Khoury, Kenneth A...... 59 Ibe, Aloysius ...... 31 Kim, Borah ...... 32 Iftekhar, Ruksana ...... 54 Kim, Eugene ...... 47 Ignacio, Luis Faustino ...... 50 Kingdon, David ...... 4, 16 Ilorente, Maria ...... 27 Kirsch, Andrew ...... 56 Indest, David ...... 17 Kleber, Herbert D...... 18, 49 Irigoyen, Fructuoso ...... 45 Kleberm, Mark ...... 18 Irwin, Michael R...... 52 Klein, Carolina ...... 28 Isaacs, Julian ...... 43 Klin, Ami ...... 36 Ishak, Waguih ...... 15 Knight, Sara J...... 51 Ivanov, Iliyan ...... 7 Kocsis, James ...... 44 Kohn, Robert ...... 44 J Koike, Alan ...... 1 Koivukangas, Jenni ...... 31 Koob, George F...... 22 Jabbarpour, Yad M...... 49, 57 Kool, Simone ...... 5, 58 Janicak, Philip G...... 29 Koopman, Cheryl ...... 55 Janofsky, Jeffrey ...... 27, 32 Koponen, Hannu ...... 45 Javed, Afzal ...... 49 Kosten, Thomas R...... 38 Jayaram, Geetha ...... 34, 43, 49 Koyanagi, Chad ...... 11 Jenkins, Rachel ...... 37 Kraemer, Helena ...... 53 Jensen, Peter ...... 56 Krakowski, Menahem ...... 45 Jeste, Dilip ...... 14, 17 Kramer, Milton ...... 15, 45, 53, 56 Jibson, Michael D...... 48 Kranzler, Henry R...... 36 Jimerson, David C...... 12 Krishnan, Ranga ...... 45 Joffe, Carole E...... 34, 35 Kronenberg, Anne ...... 22 Johnson, Bankole A...... 8, 36 Krueger, Robert ...... 18, 50 Johnson, Bradley R...... 3 Krystal, Andrew ...... 26, 40 Johnson, Jeffrey ...... 50 Kua, Ee-Heok Ehk ...... 37 Joiner, Lasa ...... 16 Kudler, Harold ...... 47 Jorgenson, Linda M...... 5, 11 Kung, Simon ...... 59 Kuo, Felicia Y...... 41 K Kuo, Irving ...... 27 Kupfer, David ...... 13 Kahan, Kara ...... 4 Kuzenko, Nina ...... 45 Kalali, Amir ...... 4 Kane, John ...... 6 L Kang, Shimi ...... 33 Kaplan, Gabriel ...... 7 LaBoy, Felicity L...... 16 Kaplan, Sandra J...... 59 Laje, Gonzalo ...... 21 Kaplan, Stuart ...... 32 Lamb, William K...... 57 Karlawish, Jason ...... 53 Landau, Judith ...... 57 Kaskutas, Lee Ann ...... 13 Lane, Richard ...... 11 72 WWW.PSYCH.ORG PRESENTER INDEX
Lansky, Melvin ...... 9 Maki, Pirjo H...... 44 Larson, Justine ...... 20 Malaspina, Dolores ...... 41 Lazarus, Arthur ...... 3 Malison, Robert T...... 52 Leamon, Martin ...... 1 Malmquist, Carl P...... 11, 27 Lebowitz, Barry D...... 8 Malphurs, Julie E...... 28 Lee, Allison ...... 32 Manber, Rachel ...... 40 Lee, Elliott ...... 29 Mangurian, Christina V...... 41, 50 Lee, Eugene ...... 56 Manring, John ...... 3, 46 Leigh, Hoyle ...... 31, 56 Mao, Alice ...... 4 Lerman, Caryn ...... 60 Marazziti, Donatella ...... 31 Leucht, Stefan ...... 6 Marchionni, Christine ...... 33 Leuchter, Andrew F...... 21 Marder, Stephen R...... 29 Levander, Eric ...... 25 Markov, Dimitri D...... 10, 33 Levav, Itzhak ...... 44 Markowitz, John C...... 1, 25 Levenson, Hanna ...... 25 Marks, Glenn ...... 43 Levenson, James L...... 25 Marks, Saul I...... 21 Levin, Edmund C...... 38 Marks, Tracey I...... 7 Levin, Frances R...... 19, 49 Martens, Elizabeth ...... 37 Levine, Stephen B...... 3 Martinez, Humberto L...... 55 Levounis, Petros ...... 27, 45 Martin-Katzman, Roy D...... 28 Levy, Matthew ...... 56 Marzani-Nissen, Gabrielle ...... 21 Levy, Norman B...... 35 Mason, Barbara J...... 36 Lewis, Jerry L...... 40 Massie, Mary Jane ...... 33 Lewis, Stephen ...... 15 Matenik, Jeffery ...... 34 Lewis-Fernandez, Roberto ...... 55 Mathalon, Daniel ...... 13 Lewy, Alfred J...... 5 Matharu, Yogi ...... 17 Liberman, Robert P...... 22, 51 Matorin, Anu A...... 41 Licinio, Julio ...... 9, 34, 45 Matthews, Annette ...... 30 Lieberman, Alicia ...... 28 May, Alison ...... 31, 41 Lim, Russell F...... 8 May, Catherine ...... 32 Lin, Chieh-Hsin ...... 55 McCabe, Sean ...... 11 Linden, Michael ...... 19 McCann, Una D...... 52 Lipsitt, Don ...... 56 McCarron, Robert ...... 1, 43 Liptzin, Benjamin ...... 42 McCarthy, Malia ...... 1 Lisanby, Sarah H...... 26 McClung, Colleen A...... 52 Litten, Raye Z...... 58 McCormick, Laurie ...... 40 Liu, Shirley ...... 10 McCrady, Barbara ...... 29 Livesley, John ...... 51, 58 McDonald, Scott ...... 11 Llocra, Pierre Michel ...... 22 McDonald, William M...... 18, 26 Lo, Ted ...... 40 McFarland, Bentson ...... 45 Loo, Colleen K...... 51 McFarr, Lynn ...... 25 Lopez-Ibor, Juan J...... 20 McGee, Michael D...... 2 Lowenkopf, Eugene L...... 54 McGlashan, Thomas H...... 60 Loza, Nasser N...... 36 McHugh, Paul R...... 12, 26 Lu, Francis G...... 8, 28 McIntyre, John ...... 26 Luby, Joan ...... 53 McIntyre, Kathryn ...... 42 Luce, John ...... 53 McKay, James R...... 27 Lukas, Scott E...... 52 McLean, Alexandra ...... 22 Luo, John ...... 7 McLean, Andrew J...... 52 Lusskin, Shari ...... 5 McNicholas, Laura F...... 18, 40 Lynch, Katherine ...... 15 McVoy, Molly K...... 10, 36 Lynch, Minda R...... 60 Mee-Lee, David ...... 33 Lynch, Wendy J...... 35 Mehl-Madrona, Lewis ...... 43 Mehta, Shivani ...... 54 Melonas, Jacqueline M...... 2, 10 M Menezes, Paulo ...... 37 Menvielle, Edgardo J...... 11, 50 Madaan, Vishal ...... 28, 31 Merikangas, Jame R...... 48 Maercker, Andreas ...... 19 Messing, Robert O...... 22 Mago, Rajinish ...... 15 Metzner, Richard ...... 44 Maj, Mario ...... 20 Meyer, Eve ...... 47 162ND ANNUAL MEETING 73 PRESENTER INDEX
Meyerson, David ...... 44 Newcorn, Jeffrey H...... 7 Micevski, Aleksandar ...... 56 Newmark, Thomas S...... 10, 21 Michaels, Laura ...... 16 Newport, D. Jeffrey ...... 18 Michaels, M...... 51 Ng, Anthony T...... 39 Michaels, Robert ...... 26 Nielssen, Olav ...... 14 Miettunen, Jouko ...... 15 Nolen, Willem W. A...... 37 Mikalac, Cecilia M...... 12, 25 Nooteboom, Annemieke ...... 5 Miller, Leonard ...... 43 Norko, Michael ...... 46 Miller, Lisa S...... 43 Northcott, Colleen ...... 53 Milrod, Barbara ...... 3 Notman, Malkah T...... 11, 27 Minoletti, Alberto ...... 35 Nunes, Edward V...... 49 Minshew, Nancy ...... 12 Nyhus, Nadine J...... 50 Minter, Shannon P...... 20 Mintz, David L...... 28, 47 Miotto, Karen ...... 33 O Mischoulon, David ...... 49 Mishra, Asha S...... 8, 46 Obatusin, Tayo ...... 45 Mitchell, James E...... 12, 37 O’Brien, Charles ...... 19 Mohamed, Zahurin ...... 15 O’Brien, Moira P...... 11 Mohandessi, Soroush ...... 49 Ochs, Len ...... 43 Mojtabai, Ramin ...... 41 Oele, Bastiaan ...... 46 Molofsky, Anna ...... 14 Ogundipe, Kehinde A...... 27 Moncrieff, Joanna ...... 59 Okasha, Ahmed ...... 20 Montenegro, Roger ...... 54 Okin, Robert L...... 23 Mora, Marie Elena Medina ...... 36 Okpaku, Samuel O...... 47, 48 Morciglio, April ...... 46 Oldham, John M...... 33, 42, 53 Morey, Leslie C...... 60 O’Leary, Paul J...... 16 Moriarty, Zach ...... 33 Oleshansky, Marvin ...... 26 Mrazek, David A...... 8, 42, 60 Oms, Juan ...... 46 Mucic, Davor ...... 55 Onate, John C...... 43 Munoz, Rodrigo A...... 10, 51, 59 Ong, Jason ...... 40 Munyandamutsa, Naasson M. N...... 57 Ongur, Dost ...... 28 Musaleck, Michael ...... 43 Ornish, Dean ...... 54,55 Musher, Jeremy ...... 17 Osinski, Alphonse ...... 42 Muskin, Philip R...... 13, 47 Oslin, David ...... 27, 42 Mustafa, Husain ...... 26 Osofsky, Howard J...... 28 Myers, Michael F...... 5, 7, 28, 30, 34, 35, 42, 46, 56 Osofsky, Joy ...... 28 Myers, Wade ...... 32 Ostacher, Michael ...... 5 Myrick, Hugh ...... 18 Ostermeyer, Britta ...... 32
N P
Nace, David ...... 2, 17 Palmer, Christina ...... 27 Nadelson, Carol ...... 22 Pandya, Anand ...... 3, 13, 43 Nader, Michael A...... 36 Papakostas, George ...... 6, 7 Nahas, Ziad H...... 1 Parikh, Rajesh M...... 48, 49 Najavits, Lisa M...... 38, 48 Paris, Joel ...... 60 Nand, Surinder Sucha ...... 8, 28, 46 Parish, Brooke ...... 32 Napoli, Joseph C...... 10, 25 Parks, Joseph J...... 39 Narasimhan, Meera ...... 21 Parnham, George ...... 27 Nardi, Antonio ...... 32 Parry, Peter I...... 38 Narrow, William E...... 18, 20 Patel, Vikram ...... 34 Nash, Sara S...... 58 Patkar, Ashwin A...... 15 Nasky, Kevin ...... 44 Pato, Michele T...... 8, 25, 43, 56 Nau, Melissa ...... 31, 41, 54, 56 Payne, James O...... 60 Nelson, Charles ...... 11 Peay, Holly L...... 27 Nemat, Ali ...... 17 Pecora, Peter, ...... 59 Nemeroff, Charles B...... 18, 60 Peele, Roger ...... 38, 51 Neufeld, Ronald ...... 1 Peeters, Frenk ...... 15 Perlis, Roy ...... 6, 7 74 WWW.PSYCH.ORG PRESENTER INDEX
Perry, Christopher ...... 53 Reardon, Claudia L...... 10, 41 Peselow, Eric D...... 42 Recupero, Patricia R...... 32, 42 Pessar, Linda F...... 20 Redden, Maurice ...... 4 Peteet, John R...... 50 Regier, Darrel A...... 13, 18 Petrakis, Ismene L...... 48 Rego, Mark D...... 19 Pettinati, Helen M...... 58 Reich, James H...... 58 Pfl anz, Steven E...... 33 Reid, Michele ...... 8 Phillips, James ...... 19, 59 Reid, William ...... 3 Pi, Edmond Hsin-Tung ...... 29 Reifl er, Burton V...... 32 Pilon, Dave ...... 43 Reliford, Aaron ...... 41 Pilotte, Nancy S...... 36 Resnick, Phillip J...... 3, 7, 17, 25 Pini, Stefano ...... 32 Reus, Victor ...... 42 Plakun, Eric M...... 28, 41, 54, 56 Reyes, Raymond ...... 42 Pleak, Richard R...... 11 Riba, Michelle B...... 33, 41, 54, 56 Pollack, David ...... 16 Richards, Lawrence K...... 38, 46 Pontius, Edward ...... 53 Richeimer, Steven ...... 17 Ponton, Lynn ...... 56 Richman, Jennifer ...... 11 Pope, Kayla ...... 10 Rifai, Muhamad Aly ...... 17 Postlethwaite, Alejandra ...... 31 Rigaud, Marie-Claude ...... 13, 28, 45 Potash, James ...... 8 Ritchie, Elspeth C...... 27, 32, 42, 48 Potenza, Marc N...... 35, 48 Roberts, Laura ...... 19 Potkin, Steven ...... 4 Robinowitz, Carolyn B...... 10, 47, 54, 60 Powsner, Seth ...... 56 Robinson, David ...... 17 Prabhakar, Deepak ...... 45 Robinson, Gail E...... 5, 19, 20, 35, 41, 50, 59 Preda, Adrian ...... 4 Robinson, Robert G...... 18 Preven, David ...... 32 Rodriguez-Suarez, Mercedes ...... 53 Price, Marilyn ...... 5, 28 Roessel, Mary H...... 41 Primm, Annelle ...... 16 Roman, Brenda J. B...... 21 Prince, Jefferson B...... 4, 7, 49 Romanoski, Alan ...... 12 Prudic, Joan ...... 51 Rondon, Marta B...... 22 Puchalski, Christina ...... 2 Rone, Lisa A...... 57 Pumariega, Andres J...... 2, 55 Rose, Diana ...... 35 Rosenberg, Stanley D...... 19 Rosenburg, Zack ...... 28 Q Rosenquist, Peter ...... 40 Rosenstock, Jason B...... 21 Qian, Yifang ...... 56 Roskes, Erik ...... 27 Quadrio, Carolyn ...... 53 Ross, Stephen ...... 33 Quanbeck, Cameron ...... 1 Roth, Thomas ...... 15 Rothschild, Anthony J...... 2, 40 R Ruano, Gualberto ...... 59 Rubik, Beverly ...... 43 Ruiz, Pedro ...... 6, 10, 41, 43 Rabow, Michael W...... 51 Russakoff, L. Mark ...... 2, 55 Rachal, Funmilayo ...... 3 Rutter, Joni L...... 60 Radke, Alan Q...... 39 Ryan, Deirdre ...... 5 Ragins, Mark ...... 43, 51 Ryan, Elizabeth ...... 35 Ramani, Meena ...... 54 Rychik, Abe M...... 54 Ramchandani, Vijay A...... 22 Ramirez, Luis F...... 7, 17 Randall, Carrie L...... 58 S Ranz, Jules ...... 56 Rao, Nyapati R...... 3, 10, 13–14, 41 Saavedra, Javier, E...... 22 Rapaport, Mark ...... 17 Sabshin, Melvin ...... 22 Raphael, Beverley ...... 18 Sachs, Gary ...... 5 Rasic, Daniel ...... 32 Sadre-Chirazi-Stark, Michael F...... 50 Rathod, Shanaya ...... 16 Saeed, Sy ...... 2 Rathore, Varinder ...... 27 Sahler, Olle Jane ...... 41 Ratliff, Brenda M...... 54 Sajatovic, Martha ...... 24 Ravindranath, Divy ...... 41 Saks, Elyn ...... 14 Raynor, Jeffrey D...... 21 Salloum, Ihsan M...... 58
162ND ANNUAL MEETING 75 PRESENTER INDEX
Samenow, Charles ...... 1 Sitzer, Lauren ...... 10 Sampson, Shirlene M...... 51 Sivrioglu, Yusuf ...... 3 Sanders, Kathy M...... 28 Sizoo, Bram B...... 36 Santiago, Patcho ...... 10 Skodol, Andrew E...... 33, 50, 60 Sareen, Jitender ...... 15 Slattery, Marcia J...... 41 Sartorius, Norman ...... 13, 20, 34 Small, Gary ...... 4 Sass, Henning ...... 5,6 Smith, David E...... 47 Sattar, Syed ...... 45 Smith, Eric ...... 45 Sawa, Akira ...... 34 Soloff, Paul H...... 33, 59 Saxena, Shekhar ...... 34 Sonawalla, Shamsah B...... 49 Saxon, Andrew J...... 40, 48 Song, Suzan ...... 41 Schäfer, Ingo ...... 38 Sorel, Eliot ...... 27 Schatzberg, Alan F...... 18, 23, 51 Soygur, Haldun ...... 44 Schiffer, Randolph ...... 12 Spack, Norman ...... 21 Schmidt, Chester W...... 17 Speller, Heather ...... 56 Schnaas, Francisco ...... 54 Spencer, C. Edgar ...... 54 Schneidman, Barbara ...... 42 Sperber, Jacob ...... 3, 10, 42 Schoener, Gary ...... 5, 53 Spinelli, Margaret ...... 27, 50 Schooler, Nina ...... 55, 56 Spitz, Deborah ...... 9, 43 Schroeder, Steve ...... 54 Srabstein, Jorge ...... 41 Schubmehl, James Q...... 12 Srinivasan, Shilpa ...... 21 Schummer, Gary ...... 43 Srinivasaraghavan, Jagannathan ...... 29 Schwartz, Harold I...... 42 Srivastava, Shefali ...... 53, 56 Scimeca, Michael M...... 16 St. Pierre, Jeanne M...... 51 Scott, Charles ...... 1, 49 Stabinsky, Susan ...... 15, 55 Scott, Marcia ...... 28 Stahle, Galen W...... 19 Scully, James, Jr...... 13 Stanley, Barbara H...... 37, 59 Sen, Srijan ...... 8, 13, 43 Starcevic, Vladan ...... 55 Seritan, Andrea ...... 1, 55 Steele, Annie ...... 32 Servis, Mark ...... 1 Steinglass, Peter ...... 25 Sevilla, Brett ...... 27 Stevens, Michael ...... 31 Sexson, Sandra B...... 41, 48 Stewart, Caroline ...... 59 Shafestein, Steven ...... 18 Stewart, Donna E...... 22, 45 Shanfi eld, Stephen ...... 31 Stigler, Kimberly A...... 4 Shapiro, Edward ...... 28, 54 Stolar, Andrea ...... 28 Shapiro, Edward Robert ...... 56 Stone, Michael ...... 47 Shapiro, Peter A...... 25 Stone, Walter N...... 40 Sharfstein, Steven S...... 42, 57 Stotland, Eve ...... 56 Shaw, Kailie ...... 42 Stotland, Nada L...... 19, 22, 23, 35, 41 Shea, Shawn C...... 29 Stotland, Naomi ...... 56 Shea, Tracie ...... 60 Strain, Eric ...... 40 Shear, Katherine ...... 19 Strain, James J...... 19, 35 Shen, Hong ...... 41 Strauss, David H...... 53 Shihabuddin, Lina ...... 53 Streltzer, Jon ...... 56 Shim, Jewel ...... 41 Stroeh, Oliver ...... 53, 56 Shinfuku, Naotaka ...... 50 Sudak, Donna M...... 1, 54 Shrivastava, Amresh K. A...... 11, 32, 36 Sukumaran, Anand ...... 28 Shuckit, Marc ...... 30 Sullivan, Maria ...... 49 Shuman, Daniel ...... 34 Sullivan, Pamela ...... 26 Shumay, Dianne M...... 51 Summers, Richard F...... 48 Siever, Larry J...... 22, 33, 37, 58 Suo, Shannon ...... 55 Silberman, Edward ...... 8, 32 Susman, Virginia L...... 45 Silberschatz, George ...... 57 Sutcliffe, James, ...... 4 Silk, Kenneth R...... 13, 26, 38, 43, 60 Sutton, Loree ...... 42 Silver, Jonathan ...... 18 Swartz, Holly A...... 2 Simmer, Ed ...... 42 Swartz, Marvin S...... 46, 49 Simmons, Chantelle ...... 53 Swift, Robert M...... 10 Simon, Robert I...... 34 Swiggart, William H...... 1 Simon, Witold ...... 15 Szarek, Bonnie ...... 31 Sinclair, Beryl D...... 16 Szigethy, Eva ...... 28, 41 Singh, Vivek ...... 15 76 WWW.PSYCH.ORG PRESENTER INDEX
T Vermani, Monica ...... 29, 43 Vianin, Pascal ...... 22 Vickar, Garry ...... 53 Taintor, Zebulon ...... 49, 50, 53 Victor, Lisa ...... 17 Talbott, John A...... 22, 49 Viguera, Adele ...... 24, 50 Tandon, Rajiv ...... 29 Vincent, Kathy ...... 46 Temporini, Humberto D...... 1, 49 Viron, Mark ...... 32 Terhakopian, Artin ...... 10 Viswanathan, Ramaswany ...... 29 Terilli, Dale ...... 16 Vogel-Scibilia, Suzanne E...... 42 Terr, Lenore C...... 23 Volberding, Paul ...... 21 Thase, Michael E...... 4, 57 Volkow, Nora D...... 11 Tiainen, Anne ...... 15 Tiamson-Kassab, Maria ...... 29 Tillman, Jane ...... 54 W Tong, Lowell ...... 41 Toomey, Jennifer ...... 33 Wagner, Eric F...... 20 Torres, Michael A...... 50 Walker, Sandra ...... 27 Townsend, Mark ...... 29 Warshaw, Carole E...... 59 Tracy, Martin G...... 10, 42 Webb, Roger ...... 45 Triesman, Glenn ...... 12, 26 Weerasekera, Priyanthy ...... 3, 46 Trivedi, Madhukar H...... 6, 7, 21, 26 Weiner, Elyse D...... 42 Trzepacz, Paula ...... 18 Weiner, Richard ...... 26 Tschan, Werner ...... 20 Weinstock, Robert ...... 32 Tsuang, John W...... 33 Weisler, Richard ...... 15 Tsuang, Ming T...... 20 Weisner, Constance ...... 33 Tuerk, Catherine L...... 50 Weisser, Lydia ...... 55 Turkington, Douglas ...... 4, 16 Weissman, Sidney ...... 32 Turner, Erick H...... 37 Weker, Jonathan I...... 19 Tyrer, Peter ...... 58 Welch, Kristen U...... 57 Tyrka, Audrey ...... 24 Westgate, Harland ...... 10 Tzuang, Dan ...... 10 Wetherington, Cora Lee ...... 35 White, Leigh Anne ...... 10 U White, Stephen G...... 20 White-Labora, Deborah ...... 46 Whyte, Doug ...... 11 Un, Hyong ...... 33 Wilens, Timothy ...... 6, 11 Unutzer, Jurgen ...... 21 Willenbring, Mark ...... 33, 54 Unwalla, Khushro ...... 27, 29 Williams, Eric ...... 53 Ursano, Amy M...... 51 Wills, Marketa ...... 28 Ursano, Robert ...... 10, 42, 47 Windle, Michael ...... 20 Winick, Bruce J...... 38, 46 V Winters, Kelley ...... 20 Wise, Michael Jan ...... 28 Vaburosa, Livia ...... 43 Wise, Robert ...... 49 Vaillant, George ...... 60 Witte, Janet ...... 39 Van, Henricus ...... 5 Wolf, Robert ...... 52 Van Dahlen Romberg, Barbara ...... 47 Wood, William C...... 28, 53, 56 Van der Gaag, Rutger J...... 36 Woolley, Stephen ...... 31 Van Horn, Patricia J...... 59 Worley, Jena ...... 11 Van Nieuwenhuizen, Adrienne ...... 31 Wright, Jesse H...... 1, 4, 25, 54 Van Wijngaarden-Cremers, Patricia J...... 36 Wulsin, Lawson ...... 60 Vanderpool, Donna ...... 2, 42 Wynn, Gary H...... 12, 27 Varghese, Mathew ...... 23, 43–44 Varma, Sudeepta S. V...... 46 X Varma, Vijoy ...... 16 Vaswani, Merra ...... 15, 31, 45, 55 Xiang, Yingqiang ...... 56 Vaswani, Sanjay ...... 44 Xie, Yuhuan ...... 1 Veijola, Juha M...... 44 Xiong, Glen L...... 1, 43 Vela, Ricardo M...... 5 Verghese, Abraham ...... 23 VerHalen, Nisha ...... 32 162ND ANNUAL MEETING 77 PRESENTER INDEX
Y
Yaffe, Kristine ...... 13 Yager, Joel ...... 12, 19 Yalom, Irvin D...... 40 Yaswani, Sanjay ...... 31 Yellowlees, Peter ...... 11 Yeoman, Alfred ...... 22 Yen, Jennifer ...... 41 Yen, Shirley ...... 58 Yeomans, Frank E...... 4, 38 Yeung, Albert ...... 49 Yohanan, Monique ...... 13, 25 Yonkers, Kimberly ...... 18 Yoo, Tai P...... 11 Youn, John Q...... 41 Young, Jeffrey E...... 38 Young, Tina ...... 17 Yudofsky, Stuart C...... 18, 26, 60
Z
Zabletny, Raymond ...... 42 Zainal, Nor ...... 31 Zajecka, John ...... 23 Zanarini, Mary C...... 22, 58 Zangen, Abraham ...... 37 Zaretsky, Ari ...... 40 Zatzick, Douglas F...... 48 Zeller, Scott L...... 39 Zhu, Ziqing ...... 56 Ziegler, Penelope ...... 7 Zubieta, Jon-Kar ...... 37 Zucker, Robert A...... 20 Zurowski, Mateusz ...... 33 Zweben, Allen ...... 10
78 WWW.PSYCH.ORG
2009 Annual Meeting • New Research
B DISCLOSURE INDEX
Addiction Psychiatry … NR2-001 to NR2-009, NR5-001 to NR5-005, NR5-007 to NR5-009 AIDS and HIV-Related Disorders … NR2-010, NR5-010 Alcohol and Drug-Related Disorders … NR2-011 to NR2-018, NR5-011 to NR5-014 Anxiety Disorders … NR3-001 to NR3-008, NR4-001 to N4-022 Attention Spectrum Disorders … NR2-019 to NR2-054, NR5-015 to NR5-020 Behavior and Cognitive Therapies … NR6-001, NR6-002 Biological Psychiatry and Neuroscience … NR3-009 to NR3-012, NR7-001 to NR7-019 Brain Imaging … NR3-013 to NR3-016, NR7-020 to NR7-028 Child & Adolescent … NR2-055 to NR2-074, NR3-054, NR5-021 to NR5-030, NR5-032 to NR5-037, NR5-039 Cognitive Disorders … NR2-075 to NR2-084 Combined Pharmacotherapy & Psychotherapy … NR3-017, NR6-003 Creativity and the Arts … NR7-029, NR7-030 Cross-Cultural and Minority Issues … NR2-085 to NR2-088, NR5-040 to NR5-045, NR6-025 Diagnostic Issues … NR1-062, NR3-018, NR3-019, NR7-031 Dissociative Disorders … NR3-020, NR7-032 Eating Disorders … NR2-089 to NR2-092, NR5-046 to NR5-050 Epidemiology … NR3-021 to NR3-028, NR3-077, NR6-083, NR7-033 to NR7-038 Forensic Psychiatry … NR5-051 to NR5-053, NR6-004 to NR6-007 Gender Issues … NR5-054 Genetics … NR3-029 to NR3-037, NR3-039, NR3-078, NR7-039 to NR7-054 Geriatric Psychiatry … NR2-093 to NR2-103, NR5-055 to NR5-060 Group Therapy … NR6-008 Health Services Research … NR5-061 to NR5-068, NR7-055 to NR7-062 Historical Questions … NR7-063 Information Technology, Internet, Virtual Reality … NR5-069, NR5-113, NR7-064 Lesbian/Gay/Bisexual/Transgender Issues … NR2-104 Managed Care and Health Care Funding … NR5-070, NR7-065 Mood Disorders … NR3-040 to NR3-063, NR4-023 to NR4-119 Neuropsychiatry … NR3-064 to NR3-067, NR7-066 to NR071 Other Somatic Therapies … NR5-071, NR5-072, NR6-009 to NR6-011 Pain Management … NR5-073, NR6-012 to NR6-017 Personality Disorders … NR3-068, NR7-072 to NR7-075 Political Questions … NR7-076 Psychiatric Administration and Services … NR6-018 to NR6-021 Psychiatric Education … NR5-074 to NR5-077, NR7-011, NR7-077, NR7-078 Psychiatric Rehabilitation … NR6-023, NR6-024, NR6-026 Psychopharmacology … NR3-069 to NR084, NR4-115, NR5-078, NR6-022, NR6-027 to NR6-074 Psychosomatic Medicine … NR5-079 ot NR5-086, NR6-075 to NR6-079 Religion, Spirituality and Psychiatry … NR5-087, NR5-088 Research Issues … NR7-080 to NR7-084 Resident & Medical Student Concerns … NR5089, NR5-090 Schizophrenia & Psychotic Disorders … NR1-001 to NR1-099, NR3-038, NR3-085 to NR3-098, NR5-006, NR5-031 Sexual & Gender Identity Disorders … NR2-105, NR2-106 Sleep Disorders … NR3-099 to NR3-108, NR7-085 to NR7-105 Social and Community Psychiatry … NR5-091, NR5-092, NR5-111, NR6-080 to NR6-086 Somatoform Disorders … NR3-109, NR3-110, NR6-087, NR6-088 Stigma/Advocacy … NR5-093 to NR5-096 Stress … NR3-111 to NR3-114, NR4-120, NR4-121 Suicide … NR2-107 to NR2-119, NR5-097 to NR5-101, NR7-106 Telepsychiatry … NR6-089, NR6-090 Treatment Techniques and Outcome Studies … NR5-038, NR5-102, NR6-091 to NR6-100 Violence, Trauma and Victimization … NR2-120 to NR2-125, NR5-103 to NR5-112 Women’s Health Issues … NR2-126 to NR2-131, NR5-114
162ND ANNUAL MEETING C DISCLOSURE INDEX
AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE
The American Psychiatric Association requires disclosure, by presenters at CME activities, of any signifi cant fi nancial or other affi liation with commercial organization(s) that may have a direct or indirect interest in the subject matter of the scientifi c program. A “fi nancial interest” may include, but is not limited to: being an employee, being a shareholder in the organization; being on retainer with the organization; or having research or honoraria paid by the organization. An “affi liation” may include holding a position on an advisory committee, speakers bureau or some other role or benefi t to a supporting organization.
In compliance with the ACCME’s Standards for Commercial Support, the APA has a management of confl ict (MCI) process for all CME activities. This process ensures that all potential confl icts of interest are identifi ed, managed and resolved prior to the educational activity. The prospective audience must be informed of the presenter’s affi liation with every commercial supporter by an acknowledgement in the printed program and verbal or visual disclosure to partici- pants at the session (disclosure by slide or overhead is required if audiovisual equipment is used for the presentation). This policy is intended to openly identify any potential confl ict(s) so that members of the audience in an educational activity are able to form their own judgments about the presentation. The APA also requires verbal disclosure of discus- sion of unlabeled uses of a commercial product or investigational use of a product not yet approved for this purpose.
The presenters on the following pages have indicated that either they or an immediate family member have a signifi cant interest or other affi liation with a commercial supporter of this meeting and/or with the manufacturer(s) of a commercial product(s) and/or provider of commercial services(s), and the company name is listed.
The second group of presenters has indicated neither they nor an immediate family member has any signifi cant relation- ship to disclose.
D WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES Other Financial Financial Other (specify) Interest Boehringer Ingelheim, GSK, Lundbeck, Labs. Lilly Research (lecturer) zer Xenoport Financial Options Financial & Johnson Johnson PRD zer zer, Janssen zer, Aventis, Wyeth- Aventis, Speaker’s BureauSpeaker’s Dev., Pharm. Shire Stock/Other Novartis GSK, Boehringer Ingelheim Eli Lilly, Forest Labs., Forest Lilly, Eli BMS, UCB Noven, Celltech, GSK, Pharma, Sanofi Pfi Ayerst, Pfi Janssen, , zer, Sepracor, Sepracor, zer, Grant/Research Grant/Research Support Wyeth- Novartis, Takeda Labs., Ayerst Pfi Abbott, Abbott Cyberonics, & Johnson Labs., Merck, PRD, Somerset Johnson Cephalon, GSK, Sanofi Xenoport Shire Pharm. Dev. Pharm. Shire Novartis, McNeil, Shire, Cephalon, AZ, NARSAD, Stanley Research Medical Labs., Abbott Institute, Lilly, Eli GSK, Janssen, NIMH, NARSAD c airs zer zer zer Pfi Employee Janssen Scientifi Janssen Aff PRD airs c Aff c Scientifi PRD, & Johnson Wyeth-Ayerst, Solvay, Labs., AZ, Abbott Labs., BMS, Forest Ortho Organon, Supernus McNeil, Forest Labs., Sepracor, Labs., Sepracor, Forest GSK Canafax, Daniel M Canafax, Daniel Name Consultant Full-Time Able, Stephen L Stephen Able, Alain, Katic Dev. Pharm. Shire Amatniek, Joan Lilly Eli HayaAscher-Svanum, RaniaAwaad, Dev., Pharm. Shire SusanBaird-Bellaire, A Ross Baker, AlessandraBarraco, M Philip Becker, Ortho-McNeil Berwaerts, Joris Lilly Eli Wyeth-Ayerst Boess, Frank CBolge, Susan Lilly Eli Bollu, Vamsi BMS CandaceBramson, ElizabethBrunner, WilliamBullen, R Joseph Calabrese, Janssen Ortho-McNeil & Johnson Johnson NIMH Johnson GSK, Janssen, Boehringer Ingelheim, Lilly Eli Pfi Lilly Eli Pfi Pfi Birgit, AmannBirgit, Lilly, Eli McNeil, Shire, Anthony, LawsonAnthony, Antonucci, Donna JohanAreberg, Artigas, Francesc Dev. Pharm. Shire Lundbeck Lilly Eli Lundbeck Dev. Pharm. Shire Camacho, Alvaro
162ND ANNUAL MEETING E DISCLOSURE INDEX OF COMPANIES Other Financial Financial Other (specify) Interest (travel Neuronetics support, 2007) NIMH Financial Options Financial & Johnson Johnson PRD & Johnson Johnson PRD zer zer zer, Wyeth-Ayerst, Wyeth-Ayerst, zer, Lilly Eli zer, Ingelheim Abbott Labs. Abbott Wyeth-Ayerst Pfi Otsuka, Speaker’s BureauSpeaker’s Stock/Other Pfi AZ Cyberonics, Pfi zer zer, Sepracor, UCB Sepracor, zer, Cyberonics, Eli Lilly, Lilly, Eli Cyberonics, Sepracor NIH, Novartis, BMS AZ, BMS, Janssen, Grant/Research Grant/Research Support NIMH, Cyberonics, NIMH, Cyberonics, Pfi NARSAD Pharma, c c c airs airs airs Janssen Scientifi Janssen Aff Employee Janssen Scientifi Janssen Aff Scientifi Janssen Aff zer, zer, zer, zer, zer Dev., Shire Dev., Otsuka, Pfi Otsuka, Vanda Supernus, Pfi Medtronics, Novartis, Novartis, Medtronics, BMS, Wyeth-Ayerst, Labs., Pfi Abbott Sepracor Cyberonics, Ellenbogen, Aaron L Aaron Ellenbogen, JamesErmer, KiaFaridi, Xenoport Jazz, Dev. Pharm. Shire Teva GSK, Pfi D’Mello, DaleD’Mello, Darwish, Mona Consuelo Dios, De RikdeGreef, MarkDemitrack, C Holland Detke, BMS BMS W William Dodson, PeterDogterom, EduardoDunayevich, MTodd Durell, Pharm. Shire Novartis, MichaelDurkin, Cephalon Inc. Neuronetics Lilly Eli Schering AZ Orexigen Schering Lilly Eli Ortho-McNeil Boehringer Lilly, AZ, Eli Pfi Wyeth-Ayerst Lilly, Eli Cognata- Smith, ChristinaCognata- Smith, Cohen, Lisa J F Daniel Connor, ACook, Ian PatriciaCorey-Lisle, Christoph UCorrell, Lilly, AZ, BMS, Eli BMS BMS Dev. Pharm. Shire BMS Dev., Pharm. Shire Systems, Aspect Medical Name Consultant Full-Time Canuso, CarlaChen, Ying-Sheue ErnestChoy, Ortho-McNeil Allergan, Jazz, Lilly, Eli Janssen Otsuka Janssen, Carlson, Berit XCarlson, Berit JenniferCarothers, Linda LCarpenter, Inc., Neuronetics BMS Ortho-McNeil
F WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES zer, GSK, zer, Otsuka (speaking fees) Otsuka Labs., Forest Lilly, Eli Dev., Pharm. Shire Wyeth-Ayerst McNeil, Labs. (honoraria) Other Financial Financial Other (specify) Interest & Johnson Johnson PRD (dvisory board) NULL Johnson & Johnson & Johnson Johnson PRD & Johnson Johnson PRD Financial Options Financial zer, zer, Aventis, Aventis, zer, Sanofi zer, AZ, BMS, Cephalon, Lilly, Eli Cyberonics, Novartis, McNeil, Lab, Pam Organon, Pfi Pharm. Shire Sepracor, UCB Takeda, Dev., Wyeth-Ayerst Pharma, Labs., Alkermes, Forest Jazz Labs., GSK, Janssen, Labs., Lilly Research Pfi BMS, Takeda, AZ, Cephalon, GSK Labs., Lilly GSK, Forest Labs., Shire Research McNeil, Dev., Pharm. Labs., Wyeth-Ayerst Novartis Speaker’s BureauSpeaker’s Stock/Other Johnson & Johnson & Johnson Johnson Dev. Pharm. PRD, Shire Aventis, Aventis, zer, GSK, zer, zer, Sanofi zer, zer, GSK zer, Pfi Lilly, Eli Wyeth-Ayerst Labs., Wyeth-Ayerst Labs., Alkermes, Abbott AZ, BMS, Cephalon, Labs., GSK, Forest Janssen, McNeil, Biosciences, Neurocrine Organon, Novartis, Otsuka, Ortho McNeil, Pfi Pharm. Shire Sepracor, UCB Takeda, Dev., Lilly Eli Pharma, Labs., Shire Forest McNeil, Dev., Pharm. Cephalon Grant/Research Grant/Research Support Abbott Labs., AZ, Abbott & Labs., Johnson Forest Lilly, PRD, Eli Johnson Pfi Otsuka, Research, Wyeth-Ayerst BMS, Solvay, Novartis, Dev. Pharm. Shire c airs PRD Scientifi Janssen Aff Employee - Aventis, Aventis, zer, Sanofi zer, zer, BMS, Sanofi zer, Forest Labs., GSK, Forest Lilly, Labs., Eli Abbott Novartis, McNeil, Ortho McNeil, Pfi Pharm. Shire Sepracor, UCB Takeda, Dev., Wyeth-Ayerst, Pharma, Cyberonics Janssen, Dev., McNeil, Forest Forest McNeil, Dev., Labs. Cypress Bioscience, Bioscience, Cypress Labs., GSK, Forest & Johnson Johnson PRD, Lilly Research Labs., Novartis, Otsuka, Organon, Pfi Synthelabo, Sepracor, Sepracor, Synthelabo, Dev., Pharm. Shire Wyeth-Ayerst Solvay, Supernus Research, PRD omas Dev. Pharm. Shire Galan, JaimeGalan, KemingGao, WagnerGattaz, Shur-Fen Susan Gau, R MichaelGendreau, D Lawrence Ginsberg, Janssen-Cilag AZ, BMS, Cephalon, AZ Bioscience Cypress Janssen-Cilag Janssen-Cilag Lilly, Eli AZ, NARSAD SriGopal, Janssen-Cilag Lilly, Eli & Johnson Johnson Gitlin, Michael Gitlin, W David Goodman, Pharm. Shire Lilly, Eli AugustoGrinspan, Ortho-McNeil Name Consultant Full-Time Findling, Robert L Robert Findling, Labs., AZ, Abbott J Karel Frasch, Th Frazier, A Toshiaki Furukawa, Pfi Fleischhacker, W WolfgangFleischhacker, & Johnson
162ND ANNUAL MEETING G DISCLOSURE INDEX OF COMPANIES zer (travel (travel zer reimbursement for reimbursement presentations) Other Financial Financial Other (specify) Interest grant, Abbott Labs. grant, Abbott grant Educational Inst., Research Forest Merck, Janssen, Labs. (advisoryRoche boards) airs c Aff c Financial Options Financial Ortho-McNeil Janssen Janssen Ortho-McNeil Scientifi Aventis, Takeda, Takeda, Aventis, zer AZ Speaker’s BureauSpeaker’s Stock/Other Sanofi Cephalon Labs., Forest Lilly, Eli Pfi
zer, Merck, Merck, zer, zer, Roche Roche zer, AZ Lilly Eli Pfi Grant/Research Grant/Research Support Aventis, BMS, Eli BMS, Eli Aventis, Pfi Lilly, AZ Biosciences, Labs.AZ, BMS, Forest Lilly BMS, Eli PRD, AZ, Cephalon, Pfi Janssen, Inst., Research Forest Novartis, Acadia, Roche Organon, Cephalon, Sanofi Takeda Sepracor, Aventis, USA Organon Abbott, Labs., Janssen Forest c c airs airs Employee Research Janssen Scientifi Janssen Aff Janssen Scientifi Janssen Aff zer, zer, -Synthelabo -Synthelabo Merck, Vanda, zer, Medtronics zer, Wyeth-Ayerst Labs., Wyeth-Ayerst & Johnson Lilly, Eli PRD Johnson Pfi BMS Janssen Research Research Janssen Pfi Foundation, omas Ortho-McNeil omas A Lilly Eli PVicki mann, Lilly Eli Haskins, J Th Haskins, Harvey, Philip D Philip Harvey, Sumitomo, Dainippon Hardy, Th Hardy, Name Consultant Full-Time Gupta, Nitin Gupta, Guico-Pabia, ChristineGuico-Pabia, Wyeth-Ayerst Grossberg, GeorgeGrossberg, Labs., Forest Novartis, Hirshkowitz, MaxHirshkowitz, Sanofi Jochelson, PhilipJochelson, KajaJohnson, SKahn, Rene Kamen, LisaKane, CeceliaW John Kasckow, M Megan Kelly, Lilly, Labs., Eli Forest E David Kemp, Somaxon BMS Wyeth-Ayerst AZ Sanofi Janssen-Cilag, NIMH GSK BMS Educational Kern Sliwa, Jennifer Sliwa, Kern Knesevich, Mary Ann SaraKollack-Walker, Ortho-McNeil Lilly Eli & Johnson Johnson Hoff EricHollander, Liu-SeifertHong, JohnHuh, EllenHulskotte, V Dan Iosifescu, Pharm Trascept Lilly Eli Schering Systems, Aspect Medical Novartis
H WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES Novartis (advisory Novartis boards) Other Financial Financial Other (specify) Interest zer Johnson & Johnson & Johnson Johnson PRD Financial Options Financial & Johnson Johnson PRD zer zer, Wyeth- zer, zer, Wyeth- zer, Biovail Labs., GSK Biovail Canada Dev. Pharm. Shire Lilly, AZ, BMS, Eli Labs., GSK, Forest Pfi Janssen, Ayerst AZ, Pfi BMS, Janssen Ayerst, Speaker’s BureauSpeaker’s Stock/Other AZ Canada, Biovail AZ Canada, Biovail Lilly Canada, Labs., Eli Canada, Janssen Servier Lundbeck, zer, zer, zer, zer, zer, zer, zer, Eli Lilly, Lilly, Eli zer, Aventis, Servier Aventis, Aventis, Aventis, GSK Canada, Eli Lilly GSK Canada, Eli Canada, Janssen-Ortho, Pfi NIH, Novartis, Sanofi Canada, Wyeth-Ayerst Canada McNeil Lilly, Eli Consumer Healthcare, Dev. Pharm. Shire AZ, GSK, BMS, Lilly, Cephalon, Eli Labs., Ortho Forest Wyeth- Janssen, McNeil, Ayerst Abbott Labs., Aspect Abbott Systems, Medical Cyberonics Grant/Research Grant/Research Support Sanofi Cephalon, GSK, Merck, Pfi Neurocrine, Somaxon, Sepracor, Neuronetics Takeda, Neuromodulation BrainCells, Systems, Lundbeck Litebook Co., Pfi Biosciences, Takeda c c airs airs zer Pfi Janssen Scientifi Janssen Aff Employee Janssen Scientifi Janssen Aff zer, zer, zer, Memory Memory zer, zer, Janssen Cilag Janssen zer, Cilag Janssen Cilag, Pfi Janssen Pharmaceuticals Eli Lilly, McNeil McNeil Lilly, Eli Consumer Healthcare Pfi Jazz, Janssen, BMS, Cephalon, Eli Wyeth- Organon, Lilly, Ayerst Eli Lilly, GSK, Jazz, GSK, Jazz, Lilly, Eli & Johnson Johnson PRD, King, Novartis, Roche Organon, Liu, Xianchen JulieLocklear, Lockwood, PeterLoebel, AnthonyLouzã, Mário WayneMacfadden, Pfi Janssen-Cilag Lilly Eli AZ Pfi Ortho-McNeil Janssen-Cilag Malone, Donald A Donald Malone, CatherineMancini, J Michael Manos, MichaelMartin, PrakashMasand, Dev., Pharm. Shire Labs., GSK, D John Matthews, Forest Medtronic AZ Canada, Cephalon, BMS Lilly BMS, Eli AZ, Pfi Mattos, PauloMattos, Janssen-Cilag Janssen-Cilag, Name Consultant Full-Time Kosik-Gonzalez, ColetteKosik-Gonzalez, Ortho-McNeil Krystal, AndrewKryzhanovskaya, Ludmila AZ, BMS, Arena, WLam, Raymond AlanLankford, Abbott Takeda WY Lee, Joseph Lilly Eli Pfi Advanced Neurocrine Somaxon,
162ND ANNUAL MEETING I DISCLOSURE INDEX OF COMPANIES Other Financial Financial Other (specify) Interest Dainippon Organon, (data Sumitomo safety monitoring committees) Honorarium Financial Options Financial & Johnson Johnson PRD zer, zer, zer Canada zer zer Lundbeck Speaker’s BureauSpeaker’s Stock/Other Forest GSK, Sepracor, Labs. McNeil Consumer McNeil Healthcare Lilly AZ Canada, Eli Canada, Pfi Lilly AZ, Eli Janssen, & Johnson Johnson Lilly PRD, Eli Eli Lilly Eli BMS, Pfi Benckiser Reckitt Cephalon, BMS, Pfi zer zer zer, Cyberonics, Cyberonics, zer, zer, BMS, NIMH, zer, zer, BMS, GSK, zer, Grant/Research Grant/Research Support NIH, Pfi Alza Corp., Johnson & Johnson Alza Corp., Lilly, PRD, Eli Johnson Dev. Pharm. Shire GSK, Wyeth-Ayerst, AZ Servier, Labs. Forest NIMH, NARSAD, Wyeth- BMS, Janssen, Pfi Ayerst, Dev., Pharm. Shire Boehringer Ingelheim, Lilly Eli Pfi Systems, Aspect Medical Medtronic Pfi Lab Pam Forest Labs., Titan, Titan, Labs., Forest Merck, Organon, Cephalon c airs zer Employee Research PRD Scientifi Janssen Aff zer, zer, zer, zer, zer, Wyeth- zer, Dev. Boehringer Ingelheim, Lilly Eli Ortho, Schering Wyeth-Ayerst, Corp., GSK, Oryx,Lundbeck, Labs., Pfi Biovail Shire Pharm, Prestwick AZ, BMS, Otsuka, Pfi GSK, Janssen, Solvay, Organon, Wyeth-Ayerst Ayerst, BMS, Eli Lilly, Lilly, BMS, Eli Ayerst, Shire Lab, Pam Jazz, Wyeth-Ayerst Wyeth-Ayerst Name Consultant Full-Time McBurnett, KeithMcBurnett, Pharm. Shire Lilly, Eli DavidMischoulon, RezaMoghadam, H Elaine Morrato, Jeff Musgnung, Lab BMS, Pam R Edward Norris, W Allen Nyhuis, Godehard Oepen, BMS T Jason Olin, JudithOwens, Shire, Takeda, & Gamble, Proctor Lab Pam Lilly Eli Novartis BMS Takeda, Wyeth-Ayerst Novartis Narasimhan, MeeraNarasimhan, BMS A Beth Pangallo, M Jessica Panish, AZ, BMS, Janssen, Lilly Eli Ortho-McNeil McDonnell, David P David McDonnell, RogerMcIntyre, Janssen- Lilly, AZ, Eli V Roumen Milev, Lilly Eli W John Newcomer, Lundbeck, Vanda, GahanPandina, I George Papakostas, GSK, Pfi & Johnson Johnson Pappadopulos, ElizabethPappadopulos, T Lawrence Park, Ashwin APatkar, Pfi Labs., Abbott Janssen, Pfi
J WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES
zer (honoraria) zer AZ, BMS, Sanofi Lilly, Eli Aventis, Lundbeck, Janssen, Pfi (writing Merck honorarium), Guilford (potential Publications royalties) Other Financial Financial Other (specify) Interest Johnson & Johnson & Johnson Johnson PRD Financial Options Financial zer, AZ, zer, zer, BMS, zer, Aventis, Aventis, Sanofi Pfi Lundbeck, Janssen Lilly, BMS, Eli AZ, Pfi Novartis Lilly Eli AZ Labs., Lilly Research Shire Novartis, McNeil, UCB Dev., Pharm. Cephalon Pharma, BMS Labs., Abbott McNeil, Lilly BMS, Eli Speaker’s BureauSpeaker’s Stock/Other
zer, zer, zer, Lundbeck zer, zer, Takeda, Takeda, zer, -Synthelabo, -Synthelabo, zer NIMH, UCB Pharma AZ, BMS, Eli Lilly, Lilly, AZ, BMS, Eli Sanofi Janssen-Cilag, Pfi Aventis, Sanofi Allergan, AZ, Solvay, BMS, Lilly Research Labs., Labs., Forest Mitsubishi Janssen, Novartis, Corp., Pharma Otsuka, Organon, Ono, Pfi Labs., Lilly Research Dev., Pharm. Shire Cephalon, BMS & Johnson Lilly, Eli PRD, Shire Johnson Dev. Pharm. Labs., BMS, Forest & Johnson Johnson Pfi PRD, Otsuka, Sepracor GSK, Supernus, Grant/Research Grant/Research Support Organon USA, Organon Cephalon, Vanda c airs PRD Scientifi Janssen Aff Employee c Aventis zer, Roche Roche zer, airs, AZ airs, AZ, BMS, Janssen, AZ, BMS, Janssen, Organon, Novartis, Pfi Otsuka, Labs. Shire Pharm. Dev., Dev., Pharm. Shire Cephalon Ortho-McNeil McNeil, Scientifi Janssen Aff Pharm. PRD, Shire Lilly Eli Dev., AZ BMS, Forest Lundbeck, Labs. Lundbeck, Janssen Janssen Lundbeck, Cilag, Sanofi Phillips, Katharine APhillips, AndreiPikalov, G Steven Potkin, Acadia, Arena, Otsuka Labs., AFSP, Forest Rathod, Shanaya Pratts, Michael Pratts, A Jorge Quiroz, DRaun, Melmed L Michael Reed, Labs., Lilly Research W Frederick Reimherr, Ortho GSK, Merz, F Perry & Johnson Johnson Renshaw, HansRittmannsberger, & Johnson Johnson S Adelaide Robb, Cilag, Janssen Lilly, Eli Labs. Roche Novartis, StephenRodriguez, Lilly, Eli Otsuka, RobertaRogowski, RussellRosenberg, GSK Lilly, Eli Ortho-McNeil Somaxon Pfi Arena, Name Consultant Full-Time Peuskens, JosephPeuskens, Lilly, AZ, BMS, Eli
162ND ANNUAL MEETING K DISCLOSURE INDEX OF COMPANIES zer, Merck, Elan, Elan, Merck, zer, Other Financial Financial Other (specify) Interest Wyeth- Medivation, Labs., Novartis Ayerst (clinical trial support) zer Financial Options Financial , zer Pfi Speaker’s BureauSpeaker’s Stock/Other Cephalon, Sanofi Abbott Takeda Shire Novartis, Lilly, Eli Lilly, AZ, BMS, Eli Cilag Janssen Lilly AZ Canada, Eli Canada Lilly AZ, BMS, Eli AZ Canada, AZ, Eli Cilag, Janssen Lilly, Canada, Roche Janssen Labs. , Sepracor, Sepracor, , zer, Sanofi zer, zer Grant/Research Grant/Research Support Aventis, Cephalon, Aventis, GSK, Neurocrine, Pfi Takeda Somaxon, Wyeth-Ayerst Abbott, Labs., Xenoport Labs., Cephalon, Abbott Pharm. Shire Lilly, Eli Dev. Servier Canada, BrainCells AZ Labs. c c airs airs zer zer Pfi Employee Janssen Scientifi Janssen Aff Scientifi Janssen Aff , zer zer zer Cephalon, Cypress Cephalon, Cypress Eli Elan, Bioscience, Pharma, Purdue Lilly, Labs., Sanofi Roche BMS, Schering Corp., Shire, Servier, Sepracor, Takeda Somaxon, Wyeth-Ayerst Abbott, Labs., Xenoport, Alza Corp., Acadia, Ancile, Alkermes, Aventis Lilly Canada, BMS, Eli Canada Pfi Novartis, Shire Pharm. Pharm. Shire Novartis, Dev. omas Pfi omas Labs., AZ, Abbott er, Ayal er, AZ Canada, Pfi er, Virginia er, Lilly Eli Name Consultant Full-Time Roth, Th Roth, MarthaSajatovic, JerzySamochowiec, RahulSasane, Schaff GSK, AZ Dev. Pharm. Shire GSK, AZ, NIMH Pfi AZ Starr, H LynnStarr, Ortho-McNeil Singh, MalaSingh, MichaelSpaeth, Stauff Lilly, Allergan, Eli MichelleStewart, Pfi Cilag Janssen Rubin, Richard L Richard Rubin, Gabriele Sachs, Carl HSadowsky, Cephalon, Lilly, Eli NovartisSchulz, S Charles MohammedShahid, K A Amresh Shrivastava, Vanda Lilly, AZ, Eli MirkoSikirica, Schering Lilly, Labs., Eli Abbott Th Stock, Pfi Novartis, Ortho-McNeil Cilag, Roche Janssen
L WWW.PSYCH.ORG DISCLOSURE INDEX OF COMPANIES
Other Financial Financial Other (specify) Interest (educational grant), Janssen-Ortho (speaker) Eli Dev., Pharm. Shire Pharma, Purdue Lilly, AZ, Janssen-Ortho, Sanofi Lundbeck, Celltech Aventis, (honoraria) zer Financial Options Financial & Johnson Johnson PRD zer, Wyeth-Ayerst Wyeth-Ayerst zer, AZ, BMS, Eli Lilly, Lilly, AZ, BMS, Eli Novartis Janssen, Speaker’s BureauSpeaker’s Stock/Other AZ, GSK McNeil Shire, Novartis, Dev. Pharm. Shire Biovail Labs., GSK Biovail Canada, Canada, Janssen Pfi Canada
, , Wyeth- , zer, Sanofi zer, zer, Alza/McNeil, Alza/McNeil, zer, zer Canada, Janssen Canada, Janssen zer Servier AZ, Eli Lilly, GSK, Lilly, AZ, Eli Cilag, Merck Janssen & Dohme, Sharp Organon, Novartis, Pfi Otsuka, Grant/Research Grant/Research Support Pfi Eli Merck, Organon, Lilly Celltech, Shire Pharm. Pharm. Celltech, Shire Purdue Lilly, Eli Dev., Janssen-Ortho, Pharma, Sanofi AZ, Lundbeck, Aventis AZ Canada, NIMH, Lilly, GSK Canada, Eli Pfi Canada, Sanofi Canada, Servier Ayerst Canada, Novartis c airs zer Pfi Employee Research Scientifi Janssen Aff Inst.
zer, zer, , Servier , zer, Shire Shire zer, zer, Sanofi zer, Jazz, Cypress Cypress Jazz, Allergan, Bioscience, Wyeth-Ayerst Lilly, Purdue Pharma, Pharma, Purdue Lilly, Sanofi Lundbeck, Celltech, Aventis, AZ Janssen-Ortho, AZ, BMS, Pharma, GSK, Janssen Lilly, Eli Sharp Cilag, Merck Novartis, & Dohme, Otsuka, Organon, Pfi Biovail Labs., Biovail Cephalon, Janssen Canada, Novartis, Wyeth- Servier Canada, Canada, GSK Ayerst Canada, Pfi Dev. Pharm. omas S Lilly Eli Janssen, Wang-Weigand, SherryWang-Weigand, Takeda Name Consultant Full-Time Surman, Craig B Craig Surman, Shire McNeil, Takeda, Labs., Abbott Strand, Vibeke Strand, A Sergio Strejilevich, Th Stroup, Labs., Pfi Forest HenrikSvedsäter, Szamosi, Johan KathyTobias, KarenTourian, NorrisTurner, AZ AZ Pfi Wyeth-Ayerst Ortho-McNeil Turgay, AtillaTurgay, Eli Dev., Pharm. Shire EduardVieta, UCB Lundbeck, Van Ameringen, MichaelVan Canada, Lundbeck DanielVentura, Research Forest
162ND ANNUAL MEETING M DISCLOSURE INDEX OF COMPANIES McNeil Consumer McNeil Abbott Healthcare, Labs., NIMH, Shire (advisory board) Other Financial Financial Other (specify) Interest zer BMS, Merck, Pfi BMS, Merck, Financial Options Financial Aventis Aventis, Wyeth- Aventis, Shire, McNeil Consumer McNeil Shire, Healthcare Ortho McNeil, Lilly, Eli Shire Novartis, AZ, BMS, Novartis, Sanofi Lilly, Labs., Eli Ayerst GSK, Sepracor, McNeil, Shire GSK, Wyeth-Ayerst Speaker’s BureauSpeaker’s Stock/Other , zer GSK, Jazz Lundbeck, zer, Sanofi zer, zer, Wyeth-Ayerst zer, erapeutics, Eisai, Eisai, erapeutics, Shire, NIMH, Eli Lilly, Lilly, NIMH, Eli Shire, Novartis McNeil, Labs., Merck, Abbott Lilly, Eli Ortho McNeil, NIDA, Shire Eli Dev., Pharm. Shire Novartis Lilly, Forest Labs., Janssen, Labs., Janssen, Forest Pfi Schwabe, Shire Pharm. Pharm. Schwabe, Shire Synaptic, Solvay, Dev., Vela, UCB Pharma, TAP, Wyeth-Ayerst Grant/Research Grant/Research Support Labs., BMS, AZ, Biovail Cephalon, Corcept Th Labs., Forest Lilly, Eli Johnson GSK, Janssen, PRD, & Johnson McNeil, Lundbeck, Novartis, Merck, Pfi Organon, Employee zer, Solvay zer, Pfi Lundbeck, Healthcare, Abbott Abbott Healthcare, Labs., NIMH, Shire Eli Ortho McNeil, NIDA, Merck, Lilly, Novartis Dev. Whitehead, Richard EWhitehead, Richard SharonWigal, ETimothy Wilens, Consumer McNeil Labs., Abbott Shire, Otsuka Young, JoelYoung, Allan HYoung, PhyllisZee, Pharm. Shire Zhao, Fangyi Lilly, Eli Zhong, Huailing Mark Zimmerman, JosephZohar, Takeda Pfi Servier, Lundbeck Lilly Eli GSK Takeda, AZ Canada Sanofi Takeda, AZ Canada West, Joyce C Joyce West, Lilly, AZ, BMS, Eli Name Consultant Full-Time Weisler, RichardWeisler, Labs., NIMH, Abbott
N WWW.PSYCH.ORG DISCLOSURE INDEX
PRESENTERS WITH NOTHING & & # TO DISCLOSE ( - &3 *' &9 4 4 -(% & 9 & &. 3 (( &(# ( & ! $ &# 4 & ; # & & $ 6(6 & (!! & ' &3( !! ! ' ' ' 7 ( ( ( 4' 4( 3 3 9 , 3 ' $ $ ' ' $ 3 ( # ' 3 7 , ' 3 ! 3 ' ' ! 3(# ' 3 (& ! $ - 3 ! ( ' (%+ ( # $( ($ / $ '( # (' % 4( % ' # 7 ( (! ( ( ( $ ' $ 7 & ' # ( & & $ & ( ( 4 ' &! 3 & ( ; (
162ND ANNUAL MEETING O DISCLOSURE INDEX